*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 81 ASP.? 9.35 MG MG A 106 A 86 HIS A 78 HIS.? 11.19 MG MG A 106 A 250 ALA A 64 ALA^? 17.52 MG MG A 106 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 18.32 7.36 35.53 19.95 8.35 34.55 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 21.83 6.49 31.11 22.88 8.20 31.70 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 15.38 5.15 26.91 14.21 4.40 27.56 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP B 81 ASP.? 16.51 N TRS B 107 A 86 HIS B 78 HIS^? 12.04 O3 TRS B 107 A 250 ALA B 64 ALA^? 10.02 N TRS B 107 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 7.19 -26.95 26.54 8.52 -26.19 26.49 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 2 hits 2wwt_o00 naa= 3 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 1 3 # 1 A 445 SER A 61 SER^? 13.76 MG MG A 106 A 524 ASP A 81 ASP.? 9.35 MG MG A 106 A 556 HIS A 78 HIS.? 11.19 MG MG A 106 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 18.32 7.36 35.53 19.95 8.35 34.55 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 21.83 6.49 31.11 22.88 8.20 31.70 3o4g_o00 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 1 hits 3o4g_o00 naa= 3 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 A 98 SER A 61 SER^? 13.76 MG MG A 106 A 123 HIS A 78 HIS.? 11.19 MG MG A 106 A 172 ASP A 81 ASP.? 9.35 MG MG A 106 coo 45.74 29.80 42.79 47.58 31.06 41.64 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 44.17 25.61 37.60 45.21 25.56 35.81 21.83 6.49 31.11 22.88 8.20 31.70 coo 39.85 24.35 34.94 41.12 25.58 33.83 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 A 98 SER B 61 SER^? 18.05 C2 TRS B 107 A 123 HIS B 78 HIS^? 12.04 O3 TRS B 107 A 172 ASP B 81 ASP.? 16.51 N TRS B 107 coo 45.74 29.80 42.79 47.58 31.06 41.64 6.61 -22.01 35.09 5.00 -20.16 35.04 coo 44.17 25.61 37.60 45.21 25.56 35.81 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 39.85 24.35 34.94 41.12 25.58 33.83 9.98 -30.67 34.70 8.29 -31.92 34.80 3qwd_o00 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 2 hits 3qwd_o00 naa= 3 ULMN 4 1a0j_c08 TRYPSIN user 1 4 # 1 A 57 HIS A 78 HIS.? 11.19 MG MG A 106 A 102 ASP A 81 ASP.? 9.35 MG MG A 106 A 195 SER A 61 SER^? 13.76 MG MG A 106 A 196 GLY A 62 GLY^? 14.78 MG MG A 106 coo 25.57 41.22 61.68 24.18 39.98 62.50 21.83 6.49 31.11 22.88 8.20 31.70 coo 22.33 45.48 59.73 23.35 43.67 60.06 18.32 7.36 35.53 19.95 8.35 34.55 coo 20.90 36.72 61.65 22.18 37.53 63.52 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 20.40 37.63 58.06 19.79 37.28 58.50 19.88 0.13 28.65 20.08 0.65 29.27 1a0j_c08 source 1a0j TRYPSIN : 1 hits 1a0j_c08 naa= 4 ULMN 4 1a0j_c09 TRYPSIN user 1 4 # 1 B 57 HIS A 78 HIS.? 11.19 MG MG A 106 B 102 ASP A 81 ASP.? 9.35 MG MG A 106 B 195 SER A 61 SER^? 13.76 MG MG A 106 B 196 GLY A 62 GLY^? 14.78 MG MG A 106 coo 44.08 45.58 52.81 45.86 46.55 52.85 21.83 6.49 31.11 22.88 8.20 31.70 coo 43.04 44.75 47.18 43.31 45.51 49.13 18.32 7.36 35.53 19.95 8.35 34.55 coo 48.11 50.52 52.24 48.62 48.46 53.13 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 45.44 52.17 50.15 46.23 52.37 50.05 19.88 0.13 28.65 20.08 0.65 29.27 1a0j_c09 source 1a0j TRYPSIN : 1 hits 1a0j_c09 naa= 4 ULMN 4 1a0j_c10 TRYPSIN user 1 4 # 1 C 57 HIS A 78 HIS.? 11.19 MG MG A 106 C 102 ASP A 81 ASP.? 9.35 MG MG A 106 C 195 SER A 61 SER^? 13.76 MG MG A 106 C 196 GLY A 62 GLY^? 14.78 MG MG A 106 coo 34.37 41.18 73.21 34.04 43.09 73.87 21.83 6.49 31.11 22.88 8.20 31.70 coo 34.89 38.34 78.12 35.11 39.59 76.42 18.32 7.36 35.53 19.95 8.35 34.55 coo 36.16 46.87 75.66 34.01 46.43 74.59 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 39.34 45.13 76.73 39.04 45.77 77.16 19.88 0.13 28.65 20.08 0.65 29.27 1a0j_c10 source 1a0j TRYPSIN : 1 hits 1a0j_c10 naa= 4 ULMN 4 1a0j_c11 TRYPSIN user 1 4 # 1 D 57 HIS A 78 HIS.? 11.19 MG MG A 106 D 102 ASP A 81 ASP.? 9.35 MG MG A 106 D 195 SER A 61 SER^? 13.76 MG MG A 106 D 196 GLY A 62 GLY^? 14.78 MG MG A 106 coo 8.19 15.01 95.72 7.78 16.53 97.01 21.83 6.49 31.11 22.88 8.20 31.70 coo 13.53 16.28 93.98 11.45 16.21 94.40 18.32 7.36 35.53 19.95 8.35 34.55 coo 6.63 21.03 97.42 6.71 19.20 98.95 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 7.63 22.04 93.90 7.66 22.58 94.52 19.88 0.13 28.65 20.08 0.65 29.27 1a0j_c11 source 1a0j TRYPSIN : 1 hits 1a0j_c11 naa= 4 ULMN 4 1ca0_c02 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 1 4 # 1 B 57 HIS A 78 HIS.? 11.19 MG MG A 106 B 102 ASP A 81 ASP.? 9.35 MG MG A 106 C 195 SER A 61 SER^? 13.76 MG MG A 106 C 196 GLY A 62 GLY^? 14.78 MG MG A 106 coo 9.31 59.87 4.78 10.85 60.06 6.19 21.83 6.49 31.11 22.88 8.20 31.70 coo 5.59 57.53 8.57 7.14 58.09 7.29 18.32 7.36 35.53 19.95 8.35 34.55 coo 14.55 58.92 8.37 13.10 60.57 7.33 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 13.67 55.27 8.79 14.08 55.70 9.37 19.88 0.13 28.65 20.08 0.65 29.27 1ca0_c02 source 1ca0 PROTEASE INHIBITOR DOMAIN OF ALZHEIMER'S AMYLO: 1 hits 1ca0_c02 naa= 4 ULMN 4 1dio_c00 DIOL DEHYDRATASE user 1 4 # 1 A 143 HIS A 78 HIS.? 11.19 MG MG A 106 A 170 GLU A 76 GLU^? 15.65 MG MG A 106 A 296 GLN A 75 GLN^? 15.91 MG MG A 106 A 335 ASP A 81 ASP.? 9.35 MG MG A 106 coo 76.90 -1.10 170.49 78.48 0.25 170.69 21.83 6.49 31.11 22.88 8.20 31.70 coo 76.45 1.78 165.92 77.83 2.80 167.12 19.27 9.35 28.47 21.14 9.50 27.54 coo 80.50 8.33 170.46 80.05 6.58 169.34 14.41 12.99 32.03 13.27 13.05 33.87 coo 79.61 2.57 174.02 81.25 3.85 173.48 18.32 7.36 35.53 19.95 8.35 34.55 1dio_c00 source 1dio DIOL DEHYDRATASE : 1 hits 1dio_c00 naa= 4 ULMN 4 1dio_c01 DIOL DEHYDRATASE user 1 4 # 1 L 143 HIS A 78 HIS.? 11.19 MG MG A 106 L 170 GLU A 76 GLU^? 15.65 MG MG A 106 L 296 GLN A 75 GLN^? 15.91 MG MG A 106 L 335 ASP A 81 ASP.? 9.35 MG MG A 106 coo 82.46 -3.64 210.53 80.56 -2.84 210.31 21.83 6.49 31.11 22.88 8.20 31.70 coo 82.52 -1.49 215.66 80.77 -0.71 214.69 19.27 9.35 28.47 21.14 9.50 27.54 coo 77.25 4.69 212.00 77.71 2.78 212.89 14.41 12.99 32.03 13.27 13.05 33.87 coo 79.03 -0.23 207.82 77.25 0.67 208.50 18.32 7.36 35.53 19.95 8.35 34.55 1dio_c01 source 1dio DIOL DEHYDRATASE : 1 hits 1dio_c01 naa= 4 ULMN 4 1doo_c04 HEAT SHOCK LOCUS U user 1 4 # 1 A 1 THR A 40 THR.? 19.17 MG MG A 106 A 33 LYS B 14 LYS.? 6.95 MG MG A 106 A 45 GLY B 13 GLY^? 14.84 MG MG A 106 A 124 SER A 25 SER^? 23.03 C2 TRS B 107 coo 20.60 80.81 78.25 19.93 81.48 80.23 10.97 -5.43 33.62 9.26 -4.14 33.42 coo 24.21 79.63 86.31 23.19 81.94 80.55 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 20.39 75.93 87.86 19.67 76.00 88.35 21.83 -9.26 37.30 21.03 -9.05 37.47 coo 15.73 80.26 75.45 17.95 80.97 75.03 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 4 1doo_c04 HEAT SHOCK LOCUS U user 2 4 # 2 A 1 THR A 40 THR.? 19.17 MG MG A 106 A 33 LYS B 14 LYS.? 6.95 MG MG A 106 A 45 GLY B 13 GLY^? 14.84 MG MG A 106 A 124 SER A 38 SER.? 20.21 MG MG A 106 coo 20.60 80.81 78.25 19.93 81.48 80.23 10.97 -5.43 33.62 9.26 -4.14 33.42 coo 24.21 79.63 86.31 23.19 81.94 80.55 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 20.39 75.93 87.86 19.67 76.00 88.35 21.83 -9.26 37.30 21.03 -9.05 37.47 coo 15.73 80.26 75.45 17.95 80.97 75.03 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 4 1doo_c04 HEAT SHOCK LOCUS U user 3 4 # 3 A 1 THR B 40 THR.? 20.45 MG A MG B 106 A 33 LYS A 14 LYS.? 24.61 C2 TRS B 107 A 45 GLY A 13 GLY^? 24.25 MG MG A 106 A 124 SER B 25 SER^? 21.93 C2 TRS B 107 coo 20.60 80.81 78.25 19.93 81.48 80.23 15.40 -17.32 31.26 16.66 -18.43 29.90 coo 24.21 79.63 86.31 23.19 81.94 80.55 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 20.39 75.93 87.86 19.67 76.00 88.35 9.06 -14.52 41.03 9.77 -14.73 40.69 coo 15.73 80.26 75.45 17.95 80.97 75.03 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 4 1doo_c04 HEAT SHOCK LOCUS U user 4 4 # 4 A 1 THR B 40 THR.? 20.45 MG A MG B 106 A 33 LYS A 14 LYS.? 24.61 C2 TRS B 107 A 45 GLY A 13 GLY^? 24.25 MG MG A 106 A 124 SER B 38 SER.? 19.23 MG A MG B 106 coo 20.60 80.81 78.25 19.93 81.48 80.23 15.40 -17.32 31.26 16.66 -18.43 29.90 coo 24.21 79.63 86.31 23.19 81.94 80.55 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 20.39 75.93 87.86 19.67 76.00 88.35 9.06 -14.52 41.03 9.77 -14.73 40.69 coo 15.73 80.26 75.45 17.95 80.97 75.03 20.61 -17.82 33.77 20.60 -17.17 31.49 1doo_c04 source 1doo HEAT SHOCK LOCUS U : 4 hits 1doo_c04 naa= 4 ULMN 4 1doo_c05 HEAT SHOCK LOCUS U user 1 4 # 1 B 1 THR A 40 THR.? 19.17 MG MG A 106 B 33 LYS B 14 LYS.? 6.95 MG MG A 106 B 45 GLY B 13 GLY^? 14.84 MG MG A 106 B 124 SER A 25 SER^? 23.03 C2 TRS B 107 coo 26.69 108.13 78.57 25.70 107.69 80.43 10.97 -5.43 33.62 9.26 -4.14 33.42 coo 30.17 110.91 86.31 27.32 111.03 80.63 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 31.73 106.00 88.02 31.34 105.46 88.62 21.83 -9.26 37.30 21.03 -9.05 37.47 coo 24.65 103.43 76.04 24.59 105.78 75.60 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 4 1doo_c05 HEAT SHOCK LOCUS U user 2 4 # 2 B 1 THR A 40 THR.? 19.17 MG MG A 106 B 33 LYS B 14 LYS.? 6.95 MG MG A 106 B 45 GLY B 13 GLY^? 14.84 MG MG A 106 B 124 SER A 38 SER.? 20.21 MG MG A 106 coo 26.69 108.13 78.57 25.70 107.69 80.43 10.97 -5.43 33.62 9.26 -4.14 33.42 coo 30.17 110.91 86.31 27.32 111.03 80.63 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 31.73 106.00 88.02 31.34 105.46 88.62 21.83 -9.26 37.30 21.03 -9.05 37.47 coo 24.65 103.43 76.04 24.59 105.78 75.60 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 4 1doo_c05 HEAT SHOCK LOCUS U user 3 4 # 3 B 1 THR B 40 THR.? 20.45 MG A MG B 106 B 33 LYS A 14 LYS.? 24.61 C2 TRS B 107 B 45 GLY A 13 GLY^? 24.25 MG MG A 106 B 124 SER B 25 SER^? 21.93 C2 TRS B 107 coo 26.69 108.13 78.57 25.70 107.69 80.43 15.40 -17.32 31.26 16.66 -18.43 29.90 coo 30.17 110.91 86.31 27.32 111.03 80.63 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 31.73 106.00 88.02 31.34 105.46 88.62 9.06 -14.52 41.03 9.77 -14.73 40.69 coo 24.65 103.43 76.04 24.59 105.78 75.60 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 4 1doo_c05 HEAT SHOCK LOCUS U user 4 4 # 4 B 1 THR B 40 THR.? 20.45 MG A MG B 106 B 33 LYS A 14 LYS.? 24.61 C2 TRS B 107 B 45 GLY A 13 GLY^? 24.25 MG MG A 106 B 124 SER B 38 SER.? 19.23 MG A MG B 106 coo 26.69 108.13 78.57 25.70 107.69 80.43 15.40 -17.32 31.26 16.66 -18.43 29.90 coo 30.17 110.91 86.31 27.32 111.03 80.63 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 31.73 106.00 88.02 31.34 105.46 88.62 9.06 -14.52 41.03 9.77 -14.73 40.69 coo 24.65 103.43 76.04 24.59 105.78 75.60 20.61 -17.82 33.77 20.60 -17.17 31.49 1doo_c05 source 1doo HEAT SHOCK LOCUS U : 4 hits 1doo_c05 naa= 4 ULMN 4 1doo_c06 HEAT SHOCK LOCUS U user 1 4 # 1 C 1 THR A 40 THR.? 19.17 MG MG A 106 C 33 LYS B 14 LYS.? 6.95 MG MG A 106 C 45 GLY B 13 GLY^? 14.84 MG MG A 106 C 124 SER A 25 SER^? 23.03 C2 TRS B 107 coo -5.30 26.59 199.66 -4.98 26.05 197.57 10.97 -5.43 33.62 9.26 -4.14 33.42 coo -4.62 30.60 191.94 -3.32 28.83 197.07 21.12 -5.80 35.93 24.74 -1.53 38.99 coo -9.57 29.11 189.94 -9.84 28.44 189.46 21.83 -9.26 37.30 21.03 -9.05 37.47 coo -8.31 23.03 202.48 -6.18 24.15 202.80 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 4 1doo_c06 HEAT SHOCK LOCUS U user 2 4 # 2 C 1 THR A 40 THR.? 19.17 MG MG A 106 C 33 LYS B 14 LYS.? 6.95 MG MG A 106 C 45 GLY B 13 GLY^? 14.84 MG MG A 106 C 124 SER A 38 SER.? 20.21 MG MG A 106 coo -5.30 26.59 199.66 -4.98 26.05 197.57 10.97 -5.43 33.62 9.26 -4.14 33.42 coo -4.62 30.60 191.94 -3.32 28.83 197.07 21.12 -5.80 35.93 24.74 -1.53 38.99 coo -9.57 29.11 189.94 -9.84 28.44 189.46 21.83 -9.26 37.30 21.03 -9.05 37.47 coo -8.31 23.03 202.48 -6.18 24.15 202.80 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 4 1doo_c06 HEAT SHOCK LOCUS U user 3 4 # 3 C 1 THR B 40 THR.? 20.45 MG A MG B 106 C 33 LYS A 14 LYS.? 24.61 C2 TRS B 107 C 45 GLY A 13 GLY^? 24.25 MG MG A 106 C 124 SER B 25 SER^? 21.93 C2 TRS B 107 coo -5.30 26.59 199.66 -4.98 26.05 197.57 15.40 -17.32 31.26 16.66 -18.43 29.90 coo -4.62 30.60 191.94 -3.32 28.83 197.07 8.74 -17.74 39.05 7.96 -22.88 42.54 coo -9.57 29.11 189.94 -9.84 28.44 189.46 9.06 -14.52 41.03 9.77 -14.73 40.69 coo -8.31 23.03 202.48 -6.18 24.15 202.80 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 4 1doo_c06 HEAT SHOCK LOCUS U user 4 4 # 4 C 1 THR B 40 THR.? 20.45 MG A MG B 106 C 33 LYS A 14 LYS.? 24.61 C2 TRS B 107 C 45 GLY A 13 GLY^? 24.25 MG MG A 106 C 124 SER B 38 SER.? 19.23 MG A MG B 106 coo -5.30 26.59 199.66 -4.98 26.05 197.57 15.40 -17.32 31.26 16.66 -18.43 29.90 coo -4.62 30.60 191.94 -3.32 28.83 197.07 8.74 -17.74 39.05 7.96 -22.88 42.54 coo -9.57 29.11 189.94 -9.84 28.44 189.46 9.06 -14.52 41.03 9.77 -14.73 40.69 coo -8.31 23.03 202.48 -6.18 24.15 202.80 20.61 -17.82 33.77 20.60 -17.17 31.49 1doo_c06 source 1doo HEAT SHOCK LOCUS U : 4 hits 1doo_c06 naa= 4 ULMN 4 1doo_c07 HEAT SHOCK LOCUS U user 1 4 # 1 D 1 THR A 40 THR.? 19.17 MG MG A 106 D 33 LYS B 14 LYS.? 6.95 MG MG A 106 D 45 GLY B 13 GLY^? 14.84 MG MG A 106 D 124 SER A 25 SER^? 23.03 C2 TRS B 107 coo 21.09 18.28 199.42 20.72 17.74 197.38 10.97 -5.43 33.62 9.26 -4.14 33.42 coo 25.54 20.08 191.91 24.21 17.77 197.54 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 21.95 23.77 189.96 21.30 23.70 189.39 21.83 -9.26 37.30 21.03 -9.05 37.47 coo 16.26 18.98 201.87 18.32 18.00 202.67 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 4 1doo_c07 HEAT SHOCK LOCUS U user 2 4 # 2 D 1 THR A 40 THR.? 19.17 MG MG A 106 D 33 LYS B 14 LYS.? 6.95 MG MG A 106 D 45 GLY B 13 GLY^? 14.84 MG MG A 106 D 124 SER A 38 SER.? 20.21 MG MG A 106 coo 21.09 18.28 199.42 20.72 17.74 197.38 10.97 -5.43 33.62 9.26 -4.14 33.42 coo 25.54 20.08 191.91 24.21 17.77 197.54 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 21.95 23.77 189.96 21.30 23.70 189.39 21.83 -9.26 37.30 21.03 -9.05 37.47 coo 16.26 18.98 201.87 18.32 18.00 202.67 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 4 1doo_c07 HEAT SHOCK LOCUS U user 3 4 # 3 D 1 THR B 40 THR.? 20.45 MG A MG B 106 D 33 LYS A 14 LYS.? 24.61 C2 TRS B 107 D 45 GLY A 13 GLY^? 24.25 MG MG A 106 D 124 SER B 25 SER^? 21.93 C2 TRS B 107 coo 21.09 18.28 199.42 20.72 17.74 197.38 15.40 -17.32 31.26 16.66 -18.43 29.90 coo 25.54 20.08 191.91 24.21 17.77 197.54 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 21.95 23.77 189.96 21.30 23.70 189.39 9.06 -14.52 41.03 9.77 -14.73 40.69 coo 16.26 18.98 201.87 18.32 18.00 202.67 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 4 1doo_c07 HEAT SHOCK LOCUS U user 4 4 # 4 D 1 THR B 40 THR.? 20.45 MG A MG B 106 D 33 LYS A 14 LYS.? 24.61 C2 TRS B 107 D 45 GLY A 13 GLY^? 24.25 MG MG A 106 D 124 SER B 38 SER.? 19.23 MG A MG B 106 coo 21.09 18.28 199.42 20.72 17.74 197.38 15.40 -17.32 31.26 16.66 -18.43 29.90 coo 25.54 20.08 191.91 24.21 17.77 197.54 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 21.95 23.77 189.96 21.30 23.70 189.39 9.06 -14.52 41.03 9.77 -14.73 40.69 coo 16.26 18.98 201.87 18.32 18.00 202.67 20.61 -17.82 33.77 20.60 -17.17 31.49 1doo_c07 source 1doo HEAT SHOCK LOCUS U : 4 hits 1doo_c07 naa= 4 ULMN 4 1exp_c00 BETA-1,4-D-GLYCANASE CEX-CD user 1 4 # 1 127 GLU A 97 GLU^? 17.69 MG MG A 106 205 HIS A 78 HIS.? 11.19 MG MG A 106 233 GLU A 76 GLU^? 15.65 MG MG A 106 235 ASP A 81 ASP.? 9.35 MG MG A 106 coo 21.30 74.05 33.80 19.79 72.64 33.96 21.20 0.85 23.82 22.93 1.52 24.76 coo 23.08 64.94 33.21 22.54 65.31 35.19 21.83 6.49 31.11 22.88 8.20 31.70 coo 25.12 67.63 37.99 23.29 68.70 37.64 19.27 9.35 28.47 21.14 9.50 27.54 coo 24.30 59.55 35.21 23.07 61.13 34.61 18.32 7.36 35.53 19.95 8.35 34.55 1exp_c00 source 1exp BETA-1,4-D-GLYCANASE CEX-CD : 1 hits 1exp_c00 naa= 4 ULMN 4 1hzd_c02 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 4 # 1 C 141 ALA A 79 ALA.? 8.97 MG MG A 106 C 186 GLY A 62 GLY^? 14.78 MG MG A 106 C 189 GLU A 97 GLU^? 17.69 MG MG A 106 C 209 GLU A 76 GLU^? 15.65 MG MG A 106 coo 24.08 -22.10 -0.34 24.67 -20.69 -0.31 21.53 2.78 33.99 22.71 1.85 33.69 coo 21.75 -21.33 5.24 22.01 -22.00 5.60 19.88 0.13 28.65 20.08 0.65 29.27 coo 21.57 -18.82 8.95 22.63 -17.75 7.49 21.20 0.85 23.82 22.93 1.52 24.76 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 19.27 9.35 28.47 21.14 9.50 27.54 1hzd_c02 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 1 hits 1hzd_c02 naa= 4 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 1 4 # 1 A 170 ARG A 58 ARG^? 9.13 MG MG A 106 A 278 ARG B 17 ARG^? 19.62 MG A MG B 106 A 298 GLU B 26 GLU^? 16.98 MG A MG B 106 A 348 ASP A 4 ASP.? 11.89 MG MG A 106 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 17.26 0.85 41.49 16.40 -0.10 44.31 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 24.18 -12.31 28.78 23.30 -13.33 31.55 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 20.09 -15.15 29.16 20.65 -16.86 27.99 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 29.77 -2.68 38.63 30.81 -3.64 37.08 1i8t_c02 source 1i8t UDP-GALACTOPYRANOSE MUTASE : 1 hits 1i8t_c02 naa= 4 ULMN 4 1n8o_c01 CHYMOTRYPSIN A, B CHAIN user 1 4 # 1 B 57 HIS A 78 HIS.? 11.19 MG MG A 106 B 102 ASP A 81 ASP.? 9.35 MG MG A 106 C 195 SER A 61 SER^? 13.76 MG MG A 106 C 196 GLY A 62 GLY^? 14.78 MG MG A 106 coo 31.98 -6.99 19.44 30.75 -5.55 18.68 21.83 6.49 31.11 22.88 8.20 31.70 coo 36.93 -4.10 19.45 35.15 -5.13 19.05 18.32 7.36 35.53 19.95 8.35 34.55 coo 28.33 -3.35 15.58 28.24 -4.45 17.63 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 31.25 -3.44 13.14 30.79 -2.74 13.19 19.88 0.13 28.65 20.08 0.65 29.27 1n8o_c01 source 1n8o CHYMOTRYPSIN A, B CHAIN : 1 hits 1n8o_c01 naa= 4 ULMN 4 1odt_c00 CEPHALOSPORIN C DEACETYLASE user 1 4 # 1 C 181 ALA A 68 ALA.? 22.95 MG MG A 106 C 182 GLN A 89 GLN.? 23.47 MG MG A 106 C 269 ASP A 73 ASP.? 24.66 MG MG A 106 C 298 HIS A 67 HIS^? 25.71 MG MG A 106 coo 19.41 78.76 44.53 18.61 79.22 45.75 5.61 12.80 30.20 5.83 13.73 31.36 coo 24.64 81.35 46.97 24.99 82.28 48.83 1.40 11.32 33.96 3.22 10.81 32.98 coo 10.40 79.73 42.00 12.16 80.19 43.16 11.88 18.46 25.62 13.34 17.78 24.18 coo 13.42 79.87 46.31 15.44 80.29 45.93 7.29 12.90 25.70 6.12 14.46 24.97 1odt_c00 source 1odt CEPHALOSPORIN C DEACETYLASE : 1 hits 1odt_c00 naa= 4 ULMN 4 1odt_c01 CEPHALOSPORIN C DEACETYLASE user 1 4 # 1 H 181 ALA A 68 ALA.? 22.95 MG MG A 106 H 182 GLN A 89 GLN.? 23.47 MG MG A 106 H 269 ASP A 73 ASP.? 24.66 MG MG A 106 H 298 HIS A 67 HIS^? 25.71 MG MG A 106 coo 17.71 105.28 65.69 16.95 104.75 64.54 5.61 12.80 30.20 5.83 13.73 31.36 coo 23.16 103.35 63.17 23.71 102.54 61.29 1.40 11.32 33.96 3.22 10.81 32.98 coo 8.91 102.95 68.35 10.66 102.77 67.10 11.88 18.46 25.62 13.34 17.78 24.18 coo 11.89 103.25 63.94 13.96 103.24 64.24 7.29 12.90 25.70 6.12 14.46 24.97 1odt_c01 source 1odt CEPHALOSPORIN C DEACETYLASE : 1 hits 1odt_c01 naa= 4 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 457 ALA A 11 ALA^? 22.31 MG MG A 106 A 458 ALA B 9 ALA^? 20.86 MG MG A 106 B 193 ALA A 32 ALA.? 14.79 MG MG A 106 B 194 GLY A 34 GLY.? 18.62 MG MG A 106 coo 43.27 124.32 20.47 43.79 125.29 21.53 13.43 -13.51 46.02 12.15 -13.77 46.76 coo 39.57 123.53 20.89 38.42 124.25 20.20 17.76 -15.45 45.57 17.28 -15.07 44.14 coo 47.95 129.15 20.31 47.81 128.95 18.79 17.33 -7.26 49.84 18.81 -6.93 49.85 coo 50.40 126.23 20.48 50.46 127.00 20.75 12.15 -6.45 51.43 12.31 -5.88 50.91 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 457 ALA B 11 ALA^? 15.97 MG MG A 106 A 458 ALA A 9 ALA^? 16.42 MG MG A 106 B 193 ALA B 32 ALA.? 24.99 MG MG A 106 B 194 GLY B 34 GLY.? 23.96 MG MG A 106 coo 43.27 124.32 20.47 43.79 125.29 21.53 21.39 -11.21 43.66 22.89 -11.27 43.43 coo 39.57 123.53 20.89 38.42 124.25 20.20 17.85 -9.53 46.38 17.64 -10.28 45.04 coo 47.95 129.15 20.31 47.81 128.95 18.79 20.24 -18.50 47.99 18.99 -18.97 48.80 coo 50.40 126.23 20.48 50.46 127.00 20.75 25.27 -18.98 46.10 24.83 -19.43 45.63 1pix_c02 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 2 hits 1pix_c02 naa= 4 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 193 ALA A 32 ALA.? 14.79 MG MG A 106 A 194 GLY A 34 GLY.? 18.62 MG MG A 106 B 457 ALA A 11 ALA^? 22.31 MG MG A 106 B 458 ALA B 9 ALA^? 20.86 MG MG A 106 coo 61.89 87.20 13.50 62.59 88.00 12.38 17.33 -7.26 49.84 18.81 -6.93 49.85 coo 59.34 89.99 13.88 59.24 89.18 13.73 12.15 -6.45 51.43 12.31 -5.88 50.91 coo 65.50 91.13 17.77 64.65 89.88 18.00 13.43 -13.51 46.02 12.15 -13.77 46.76 coo 68.56 91.15 20.03 69.95 90.68 19.64 17.76 -15.45 45.57 17.28 -15.07 44.14 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 193 ALA B 32 ALA.? 24.99 MG MG A 106 A 194 GLY B 34 GLY.? 23.96 MG MG A 106 B 457 ALA B 11 ALA^? 15.97 MG MG A 106 B 458 ALA A 9 ALA^? 16.42 MG MG A 106 coo 61.89 87.20 13.50 62.59 88.00 12.38 20.24 -18.50 47.99 18.99 -18.97 48.80 coo 59.34 89.99 13.88 59.24 89.18 13.73 25.27 -18.98 46.10 24.83 -19.43 45.63 coo 65.50 91.13 17.77 64.65 89.88 18.00 21.39 -11.21 43.66 22.89 -11.27 43.43 coo 68.56 91.15 20.03 69.95 90.68 19.64 17.85 -9.53 46.38 17.64 -10.28 45.04 1pix_c03 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 2 hits 1pix_c03 naa= 4 ULMN 4 1pma_c14 PROTEASOME user 1 4 # 1 A 35 SER B 28 SER^? 20.11 MG MG A 106 A 66 LYS B 14 LYS.? 6.95 MG MG A 106 A 80 GLY A 0 GLY.? 21.04 MG MG A 106 A 167 SER B 38 SER.? 19.23 MG A MG B 106 coo 89.76 104.51 121.28 91.03 106.44 121.99 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 99.01 105.66 122.24 93.37 107.22 124.79 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 91.58 97.09 120.24 92.08 97.51 120.80 30.68 -14.77 37.51 30.70 -14.13 38.06 coo 85.59 103.89 117.95 84.01 104.68 119.62 20.61 -17.82 33.77 20.60 -17.17 31.49 1pma_c14 source 1pma PROTEASOME : 1 hits 1pma_c14 naa= 4 ULMN 4 1pma_c15 PROTEASOME user 1 4 # 1 C 35 SER B 28 SER^? 20.11 MG MG A 106 C 66 LYS B 14 LYS.? 6.95 MG MG A 106 C 80 GLY A 0 GLY.? 21.04 MG MG A 106 C 167 SER B 38 SER.? 19.23 MG A MG B 106 coo 86.16 90.99 92.80 87.35 92.60 91.45 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 95.08 92.95 91.94 89.21 95.51 92.55 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 88.54 85.72 97.78 89.01 86.43 97.78 30.68 -14.77 37.51 30.70 -14.13 38.06 coo 81.98 87.51 91.60 80.26 89.10 92.17 20.61 -17.82 33.77 20.60 -17.17 31.49 1pma_c15 source 1pma PROTEASOME : 1 hits 1pma_c15 naa= 4 ULMN 4 1pma_c17 PROTEASOME user 1 4 # 1 E 35 SER B 28 SER^? 20.11 MG MG A 106 E 66 LYS B 14 LYS.? 6.95 MG MG A 106 E 80 GLY A 0 GLY.? 21.04 MG MG A 106 E 167 SER B 38 SER.? 19.23 MG A MG B 106 coo 85.87 34.81 105.43 86.85 33.25 103.89 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 94.23 34.01 101.89 88.08 33.81 100.38 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 88.45 41.00 109.01 88.80 40.87 108.21 30.68 -14.77 37.51 30.70 -14.13 38.06 coo 82.37 33.96 109.76 80.42 34.00 108.25 20.61 -17.82 33.77 20.60 -17.17 31.49 1pma_c17 source 1pma PROTEASOME : 1 hits 1pma_c17 naa= 4 ULMN 4 1pma_c18 PROTEASOME user 1 4 # 1 F 35 SER B 28 SER^? 20.11 MG MG A 106 F 66 LYS B 14 LYS.? 6.95 MG MG A 106 F 80 GLY A 0 GLY.? 21.04 MG MG A 106 F 167 SER B 38 SER.? 19.23 MG A MG B 106 coo 89.47 34.70 136.77 90.56 32.53 136.87 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 98.16 32.25 134.54 92.11 30.32 134.15 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 91.52 41.49 134.05 91.91 40.83 133.64 30.68 -14.77 37.51 30.70 -14.13 38.06 coo 86.20 37.37 140.32 84.33 36.07 139.50 20.61 -17.82 33.77 20.60 -17.17 31.49 1pma_c18 source 1pma PROTEASOME : 1 hits 1pma_c18 naa= 4 ULMN 4 1pma_c22 PROTEASOME user 1 4 # 1 J 35 SER B 28 SER^? 20.11 MG MG A 106 J 66 LYS B 14 LYS.? 6.95 MG MG A 106 J 80 GLY A 0 GLY.? 21.04 MG MG A 106 J 167 SER B 38 SER.? 19.23 MG A MG B 106 coo 213.55 39.87 78.52 212.15 38.11 77.66 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 204.73 37.66 79.74 210.59 35.12 79.14 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 212.36 45.21 83.76 211.92 44.47 83.89 30.68 -14.77 37.51 30.70 -14.13 38.06 coo 217.34 43.17 76.17 219.16 41.55 76.51 20.61 -17.82 33.77 20.60 -17.17 31.49 1pma_c22 source 1pma PROTEASOME : 1 hits 1pma_c22 naa= 4 ULMN 4 1pma_c23 PROTEASOME user 1 4 # 1 K 35 SER B 28 SER^? 20.11 MG MG A 106 K 66 LYS B 14 LYS.? 6.95 MG MG A 106 K 80 GLY A 0 GLY.? 21.04 MG MG A 106 K 167 SER B 38 SER.? 19.23 MG A MG B 106 coo 213.86 70.48 70.36 212.52 70.13 68.37 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 204.71 69.18 69.70 210.34 67.50 67.20 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 212.56 69.98 77.87 212.03 69.49 77.40 30.68 -14.77 37.51 30.70 -14.13 38.06 coo 217.85 74.08 71.56 219.45 72.67 70.36 20.61 -17.82 33.77 20.60 -17.17 31.49 1pma_c23 source 1pma PROTEASOME : 1 hits 1pma_c23 naa= 4 ULMN 4 1pma_c24 PROTEASOME user 1 4 # 1 L 35 SER B 28 SER^? 20.11 MG MG A 106 L 66 LYS B 14 LYS.? 6.95 MG MG A 106 L 80 GLY A 0 GLY.? 21.04 MG MG A 106 L 167 SER B 38 SER.? 19.23 MG A MG B 106 coo 216.64 96.16 88.97 215.38 97.58 87.49 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 207.55 96.84 87.56 213.26 97.06 84.64 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 214.90 90.14 93.16 214.41 90.25 92.47 30.68 -14.77 37.51 30.70 -14.13 38.06 coo 220.95 97.14 92.21 222.53 97.02 90.36 20.61 -17.82 33.77 20.60 -17.17 31.49 1pma_c24 source 1pma PROTEASOME : 1 hits 1pma_c24 naa= 4 ULMN 4 1pma_c25 PROTEASOME user 1 4 # 1 M 35 SER B 28 SER^? 20.11 MG MG A 106 M 66 LYS B 14 LYS.? 6.95 MG MG A 106 M 80 GLY A 0 GLY.? 21.04 MG MG A 106 M 167 SER B 38 SER.? 19.23 MG A MG B 106 coo 220.44 97.39 120.24 219.28 99.46 120.61 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 211.44 99.73 120.08 217.33 101.48 118.24 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 217.83 90.43 118.26 217.38 91.08 117.92 30.68 -14.77 37.51 30.70 -14.13 38.06 coo 224.42 94.96 123.04 226.02 96.08 121.60 20.61 -17.82 33.77 20.60 -17.17 31.49 1pma_c25 source 1pma PROTEASOME : 1 hits 1pma_c25 naa= 4 ULMN 4 1rtf_c04 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 4 # 1 B 57 HIS A 78 HIS.? 11.19 MG MG A 106 B 102 ASP A 81 ASP.? 9.35 MG MG A 106 B 195 SER A 61 SER^? 13.76 MG MG A 106 B 196 GLY A 62 GLY^? 14.78 MG MG A 106 coo -4.60 27.52 42.88 -4.63 27.41 40.76 21.83 6.49 31.11 22.88 8.20 31.70 coo -0.27 31.24 43.51 -1.49 29.62 42.98 18.32 7.36 35.53 19.95 8.35 34.55 coo -2.83 25.96 36.71 -4.77 27.03 37.63 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 0.64 25.09 37.94 0.51 25.31 37.16 19.88 0.13 28.65 20.08 0.65 29.27 1rtf_c04 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 1 hits 1rtf_c04 naa= 4 ULMN 4 1xyz_c00 1,4-BETA-D-XYLAN-XYLANOHYDROLASE user 1 4 # 1 A 645 GLU A 97 GLU^? 17.69 MG MG A 106 A 723 HIS A 78 HIS.? 11.19 MG MG A 106 A 754 GLU A 76 GLU^? 15.65 MG MG A 106 A 756 ASP A 81 ASP.? 9.35 MG MG A 106 coo 8.52 14.29 34.54 9.38 13.03 33.07 21.20 0.85 23.82 22.93 1.52 24.76 coo 14.75 17.66 28.95 15.62 16.26 30.25 21.83 6.49 31.11 22.88 8.20 31.70 coo 16.72 16.24 34.49 15.11 14.90 34.21 19.27 9.35 28.47 21.14 9.50 27.54 coo 20.22 18.04 27.00 18.34 17.09 27.29 18.32 7.36 35.53 19.95 8.35 34.55 1xyz_c00 source 1xyz 1,4-BETA-D-XYLAN-XYLANOHYDROLASE : 1 hits 1xyz_c00 naa= 4 ULMN 4 1xyz_c01 1,4-BETA-D-XYLAN-XYLANOHYDROLASE user 1 4 # 1 B 645 GLU A 97 GLU^? 17.69 MG MG A 106 B 723 HIS A 78 HIS.? 11.19 MG MG A 106 B 754 GLU A 76 GLU^? 15.65 MG MG A 106 B 756 ASP A 81 ASP.? 9.35 MG MG A 106 coo 15.60 30.64 69.31 14.72 29.15 68.11 21.20 0.85 23.82 22.93 1.52 24.76 coo 9.08 25.15 72.84 8.18 26.43 71.44 21.83 6.49 31.11 22.88 8.20 31.70 coo 7.29 30.67 71.38 8.86 30.34 70.00 19.27 9.35 28.47 21.14 9.50 27.54 coo 3.67 23.22 73.36 5.48 23.51 72.37 18.32 7.36 35.53 19.95 8.35 34.55 1xyz_c01 source 1xyz 1,4-BETA-D-XYLAN-XYLANOHYDROLASE : 1 hits 1xyz_c01 naa= 4 ULMN 3 1a0j_c00 TRYPSIN user 1 3 # 1 A 57 HIS A 78 HIS.? 11.19 MG MG A 106 A 102 ASP A 81 ASP.? 9.35 MG MG A 106 A 195 SER A 61 SER^? 13.76 MG MG A 106 coo 25.57 41.22 61.68 24.18 39.98 62.50 21.83 6.49 31.11 22.88 8.20 31.70 coo 22.33 45.48 59.73 23.35 43.67 60.06 18.32 7.36 35.53 19.95 8.35 34.55 coo 20.90 36.72 61.65 22.18 37.53 63.52 20.58 -1.27 32.13 21.77 -3.05 30.92 1a0j_c00 source 1a0j TRYPSIN : 1 hits 1a0j_c00 naa= 3 ULMN 3 1a0j_c01 TRYPSIN user 1 3 # 1 B 57 HIS A 78 HIS.? 11.19 MG MG A 106 B 102 ASP A 81 ASP.? 9.35 MG MG A 106 B 195 SER A 61 SER^? 13.76 MG MG A 106 coo 44.08 45.58 52.81 45.86 46.55 52.85 21.83 6.49 31.11 22.88 8.20 31.70 coo 43.04 44.75 47.18 43.31 45.51 49.13 18.32 7.36 35.53 19.95 8.35 34.55 coo 48.11 50.52 52.24 48.62 48.46 53.13 20.58 -1.27 32.13 21.77 -3.05 30.92 1a0j_c01 source 1a0j TRYPSIN : 1 hits 1a0j_c01 naa= 3 ULMN 3 1a0j_c02 TRYPSIN user 1 3 # 1 C 57 HIS A 78 HIS.? 11.19 MG MG A 106 C 102 ASP A 81 ASP.? 9.35 MG MG A 106 C 195 SER A 61 SER^? 13.76 MG MG A 106 coo 34.37 41.18 73.21 34.04 43.09 73.87 21.83 6.49 31.11 22.88 8.20 31.70 coo 34.89 38.34 78.12 35.11 39.59 76.42 18.32 7.36 35.53 19.95 8.35 34.55 coo 36.16 46.87 75.66 34.01 46.43 74.59 20.58 -1.27 32.13 21.77 -3.05 30.92 1a0j_c02 source 1a0j TRYPSIN : 1 hits 1a0j_c02 naa= 3 ULMN 3 1a0j_c03 TRYPSIN user 1 3 # 1 D 57 HIS A 78 HIS.? 11.19 MG MG A 106 D 102 ASP A 81 ASP.? 9.35 MG MG A 106 D 195 SER A 61 SER^? 13.76 MG MG A 106 coo 8.19 15.01 95.72 7.78 16.53 97.01 21.83 6.49 31.11 22.88 8.20 31.70 coo 13.53 16.28 93.98 11.45 16.21 94.40 18.32 7.36 35.53 19.95 8.35 34.55 coo 6.63 21.03 97.42 6.71 19.20 98.95 20.58 -1.27 32.13 21.77 -3.05 30.92 1a0j_c03 source 1a0j TRYPSIN : 1 hits 1a0j_c03 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 23 ARG.? 26.26 O2 TRS B 107 265 HIS B 43 HIS.? 17.46 C2 TRS B 107 274 TYR A 101 TYR^? 16.63 MG MG A 106 coo -15.18 55.46 8.55 -14.82 52.98 10.38 7.13 -4.89 20.32 8.16 -2.85 18.32 coo -14.48 45.59 11.18 -14.02 47.49 10.42 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 0.94 52.26 9.16 1.95 54.78 9.91 12.29 -0.55 33.68 9.97 -0.77 32.12 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG A 24 ARG^? 24.75 MG MG A 106 265 HIS A 43 HIS.? 24.06 C2 TRS B 107 274 TYR A 65 TYR^? 20.31 MG MG A 106 coo -15.18 55.46 8.55 -14.82 52.98 10.38 6.24 -3.67 29.98 3.39 -2.61 30.35 coo -14.48 45.59 11.18 -14.02 47.49 10.42 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 0.94 52.26 9.16 1.95 54.78 9.91 15.06 9.60 24.66 17.54 9.96 23.42 ULMN 3 1a41_c01 TOPOISOMERASE I user 3 3 # 3 223 ARG B 23 ARG.? 13.56 O1 TRS B 107 265 HIS A 43 HIS.? 24.06 C2 TRS B 107 274 TYR B 101 TYR^? 17.91 N TRS B 107 coo -15.18 55.46 8.55 -14.82 52.98 10.38 9.90 -15.60 19.03 10.94 -17.68 17.04 coo -14.48 45.59 11.18 -14.02 47.49 10.42 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 0.94 52.26 9.16 1.95 54.78 9.91 14.17 -22.17 31.30 14.99 -21.52 28.71 ULMN 3 1a41_c01 TOPOISOMERASE I user 4 3 # 4 223 ARG B 24 ARG^? 14.88 MG A MG B 106 265 HIS B 43 HIS.? 17.46 C2 TRS B 107 274 TYR B 65 TYR^? 4.85 N TRS B 107 coo -15.18 55.46 8.55 -14.82 52.98 10.38 16.79 -18.48 25.10 19.01 -19.70 23.40 coo -14.48 45.59 11.18 -14.02 47.49 10.42 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 0.94 52.26 9.16 1.95 54.78 9.91 5.69 -30.65 23.64 2.95 -31.03 24.05 1a41_c01 source 1a41 TOPOISOMERASE I : 4 hits 1a41_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 69 GLU.? 30.27 MG MG A 106 A 60 ASP A 73 ASP.? 24.66 MG MG A 106 A 175 TYR A 91 TYR^? 21.63 MG MG A 106 coo 46.10 28.27 19.27 45.48 26.99 20.84 -0.37 13.72 28.81 -2.24 12.81 29.30 coo 56.42 28.06 12.93 55.01 27.92 14.50 11.88 18.46 25.62 13.34 17.78 24.18 coo 45.02 22.04 15.38 46.16 24.00 13.76 4.86 7.39 31.16 5.04 4.97 32.56 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU B 69 GLU.? 15.42 MG A MG B 106 A 60 ASP B 73 ASP.? 13.34 N TRS B 107 A 175 TYR B 91 TYR^? 15.35 N TRS B 107 coo 46.10 28.27 19.27 45.48 26.99 20.84 18.54 -34.22 15.35 19.90 -33.02 14.45 coo 56.42 28.06 12.93 55.01 27.92 14.50 9.64 -40.18 22.89 9.15 -42.09 22.32 coo 45.02 22.04 15.38 46.16 24.00 13.76 17.61 -29.10 22.17 18.36 -26.78 23.51 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 2 hits 1a50_c03 naa= 3 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 1 3 # 1 A 98 SER A 61 SER^? 13.76 MG MG A 106 A 228 ASP A 81 ASP.? 9.35 MG MG A 106 A 257 HIS A 78 HIS.? 11.19 MG MG A 106 coo 9.47 41.64 34.15 9.10 39.28 33.93 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 2.03 38.95 28.44 3.60 38.60 29.83 18.32 7.36 35.53 19.95 8.35 34.55 coo 6.85 37.62 29.99 7.50 38.47 31.78 21.83 6.49 31.11 22.88 8.20 31.70 1a7u_c02 source 1a7u CHLOROPEROXIDASE T : 1 hits 1a7u_c02 naa= 3 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 1 3 # 1 B 98 SER A 61 SER^? 13.76 MG MG A 106 B 228 ASP A 81 ASP.? 9.35 MG MG A 106 B 257 HIS A 78 HIS.? 11.19 MG MG A 106 coo 28.35 71.07 3.94 30.08 69.46 4.49 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 18.32 7.36 35.53 19.95 8.35 34.55 coo 32.76 68.02 0.70 31.21 68.44 2.05 21.83 6.49 31.11 22.88 8.20 31.70 1a7u_c03 source 1a7u CHLOROPEROXIDASE T : 1 hits 1a7u_c03 naa= 3 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 1 3 # 1 94 SER A 61 SER^? 13.76 MG MG A 106 223 ASP A 81 ASP.? 9.35 MG MG A 106 252 HIS A 78 HIS.? 11.19 MG MG A 106 coo 40.95 0.07 3.20 39.54 1.39 4.66 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 18.32 7.36 35.53 19.95 8.35 34.55 coo 41.54 1.64 9.09 40.82 1.05 7.19 21.83 6.49 31.11 22.88 8.20 31.70 1a8q_c00 source 1a8q BROMOPEROXIDASE A1 : 1 hits 1a8q_c00 naa= 3 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 1 3 # 1 94 SER A 61 SER^? 13.76 MG MG A 106 224 ASP A 81 ASP.? 9.35 MG MG A 106 253 HIS A 78 HIS.? 11.19 MG MG A 106 coo 16.00 80.13 58.60 16.16 82.12 59.96 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 8.47 84.84 62.27 10.52 84.40 62.08 18.32 7.36 35.53 19.95 8.35 34.55 coo 13.14 83.03 63.68 14.37 82.62 62.02 21.83 6.49 31.11 22.88 8.20 31.70 1a8s_c00 source 1a8s CHLOROPEROXIDASE F : 1 hits 1a8s_c00 naa= 3 ULMN 3 1ab4_c00 GYRASE A user 1 3 # 1 32 ARG A 24 ARG^? 24.75 MG MG A 106 78 HIS A 43 HIS.? 24.06 C2 TRS B 107 122 TYR B 91 TYR^? 15.35 N TRS B 107 coo 48.32 72.26 30.89 48.69 69.28 31.53 6.24 -3.67 29.98 3.39 -2.61 30.35 coo 53.63 68.24 34.99 53.08 69.10 33.16 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 75.01 61.87 32.93 75.34 59.26 31.96 17.61 -29.10 22.17 18.36 -26.78 23.51 ULMN 3 1ab4_c00 GYRASE A user 2 3 # 2 32 ARG B 24 ARG^? 14.88 MG A MG B 106 78 HIS B 43 HIS.? 17.46 C2 TRS B 107 122 TYR A 91 TYR^? 21.63 MG MG A 106 coo 48.32 72.26 30.89 48.69 69.28 31.53 16.79 -18.48 25.10 19.01 -19.70 23.40 coo 53.63 68.24 34.99 53.08 69.10 33.16 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 75.01 61.87 32.93 75.34 59.26 31.96 4.86 7.39 31.16 5.04 4.97 32.56 ULMN 3 1ab4_c00 GYRASE A user 3 3 # 3 32 ARG B 58 ARG^? 24.73 MG A MG B 106 78 HIS B 37 HIS.? 23.74 MG A MG B 106 122 TYR A 101 TYR^? 16.63 MG MG A 106 coo 48.32 72.26 30.89 48.69 69.28 31.53 17.07 -26.36 39.29 20.10 -26.73 39.11 coo 53.63 68.24 34.99 53.08 69.10 33.16 21.69 -21.14 38.43 22.55 -22.53 39.75 coo 75.01 61.87 32.93 75.34 59.26 31.96 12.29 -0.55 33.68 9.97 -0.77 32.12 1ab4_c00 source 1ab4 GYRASE A : 3 hits 1ab4_c00 naa= 3 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 1 3 # 1 A 223 HIS A 43 HIS.? 24.06 C2 TRS B 107 A 262 HIS B 43 HIS.? 17.46 C2 TRS B 107 A 312 ASP A 21 ASP.? 20.18 O2 TRS B 107 coo 29.33 36.13 69.70 30.07 34.20 70.11 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 38.54 36.60 66.38 37.88 34.77 67.15 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 30.62 37.23 61.07 30.08 35.73 62.49 2.80 -6.84 20.40 2.88 -7.95 18.60 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 2 3 # 2 A 223 HIS A 43 HIS.? 24.06 C2 TRS B 107 A 262 HIS B 43 HIS.? 17.46 C2 TRS B 107 A 312 ASP B 21 ASP.? 19.35 O1 TRS B 107 coo 29.33 36.13 69.70 30.07 34.20 70.11 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 38.54 36.60 66.38 37.88 34.77 67.15 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 30.62 37.23 61.07 30.08 35.73 62.49 13.91 -13.27 16.06 15.24 -13.79 14.55 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 3 3 # 3 A 223 HIS B 43 HIS.? 17.46 C2 TRS B 107 A 262 HIS A 43 HIS.? 24.06 C2 TRS B 107 A 312 ASP A 21 ASP.? 20.18 O2 TRS B 107 coo 29.33 36.13 69.70 30.07 34.20 70.11 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 38.54 36.60 66.38 37.88 34.77 67.15 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 30.62 37.23 61.07 30.08 35.73 62.49 2.80 -6.84 20.40 2.88 -7.95 18.60 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 4 3 # 4 A 223 HIS B 43 HIS.? 17.46 C2 TRS B 107 A 262 HIS A 43 HIS.? 24.06 C2 TRS B 107 A 312 ASP B 21 ASP.? 19.35 O1 TRS B 107 coo 29.33 36.13 69.70 30.07 34.20 70.11 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 38.54 36.60 66.38 37.88 34.77 67.15 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 30.62 37.23 61.07 30.08 35.73 62.49 13.91 -13.27 16.06 15.24 -13.79 14.55 1aj8_c00 source 1aj8 CITRATE SYNTHASE : 4 hits 1aj8_c00 naa= 3 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 1 3 # 1 B 223 HIS A 43 HIS.? 24.06 C2 TRS B 107 B 262 HIS B 43 HIS.? 17.46 C2 TRS B 107 B 312 ASP A 21 ASP.? 20.18 O2 TRS B 107 coo 23.86 29.50 91.20 24.12 31.58 91.00 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 29.35 31.42 99.15 28.72 33.09 98.04 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 20.42 28.25 99.26 20.25 29.62 97.63 2.80 -6.84 20.40 2.88 -7.95 18.60 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 2 3 # 2 B 223 HIS A 43 HIS.? 24.06 C2 TRS B 107 B 262 HIS B 43 HIS.? 17.46 C2 TRS B 107 B 312 ASP B 21 ASP.? 19.35 O1 TRS B 107 coo 23.86 29.50 91.20 24.12 31.58 91.00 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 29.35 31.42 99.15 28.72 33.09 98.04 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 20.42 28.25 99.26 20.25 29.62 97.63 13.91 -13.27 16.06 15.24 -13.79 14.55 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 3 3 # 3 B 223 HIS B 43 HIS.? 17.46 C2 TRS B 107 B 262 HIS A 43 HIS.? 24.06 C2 TRS B 107 B 312 ASP A 21 ASP.? 20.18 O2 TRS B 107 coo 23.86 29.50 91.20 24.12 31.58 91.00 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 29.35 31.42 99.15 28.72 33.09 98.04 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 20.42 28.25 99.26 20.25 29.62 97.63 2.80 -6.84 20.40 2.88 -7.95 18.60 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 4 3 # 4 B 223 HIS B 43 HIS.? 17.46 C2 TRS B 107 B 262 HIS A 43 HIS.? 24.06 C2 TRS B 107 B 312 ASP B 21 ASP.? 19.35 O1 TRS B 107 coo 23.86 29.50 91.20 24.12 31.58 91.00 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 29.35 31.42 99.15 28.72 33.09 98.04 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 20.42 28.25 99.26 20.25 29.62 97.63 13.91 -13.27 16.06 15.24 -13.79 14.55 1aj8_c01 source 1aj8 CITRATE SYNTHASE : 4 hits 1aj8_c01 naa= 3 ULMN 3 1al6_c00 CITRATE SYNTHASE user 1 3 # 1 274 HIS A 43 HIS.? 24.06 C2 TRS B 107 320 HIS B 43 HIS.? 17.46 C2 TRS B 107 375 ASP A 21 ASP.? 20.18 O2 TRS B 107 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 2.80 -6.84 20.40 2.88 -7.95 18.60 ULMN 3 1al6_c00 CITRATE SYNTHASE user 2 3 # 2 274 HIS A 43 HIS.? 24.06 C2 TRS B 107 320 HIS B 43 HIS.? 17.46 C2 TRS B 107 375 ASP B 21 ASP.? 19.35 O1 TRS B 107 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 13.91 -13.27 16.06 15.24 -13.79 14.55 ULMN 3 1al6_c00 CITRATE SYNTHASE user 3 3 # 3 274 HIS B 43 HIS.? 17.46 C2 TRS B 107 320 HIS A 43 HIS.? 24.06 C2 TRS B 107 375 ASP A 21 ASP.? 20.18 O2 TRS B 107 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 2.80 -6.84 20.40 2.88 -7.95 18.60 ULMN 3 1al6_c00 CITRATE SYNTHASE user 4 3 # 4 274 HIS B 43 HIS.? 17.46 C2 TRS B 107 320 HIS A 43 HIS.? 24.06 C2 TRS B 107 375 ASP B 21 ASP.? 19.35 O1 TRS B 107 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 13.91 -13.27 16.06 15.24 -13.79 14.55 1al6_c00 source 1al6 CITRATE SYNTHASE : 4 hits 1al6_c00 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 81 ASP.? 9.35 MG MG A 106 214 ASP B 4 ASP.? 25.97 C2 TRS B 107 289 ASP A 100 ASP^? 16.25 MG MG A 106 coo -0.62 65.95 29.97 0.31 67.47 31.05 18.32 7.36 35.53 19.95 8.35 34.55 coo 26.86 59.76 46.36 25.42 58.23 45.92 4.45 -22.45 45.85 5.06 -24.19 44.80 coo 9.42 68.07 30.27 7.35 68.27 30.10 17.24 -4.20 32.64 17.59 -5.86 31.44 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 81 ASP.? 9.35 MG MG A 106 214 ASP B 33 ASP.? 27.59 MG MG A 106 289 ASP A 100 ASP^? 16.25 MG MG A 106 coo -0.62 65.95 29.97 0.31 67.47 31.05 18.32 7.36 35.53 19.95 8.35 34.55 coo 26.86 59.76 46.36 25.42 58.23 45.92 22.46 -22.72 47.13 22.23 -22.78 45.03 coo 9.42 68.07 30.27 7.35 68.27 30.10 17.24 -4.20 32.64 17.59 -5.86 31.44 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP B 81 ASP.? 16.51 N TRS B 107 214 ASP A 4 ASP.? 11.89 MG MG A 106 289 ASP B 100 ASP^? 19.56 C2 TRS B 107 coo -0.62 65.95 29.97 0.31 67.47 31.05 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 26.86 59.76 46.36 25.42 58.23 45.92 29.77 -2.68 38.63 30.81 -3.64 37.08 coo 9.42 68.07 30.27 7.35 68.27 30.10 9.71 -18.83 33.97 8.85 -16.99 33.47 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 81 ASP.? 16.51 N TRS B 107 214 ASP A 33 ASP.? 14.12 MG MG A 106 289 ASP B 100 ASP^? 19.56 C2 TRS B 107 coo -0.62 65.95 29.97 0.31 67.47 31.05 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 26.86 59.76 46.36 25.42 58.23 45.92 15.57 -3.11 51.57 14.43 -2.38 49.92 coo 9.42 68.07 30.27 7.35 68.27 30.10 9.71 -18.83 33.97 8.85 -16.99 33.47 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 4 hits 1amy_c01 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 81 ASP.? 9.35 MG MG A 106 227 GLU A 55 GLU^? 21.04 MG MG A 106 289 ASP A 100 ASP^? 16.25 MG MG A 106 coo -0.62 65.95 29.97 0.31 67.47 31.05 18.32 7.36 35.53 19.95 8.35 34.55 coo 3.96 55.76 41.24 4.83 57.69 41.17 4.10 2.62 39.65 3.53 1.29 38.12 coo 9.42 68.07 30.27 7.35 68.27 30.10 17.24 -4.20 32.64 17.59 -5.86 31.44 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 81 ASP.? 9.35 MG MG A 106 227 GLU A 94 GLU^? 25.02 MG MG A 106 289 ASP A 100 ASP^? 16.25 MG MG A 106 coo -0.62 65.95 29.97 0.31 67.47 31.05 18.32 7.36 35.53 19.95 8.35 34.55 coo 3.96 55.76 41.24 4.83 57.69 41.17 12.51 6.05 21.43 12.73 7.51 19.95 coo 9.42 68.07 30.27 7.35 68.27 30.10 17.24 -4.20 32.64 17.59 -5.86 31.44 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 100 ASP^? 16.25 MG MG A 106 227 GLU A 55 GLU^? 21.04 MG MG A 106 289 ASP A 81 ASP.? 9.35 MG MG A 106 coo -0.62 65.95 29.97 0.31 67.47 31.05 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 3.96 55.76 41.24 4.83 57.69 41.17 4.10 2.62 39.65 3.53 1.29 38.12 coo 9.42 68.07 30.27 7.35 68.27 30.10 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 81 ASP.? 16.51 N TRS B 107 227 GLU B 55 GLU^? 13.53 MG A MG B 106 289 ASP B 100 ASP^? 19.56 C2 TRS B 107 coo -0.62 65.95 29.97 0.31 67.47 31.05 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 3.96 55.76 41.24 4.83 57.69 41.17 23.27 -25.76 28.72 22.41 -24.66 27.12 coo 9.42 68.07 30.27 7.35 68.27 30.10 9.71 -18.83 33.97 8.85 -16.99 33.47 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 81 ASP.? 16.51 N TRS B 107 227 GLU B 94 GLU^? -2.83 O1 TRS B 107s 289 ASP B 100 ASP^? 19.56 C2 TRS B 107 coo -0.62 65.95 29.97 0.31 67.47 31.05 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 3.96 55.76 41.24 4.83 57.69 41.17 6.14 -26.56 20.04 4.87 -27.89 19.04 coo 9.42 68.07 30.27 7.35 68.27 30.10 9.71 -18.83 33.97 8.85 -16.99 33.47 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 100 ASP^? 19.56 C2 TRS B 107 227 GLU B 94 GLU^? -2.83 O1 TRS B 107s 289 ASP B 81 ASP.? 16.51 N TRS B 107 coo -0.62 65.95 29.97 0.31 67.47 31.05 9.71 -18.83 33.97 8.85 -16.99 33.47 coo 3.96 55.76 41.24 4.83 57.69 41.17 6.14 -26.56 20.04 4.87 -27.89 19.04 coo 9.42 68.07 30.27 7.35 68.27 30.10 9.98 -30.67 34.70 8.29 -31.92 34.80 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 6 hits 1amy_c06 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 15 SER.? 22.03 C2 TRS B 107 A 292 ASP A 33 ASP.? 14.12 MG MG A 106 A 322 HIS B 78 HIS^? 12.04 O3 TRS B 107 coo 36.34 32.23 39.60 36.43 34.62 39.93 6.32 -16.58 36.41 4.17 -16.19 37.45 coo 19.73 19.18 41.39 21.50 18.65 40.34 15.57 -3.11 51.57 14.43 -2.38 49.92 coo 41.69 45.14 46.60 41.78 47.19 46.18 4.34 -30.02 32.49 3.20 -30.88 30.99 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER A 16 SER.? 21.37 C2 TRS B 107 A 292 ASP A 33 ASP.? 14.12 MG MG A 106 A 322 HIS B 78 HIS^? 12.04 O3 TRS B 107 coo 36.34 32.23 39.60 36.43 34.62 39.93 6.77 -13.81 33.93 9.10 -14.03 33.22 coo 19.73 19.18 41.39 21.50 18.65 40.34 15.57 -3.11 51.57 14.43 -2.38 49.92 coo 41.69 45.14 46.60 41.78 47.19 46.18 4.34 -30.02 32.49 3.20 -30.88 30.99 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER B 16 SER.? 18.72 MG MG A 106 A 292 ASP B 33 ASP.? 27.59 MG MG A 106 A 322 HIS A 78 HIS.? 11.19 MG MG A 106 coo 36.34 32.23 39.60 36.43 34.62 39.93 19.38 -8.95 30.12 17.10 -8.78 30.97 coo 19.73 19.18 41.39 21.50 18.65 40.34 22.46 -22.72 47.13 22.23 -22.78 45.03 coo 41.69 45.14 46.60 41.78 47.19 46.18 21.83 6.49 31.11 22.88 8.20 31.70 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 3 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 15 SER.? 22.03 C2 TRS B 107 B 292 ASP A 33 ASP.? 14.12 MG MG A 106 B 322 HIS B 78 HIS^? 12.04 O3 TRS B 107 coo 35.42 71.28 22.94 36.24 69.06 22.37 6.32 -16.58 36.41 4.17 -16.19 37.45 coo 24.74 78.07 5.59 24.32 79.03 7.46 15.57 -3.11 51.57 14.43 -2.38 49.92 coo 48.81 64.16 26.34 49.30 62.16 26.73 4.34 -30.02 32.49 3.20 -30.88 30.99 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER A 16 SER.? 21.37 C2 TRS B 107 B 292 ASP A 33 ASP.? 14.12 MG MG A 106 B 322 HIS B 78 HIS^? 12.04 O3 TRS B 107 coo 35.42 71.28 22.94 36.24 69.06 22.37 6.77 -13.81 33.93 9.10 -14.03 33.22 coo 24.74 78.07 5.59 24.32 79.03 7.46 15.57 -3.11 51.57 14.43 -2.38 49.92 coo 48.81 64.16 26.34 49.30 62.16 26.73 4.34 -30.02 32.49 3.20 -30.88 30.99 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER B 16 SER.? 18.72 MG MG A 106 B 292 ASP B 33 ASP.? 27.59 MG MG A 106 B 322 HIS A 78 HIS.? 11.19 MG MG A 106 coo 35.42 71.28 22.94 36.24 69.06 22.37 19.38 -8.95 30.12 17.10 -8.78 30.97 coo 24.74 78.07 5.59 24.32 79.03 7.46 22.46 -22.72 47.13 22.23 -22.78 45.03 coo 48.81 64.16 26.34 49.30 62.16 26.73 21.83 6.49 31.11 22.88 8.20 31.70 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 3 hits 1aql_c03 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 17 ARG^? 24.52 MG MG A 106 B 342 ASP B 100 ASP^? 19.56 C2 TRS B 107 B 531 ARG A 24 ARG^? 24.75 MG MG A 106 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 2.20 -10.40 35.71 4.44 -9.62 37.71 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 9.71 -18.83 33.97 8.85 -16.99 33.47 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 6.24 -3.67 29.98 3.39 -2.61 30.35 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG A 24 ARG^? 24.75 MG MG A 106 B 342 ASP A 21 ASP.? 20.18 O2 TRS B 107 B 531 ARG A 17 ARG^? 24.52 MG MG A 106 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 6.24 -3.67 29.98 3.39 -2.61 30.35 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 2.80 -6.84 20.40 2.88 -7.95 18.60 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 2.20 -10.40 35.71 4.44 -9.62 37.71 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 B 325 ARG A 24 ARG^? 24.75 MG MG A 106 B 342 ASP A 100 ASP^? 16.25 MG MG A 106 B 531 ARG A 17 ARG^? 24.52 MG MG A 106 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 6.24 -3.67 29.98 3.39 -2.61 30.35 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 2.20 -10.40 35.71 4.44 -9.62 37.71 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 B 325 ARG A 24 ARG^? 24.75 MG MG A 106 B 342 ASP A 100 ASP^? 16.25 MG MG A 106 B 531 ARG A 23 ARG.? 26.26 O2 TRS B 107 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 6.24 -3.67 29.98 3.39 -2.61 30.35 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 7.13 -4.89 20.32 8.16 -2.85 18.32 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 B 325 ARG A 27 ARG^? 22.99 C2 TRS B 107 B 342 ASP A 100 ASP^? 16.25 MG MG A 106 B 531 ARG A 17 ARG^? 24.52 MG MG A 106 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 11.78 -12.78 37.42 11.40 -15.00 35.25 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 2.20 -10.40 35.71 4.44 -9.62 37.71 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 B 325 ARG A 58 ARG^? 9.13 MG MG A 106 B 342 ASP A 4 ASP.? 11.89 MG MG A 106 B 531 ARG B 27 ARG^? 16.66 MG MG A 106 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 17.26 0.85 41.49 16.40 -0.10 44.31 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 29.77 -2.68 38.63 30.81 -3.64 37.08 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 17.35 -10.54 35.83 16.56 -8.02 34.14 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 7 3 # 7 B 325 ARG B 17 ARG^? 19.62 MG A MG B 106 B 342 ASP A 100 ASP^? 16.25 MG MG A 106 B 531 ARG B 24 ARG^? 14.88 MG A MG B 106 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 24.18 -12.31 28.78 23.30 -13.33 31.55 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 16.79 -18.48 25.10 19.01 -19.70 23.40 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 8 3 # 8 B 325 ARG B 24 ARG^? 14.88 MG A MG B 106 B 342 ASP B 21 ASP.? 19.35 O1 TRS B 107 B 531 ARG B 17 ARG^? 19.62 MG A MG B 106 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 16.79 -18.48 25.10 19.01 -19.70 23.40 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 13.91 -13.27 16.06 15.24 -13.79 14.55 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 24.18 -12.31 28.78 23.30 -13.33 31.55 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 9 3 # 9 B 325 ARG B 24 ARG^? 14.88 MG A MG B 106 B 342 ASP B 100 ASP^? 19.56 C2 TRS B 107 B 531 ARG B 17 ARG^? 19.62 MG A MG B 106 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 16.79 -18.48 25.10 19.01 -19.70 23.40 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 9.71 -18.83 33.97 8.85 -16.99 33.47 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 24.18 -12.31 28.78 23.30 -13.33 31.55 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 10 3 # 10 B 325 ARG B 24 ARG^? 14.88 MG A MG B 106 B 342 ASP B 100 ASP^? 19.56 C2 TRS B 107 B 531 ARG B 23 ARG.? 13.56 O1 TRS B 107 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 16.79 -18.48 25.10 19.01 -19.70 23.40 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 9.71 -18.83 33.97 8.85 -16.99 33.47 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 9.90 -15.60 19.03 10.94 -17.68 17.04 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 11 3 # 11 B 325 ARG B 27 ARG^? 16.66 MG MG A 106 B 342 ASP B 100 ASP^? 19.56 C2 TRS B 107 B 531 ARG B 17 ARG^? 19.62 MG A MG B 106 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 17.35 -10.54 35.83 16.56 -8.02 34.14 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 9.71 -18.83 33.97 8.85 -16.99 33.47 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 24.18 -12.31 28.78 23.30 -13.33 31.55 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 11 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG A 17 ARG^? 24.52 MG MG A 106 A 342 ASP B 100 ASP^? 19.56 C2 TRS B 107 A 531 ARG A 24 ARG^? 24.75 MG MG A 106 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 2.20 -10.40 35.71 4.44 -9.62 37.71 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 9.71 -18.83 33.97 8.85 -16.99 33.47 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 6.24 -3.67 29.98 3.39 -2.61 30.35 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG A 24 ARG^? 24.75 MG MG A 106 A 342 ASP A 100 ASP^? 16.25 MG MG A 106 A 531 ARG A 17 ARG^? 24.52 MG MG A 106 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 6.24 -3.67 29.98 3.39 -2.61 30.35 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 2.20 -10.40 35.71 4.44 -9.62 37.71 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 A 325 ARG A 24 ARG^? 24.75 MG MG A 106 A 342 ASP A 100 ASP^? 16.25 MG MG A 106 A 531 ARG A 23 ARG.? 26.26 O2 TRS B 107 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 6.24 -3.67 29.98 3.39 -2.61 30.35 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 7.13 -4.89 20.32 8.16 -2.85 18.32 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 A 325 ARG A 27 ARG^? 22.99 C2 TRS B 107 A 342 ASP A 100 ASP^? 16.25 MG MG A 106 A 531 ARG A 17 ARG^? 24.52 MG MG A 106 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 11.78 -12.78 37.42 11.40 -15.00 35.25 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 2.20 -10.40 35.71 4.44 -9.62 37.71 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 A 325 ARG A 27 ARG^? 22.99 C2 TRS B 107 A 342 ASP B 4 ASP.? 25.97 C2 TRS B 107 A 531 ARG A 17 ARG^? 24.52 MG MG A 106 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 11.78 -12.78 37.42 11.40 -15.00 35.25 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 4.45 -22.45 45.85 5.06 -24.19 44.80 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 2.20 -10.40 35.71 4.44 -9.62 37.71 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 A 325 ARG A 58 ARG^? 9.13 MG MG A 106 A 342 ASP A 4 ASP.? 11.89 MG MG A 106 A 531 ARG B 27 ARG^? 16.66 MG MG A 106 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 17.26 0.85 41.49 16.40 -0.10 44.31 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 29.77 -2.68 38.63 30.81 -3.64 37.08 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 17.35 -10.54 35.83 16.56 -8.02 34.14 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 7 3 # 7 A 325 ARG B 17 ARG^? 19.62 MG A MG B 106 A 342 ASP A 4 ASP.? 11.89 MG MG A 106 A 531 ARG B 27 ARG^? 16.66 MG MG A 106 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 24.18 -12.31 28.78 23.30 -13.33 31.55 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 29.77 -2.68 38.63 30.81 -3.64 37.08 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 17.35 -10.54 35.83 16.56 -8.02 34.14 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 8 3 # 8 A 325 ARG B 17 ARG^? 19.62 MG A MG B 106 A 342 ASP A 100 ASP^? 16.25 MG MG A 106 A 531 ARG B 24 ARG^? 14.88 MG A MG B 106 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 24.18 -12.31 28.78 23.30 -13.33 31.55 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 16.79 -18.48 25.10 19.01 -19.70 23.40 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 9 3 # 9 A 325 ARG B 24 ARG^? 14.88 MG A MG B 106 A 342 ASP B 100 ASP^? 19.56 C2 TRS B 107 A 531 ARG B 17 ARG^? 19.62 MG A MG B 106 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 16.79 -18.48 25.10 19.01 -19.70 23.40 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 9.71 -18.83 33.97 8.85 -16.99 33.47 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 24.18 -12.31 28.78 23.30 -13.33 31.55 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 10 3 # 10 A 325 ARG B 27 ARG^? 16.66 MG MG A 106 A 342 ASP A 4 ASP.? 11.89 MG MG A 106 A 531 ARG A 58 ARG^? 9.13 MG MG A 106 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 17.35 -10.54 35.83 16.56 -8.02 34.14 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 29.77 -2.68 38.63 30.81 -3.64 37.08 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 17.26 0.85 41.49 16.40 -0.10 44.31 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 11 3 # 11 A 325 ARG B 27 ARG^? 16.66 MG MG A 106 A 342 ASP A 4 ASP.? 11.89 MG MG A 106 A 531 ARG B 17 ARG^? 19.62 MG A MG B 106 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 17.35 -10.54 35.83 16.56 -8.02 34.14 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 29.77 -2.68 38.63 30.81 -3.64 37.08 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 24.18 -12.31 28.78 23.30 -13.33 31.55 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 12 3 # 12 A 325 ARG B 27 ARG^? 16.66 MG MG A 106 A 342 ASP B 100 ASP^? 19.56 C2 TRS B 107 A 531 ARG B 17 ARG^? 19.62 MG A MG B 106 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 17.35 -10.54 35.83 16.56 -8.02 34.14 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 9.71 -18.83 33.97 8.85 -16.99 33.47 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 24.18 -12.31 28.78 23.30 -13.33 31.55 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 12 hits 1asy_c01 naa= 3 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 110 SER A 61 SER^? 13.76 MG MG A 106 A 266 ASP A 81 ASP.? 9.35 MG MG A 106 A 294 HIS A 78 HIS.? 11.19 MG MG A 106 coo 32.07 25.76 77.83 34.46 26.05 77.46 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 33.07 35.01 79.81 33.39 33.02 79.13 18.32 7.36 35.53 19.95 8.35 34.55 coo 35.53 30.26 79.89 34.62 28.71 78.80 21.83 6.49 31.11 22.88 8.20 31.70 1azw_c00 source 1azw PROLINE IMINOPEPTIDASE : 1 hits 1azw_c00 naa= 3 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 A 18 HIS B 43 HIS.? 17.46 C2 TRS B 107 A 91 ARG B 24 ARG^? 14.88 MG A MG B 106 A 129 SER B 25 SER^? 21.93 C2 TRS B 107 coo 24.39 47.01 49.70 26.42 47.04 49.21 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 25.98 44.20 42.23 28.53 42.98 43.43 16.79 -18.48 25.10 19.01 -19.70 23.40 coo 30.00 49.76 45.68 28.73 48.72 47.47 15.65 -13.25 27.32 13.56 -12.34 28.19 1b6t_c00 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 1 hits 1b6t_c00 naa= 3 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 B 18 HIS A 43 HIS.? 24.06 C2 TRS B 107 B 91 ARG B 23 ARG.? 13.56 O1 TRS B 107 B 129 SER B 25 SER^? 21.93 C2 TRS B 107 coo 18.19 17.03 40.71 18.55 17.18 38.64 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 25.60 21.10 38.54 23.57 20.93 36.25 9.90 -15.60 19.03 10.94 -17.68 17.04 coo 21.33 14.29 34.62 19.25 14.88 35.71 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 B 18 HIS B 37 HIS.? 23.74 MG A MG B 106 B 91 ARG B 58 ARG^? 24.73 MG A MG B 106 B 129 SER B 35 SER.? 26.37 MG A MG B 106 coo 18.19 17.03 40.71 18.55 17.18 38.64 21.69 -21.14 38.43 22.55 -22.53 39.75 coo 25.60 21.10 38.54 23.57 20.93 36.25 17.07 -26.36 39.29 20.10 -26.73 39.11 coo 21.33 14.29 34.62 19.25 14.88 35.71 25.15 -20.56 42.66 23.31 -22.12 42.44 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 3 3 # 3 B 18 HIS B 37 HIS.? 23.74 MG A MG B 106 B 91 ARG B 58 ARG^? 24.73 MG A MG B 106 B 129 SER B 38 SER.? 19.23 MG A MG B 106 coo 18.19 17.03 40.71 18.55 17.18 38.64 21.69 -21.14 38.43 22.55 -22.53 39.75 coo 25.60 21.10 38.54 23.57 20.93 36.25 17.07 -26.36 39.29 20.10 -26.73 39.11 coo 21.33 14.29 34.62 19.25 14.88 35.71 20.61 -17.82 33.77 20.60 -17.17 31.49 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 4 3 # 4 B 18 HIS B 43 HIS.? 17.46 C2 TRS B 107 B 91 ARG A 23 ARG.? 26.26 O2 TRS B 107 B 129 SER A 19 SER^? 24.19 O2 TRS B 107 coo 18.19 17.03 40.71 18.55 17.18 38.64 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 25.60 21.10 38.54 23.57 20.93 36.25 7.13 -4.89 20.32 8.16 -2.85 18.32 coo 21.33 14.29 34.62 19.25 14.88 35.71 2.67 -7.78 27.23 3.23 -6.16 28.95 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 5 3 # 5 B 18 HIS B 43 HIS.? 17.46 C2 TRS B 107 B 91 ARG A 23 ARG.? 26.26 O2 TRS B 107 B 129 SER A 25 SER^? 23.03 C2 TRS B 107 coo 18.19 17.03 40.71 18.55 17.18 38.64 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 25.60 21.10 38.54 23.57 20.93 36.25 7.13 -4.89 20.32 8.16 -2.85 18.32 coo 21.33 14.29 34.62 19.25 14.88 35.71 8.15 -8.88 30.15 10.32 -9.84 29.66 1b6t_c01 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 5 hits 1b6t_c01 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR A 101 TYR^? 16.63 MG MG A 106 A 230 ASP A 81 ASP.? 9.35 MG MG A 106 A 273 LYS B 14 LYS.? 6.95 MG MG A 106 coo 9.23 21.44 106.88 10.18 19.34 105.31 12.29 -0.55 33.68 9.97 -0.77 32.12 coo 1.45 22.80 104.16 2.58 21.02 104.01 18.32 7.36 35.53 19.95 8.35 34.55 coo 2.97 11.64 107.87 6.59 15.13 107.03 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 A 145 TYR B 101 TYR^? 17.91 N TRS B 107 A 230 ASP B 81 ASP.? 16.51 N TRS B 107 A 273 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 9.23 21.44 106.88 10.18 19.34 105.31 14.17 -22.17 31.30 14.99 -21.52 28.71 coo 1.45 22.80 104.16 2.58 21.02 104.01 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 2.97 11.64 107.87 6.59 15.13 107.03 8.74 -17.74 39.05 7.96 -22.88 42.54 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 2 hits 1b8g_c04 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR A 101 TYR^? 16.63 MG MG A 106 B 230 ASP A 81 ASP.? 9.35 MG MG A 106 B 273 LYS B 14 LYS.? 6.95 MG MG A 106 coo 11.81 13.41 73.03 10.00 13.03 75.12 12.29 -0.55 33.68 9.97 -0.77 32.12 coo 19.17 11.01 76.14 17.26 10.42 76.77 18.32 7.36 35.53 19.95 8.35 34.55 coo 11.10 2.31 76.60 10.24 7.24 75.62 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 B 145 TYR B 101 TYR^? 17.91 N TRS B 107 B 230 ASP B 81 ASP.? 16.51 N TRS B 107 B 273 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 11.81 13.41 73.03 10.00 13.03 75.12 14.17 -22.17 31.30 14.99 -21.52 28.71 coo 19.17 11.01 76.14 17.26 10.42 76.77 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 11.10 2.31 76.60 10.24 7.24 75.62 8.74 -17.74 39.05 7.96 -22.88 42.54 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 2 hits 1b8g_c05 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 27 ARG^? 22.99 C2 TRS B 107 A 141 THR A 40 THR.? 19.17 MG MG A 106 A 235 ASP B 4 ASP.? 25.97 C2 TRS B 107 coo 6.21 93.81 36.58 4.58 96.33 37.17 11.78 -12.78 37.42 11.40 -15.00 35.25 coo 6.80 92.87 28.33 4.91 92.74 27.40 10.97 -5.43 33.62 9.26 -4.14 33.42 coo 12.98 90.36 47.57 11.26 89.62 46.62 4.45 -22.45 45.85 5.06 -24.19 44.80 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG A 27 ARG^? 22.99 C2 TRS B 107 A 141 THR B 40 THR.? 20.45 MG A MG B 106 A 235 ASP B 4 ASP.? 25.97 C2 TRS B 107 coo 6.21 93.81 36.58 4.58 96.33 37.17 11.78 -12.78 37.42 11.40 -15.00 35.25 coo 6.80 92.87 28.33 4.91 92.74 27.40 15.40 -17.32 31.26 16.66 -18.43 29.90 coo 12.98 90.36 47.57 11.26 89.62 46.62 4.45 -22.45 45.85 5.06 -24.19 44.80 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG A 58 ARG^? 9.13 MG MG A 106 A 141 THR A 56 THR^? 13.39 MG MG A 106 A 235 ASP A 4 ASP.? 11.89 MG MG A 106 coo 6.21 93.81 36.58 4.58 96.33 37.17 17.26 0.85 41.49 16.40 -0.10 44.31 coo 6.80 92.87 28.33 4.91 92.74 27.40 9.35 4.66 41.11 10.55 5.11 42.82 coo 12.98 90.36 47.57 11.26 89.62 46.62 29.77 -2.68 38.63 30.81 -3.64 37.08 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 A 137 ARG B 27 ARG^? 16.66 MG MG A 106 A 141 THR A 40 THR.? 19.17 MG MG A 106 A 235 ASP A 4 ASP.? 11.89 MG MG A 106 coo 6.21 93.81 36.58 4.58 96.33 37.17 17.35 -10.54 35.83 16.56 -8.02 34.14 coo 6.80 92.87 28.33 4.91 92.74 27.40 10.97 -5.43 33.62 9.26 -4.14 33.42 coo 12.98 90.36 47.57 11.26 89.62 46.62 29.77 -2.68 38.63 30.81 -3.64 37.08 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 A 137 ARG B 27 ARG^? 16.66 MG MG A 106 A 141 THR B 40 THR.? 20.45 MG A MG B 106 A 235 ASP A 4 ASP.? 11.89 MG MG A 106 coo 6.21 93.81 36.58 4.58 96.33 37.17 17.35 -10.54 35.83 16.56 -8.02 34.14 coo 6.80 92.87 28.33 4.91 92.74 27.40 15.40 -17.32 31.26 16.66 -18.43 29.90 coo 12.98 90.36 47.57 11.26 89.62 46.62 29.77 -2.68 38.63 30.81 -3.64 37.08 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 A 137 ARG B 58 ARG^? 24.73 MG A MG B 106 A 141 THR B 56 THR^? 21.43 MG A MG B 106 A 235 ASP B 4 ASP.? 25.97 C2 TRS B 107 coo 6.21 93.81 36.58 4.58 96.33 37.17 17.07 -26.36 39.29 20.10 -26.73 39.11 coo 6.80 92.87 28.33 4.91 92.74 27.40 20.84 -28.16 33.58 21.33 -29.01 35.51 coo 12.98 90.36 47.57 11.26 89.62 46.62 4.45 -22.45 45.85 5.06 -24.19 44.80 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 6 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 27 ARG^? 22.99 C2 TRS B 107 D 141 THR A 40 THR.? 19.17 MG MG A 106 D 235 ASP B 4 ASP.? 25.97 C2 TRS B 107 coo -8.33 92.80 100.06 -7.71 95.33 98.44 11.78 -12.78 37.42 11.40 -15.00 35.25 coo -9.24 93.49 108.77 -7.37 94.21 109.61 10.97 -5.43 33.62 9.26 -4.14 33.42 coo -14.64 87.74 89.51 -12.89 87.43 90.65 4.45 -22.45 45.85 5.06 -24.19 44.80 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG A 27 ARG^? 22.99 C2 TRS B 107 D 141 THR B 40 THR.? 20.45 MG A MG B 106 D 235 ASP B 4 ASP.? 25.97 C2 TRS B 107 coo -8.33 92.80 100.06 -7.71 95.33 98.44 11.78 -12.78 37.42 11.40 -15.00 35.25 coo -9.24 93.49 108.77 -7.37 94.21 109.61 15.40 -17.32 31.26 16.66 -18.43 29.90 coo -14.64 87.74 89.51 -12.89 87.43 90.65 4.45 -22.45 45.85 5.06 -24.19 44.80 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 D 137 ARG A 58 ARG^? 9.13 MG MG A 106 D 141 THR A 56 THR^? 13.39 MG MG A 106 D 235 ASP A 4 ASP.? 11.89 MG MG A 106 coo -8.33 92.80 100.06 -7.71 95.33 98.44 17.26 0.85 41.49 16.40 -0.10 44.31 coo -9.24 93.49 108.77 -7.37 94.21 109.61 9.35 4.66 41.11 10.55 5.11 42.82 coo -14.64 87.74 89.51 -12.89 87.43 90.65 29.77 -2.68 38.63 30.81 -3.64 37.08 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 D 137 ARG B 17 ARG^? 19.62 MG A MG B 106 D 141 THR B 40 THR.? 20.45 MG A MG B 106 D 235 ASP A 4 ASP.? 11.89 MG MG A 106 coo -8.33 92.80 100.06 -7.71 95.33 98.44 24.18 -12.31 28.78 23.30 -13.33 31.55 coo -9.24 93.49 108.77 -7.37 94.21 109.61 15.40 -17.32 31.26 16.66 -18.43 29.90 coo -14.64 87.74 89.51 -12.89 87.43 90.65 29.77 -2.68 38.63 30.81 -3.64 37.08 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 D 137 ARG B 24 ARG^? 14.88 MG A MG B 106 D 141 THR B 48 THR^? 12.62 O1 TRS B 107 D 235 ASP B 100 ASP^? 19.56 C2 TRS B 107 coo -8.33 92.80 100.06 -7.71 95.33 98.44 16.79 -18.48 25.10 19.01 -19.70 23.40 coo -9.24 93.49 108.77 -7.37 94.21 109.61 15.74 -25.23 16.81 15.69 -26.00 14.77 coo -14.64 87.74 89.51 -12.89 87.43 90.65 9.71 -18.83 33.97 8.85 -16.99 33.47 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 D 137 ARG B 27 ARG^? 16.66 MG MG A 106 D 141 THR A 40 THR.? 19.17 MG MG A 106 D 235 ASP A 4 ASP.? 11.89 MG MG A 106 coo -8.33 92.80 100.06 -7.71 95.33 98.44 17.35 -10.54 35.83 16.56 -8.02 34.14 coo -9.24 93.49 108.77 -7.37 94.21 109.61 10.97 -5.43 33.62 9.26 -4.14 33.42 coo -14.64 87.74 89.51 -12.89 87.43 90.65 29.77 -2.68 38.63 30.81 -3.64 37.08 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 D 137 ARG B 27 ARG^? 16.66 MG MG A 106 D 141 THR B 40 THR.? 20.45 MG A MG B 106 D 235 ASP A 4 ASP.? 11.89 MG MG A 106 coo -8.33 92.80 100.06 -7.71 95.33 98.44 17.35 -10.54 35.83 16.56 -8.02 34.14 coo -9.24 93.49 108.77 -7.37 94.21 109.61 15.40 -17.32 31.26 16.66 -18.43 29.90 coo -14.64 87.74 89.51 -12.89 87.43 90.65 29.77 -2.68 38.63 30.81 -3.64 37.08 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 D 137 ARG B 58 ARG^? 24.73 MG A MG B 106 D 141 THR B 56 THR^? 21.43 MG A MG B 106 D 235 ASP B 4 ASP.? 25.97 C2 TRS B 107 coo -8.33 92.80 100.06 -7.71 95.33 98.44 17.07 -26.36 39.29 20.10 -26.73 39.11 coo -9.24 93.49 108.77 -7.37 94.21 109.61 20.84 -28.16 33.58 21.33 -29.01 35.51 coo -14.64 87.74 89.51 -12.89 87.43 90.65 4.45 -22.45 45.85 5.06 -24.19 44.80 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 8 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 27 ARG^? 22.99 C2 TRS B 107 C 141 THR A 40 THR.? 19.17 MG MG A 106 C 235 ASP B 4 ASP.? 25.97 C2 TRS B 107 coo -5.79 67.26 36.83 -4.57 64.58 37.74 11.78 -12.78 37.42 11.40 -15.00 35.25 coo -6.81 68.31 28.28 -4.82 68.47 27.57 10.97 -5.43 33.62 9.26 -4.14 33.42 coo -13.01 70.96 47.58 -11.44 71.65 46.34 4.45 -22.45 45.85 5.06 -24.19 44.80 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG A 27 ARG^? 22.99 C2 TRS B 107 C 141 THR B 40 THR.? 20.45 MG A MG B 106 C 235 ASP B 4 ASP.? 25.97 C2 TRS B 107 coo -5.79 67.26 36.83 -4.57 64.58 37.74 11.78 -12.78 37.42 11.40 -15.00 35.25 coo -6.81 68.31 28.28 -4.82 68.47 27.57 15.40 -17.32 31.26 16.66 -18.43 29.90 coo -13.01 70.96 47.58 -11.44 71.65 46.34 4.45 -22.45 45.85 5.06 -24.19 44.80 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 C 137 ARG A 58 ARG^? 9.13 MG MG A 106 C 141 THR A 56 THR^? 13.39 MG MG A 106 C 235 ASP A 4 ASP.? 11.89 MG MG A 106 coo -5.79 67.26 36.83 -4.57 64.58 37.74 17.26 0.85 41.49 16.40 -0.10 44.31 coo -6.81 68.31 28.28 -4.82 68.47 27.57 9.35 4.66 41.11 10.55 5.11 42.82 coo -13.01 70.96 47.58 -11.44 71.65 46.34 29.77 -2.68 38.63 30.81 -3.64 37.08 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 C 137 ARG B 17 ARG^? 19.62 MG A MG B 106 C 141 THR B 40 THR.? 20.45 MG A MG B 106 C 235 ASP A 4 ASP.? 11.89 MG MG A 106 coo -5.79 67.26 36.83 -4.57 64.58 37.74 24.18 -12.31 28.78 23.30 -13.33 31.55 coo -6.81 68.31 28.28 -4.82 68.47 27.57 15.40 -17.32 31.26 16.66 -18.43 29.90 coo -13.01 70.96 47.58 -11.44 71.65 46.34 29.77 -2.68 38.63 30.81 -3.64 37.08 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 C 137 ARG B 27 ARG^? 16.66 MG MG A 106 C 141 THR A 40 THR.? 19.17 MG MG A 106 C 235 ASP A 4 ASP.? 11.89 MG MG A 106 coo -5.79 67.26 36.83 -4.57 64.58 37.74 17.35 -10.54 35.83 16.56 -8.02 34.14 coo -6.81 68.31 28.28 -4.82 68.47 27.57 10.97 -5.43 33.62 9.26 -4.14 33.42 coo -13.01 70.96 47.58 -11.44 71.65 46.34 29.77 -2.68 38.63 30.81 -3.64 37.08 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 C 137 ARG B 27 ARG^? 16.66 MG MG A 106 C 141 THR B 40 THR.? 20.45 MG A MG B 106 C 235 ASP A 4 ASP.? 11.89 MG MG A 106 coo -5.79 67.26 36.83 -4.57 64.58 37.74 17.35 -10.54 35.83 16.56 -8.02 34.14 coo -6.81 68.31 28.28 -4.82 68.47 27.57 15.40 -17.32 31.26 16.66 -18.43 29.90 coo -13.01 70.96 47.58 -11.44 71.65 46.34 29.77 -2.68 38.63 30.81 -3.64 37.08 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 C 137 ARG B 58 ARG^? 24.73 MG A MG B 106 C 141 THR B 56 THR^? 21.43 MG A MG B 106 C 235 ASP B 4 ASP.? 25.97 C2 TRS B 107 coo -5.79 67.26 36.83 -4.57 64.58 37.74 17.07 -26.36 39.29 20.10 -26.73 39.11 coo -6.81 68.31 28.28 -4.82 68.47 27.57 20.84 -28.16 33.58 21.33 -29.01 35.51 coo -13.01 70.96 47.58 -11.44 71.65 46.34 4.45 -22.45 45.85 5.06 -24.19 44.80 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 7 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 17 ARG^? 24.52 MG MG A 106 B 141 THR A 40 THR.? 19.17 MG MG A 106 B 235 ASP B 4 ASP.? 25.97 C2 TRS B 107 coo 8.13 67.41 100.27 7.18 68.35 97.45 2.20 -10.40 35.71 4.44 -9.62 37.71 coo 8.28 67.78 108.81 6.22 67.65 109.43 10.97 -5.43 33.62 9.26 -4.14 33.42 coo 14.55 73.52 89.47 12.81 73.95 90.56 4.45 -22.45 45.85 5.06 -24.19 44.80 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG A 27 ARG^? 22.99 C2 TRS B 107 B 141 THR A 40 THR.? 19.17 MG MG A 106 B 235 ASP B 4 ASP.? 25.97 C2 TRS B 107 coo 8.13 67.41 100.27 7.18 68.35 97.45 11.78 -12.78 37.42 11.40 -15.00 35.25 coo 8.28 67.78 108.81 6.22 67.65 109.43 10.97 -5.43 33.62 9.26 -4.14 33.42 coo 14.55 73.52 89.47 12.81 73.95 90.56 4.45 -22.45 45.85 5.06 -24.19 44.80 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 B 137 ARG A 58 ARG^? 9.13 MG MG A 106 B 141 THR A 56 THR^? 13.39 MG MG A 106 B 235 ASP A 4 ASP.? 11.89 MG MG A 106 coo 8.13 67.41 100.27 7.18 68.35 97.45 17.26 0.85 41.49 16.40 -0.10 44.31 coo 8.28 67.78 108.81 6.22 67.65 109.43 9.35 4.66 41.11 10.55 5.11 42.82 coo 14.55 73.52 89.47 12.81 73.95 90.56 29.77 -2.68 38.63 30.81 -3.64 37.08 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 B 137 ARG B 17 ARG^? 19.62 MG A MG B 106 B 141 THR B 40 THR.? 20.45 MG A MG B 106 B 235 ASP A 4 ASP.? 11.89 MG MG A 106 coo 8.13 67.41 100.27 7.18 68.35 97.45 24.18 -12.31 28.78 23.30 -13.33 31.55 coo 8.28 67.78 108.81 6.22 67.65 109.43 15.40 -17.32 31.26 16.66 -18.43 29.90 coo 14.55 73.52 89.47 12.81 73.95 90.56 29.77 -2.68 38.63 30.81 -3.64 37.08 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 B 137 ARG B 27 ARG^? 16.66 MG MG A 106 B 141 THR A 40 THR.? 19.17 MG MG A 106 B 235 ASP A 4 ASP.? 11.89 MG MG A 106 coo 8.13 67.41 100.27 7.18 68.35 97.45 17.35 -10.54 35.83 16.56 -8.02 34.14 coo 8.28 67.78 108.81 6.22 67.65 109.43 10.97 -5.43 33.62 9.26 -4.14 33.42 coo 14.55 73.52 89.47 12.81 73.95 90.56 29.77 -2.68 38.63 30.81 -3.64 37.08 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 B 137 ARG B 27 ARG^? 16.66 MG MG A 106 B 141 THR B 40 THR.? 20.45 MG A MG B 106 B 235 ASP A 4 ASP.? 11.89 MG MG A 106 coo 8.13 67.41 100.27 7.18 68.35 97.45 17.35 -10.54 35.83 16.56 -8.02 34.14 coo 8.28 67.78 108.81 6.22 67.65 109.43 15.40 -17.32 31.26 16.66 -18.43 29.90 coo 14.55 73.52 89.47 12.81 73.95 90.56 29.77 -2.68 38.63 30.81 -3.64 37.08 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 B 137 ARG B 58 ARG^? 24.73 MG A MG B 106 B 141 THR B 56 THR^? 21.43 MG A MG B 106 B 235 ASP B 4 ASP.? 25.97 C2 TRS B 107 coo 8.13 67.41 100.27 7.18 68.35 97.45 17.07 -26.36 39.29 20.10 -26.73 39.11 coo 8.28 67.78 108.81 6.22 67.65 109.43 20.84 -28.16 33.58 21.33 -29.01 35.51 coo 14.55 73.52 89.47 12.81 73.95 90.56 4.45 -22.45 45.85 5.06 -24.19 44.80 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 7 hits 1bd3_c03 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP A 73 ASP.? 24.66 MG MG A 106 16 HIS A 67 HIS^? 25.71 MG MG A 106 67 GLY A 62 GLY^? 14.78 MG MG A 106 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 11.88 18.46 25.62 13.34 17.78 24.18 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 7.29 12.90 25.70 6.12 14.46 24.97 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 19.88 0.13 28.65 20.08 0.65 29.27 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP A 73 ASP.? 24.66 MG MG A 106 16 HIS A 67 HIS^? 25.71 MG MG A 106 67 GLY A 80 GLY.? 5.31 MG MG A 106 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 11.88 18.46 25.62 13.34 17.78 24.18 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 7.29 12.90 25.70 6.12 14.46 24.97 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 21.40 4.18 37.49 20.81 4.36 37.01 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 3 3 # 3 14 ASP B 73 ASP.? 13.34 N TRS B 107 16 HIS B 67 HIS^? 10.25 N TRS B 107 67 GLY B 62 GLY^? 13.99 C2 TRS B 107 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 9.64 -40.18 22.89 9.15 -42.09 22.32 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 5.13 -22.73 31.66 5.25 -23.38 32.15 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 4 3 # 4 14 ASP B 81 ASP.? 16.51 N TRS B 107 16 HIS B 78 HIS^? 12.04 O3 TRS B 107 67 GLY B 70 GLY.? 16.80 N TRS B 107 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 9.98 -30.67 34.70 8.29 -31.92 34.80 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 18.04 -38.49 17.68 17.55 -38.22 18.20 1be1_c02 source 1be1 GLUTAMATE MUTASE : 4 hits 1be1_c02 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 97 GLU^? 17.69 MG MG A 106 A 503 TYR A 65 TYR^? 20.31 MG MG A 106 A 537 GLU A 76 GLU^? 15.65 MG MG A 106 coo 24.06 146.21 11.09 22.89 146.18 9.36 21.20 0.85 23.82 22.93 1.52 24.76 coo 15.91 140.69 8.32 15.71 143.39 9.13 15.06 9.60 24.66 17.54 9.96 23.42 coo 16.65 144.44 13.24 18.34 145.22 12.33 19.27 9.35 28.47 21.14 9.50 27.54 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 1 hits 1bgl_c08 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 17 ARG^? 24.52 MG MG A 106 183 LYS A 14 LYS.? 24.61 C2 TRS B 107 317 ARG B 17 ARG^? 19.62 MG A MG B 106 coo 76.57 109.19 73.41 73.86 110.26 72.16 2.20 -10.40 35.71 4.44 -9.62 37.71 coo 82.09 117.51 66.37 80.60 114.32 71.44 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 65.21 120.62 58.76 63.62 123.14 59.66 24.18 -12.31 28.78 23.30 -13.33 31.55 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 1 hits 1bib_c00 naa= 3 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 3 # 1 A 757 ASP A 81 ASP.? 9.35 MG MG A 106 A 759 HIS A 78 HIS.? 11.19 MG MG A 106 A 810 SER A 82 SER^? 9.28 MG MG A 106 coo 30.11 61.02 29.12 29.36 59.77 27.63 18.32 7.36 35.53 19.95 8.35 34.55 coo 30.94 56.62 25.28 29.94 54.94 26.14 21.83 6.49 31.11 22.88 8.20 31.70 coo 25.05 62.74 29.97 26.88 61.45 29.19 15.58 6.86 38.93 14.78 5.91 41.12 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 2 3 # 2 A 757 ASP B 81 ASP.? 16.51 N TRS B 107 A 759 HIS B 78 HIS^? 12.04 O3 TRS B 107 A 810 SER B 82 SER^? 21.85 N TRS B 107 coo 30.11 61.02 29.12 29.36 59.77 27.63 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 30.94 56.62 25.28 29.94 54.94 26.14 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 25.05 62.74 29.97 26.88 61.45 29.19 14.28 -30.55 35.57 14.97 -31.78 37.56 1bmt_c04 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 2 hits 1bmt_c04 naa= 3 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 3 # 1 B 757 ASP A 81 ASP.? 9.35 MG MG A 106 B 759 HIS A 78 HIS.? 11.19 MG MG A 106 B 810 SER A 82 SER^? 9.28 MG MG A 106 coo -2.30 64.08 6.41 -0.36 64.72 6.26 18.32 7.36 35.53 19.95 8.35 34.55 coo 1.96 66.39 3.07 2.10 68.48 3.58 21.83 6.49 31.11 22.88 8.20 31.70 coo -1.50 63.90 11.86 -1.31 64.33 9.52 15.58 6.86 38.93 14.78 5.91 41.12 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 2 3 # 2 B 757 ASP B 81 ASP.? 16.51 N TRS B 107 B 759 HIS B 78 HIS^? 12.04 O3 TRS B 107 B 810 SER B 82 SER^? 21.85 N TRS B 107 coo -2.30 64.08 6.41 -0.36 64.72 6.26 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 1.96 66.39 3.07 2.10 68.48 3.58 4.34 -30.02 32.49 3.20 -30.88 30.99 coo -1.50 63.90 11.86 -1.31 64.33 9.52 14.28 -30.55 35.57 14.97 -31.78 37.56 1bmt_c05 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 2 hits 1bmt_c05 naa= 3 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 1 3 # 1 A 110 SER A 61 SER^? 13.76 MG MG A 106 A 235 ASP A 81 ASP.? 9.35 MG MG A 106 A 263 HIS A 78 HIS.? 11.19 MG MG A 106 coo 30.32 56.27 16.76 31.62 57.99 17.94 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 31.33 62.80 9.68 31.68 62.04 11.62 18.32 7.36 35.53 19.95 8.35 34.55 coo 30.23 62.32 14.77 30.86 60.47 15.53 21.83 6.49 31.11 22.88 8.20 31.70 1c4x_c00 source 1c4x 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOATE HYDR: 1 hits 1c4x_c00 naa= 3 ULMN 3 1c82_c01 HYALURONATE LYASE user 1 3 # 1 A 399 HIS B 67 HIS^? 10.25 N TRS B 107 A 408 TYR B 66 TYR^? 13.48 N TRS B 107 A 462 ARG B 92 ARG^? 5.10 O1 TRS B 107 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 14.02 -31.53 25.24 16.67 -32.32 24.84 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 10.89 -28.76 16.90 8.49 -30.55 16.32 1c82_c01 source 1c82 HYALURONATE LYASE : 1 hits 1c82_c01 naa= 3 ULMN 3 1c82_c02 HYALURONATE LYASE user 1 3 # 1 A 399 HIS A 67 HIS^? 25.71 MG MG A 106 A 408 TYR A 66 TYR^? 18.96 MG MG A 106 A 480 ARG A 58 ARG^? 9.13 MG MG A 106 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 7.29 12.90 25.70 6.12 14.46 24.97 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 9.99 9.72 31.21 7.76 10.46 32.78 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 17.26 0.85 41.49 16.40 -0.10 44.31 ULMN 3 1c82_c02 HYALURONATE LYASE user 2 3 # 2 A 399 HIS B 67 HIS^? 10.25 N TRS B 107 A 408 TYR B 66 TYR^? 13.48 N TRS B 107 A 480 ARG B 58 ARG^? 24.73 MG A MG B 106 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 14.02 -31.53 25.24 16.67 -32.32 24.84 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 17.07 -26.36 39.29 20.10 -26.73 39.11 1c82_c02 source 1c82 HYALURONATE LYASE : 2 hits 1c82_c02 naa= 3 ULMN 3 1cb8_c01 CHONDROITINASE AC user 1 3 # 1 A 225 HIS B 67 HIS^? 10.25 N TRS B 107 A 234 TYR B 66 TYR^? 13.48 N TRS B 107 A 288 ARG B 92 ARG^? 5.10 O1 TRS B 107 coo 27.04 28.61 41.75 26.86 28.65 43.84 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 21.80 30.48 43.67 23.70 29.06 45.12 14.02 -31.53 25.24 16.67 -32.32 24.84 coo 24.79 22.62 45.60 24.87 25.42 46.81 10.89 -28.76 16.90 8.49 -30.55 16.32 1cb8_c01 source 1cb8 CHONDROITINASE AC : 1 hits 1cb8_c01 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 13 GLY^? 24.25 MG MG A 106 A 228 SER A 15 SER.? 22.03 C2 TRS B 107 A 549 ASP B 100 ASP^? 19.56 C2 TRS B 107 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 9.06 -14.52 41.03 9.77 -14.73 40.69 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 6.32 -16.58 36.41 4.17 -16.19 37.45 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 9.71 -18.83 33.97 8.85 -16.99 33.47 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY A 13 GLY^? 24.25 MG MG A 106 A 228 SER A 16 SER.? 21.37 C2 TRS B 107 A 549 ASP B 100 ASP^? 19.56 C2 TRS B 107 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 9.06 -14.52 41.03 9.77 -14.73 40.69 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 6.77 -13.81 33.93 9.10 -14.03 33.22 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 9.71 -18.83 33.97 8.85 -16.99 33.47 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY A 80 GLY.? 5.31 MG MG A 106 A 228 SER A 61 SER^? 13.76 MG MG A 106 A 549 ASP A 100 ASP^? 16.25 MG MG A 106 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 21.40 4.18 37.49 20.81 4.36 37.01 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 17.24 -4.20 32.64 17.59 -5.86 31.44 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 A 198 GLY B 13 GLY^? 14.84 MG MG A 106 A 228 SER B 15 SER.? 15.78 MG MG A 106 A 549 ASP A 100 ASP^? 16.25 MG MG A 106 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 21.83 -9.26 37.30 21.03 -9.05 37.47 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 21.32 -6.59 32.27 23.57 -7.13 31.60 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 17.24 -4.20 32.64 17.59 -5.86 31.44 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 A 198 GLY B 13 GLY^? 14.84 MG MG A 106 A 228 SER B 16 SER.? 18.72 MG MG A 106 A 549 ASP A 100 ASP^? 16.25 MG MG A 106 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 21.83 -9.26 37.30 21.03 -9.05 37.47 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 19.38 -8.95 30.12 17.10 -8.78 30.97 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 17.24 -4.20 32.64 17.59 -5.86 31.44 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 A 198 GLY B 80 GLY.? 20.50 N TRS B 107 A 228 SER B 61 SER^? 18.05 C2 TRS B 107 A 549 ASP B 100 ASP^? 19.56 C2 TRS B 107 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 8.91 -28.16 38.69 9.02 -28.24 37.93 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 6.61 -22.01 35.09 5.00 -20.16 35.04 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 9.71 -18.83 33.97 8.85 -16.99 33.47 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 6 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 13 GLY^? 24.25 MG MG A 106 B1228 SER A 15 SER.? 22.03 C2 TRS B 107 B1549 ASP B 100 ASP^? 19.56 C2 TRS B 107 coo 126.34 72.75 125.66 125.95 73.27 126.11 9.06 -14.52 41.03 9.77 -14.73 40.69 coo 131.65 74.68 129.41 130.31 72.73 128.82 6.32 -16.58 36.41 4.17 -16.19 37.45 coo 134.72 69.43 130.42 133.03 70.65 130.08 9.71 -18.83 33.97 8.85 -16.99 33.47 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY A 13 GLY^? 24.25 MG MG A 106 B1228 SER A 16 SER.? 21.37 C2 TRS B 107 B1549 ASP B 100 ASP^? 19.56 C2 TRS B 107 coo 126.34 72.75 125.66 125.95 73.27 126.11 9.06 -14.52 41.03 9.77 -14.73 40.69 coo 131.65 74.68 129.41 130.31 72.73 128.82 6.77 -13.81 33.93 9.10 -14.03 33.22 coo 134.72 69.43 130.42 133.03 70.65 130.08 9.71 -18.83 33.97 8.85 -16.99 33.47 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY A 80 GLY.? 5.31 MG MG A 106 B1228 SER A 61 SER^? 13.76 MG MG A 106 B1549 ASP A 100 ASP^? 16.25 MG MG A 106 coo 126.34 72.75 125.66 125.95 73.27 126.11 21.40 4.18 37.49 20.81 4.36 37.01 coo 131.65 74.68 129.41 130.31 72.73 128.82 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 134.72 69.43 130.42 133.03 70.65 130.08 17.24 -4.20 32.64 17.59 -5.86 31.44 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 B1198 GLY B 13 GLY^? 14.84 MG MG A 106 B1228 SER B 15 SER.? 15.78 MG MG A 106 B1549 ASP A 100 ASP^? 16.25 MG MG A 106 coo 126.34 72.75 125.66 125.95 73.27 126.11 21.83 -9.26 37.30 21.03 -9.05 37.47 coo 131.65 74.68 129.41 130.31 72.73 128.82 21.32 -6.59 32.27 23.57 -7.13 31.60 coo 134.72 69.43 130.42 133.03 70.65 130.08 17.24 -4.20 32.64 17.59 -5.86 31.44 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 B1198 GLY B 13 GLY^? 14.84 MG MG A 106 B1228 SER B 16 SER.? 18.72 MG MG A 106 B1549 ASP A 100 ASP^? 16.25 MG MG A 106 coo 126.34 72.75 125.66 125.95 73.27 126.11 21.83 -9.26 37.30 21.03 -9.05 37.47 coo 131.65 74.68 129.41 130.31 72.73 128.82 19.38 -8.95 30.12 17.10 -8.78 30.97 coo 134.72 69.43 130.42 133.03 70.65 130.08 17.24 -4.20 32.64 17.59 -5.86 31.44 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 B1198 GLY B 80 GLY.? 20.50 N TRS B 107 B1228 SER B 61 SER^? 18.05 C2 TRS B 107 B1549 ASP B 100 ASP^? 19.56 C2 TRS B 107 coo 126.34 72.75 125.66 125.95 73.27 126.11 8.91 -28.16 38.69 9.02 -28.24 37.93 coo 131.65 74.68 129.41 130.31 72.73 128.82 6.61 -22.01 35.09 5.00 -20.16 35.04 coo 134.72 69.43 130.42 133.03 70.65 130.08 9.71 -18.83 33.97 8.85 -16.99 33.47 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 6 hits 1cjy_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 55 GLU^? 21.04 MG MG A 106 A 89 GLU A 52 GLU.? 31.04 MG MG A 106 A 120 SER A 50 SER.? 27.61 MG MG A 106 coo -24.35 9.53 67.64 -25.07 11.29 68.60 4.10 2.62 39.65 3.53 1.29 38.12 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -5.17 3.56 37.35 -6.70 2.07 37.65 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -0.06 4.91 32.10 -1.94 6.16 32.59 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU A 76 GLU^? 15.65 MG MG A 106 A 89 GLU A 97 GLU^? 17.69 MG MG A 106 A 120 SER A 61 SER^? 13.76 MG MG A 106 coo -24.35 9.53 67.64 -25.07 11.29 68.60 19.27 9.35 28.47 21.14 9.50 27.54 coo -31.18 6.91 75.60 -32.39 8.51 74.91 21.20 0.85 23.82 22.93 1.52 24.76 coo -34.73 8.57 68.21 -33.63 9.08 70.28 20.58 -1.27 32.13 21.77 -3.05 30.92 1cns_c00 source 1cns CHITINASE : 2 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 55 GLU^? 21.04 MG MG A 106 B 89 GLU A 26 GLU^? 23.08 MG MG A 106 B 120 SER A 28 SER^? 23.29 MG MG A 106 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 4.10 2.62 39.65 3.53 1.29 38.12 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 6.59 -6.32 33.57 4.76 -5.37 34.00 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 7.93 -9.68 40.46 5.50 -9.56 40.62 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU A 76 GLU^? 15.65 MG MG A 106 B 89 GLU A 97 GLU^? 17.69 MG MG A 106 B 120 SER A 61 SER^? 13.76 MG MG A 106 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 19.27 9.35 28.47 21.14 9.50 27.54 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 21.20 0.85 23.82 22.93 1.52 24.76 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 20.58 -1.27 32.13 21.77 -3.05 30.92 1cns_c01 source 1cns CHITINASE : 2 hits 1cns_c01 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 47 TYR^? 25.20 MG MG A 106 A 173 ASP A 21 ASP.? 20.18 O2 TRS B 107 C 48 ARG A 92 ARG^? 29.81 MG MG A 106 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 6.73 0.56 24.29 8.36 -1.29 22.99 coo 24.35 4.55 25.11 25.94 3.23 25.53 2.80 -6.84 20.40 2.88 -7.95 18.60 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 4.92 8.97 23.23 2.03 9.56 22.51 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR B 47 TYR^? 12.23 O1 TRS B 107 A 173 ASP B 21 ASP.? 19.35 O1 TRS B 107 C 48 ARG B 92 ARG^? 5.10 O1 TRS B 107 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 12.41 -21.54 20.17 10.64 -19.48 20.79 coo 24.35 4.55 25.11 25.94 3.23 25.53 13.91 -13.27 16.06 15.24 -13.79 14.55 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 10.89 -28.76 16.90 8.49 -30.55 16.32 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG B 92 ARG^? 5.10 O1 TRS B 107 C 101 TYR B 47 TYR^? 12.23 O1 TRS B 107 C 173 ASP B 21 ASP.? 19.35 O1 TRS B 107 coo 32.27 5.62 48.15 31.93 6.48 51.06 10.89 -28.76 16.90 8.49 -30.55 16.32 coo 29.64 3.64 57.39 31.22 5.14 55.65 12.41 -21.54 20.17 10.64 -19.48 20.79 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 13.91 -13.27 16.06 15.24 -13.79 14.55 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 92 ARG^? 29.81 MG MG A 106 D 101 TYR A 65 TYR^? 20.31 MG MG A 106 D 173 ASP A 73 ASP.? 24.66 MG MG A 106 coo 69.08 8.58 32.60 69.70 10.81 30.58 4.92 8.97 23.23 2.03 9.56 22.51 coo 71.77 11.86 24.26 70.23 12.22 26.56 15.06 9.60 24.66 17.54 9.96 23.42 coo 71.60 6.14 19.25 70.26 6.87 20.69 11.88 18.46 25.62 13.34 17.78 24.18 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR B 47 TYR^? 12.23 O1 TRS B 107 B 173 ASP B 21 ASP.? 19.35 O1 TRS B 107 D 48 ARG B 92 ARG^? 5.10 O1 TRS B 107 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 12.41 -21.54 20.17 10.64 -19.48 20.79 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 13.91 -13.27 16.06 15.24 -13.79 14.55 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 10.89 -28.76 16.90 8.49 -30.55 16.32 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1cs1_c03 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 81 ASP.? 9.35 MG MG A 106 A 56 ILE A 85 ILE^? 18.53 MG MG A 106 A 82 TYR A 66 TYR^? 18.96 MG MG A 106 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 18.32 7.36 35.53 19.95 8.35 34.55 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 6.56 7.35 36.39 6.82 6.75 35.12 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 9.99 9.72 31.21 7.76 10.46 32.78 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP B 81 ASP.? 16.51 N TRS B 107 A 56 ILE B 85 ILE^? 16.15 MG A MG B 106 A 82 TYR B 66 TYR^? 13.48 N TRS B 107 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 20.33 -29.96 27.28 19.57 -29.14 26.35 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 14.02 -31.53 25.24 16.67 -32.32 24.84 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 2 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 81 ASP.? 9.35 MG MG A 106 B 56 ILE A 85 ILE^? 18.53 MG MG A 106 B 82 TYR A 66 TYR^? 18.96 MG MG A 106 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 18.32 7.36 35.53 19.95 8.35 34.55 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 6.56 7.35 36.39 6.82 6.75 35.12 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 9.99 9.72 31.21 7.76 10.46 32.78 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP B 81 ASP.? 16.51 N TRS B 107 B 56 ILE B 85 ILE^? 16.15 MG A MG B 106 B 82 TYR B 66 TYR^? 13.48 N TRS B 107 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 20.33 -29.96 27.28 19.57 -29.14 26.35 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 14.02 -31.53 25.24 16.67 -32.32 24.84 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 2 hits 1d6o_c01 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 10 THR^? 20.08 MG MG A 106 A 45 THR B 10 THR^? 20.10 MG MG A 106 A 161 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 26.16 88.25 79.16 25.22 89.47 80.71 15.81 -11.85 48.47 15.03 -11.36 50.46 coo 27.73 89.90 76.08 29.24 91.46 75.95 20.48 -13.14 46.88 21.84 -14.55 47.85 coo 33.83 91.15 88.62 31.07 91.06 83.02 8.74 -17.74 39.05 7.96 -22.88 42.54 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 44 THR B 10 THR^? 20.10 MG MG A 106 A 45 THR A 10 THR^? 20.08 MG MG A 106 A 161 LYS B 14 LYS.? 6.95 MG MG A 106 coo 26.16 88.25 79.16 25.22 89.47 80.71 20.48 -13.14 46.88 21.84 -14.55 47.85 coo 27.73 89.90 76.08 29.24 91.46 75.95 15.81 -11.85 48.47 15.03 -11.36 50.46 coo 33.83 91.15 88.62 31.07 91.06 83.02 21.12 -5.80 35.93 24.74 -1.53 38.99 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 2 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 10 THR^? 20.08 MG MG A 106 B 45 THR B 10 THR^? 20.10 MG MG A 106 B 161 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 7.39 128.28 94.56 8.34 126.36 94.79 15.81 -11.85 48.47 15.03 -11.36 50.46 coo 5.75 129.25 91.25 4.29 128.16 90.07 20.48 -13.14 46.88 21.84 -14.55 47.85 coo -0.17 119.75 99.65 2.51 123.83 95.70 8.74 -17.74 39.05 7.96 -22.88 42.54 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 44 THR B 10 THR^? 20.10 MG MG A 106 B 45 THR A 10 THR^? 20.08 MG MG A 106 B 161 LYS B 14 LYS.? 6.95 MG MG A 106 coo 7.39 128.28 94.56 8.34 126.36 94.79 20.48 -13.14 46.88 21.84 -14.55 47.85 coo 5.75 129.25 91.25 4.29 128.16 90.07 15.81 -11.85 48.47 15.03 -11.36 50.46 coo -0.17 119.75 99.65 2.51 123.83 95.70 21.12 -5.80 35.93 24.74 -1.53 38.99 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 2 hits 1dhp_c03 naa= 3 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 1 3 # 1 A 80 SER A 61 SER^? 13.76 MG MG A 106 A 208 ASP A 81 ASP.? 9.35 MG MG A 106 A 236 HIS A 78 HIS.? 11.19 MG MG A 106 coo 49.19 42.85 125.39 50.92 43.54 123.63 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 57.80 42.94 129.59 56.47 43.28 127.93 18.32 7.36 35.53 19.95 8.35 34.55 coo 55.54 41.70 125.00 53.71 42.50 124.53 21.83 6.49 31.11 22.88 8.20 31.70 1dwo_c00 source 1dwo HYDROXYNITRILE LYASE : 1 hits 1dwo_c00 naa= 3 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 1 3 # 1 B 80 SER A 61 SER^? 13.76 MG MG A 106 B 208 ASP A 81 ASP.? 9.35 MG MG A 106 B 236 HIS A 78 HIS.? 11.19 MG MG A 106 coo 55.25 19.46 97.60 53.04 19.32 98.76 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 57.34 11.46 102.30 56.11 13.10 101.70 18.32 7.36 35.53 19.95 8.35 34.55 coo 55.03 16.17 103.08 54.39 17.23 101.45 21.83 6.49 31.11 22.88 8.20 31.70 1dwo_c01 source 1dwo HYDROXYNITRILE LYASE : 1 hits 1dwo_c01 naa= 3 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 1 3 # 1 A 99 HIS A 78 HIS.? 11.19 MG MG A 106 A 177 ASP A 81 ASP.? 9.35 MG MG A 106 A 203 LYS B 14 LYS.? 6.95 MG MG A 106 coo 8.74 45.76 47.19 9.33 46.93 45.56 21.83 6.49 31.11 22.88 8.20 31.70 coo 11.68 42.31 52.96 12.05 43.92 51.65 18.32 7.36 35.53 19.95 8.35 34.55 coo 18.07 52.81 49.62 14.17 49.99 48.07 21.12 -5.80 35.93 24.74 -1.53 38.99 1ecx_c02 source 1ecx AMINOTRANSFERASE : 1 hits 1ecx_c02 naa= 3 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 1 3 # 1 B 99 HIS A 78 HIS.? 11.19 MG MG A 106 B 177 ASP A 81 ASP.? 9.35 MG MG A 106 B 203 LYS B 14 LYS.? 6.95 MG MG A 106 coo 14.87 88.04 21.51 13.64 87.90 19.81 21.83 6.49 31.11 22.88 8.20 31.70 coo 15.87 92.46 27.37 14.46 91.76 25.94 18.32 7.36 35.53 19.95 8.35 34.55 coo 3.60 91.42 23.52 8.20 89.55 22.63 21.12 -5.80 35.93 24.74 -1.53 38.99 1ecx_c03 source 1ecx AMINOTRANSFERASE : 1 hits 1ecx_c03 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS A 78 HIS.? 11.19 MG MG A 106 A 197 ASP A 81 ASP.? 9.35 MG MG A 106 A 223 LYS B 14 LYS.? 6.95 MG MG A 106 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 21.83 6.49 31.11 22.88 8.20 31.70 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 18.32 7.36 35.53 19.95 8.35 34.55 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 A 114 HIS B 78 HIS^? 12.04 O3 TRS B 107 A 197 ASP B 81 ASP.? 16.51 N TRS B 107 A 223 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 4.34 -30.02 32.49 3.20 -30.88 30.99 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 9.98 -30.67 34.70 8.29 -31.92 34.80 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 8.74 -17.74 39.05 7.96 -22.88 42.54 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 2 hits 1elq_c02 naa= 3 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 B 114 HIS A 78 HIS.? 11.19 MG MG A 106 B 197 ASP A 81 ASP.? 9.35 MG MG A 106 B 223 LYS B 14 LYS.? 6.95 MG MG A 106 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 21.83 6.49 31.11 22.88 8.20 31.70 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 18.32 7.36 35.53 19.95 8.35 34.55 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 B 114 HIS B 78 HIS^? 12.04 O3 TRS B 107 B 197 ASP B 81 ASP.? 16.51 N TRS B 107 B 223 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 4.34 -30.02 32.49 3.20 -30.88 30.99 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 9.98 -30.67 34.70 8.29 -31.92 34.80 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 8.74 -17.74 39.05 7.96 -22.88 42.54 1elq_c03 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 2 hits 1elq_c03 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 11 ALA^? 22.31 MG MG A 106 A 257 ALA A 9 ALA^? 16.42 MG MG A 106 A 328 ASP A 33 ASP.? 14.12 MG MG A 106 coo 39.84 24.12 8.44 38.50 24.23 9.11 13.43 -13.51 46.02 12.15 -13.77 46.76 coo 43.22 26.73 5.37 41.81 27.09 5.79 17.85 -9.53 46.38 17.64 -10.28 45.04 coo 38.17 34.10 6.67 37.72 32.06 6.84 15.57 -3.11 51.57 14.43 -2.38 49.92 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA B 11 ALA^? 15.97 MG MG A 106 A 257 ALA B 9 ALA^? 20.86 MG MG A 106 A 328 ASP B 33 ASP.? 27.59 MG MG A 106 coo 39.84 24.12 8.44 38.50 24.23 9.11 21.39 -11.21 43.66 22.89 -11.27 43.43 coo 43.22 26.73 5.37 41.81 27.09 5.79 17.76 -15.45 45.57 17.28 -15.07 44.14 coo 38.17 34.10 6.67 37.72 32.06 6.84 22.46 -22.72 47.13 22.23 -22.78 45.03 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 2 hits 1eo7_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 40 THR.? 19.17 MG MG A 106 A 159 LYS B 14 LYS.? 6.95 MG MG A 106 A 193 GLU B 26 GLU^? 16.98 MG A MG B 106 coo -2.58 16.31 54.79 -4.02 14.93 55.64 10.97 -5.43 33.62 9.26 -4.14 33.42 coo 2.10 10.68 61.44 -2.14 13.16 60.61 21.12 -5.80 35.93 24.74 -1.53 38.99 coo -5.33 11.71 69.72 -4.62 11.92 67.73 20.09 -15.15 29.16 20.65 -16.86 27.99 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR B 40 THR.? 20.45 MG A MG B 106 A 159 LYS A 14 LYS.? 24.61 C2 TRS B 107 A 193 GLU A 26 GLU^? 23.08 MG MG A 106 coo -2.58 16.31 54.79 -4.02 14.93 55.64 15.40 -17.32 31.26 16.66 -18.43 29.90 coo 2.10 10.68 61.44 -2.14 13.16 60.61 8.74 -17.74 39.05 7.96 -22.88 42.54 coo -5.33 11.71 69.72 -4.62 11.92 67.73 6.59 -6.32 33.57 4.76 -5.37 34.00 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 2 hits 1et0_c02 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 73 ASP.? 24.66 MG MG A 106 260 GLU A 76 GLU^? 15.65 MG MG A 106 370 TYR A 65 TYR^? 20.31 MG MG A 106 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 11.88 18.46 25.62 13.34 17.78 24.18 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 19.27 9.35 28.47 21.14 9.50 27.54 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 15.06 9.60 24.66 17.54 9.96 23.42 1euu_c00 source 1euu SIALIDASE : 1 hits 1euu_c00 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS A 78 HIS.? 11.19 MG MG A 106 C 62 LYS B 14 LYS.? 6.95 MG MG A 106 F 35 ASP A 81 ASP.? 9.35 MG MG A 106 coo 15.40 22.79 16.66 13.93 24.10 15.98 21.83 6.49 31.11 22.88 8.20 31.70 coo 19.95 18.98 4.81 18.82 20.94 10.49 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 16.32 15.30 17.19 17.71 14.73 18.69 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 2 3 # 2 A 105 HIS B 78 HIS^? 12.04 O3 TRS B 107 C 62 LYS A 14 LYS.? 24.61 C2 TRS B 107 F 35 ASP B 81 ASP.? 16.51 N TRS B 107 coo 15.40 22.79 16.66 13.93 24.10 15.98 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 19.95 18.98 4.81 18.82 20.94 10.49 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 16.32 15.30 17.19 17.71 14.73 18.69 9.98 -30.67 34.70 8.29 -31.92 34.80 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 2 hits 1f80_c03 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS A 14 LYS.? 24.61 C2 TRS B 107 C 105 HIS B 78 HIS^? 12.04 O3 TRS B 107 D 35 ASP B 81 ASP.? 16.51 N TRS B 107 coo 38.76 28.25 7.87 36.33 26.41 13.58 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 34.93 19.72 17.37 34.72 18.17 15.98 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 41.01 23.02 20.83 40.65 24.26 22.55 9.98 -30.67 34.70 8.29 -31.92 34.80 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 2 3 # 2 B 62 LYS B 14 LYS.? 6.95 MG MG A 106 C 105 HIS A 78 HIS.? 11.19 MG MG A 106 D 35 ASP A 81 ASP.? 9.35 MG MG A 106 coo 38.76 28.25 7.87 36.33 26.41 13.58 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 34.93 19.72 17.37 34.72 18.17 15.98 21.83 6.49 31.11 22.88 8.20 31.70 coo 41.01 23.02 20.83 40.65 24.26 22.55 18.32 7.36 35.53 19.95 8.35 34.55 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 2 hits 1f80_c04 naa= 3 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 1 3 # 1 A 62 LYS A 14 LYS.? 24.61 C2 TRS B 107 B 105 HIS B 78 HIS^? 12.04 O3 TRS B 107 E 35 ASP B 81 ASP.? 16.51 N TRS B 107 coo 20.51 39.76 8.83 21.23 37.38 14.18 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 27.18 37.56 20.68 29.07 38.28 20.13 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 19.97 40.39 22.03 18.53 39.30 23.18 9.98 -30.67 34.70 8.29 -31.92 34.80 1f80_c05 source 1f80 ACYL CARRIER PROTEIN : 1 hits 1f80_c05 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS A 78 HIS.? 11.19 MG MG A 106 A 210 ASP A 81 ASP.? 9.35 MG MG A 106 A 244 LYS B 14 LYS.? 6.95 MG MG A 106 coo 11.28 44.53 18.60 9.91 46.00 19.20 21.83 6.49 31.11 22.88 8.20 31.70 coo 10.51 37.86 19.71 9.07 39.38 20.04 18.32 7.36 35.53 19.95 8.35 34.55 coo -1.20 42.34 17.67 3.19 45.13 19.06 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 136 HIS B 78 HIS^? 12.04 O3 TRS B 107 A 210 ASP B 81 ASP.? 16.51 N TRS B 107 A 244 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 11.28 44.53 18.60 9.91 46.00 19.20 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 10.51 37.86 19.71 9.07 39.38 20.04 9.98 -30.67 34.70 8.29 -31.92 34.80 coo -1.20 42.34 17.67 3.19 45.13 19.06 8.74 -17.74 39.05 7.96 -22.88 42.54 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 2 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS A 78 HIS.? 11.19 MG MG A 106 B 210 ASP A 81 ASP.? 9.35 MG MG A 106 B 244 LYS B 14 LYS.? 6.95 MG MG A 106 coo 10.08 50.18 41.78 8.91 48.61 41.04 21.83 6.49 31.11 22.88 8.20 31.70 coo 9.06 56.85 40.30 7.71 55.27 39.90 18.32 7.36 35.53 19.95 8.35 34.55 coo -2.38 51.82 41.62 2.07 49.19 40.42 21.12 -5.80 35.93 24.74 -1.53 38.99 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 1 hits 1fc4_c05 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 25 SER^? 23.03 C2 TRS B 107 A 48 THR A 40 THR.? 19.17 MG MG A 106 A 165 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 8.15 -8.88 30.15 10.32 -9.84 29.66 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 10.97 -5.43 33.62 9.26 -4.14 33.42 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 8.74 -17.74 39.05 7.96 -22.88 42.54 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER B 25 SER^? 21.93 C2 TRS B 107 A 48 THR B 40 THR.? 20.45 MG A MG B 106 A 165 LYS B 14 LYS.? 6.95 MG MG A 106 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 15.65 -13.25 27.32 13.56 -12.34 28.19 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 15.40 -17.32 31.26 16.66 -18.43 29.90 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 21.12 -5.80 35.93 24.74 -1.53 38.99 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER A 25 SER^? 23.03 C2 TRS B 107 B 48 THR A 40 THR.? 19.17 MG MG A 106 B 165 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 8.15 -8.88 30.15 10.32 -9.84 29.66 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 10.97 -5.43 33.62 9.26 -4.14 33.42 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 8.74 -17.74 39.05 7.96 -22.88 42.54 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER B 25 SER^? 21.93 C2 TRS B 107 B 48 THR B 40 THR.? 20.45 MG A MG B 106 B 165 LYS B 14 LYS.? 6.95 MG MG A 106 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 15.65 -13.25 27.32 13.56 -12.34 28.19 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 15.40 -17.32 31.26 16.66 -18.43 29.90 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 21.12 -5.80 35.93 24.74 -1.53 38.99 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 25 SER^? 23.03 C2 TRS B 107 C 48 THR A 40 THR.? 19.17 MG MG A 106 C 165 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 8.15 -8.88 30.15 10.32 -9.84 29.66 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 10.97 -5.43 33.62 9.26 -4.14 33.42 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 8.74 -17.74 39.05 7.96 -22.88 42.54 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER B 25 SER^? 21.93 C2 TRS B 107 C 48 THR B 40 THR.? 20.45 MG A MG B 106 C 165 LYS B 14 LYS.? 6.95 MG MG A 106 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 15.65 -13.25 27.32 13.56 -12.34 28.19 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 15.40 -17.32 31.26 16.66 -18.43 29.90 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 21.12 -5.80 35.93 24.74 -1.53 38.99 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER A 25 SER^? 23.03 C2 TRS B 107 D 48 THR A 40 THR.? 19.17 MG MG A 106 D 165 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 8.15 -8.88 30.15 10.32 -9.84 29.66 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 10.97 -5.43 33.62 9.26 -4.14 33.42 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 8.74 -17.74 39.05 7.96 -22.88 42.54 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER B 25 SER^? 21.93 C2 TRS B 107 D 48 THR B 40 THR.? 20.45 MG A MG B 106 D 165 LYS B 14 LYS.? 6.95 MG MG A 106 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 15.65 -13.25 27.32 13.56 -12.34 28.19 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 15.40 -17.32 31.26 16.66 -18.43 29.90 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 21.12 -5.80 35.93 24.74 -1.53 38.99 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c07 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU B 94 GLU^? -2.83 O1 TRS B 107s A 47 ASP B 73 ASP.? 13.34 N TRS B 107 A 161 TYR B 65 TYR^? 4.85 N TRS B 107 coo 37.12 18.35 73.76 37.09 16.69 72.44 6.14 -26.56 20.04 4.87 -27.89 19.04 coo 29.81 8.06 73.13 30.21 10.11 72.95 9.64 -40.18 22.89 9.15 -42.09 22.32 coo 37.29 15.56 67.90 37.37 13.79 70.08 5.69 -30.65 23.64 2.95 -31.03 24.05 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 1 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU B 94 GLU^? -2.83 O1 TRS B 107s B 47 ASP B 73 ASP.? 13.34 N TRS B 107 B 161 TYR B 65 TYR^? 4.85 N TRS B 107 coo 53.87 35.49 53.22 55.44 35.72 54.61 6.14 -26.56 20.04 4.87 -27.89 19.04 coo 63.47 43.65 53.95 61.45 43.07 54.06 9.64 -40.18 22.89 9.15 -42.09 22.32 coo 56.38 35.81 59.19 58.25 35.77 57.10 5.69 -30.65 23.64 2.95 -31.03 24.05 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 1 hits 1geq_c03 naa= 3 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 1 3 # 1 13 ASP A 73 ASP.? 24.66 MG MG A 106 41 HIS A 67 HIS^? 25.71 MG MG A 106 224 GLN A 75 GLN^? 15.91 MG MG A 106 coo -3.80 50.71 49.48 -5.59 51.85 49.27 11.88 18.46 25.62 13.34 17.78 24.18 coo -6.45 47.32 41.99 -8.32 46.87 42.83 7.29 12.90 25.70 6.12 14.46 24.97 coo -12.35 49.13 49.89 -13.38 48.89 48.03 14.41 12.99 32.03 13.27 13.05 33.87 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 2 3 # 2 13 ASP B 73 ASP.? 13.34 N TRS B 107 41 HIS B 67 HIS^? 10.25 N TRS B 107 224 GLN B 75 GLN^? 15.11 N TRS B 107 coo -3.80 50.71 49.48 -5.59 51.85 49.27 9.64 -40.18 22.89 9.15 -42.09 22.32 coo -6.45 47.32 41.99 -8.32 46.87 42.83 12.23 -34.37 19.25 12.68 -35.93 17.95 coo -12.35 49.13 49.89 -13.38 48.89 48.03 11.20 -34.51 28.76 13.07 -34.87 29.80 1gim_c00 source 1gim ADENYLOSUCCINATE SYNTHETASE : 2 hits 1gim_c00 naa= 3 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 A 106 ASN B 72 ASN.? 16.16 N TRS B 107 A 108 HIS B 67 HIS^? 10.25 N TRS B 107 A 144 ASP B 73 ASP.? 13.34 N TRS B 107 coo 51.28 61.14 17.85 51.16 61.61 19.96 11.77 -42.42 18.70 13.18 -43.21 17.33 coo 52.62 57.63 23.12 50.77 57.51 22.26 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 46.65 56.95 20.09 48.42 58.17 20.01 9.64 -40.18 22.89 9.15 -42.09 22.32 1grc_c02 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 1 hits 1grc_c02 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS A 78 HIS.? 11.19 MG MG A 106 A 200 ASP A 81 ASP.? 9.35 MG MG A 106 A 226 LYS B 14 LYS.? 6.95 MG MG A 106 coo 23.24 46.58 4.39 24.43 46.59 2.66 21.83 6.49 31.11 22.88 8.20 31.70 coo 24.51 43.28 11.18 25.17 44.50 9.58 18.32 7.36 35.53 19.95 8.35 34.55 coo 34.47 51.09 7.19 28.58 51.18 7.53 21.12 -5.80 35.93 24.74 -1.53 38.99 1i29_c01 source 1i29 CSDB : 1 hits 1i29_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 84 VAL^? 16.25 MG MG A 106 A 200 ASP A 81 ASP.? 9.35 MG MG A 106 A 226 LYS B 14 LYS.? 6.95 MG MG A 106 coo 19.13 38.05 1.41 19.72 38.80 -0.53 8.88 8.96 40.35 7.81 9.40 42.18 coo 24.51 43.28 11.18 25.17 44.50 9.58 18.32 7.36 35.53 19.95 8.35 34.55 coo 34.47 51.09 7.19 28.58 51.18 7.53 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL B 84 VAL^? 20.15 MG A MG B 106 A 200 ASP B 81 ASP.? 16.51 N TRS B 107 A 226 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 19.13 38.05 1.41 19.72 38.80 -0.53 19.97 -32.12 31.62 21.74 -32.70 32.69 coo 24.51 43.28 11.18 25.17 44.50 9.58 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 34.47 51.09 7.19 28.58 51.18 7.53 8.74 -17.74 39.05 7.96 -22.88 42.54 1i29_c03 source 1i29 CSDB : 2 hits 1i29_c03 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER A 16 SER.? 21.37 C2 TRS B 107 A 173 ARG A 24 ARG^? 24.75 MG MG A 106 A 211 ASP B 100 ASP^? 19.56 C2 TRS B 107 coo 22.72 76.24 0.23 24.60 76.86 -1.25 6.77 -13.81 33.93 9.10 -14.03 33.22 coo 18.77 77.82 11.69 20.55 80.22 10.73 6.24 -3.67 29.98 3.39 -2.61 30.35 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 9.71 -18.83 33.97 8.85 -16.99 33.47 ULMN 3 1ig8_c00 HEXOKINASE PII user 2 3 # 2 A 158 SER B 16 SER.? 18.72 MG MG A 106 A 173 ARG B 24 ARG^? 14.88 MG A MG B 106 A 211 ASP A 100 ASP^? 16.25 MG MG A 106 coo 22.72 76.24 0.23 24.60 76.86 -1.25 19.38 -8.95 30.12 17.10 -8.78 30.97 coo 18.77 77.82 11.69 20.55 80.22 10.73 16.79 -18.48 25.10 19.01 -19.70 23.40 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 17.24 -4.20 32.64 17.59 -5.86 31.44 1ig8_c00 source 1ig8 HEXOKINASE PII : 2 hits 1ig8_c00 naa= 3 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 1 3 # 1 A1132 ASP A 73 ASP.? 24.66 MG MG A 106 A1134 ALA A 71 ALA.? 25.01 MG MG A 106 A1137 ASN A 72 ASN.? 29.16 MG MG A 106 coo -27.05 34.58 17.12 -25.81 32.84 17.16 11.88 18.46 25.62 13.34 17.78 24.18 coo -20.53 36.39 15.81 -20.80 35.01 16.40 5.76 17.65 27.92 6.71 16.75 28.65 coo -23.72 34.69 12.49 -24.32 32.83 13.34 8.18 21.40 26.42 8.86 22.63 24.85 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 2 3 # 2 A1132 ASP B 73 ASP.? 13.34 N TRS B 107 A1134 ALA B 71 ALA.? 14.25 N TRS B 107 A1137 ASN B 72 ASN.? 16.16 N TRS B 107 coo -27.05 34.58 17.12 -25.81 32.84 17.16 9.64 -40.18 22.89 9.15 -42.09 22.32 coo -20.53 36.39 15.81 -20.80 35.01 16.40 15.22 -39.46 20.09 14.83 -38.64 21.30 coo -23.72 34.69 12.49 -24.32 32.83 13.34 11.77 -42.42 18.70 13.18 -43.21 17.33 1ir3_c02 source 1ir3 INSULIN RECEPTOR : 2 hits 1ir3_c02 naa= 3 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 1 3 # 1 A 202 SER A 61 SER^? 13.76 MG MG A 106 A 308 ASP A 81 ASP.? 9.35 MG MG A 106 A 338 HIS A 78 HIS.? 11.19 MG MG A 106 coo 37.44 15.05 21.90 37.18 17.02 20.71 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 45.75 18.77 19.41 43.72 18.70 19.99 18.32 7.36 35.53 19.95 8.35 34.55 coo 41.13 18.39 17.83 39.67 17.70 19.17 21.83 6.49 31.11 22.88 8.20 31.70 1jkm_c00 source 1jkm BREFELDIN A ESTERASE : 1 hits 1jkm_c00 naa= 3 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 1 3 # 1 B 202 SER A 61 SER^? 13.76 MG MG A 106 B 308 ASP A 81 ASP.? 9.35 MG MG A 106 B 338 HIS A 78 HIS.? 11.19 MG MG A 106 coo 67.81 2.11 21.29 69.09 3.00 23.04 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 64.20 9.21 26.15 65.67 7.96 25.24 18.32 7.36 35.53 19.95 8.35 34.55 coo 66.92 5.20 26.82 67.69 4.22 25.14 21.83 6.49 31.11 22.88 8.20 31.70 1jkm_c01 source 1jkm BREFELDIN A ESTERASE : 1 hits 1jkm_c01 naa= 3 ULMN 3 1joa_c00 NADH PEROXIDASE user 1 3 # 1 10 HIS B 43 HIS.? 17.46 C2 TRS B 107 41 SER A 19 SER^? 24.19 O2 TRS B 107 303 ARG B 23 ARG.? 13.56 O1 TRS B 107 coo 62.94 54.74 73.45 64.13 56.17 74.27 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 65.67 62.51 70.93 64.56 61.94 68.74 2.67 -7.78 27.23 3.23 -6.16 28.95 coo 63.38 52.38 77.01 66.48 52.75 76.49 9.90 -15.60 19.03 10.94 -17.68 17.04 ULMN 3 1joa_c00 NADH PEROXIDASE user 2 3 # 2 10 HIS B 43 HIS.? 17.46 C2 TRS B 107 41 SER A 25 SER^? 23.03 C2 TRS B 107 303 ARG B 23 ARG.? 13.56 O1 TRS B 107 coo 62.94 54.74 73.45 64.13 56.17 74.27 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 65.67 62.51 70.93 64.56 61.94 68.74 8.15 -8.88 30.15 10.32 -9.84 29.66 coo 63.38 52.38 77.01 66.48 52.75 76.49 9.90 -15.60 19.03 10.94 -17.68 17.04 ULMN 3 1joa_c00 NADH PEROXIDASE user 3 3 # 3 10 HIS B 43 HIS.? 17.46 C2 TRS B 107 41 SER B 25 SER^? 21.93 C2 TRS B 107 303 ARG B 23 ARG.? 13.56 O1 TRS B 107 coo 62.94 54.74 73.45 64.13 56.17 74.27 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 65.67 62.51 70.93 64.56 61.94 68.74 15.65 -13.25 27.32 13.56 -12.34 28.19 coo 63.38 52.38 77.01 66.48 52.75 76.49 9.90 -15.60 19.03 10.94 -17.68 17.04 ULMN 3 1joa_c00 NADH PEROXIDASE user 4 3 # 4 10 HIS B 67 HIS^? 10.25 N TRS B 107 41 SER B 90 SER^? 13.47 MG A MG B 106 303 ARG B 92 ARG^? 5.10 O1 TRS B 107 coo 62.94 54.74 73.45 64.13 56.17 74.27 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 65.67 62.51 70.93 64.56 61.94 68.74 20.80 -30.45 18.82 19.90 -29.83 16.69 coo 63.38 52.38 77.01 66.48 52.75 76.49 10.89 -28.76 16.90 8.49 -30.55 16.32 1joa_c00 source 1joa NADH PEROXIDASE : 4 hits 1joa_c00 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU A 26 GLU^? 23.08 MG MG A 106 A 163 ARG A 17 ARG^? 24.52 MG MG A 106 A 222 ARG A 24 ARG^? 24.75 MG MG A 106 coo 51.27 81.34 48.31 51.67 80.79 50.28 6.59 -6.32 33.57 4.76 -5.37 34.00 coo 48.06 78.22 50.94 48.51 78.27 53.98 2.20 -10.40 35.71 4.44 -9.62 37.71 coo 54.85 84.16 52.60 54.26 81.23 53.34 6.24 -3.67 29.98 3.39 -2.61 30.35 ULMN 3 1kim_c00 THYMIDINE KINASE user 2 3 # 2 A 83 GLU A 26 GLU^? 23.08 MG MG A 106 A 163 ARG A 24 ARG^? 24.75 MG MG A 106 A 222 ARG A 17 ARG^? 24.52 MG MG A 106 coo 51.27 81.34 48.31 51.67 80.79 50.28 6.59 -6.32 33.57 4.76 -5.37 34.00 coo 48.06 78.22 50.94 48.51 78.27 53.98 6.24 -3.67 29.98 3.39 -2.61 30.35 coo 54.85 84.16 52.60 54.26 81.23 53.34 2.20 -10.40 35.71 4.44 -9.62 37.71 ULMN 3 1kim_c00 THYMIDINE KINASE user 3 3 # 3 A 83 GLU B 26 GLU^? 16.98 MG A MG B 106 A 163 ARG B 17 ARG^? 19.62 MG A MG B 106 A 222 ARG B 24 ARG^? 14.88 MG A MG B 106 coo 51.27 81.34 48.31 51.67 80.79 50.28 20.09 -15.15 29.16 20.65 -16.86 27.99 coo 48.06 78.22 50.94 48.51 78.27 53.98 24.18 -12.31 28.78 23.30 -13.33 31.55 coo 54.85 84.16 52.60 54.26 81.23 53.34 16.79 -18.48 25.10 19.01 -19.70 23.40 ULMN 3 1kim_c00 THYMIDINE KINASE user 4 3 # 4 A 83 GLU B 26 GLU^? 16.98 MG A MG B 106 A 163 ARG B 24 ARG^? 14.88 MG A MG B 106 A 222 ARG B 17 ARG^? 19.62 MG A MG B 106 coo 51.27 81.34 48.31 51.67 80.79 50.28 20.09 -15.15 29.16 20.65 -16.86 27.99 coo 48.06 78.22 50.94 48.51 78.27 53.98 16.79 -18.48 25.10 19.01 -19.70 23.40 coo 54.85 84.16 52.60 54.26 81.23 53.34 24.18 -12.31 28.78 23.30 -13.33 31.55 1kim_c00 source 1kim THYMIDINE KINASE : 4 hits 1kim_c00 naa= 3 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 1 3 # 1 A 290 ARG A 23 ARG.? 26.26 O2 TRS B 107 A 351 HIS A 43 HIS.? 24.06 C2 TRS B 107 A 386 LEU A 20 LEU.? 25.75 O2 TRS B 107 coo 57.36 53.34 128.83 58.45 50.56 128.34 7.13 -4.89 20.32 8.16 -2.85 18.32 coo 60.60 50.64 133.59 60.63 48.82 132.56 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 63.28 54.23 126.45 63.53 52.07 126.70 3.87 -4.16 24.96 3.32 -2.51 26.31 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 2 3 # 2 A 290 ARG A 92 ARG^? 29.81 MG MG A 106 A 351 HIS A 67 HIS^? 25.71 MG MG A 106 A 386 LEU A 93 LEU^? 19.58 MG MG A 106 coo 57.36 53.34 128.83 58.45 50.56 128.34 4.92 8.97 23.23 2.03 9.56 22.51 coo 60.60 50.64 133.59 60.63 48.82 132.56 7.29 12.90 25.70 6.12 14.46 24.97 coo 63.28 54.23 126.45 63.53 52.07 126.70 9.51 4.13 27.64 9.84 4.23 29.78 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 3 3 # 3 A 290 ARG B 23 ARG.? 13.56 O1 TRS B 107 A 351 HIS B 43 HIS.? 17.46 C2 TRS B 107 A 386 LEU B 20 LEU.? 17.06 O1 TRS B 107 coo 57.36 53.34 128.83 58.45 50.56 128.34 9.90 -15.60 19.03 10.94 -17.68 17.04 coo 60.60 50.64 133.59 60.63 48.82 132.56 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 63.28 54.23 126.45 63.53 52.07 126.70 15.45 -16.97 19.93 16.63 -18.81 20.38 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 4 3 # 4 A 290 ARG B 92 ARG^? 5.10 O1 TRS B 107 A 351 HIS B 67 HIS^? 10.25 N TRS B 107 A 386 LEU B 93 LEU^? 11.62 N TRS B 107 coo 57.36 53.34 128.83 58.45 50.56 128.34 10.89 -28.76 16.90 8.49 -30.55 16.32 coo 60.60 50.64 133.59 60.63 48.82 132.56 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 63.28 54.23 126.45 63.53 52.07 126.70 12.94 -26.06 22.98 12.69 -25.94 25.16 1knp_c00 source 1knp L-ASPARTATE OXIDASE : 4 hits 1knp_c00 naa= 3 ULMN 3 1lci_c00 LUCIFERASE user 1 3 # 1 218 ARG B 24 ARG^? 14.88 MG A MG B 106 245 HIS B 37 HIS.? 23.74 MG A MG B 106 343 THR B 56 THR^? 21.43 MG A MG B 106 coo 18.11 85.25 41.19 18.04 83.33 43.59 16.79 -18.48 25.10 19.01 -19.70 23.40 coo 5.34 86.23 43.48 6.16 87.26 45.12 21.69 -21.14 38.43 22.55 -22.53 39.75 coo 9.06 92.76 42.80 7.04 92.63 42.14 20.84 -28.16 33.58 21.33 -29.01 35.51 1lci_c00 source 1lci LUCIFERASE : 1 hits 1lci_c00 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 32 ALA.? 14.79 MG MG A 106 A 317 GLY A 34 GLY.? 18.62 MG MG A 106 A 318 ASP A 33 ASP.? 14.12 MG MG A 106 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 17.33 -7.26 49.84 18.81 -6.93 49.85 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 12.15 -6.45 51.43 12.31 -5.88 50.91 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 15.57 -3.11 51.57 14.43 -2.38 49.92 ULMN 3 1lij_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA A 79 ALA.? 8.97 MG MG A 106 A 317 GLY A 80 GLY.? 5.31 MG MG A 106 A 318 ASP A 81 ASP.? 9.35 MG MG A 106 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 21.53 2.78 33.99 22.71 1.85 33.69 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 21.40 4.18 37.49 20.81 4.36 37.01 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 1lij_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA B 32 ALA.? 24.99 MG MG A 106 A 317 GLY B 34 GLY.? 23.96 MG MG A 106 A 318 ASP B 33 ASP.? 27.59 MG MG A 106 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 20.24 -18.50 47.99 18.99 -18.97 48.80 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 25.27 -18.98 46.10 24.83 -19.43 45.63 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 22.46 -22.72 47.13 22.23 -22.78 45.03 ULMN 3 1lij_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA B 79 ALA.? 18.26 C2 TRS B 107 A 317 GLY B 80 GLY.? 20.50 N TRS B 107 A 318 ASP B 81 ASP.? 16.51 N TRS B 107 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 6.61 -26.34 36.32 5.53 -25.53 37.02 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 8.91 -28.16 38.69 9.02 -28.24 37.93 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 9.98 -30.67 34.70 8.29 -31.92 34.80 1lij_c01 source 1lij ADENOSINE KINASE : 4 hits 1lij_c01 naa= 3 ULMN 3 1lio_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 32 ALA.? 14.79 MG MG A 106 A 317 GLY A 34 GLY.? 18.62 MG MG A 106 A 318 ASP A 33 ASP.? 14.12 MG MG A 106 coo 27.04 23.54 41.85 25.72 24.19 42.18 17.33 -7.26 49.84 18.81 -6.93 49.85 coo 27.87 23.16 38.17 28.43 22.97 38.87 12.15 -6.45 51.43 12.31 -5.88 50.91 coo 32.11 22.71 40.58 33.42 24.22 39.78 15.57 -3.11 51.57 14.43 -2.38 49.92 ULMN 3 1lio_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA A 79 ALA.? 8.97 MG MG A 106 A 317 GLY A 80 GLY.? 5.31 MG MG A 106 A 318 ASP A 81 ASP.? 9.35 MG MG A 106 coo 27.04 23.54 41.85 25.72 24.19 42.18 21.53 2.78 33.99 22.71 1.85 33.69 coo 27.87 23.16 38.17 28.43 22.97 38.87 21.40 4.18 37.49 20.81 4.36 37.01 coo 32.11 22.71 40.58 33.42 24.22 39.78 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 1lio_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA B 32 ALA.? 24.99 MG MG A 106 A 317 GLY B 34 GLY.? 23.96 MG MG A 106 A 318 ASP B 33 ASP.? 27.59 MG MG A 106 coo 27.04 23.54 41.85 25.72 24.19 42.18 20.24 -18.50 47.99 18.99 -18.97 48.80 coo 27.87 23.16 38.17 28.43 22.97 38.87 25.27 -18.98 46.10 24.83 -19.43 45.63 coo 32.11 22.71 40.58 33.42 24.22 39.78 22.46 -22.72 47.13 22.23 -22.78 45.03 ULMN 3 1lio_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA B 79 ALA.? 18.26 C2 TRS B 107 A 317 GLY B 80 GLY.? 20.50 N TRS B 107 A 318 ASP B 81 ASP.? 16.51 N TRS B 107 coo 27.04 23.54 41.85 25.72 24.19 42.18 6.61 -26.34 36.32 5.53 -25.53 37.02 coo 27.87 23.16 38.17 28.43 22.97 38.87 8.91 -28.16 38.69 9.02 -28.24 37.93 coo 32.11 22.71 40.58 33.42 24.22 39.78 9.98 -30.67 34.70 8.29 -31.92 34.80 1lio_c01 source 1lio ADENOSINE KINASE : 4 hits 1lio_c01 naa= 3 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 1 3 # 1 A 123 LYS A 14 LYS.? 24.61 C2 TRS B 107 A 202 SER A 28 SER^? 23.29 MG MG A 106 A 226 SER A 38 SER.? 20.21 MG MG A 106 coo 1.62 6.10 69.30 3.81 1.25 65.91 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 4.43 1.89 61.79 4.31 0.09 63.40 7.93 -9.68 40.46 5.50 -9.56 40.62 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 2 3 # 2 A 123 LYS B 14 LYS.? 6.95 MG MG A 106 A 202 SER B 28 SER^? 20.11 MG MG A 106 A 226 SER B 38 SER.? 19.23 MG A MG B 106 coo 1.62 6.10 69.30 3.81 1.25 65.91 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 4.43 1.89 61.79 4.31 0.09 63.40 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 20.61 -17.82 33.77 20.60 -17.17 31.49 1m21_c00 source 1m21 PEPTIDE AMIDASE : 2 hits 1m21_c00 naa= 3 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 1 3 # 1 B 123 LYS A 14 LYS.? 24.61 C2 TRS B 107 B 202 SER A 28 SER^? 23.29 MG MG A 106 B 226 SER A 38 SER.? 20.21 MG MG A 106 coo 35.67 -0.01 18.11 33.47 4.84 14.73 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 32.81 4.27 10.70 32.87 6.07 12.31 7.93 -9.68 40.46 5.50 -9.56 40.62 coo 28.77 6.36 12.44 30.83 7.25 11.75 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 2 3 # 2 B 123 LYS B 14 LYS.? 6.95 MG MG A 106 B 202 SER B 28 SER^? 20.11 MG MG A 106 B 226 SER B 38 SER.? 19.23 MG A MG B 106 coo 35.67 -0.01 18.11 33.47 4.84 14.73 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 32.81 4.27 10.70 32.87 6.07 12.31 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 28.77 6.36 12.44 30.83 7.25 11.75 20.61 -17.82 33.77 20.60 -17.17 31.49 1m21_c01 source 1m21 PEPTIDE AMIDASE : 2 hits 1m21_c01 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP B 81 ASP.? 16.51 N TRS B 107 A 265 GLU B 94 GLU^? -2.83 O1 TRS B 107s A 369 ASP B 100 ASP^? 19.56 C2 TRS B 107 coo 11.74 38.14 80.19 10.63 36.40 80.65 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 17.36 23.57 72.04 18.68 21.92 71.98 6.14 -26.56 20.04 4.87 -27.89 19.04 coo 12.19 31.08 87.29 11.13 32.66 86.38 9.71 -18.83 33.97 8.85 -16.99 33.47 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 1 hits 1m53_c05 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG A 24 ARG^? 24.75 MG MG A 106 229 SER A 38 SER.? 20.21 MG MG A 106 325 GLU A 26 GLU^? 23.08 MG MG A 106 coo 2.54 15.84 18.57 3.24 17.85 16.30 6.24 -3.67 29.98 3.39 -2.61 30.35 coo 10.17 13.48 15.92 9.61 15.76 15.27 8.35 -5.49 38.91 7.27 -5.53 36.78 coo 5.42 13.04 19.75 5.74 13.81 17.79 6.59 -6.32 33.57 4.76 -5.37 34.00 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 2 3 # 2 159 ARG B 17 ARG^? 19.62 MG A MG B 106 229 SER B 19 SER^? 16.73 MG A MG B 106 325 GLU B 26 GLU^? 16.98 MG A MG B 106 coo 2.54 15.84 18.57 3.24 17.85 16.30 24.18 -12.31 28.78 23.30 -13.33 31.55 coo 10.17 13.48 15.92 9.61 15.76 15.27 18.16 -13.84 21.51 18.56 -15.70 23.02 coo 5.42 13.04 19.75 5.74 13.81 17.79 20.09 -15.15 29.16 20.65 -16.86 27.99 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 3 3 # 3 159 ARG B 17 ARG^? 19.62 MG A MG B 106 229 SER B 25 SER^? 21.93 C2 TRS B 107 325 GLU B 26 GLU^? 16.98 MG A MG B 106 coo 2.54 15.84 18.57 3.24 17.85 16.30 24.18 -12.31 28.78 23.30 -13.33 31.55 coo 10.17 13.48 15.92 9.61 15.76 15.27 15.65 -13.25 27.32 13.56 -12.34 28.19 coo 5.42 13.04 19.75 5.74 13.81 17.79 20.09 -15.15 29.16 20.65 -16.86 27.99 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 4 3 # 4 159 ARG B 17 ARG^? 19.62 MG A MG B 106 229 SER B 28 SER^? 20.11 MG MG A 106 325 GLU B 26 GLU^? 16.98 MG A MG B 106 coo 2.54 15.84 18.57 3.24 17.85 16.30 24.18 -12.31 28.78 23.30 -13.33 31.55 coo 10.17 13.48 15.92 9.61 15.76 15.27 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 5.42 13.04 19.75 5.74 13.81 17.79 20.09 -15.15 29.16 20.65 -16.86 27.99 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 5 3 # 5 159 ARG B 17 ARG^? 19.62 MG A MG B 106 229 SER B 38 SER.? 19.23 MG A MG B 106 325 GLU B 26 GLU^? 16.98 MG A MG B 106 coo 2.54 15.84 18.57 3.24 17.85 16.30 24.18 -12.31 28.78 23.30 -13.33 31.55 coo 10.17 13.48 15.92 9.61 15.76 15.27 20.61 -17.82 33.77 20.60 -17.17 31.49 coo 5.42 13.04 19.75 5.74 13.81 17.79 20.09 -15.15 29.16 20.65 -16.86 27.99 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 5 hits 1mbb_c00 naa= 3 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 B 199 HIS B 43 HIS.? 17.46 C2 TRS B 107 B 246 HIS A 43 HIS.? 24.06 C2 TRS B 107 B 255 TYR A 47 TYR^? 25.20 MG MG A 106 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 6.73 0.56 24.29 8.36 -1.29 22.99 1mpy_c01 source 1mpy CATECHOL 2,3-DIOXYGENASE : 1 hits 1mpy_c01 naa= 3 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 C 199 HIS B 43 HIS.? 17.46 C2 TRS B 107 C 246 HIS A 43 HIS.? 24.06 C2 TRS B 107 C 255 TYR A 47 TYR^? 25.20 MG MG A 106 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 6.73 0.56 24.29 8.36 -1.29 22.99 1mpy_c02 source 1mpy CATECHOL 2,3-DIOXYGENASE : 1 hits 1mpy_c02 naa= 3 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 D 199 HIS B 43 HIS.? 17.46 C2 TRS B 107 D 246 HIS A 43 HIS.? 24.06 C2 TRS B 107 D 255 TYR A 47 TYR^? 25.20 MG MG A 106 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 6.73 0.56 24.29 8.36 -1.29 22.99 1mpy_c03 source 1mpy CATECHOL 2,3-DIOXYGENASE : 1 hits 1mpy_c03 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 0 GLY.? 21.04 MG MG A 106 A 501 ASP A 33 ASP.? 14.12 MG MG A 106 B 367 TYR B 47 TYR^? 12.23 O1 TRS B 107 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 30.68 -14.77 37.51 30.70 -14.13 38.06 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 15.57 -3.11 51.57 14.43 -2.38 49.92 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 12.41 -21.54 20.17 10.64 -19.48 20.79 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 0 GLY.? 21.04 MG MG A 106 A 501 ASP A 33 ASP.? 14.12 MG MG A 106 B 367 TYR B 66 TYR^? 13.48 N TRS B 107 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 30.68 -14.77 37.51 30.70 -14.13 38.06 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 15.57 -3.11 51.57 14.43 -2.38 49.92 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 14.02 -31.53 25.24 16.67 -32.32 24.84 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY A 13 GLY^? 24.25 MG MG A 106 A 501 ASP A 81 ASP.? 9.35 MG MG A 106 B 367 TYR B 91 TYR^? 15.35 N TRS B 107 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 9.06 -14.52 41.03 9.77 -14.73 40.69 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 18.32 7.36 35.53 19.95 8.35 34.55 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 17.61 -29.10 22.17 18.36 -26.78 23.51 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY B 0 GLY.? 26.84 MG MG A 106 A 501 ASP B 33 ASP.? 27.59 MG MG A 106 B 367 TYR A 47 TYR^? 25.20 MG MG A 106 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 2.31 -10.32 47.70 2.75 -10.98 48.04 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 22.46 -22.72 47.13 22.23 -22.78 45.03 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 6.73 0.56 24.29 8.36 -1.29 22.99 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY B 0 GLY.? 26.84 MG MG A 106 A 501 ASP B 33 ASP.? 27.59 MG MG A 106 B 367 TYR A 66 TYR^? 18.96 MG MG A 106 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 2.31 -10.32 47.70 2.75 -10.98 48.04 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 22.46 -22.72 47.13 22.23 -22.78 45.03 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 9.99 9.72 31.21 7.76 10.46 32.78 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 5 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 0 GLY.? 21.04 MG MG A 106 D 501 ASP A 33 ASP.? 14.12 MG MG A 106 E 367 TYR B 47 TYR^? 12.23 O1 TRS B 107 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 30.68 -14.77 37.51 30.70 -14.13 38.06 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 15.57 -3.11 51.57 14.43 -2.38 49.92 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 12.41 -21.54 20.17 10.64 -19.48 20.79 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 0 GLY.? 21.04 MG MG A 106 D 501 ASP A 33 ASP.? 14.12 MG MG A 106 E 367 TYR B 66 TYR^? 13.48 N TRS B 107 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 30.68 -14.77 37.51 30.70 -14.13 38.06 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 15.57 -3.11 51.57 14.43 -2.38 49.92 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 14.02 -31.53 25.24 16.67 -32.32 24.84 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY B 0 GLY.? 26.84 MG MG A 106 D 501 ASP B 33 ASP.? 27.59 MG MG A 106 E 367 TYR A 47 TYR^? 25.20 MG MG A 106 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 2.31 -10.32 47.70 2.75 -10.98 48.04 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 22.46 -22.72 47.13 22.23 -22.78 45.03 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 6.73 0.56 24.29 8.36 -1.29 22.99 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY B 0 GLY.? 26.84 MG MG A 106 D 501 ASP B 33 ASP.? 27.59 MG MG A 106 E 367 TYR A 66 TYR^? 18.96 MG MG A 106 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 2.31 -10.32 47.70 2.75 -10.98 48.04 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 22.46 -22.72 47.13 22.23 -22.78 45.03 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 9.99 9.72 31.21 7.76 10.46 32.78 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 4 hits 1mro_c01 naa= 3 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 A 142 LYS A 14 LYS.? 24.61 C2 TRS B 107 A 217 SER A 28 SER^? 23.29 MG MG A 106 A 241 SER A 38 SER.? 20.21 MG MG A 106 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 7.93 -9.68 40.46 5.50 -9.56 40.62 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 A 142 LYS B 14 LYS.? 6.95 MG MG A 106 A 217 SER B 16 SER.? 18.72 MG MG A 106 A 241 SER B 25 SER^? 21.93 C2 TRS B 107 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 19.38 -8.95 30.12 17.10 -8.78 30.97 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 A 142 LYS B 14 LYS.? 6.95 MG MG A 106 A 217 SER B 28 SER^? 20.11 MG MG A 106 A 241 SER B 38 SER.? 19.23 MG A MG B 106 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 20.61 -17.82 33.77 20.60 -17.17 31.49 1mt5_c00 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c00 naa= 3 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 B 142 LYS A 14 LYS.? 24.61 C2 TRS B 107 B 217 SER A 28 SER^? 23.29 MG MG A 106 B 241 SER A 38 SER.? 20.21 MG MG A 106 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 8.74 -17.74 39.05 7.96 -22.88 42.54 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 7.93 -9.68 40.46 5.50 -9.56 40.62 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 B 142 LYS B 14 LYS.? 6.95 MG MG A 106 B 217 SER B 28 SER^? 20.11 MG MG A 106 B 241 SER B 38 SER.? 19.23 MG A MG B 106 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 21.12 -5.80 35.93 24.74 -1.53 38.99 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 22.08 -13.91 35.51 24.12 -13.89 34.25 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 20.61 -17.82 33.77 20.60 -17.17 31.49 1mt5_c01 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c01 naa= 3 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 C 142 LYS A 14 LYS.? 24.61 C2 TRS B 107 C 217 SER A 28 SER^? 23.29 MG MG A 106 C 241 SER A 38 SER.? 20.21 MG MG A 106 coo -12.07 2.83 63.52 -8.95 7.56 61.01 8.74 -17.74 39.05 7.96 -22.88 42.54 coo -11.64 10.12 58.62 -9.34 9.31 58.79 7.93 -9.68 40.46 5.50 -9.56 40.62 coo -9.31 12.91 61.58 -8.56 11.90 59.50 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 C 142 LYS B 14 LYS.? 6.95 MG MG A 106 C 217 SER B 28 SER^? 20.11 MG MG A 106 C 241 SER B 38 SER.? 19.23 MG A MG B 106 coo -12.07 2.83 63.52 -8.95 7.56 61.01 21.12 -5.80 35.93 24.74 -1.53 38.99 coo -11.64 10.12 58.62 -9.34 9.31 58.79 22.08 -13.91 35.51 24.12 -13.89 34.25 coo -9.31 12.91 61.58 -8.56 11.90 59.50 20.61 -17.82 33.77 20.60 -17.17 31.49 1mt5_c02 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c02 naa= 3 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 D 142 LYS A 14 LYS.? 24.61 C2 TRS B 107 D 217 SER A 28 SER^? 23.29 MG MG A 106 D 241 SER A 38 SER.? 20.21 MG MG A 106 coo 32.93 17.78 71.88 30.89 13.50 67.83 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 34.38 11.17 66.10 32.18 12.14 65.65 7.93 -9.68 40.46 5.50 -9.56 40.62 coo 31.34 7.96 67.74 31.44 9.08 65.62 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 D 142 LYS B 14 LYS.? 6.95 MG MG A 106 D 217 SER B 28 SER^? 20.11 MG MG A 106 D 241 SER B 38 SER.? 19.23 MG A MG B 106 coo 32.93 17.78 71.88 30.89 13.50 67.83 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 34.38 11.17 66.10 32.18 12.14 65.65 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 31.34 7.96 67.74 31.44 9.08 65.62 20.61 -17.82 33.77 20.60 -17.17 31.49 1mt5_c03 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c03 naa= 3 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 E 142 LYS A 14 LYS.? 24.61 C2 TRS B 107 E 217 SER A 28 SER^? 23.29 MG MG A 106 E 241 SER A 38 SER.? 20.21 MG MG A 106 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 7.93 -9.68 40.46 5.50 -9.56 40.62 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 E 142 LYS B 14 LYS.? 6.95 MG MG A 106 E 217 SER B 16 SER.? 18.72 MG MG A 106 E 241 SER B 25 SER^? 21.93 C2 TRS B 107 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 19.38 -8.95 30.12 17.10 -8.78 30.97 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 E 142 LYS B 14 LYS.? 6.95 MG MG A 106 E 217 SER B 28 SER^? 20.11 MG MG A 106 E 241 SER B 38 SER.? 19.23 MG A MG B 106 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 20.61 -17.82 33.77 20.60 -17.17 31.49 1mt5_c04 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c04 naa= 3 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 F 142 LYS A 14 LYS.? 24.61 C2 TRS B 107 F 217 SER A 28 SER^? 23.29 MG MG A 106 F 241 SER A 38 SER.? 20.21 MG MG A 106 coo 85.78 13.19 64.96 85.47 13.47 58.63 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 87.43 17.13 57.15 85.84 15.39 56.76 7.93 -9.68 40.46 5.50 -9.56 40.62 coo 89.69 13.60 54.86 87.60 14.67 54.46 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 F 142 LYS B 14 LYS.? 6.95 MG MG A 106 F 217 SER B 28 SER^? 20.11 MG MG A 106 F 241 SER B 38 SER.? 19.23 MG A MG B 106 coo 85.78 13.19 64.96 85.47 13.47 58.63 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 87.43 17.13 57.15 85.84 15.39 56.76 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 89.69 13.60 54.86 87.60 14.67 54.46 20.61 -17.82 33.77 20.60 -17.17 31.49 1mt5_c05 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c05 naa= 3 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 G 142 LYS A 14 LYS.? 24.61 C2 TRS B 107 G 217 SER A 16 SER.? 21.37 C2 TRS B 107 G 241 SER A 25 SER^? 23.03 C2 TRS B 107 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 6.77 -13.81 33.93 9.10 -14.03 33.22 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 G 142 LYS A 14 LYS.? 24.61 C2 TRS B 107 G 217 SER A 28 SER^? 23.29 MG MG A 106 G 241 SER A 38 SER.? 20.21 MG MG A 106 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 7.93 -9.68 40.46 5.50 -9.56 40.62 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 G 142 LYS B 14 LYS.? 6.95 MG MG A 106 G 217 SER B 16 SER.? 18.72 MG MG A 106 G 241 SER B 25 SER^? 21.93 C2 TRS B 107 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 19.38 -8.95 30.12 17.10 -8.78 30.97 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 G 142 LYS B 14 LYS.? 6.95 MG MG A 106 G 217 SER B 28 SER^? 20.11 MG MG A 106 G 241 SER B 38 SER.? 19.23 MG A MG B 106 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 20.61 -17.82 33.77 20.60 -17.17 31.49 1mt5_c06 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 4 hits 1mt5_c06 naa= 3 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 H 142 LYS A 14 LYS.? 24.61 C2 TRS B 107 H 217 SER A 28 SER^? 23.29 MG MG A 106 H 241 SER A 38 SER.? 20.21 MG MG A 106 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 7.93 -9.68 40.46 5.50 -9.56 40.62 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 H 142 LYS B 14 LYS.? 6.95 MG MG A 106 H 217 SER B 16 SER.? 18.72 MG MG A 106 H 241 SER B 25 SER^? 21.93 C2 TRS B 107 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 19.38 -8.95 30.12 17.10 -8.78 30.97 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 H 142 LYS B 14 LYS.? 6.95 MG MG A 106 H 217 SER B 28 SER^? 20.11 MG MG A 106 H 241 SER B 38 SER.? 19.23 MG A MG B 106 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 20.61 -17.82 33.77 20.60 -17.17 31.49 1mt5_c07 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c07 naa= 3 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 I 142 LYS A 14 LYS.? 24.61 C2 TRS B 107 I 217 SER A 16 SER.? 21.37 C2 TRS B 107 I 241 SER A 25 SER^? 23.03 C2 TRS B 107 coo -5.05 91.11 27.04 -1.24 87.39 30.21 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 2.83 88.63 29.54 1.30 86.82 30.03 6.77 -13.81 33.93 9.10 -14.03 33.22 coo 2.37 88.32 34.25 2.82 86.58 32.61 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 I 142 LYS A 14 LYS.? 24.61 C2 TRS B 107 I 217 SER A 28 SER^? 23.29 MG MG A 106 I 241 SER A 38 SER.? 20.21 MG MG A 106 coo -5.05 91.11 27.04 -1.24 87.39 30.21 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 2.83 88.63 29.54 1.30 86.82 30.03 7.93 -9.68 40.46 5.50 -9.56 40.62 coo 2.37 88.32 34.25 2.82 86.58 32.61 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 I 142 LYS B 14 LYS.? 6.95 MG MG A 106 I 217 SER B 16 SER.? 18.72 MG MG A 106 I 241 SER B 25 SER^? 21.93 C2 TRS B 107 coo -5.05 91.11 27.04 -1.24 87.39 30.21 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 2.83 88.63 29.54 1.30 86.82 30.03 19.38 -8.95 30.12 17.10 -8.78 30.97 coo 2.37 88.32 34.25 2.82 86.58 32.61 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 I 142 LYS B 14 LYS.? 6.95 MG MG A 106 I 217 SER B 28 SER^? 20.11 MG MG A 106 I 241 SER B 38 SER.? 19.23 MG A MG B 106 coo -5.05 91.11 27.04 -1.24 87.39 30.21 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 2.83 88.63 29.54 1.30 86.82 30.03 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 2.37 88.32 34.25 2.82 86.58 32.61 20.61 -17.82 33.77 20.60 -17.17 31.49 1mt5_c08 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 4 hits 1mt5_c08 naa= 3 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 J 142 LYS A 14 LYS.? 24.61 C2 TRS B 107 J 217 SER A 28 SER^? 23.29 MG MG A 106 J 241 SER A 38 SER.? 20.21 MG MG A 106 coo -16.11 59.78 61.53 -15.92 58.68 55.43 8.74 -17.74 39.05 7.96 -22.88 42.54 coo -17.65 54.92 54.17 -15.81 56.46 53.79 7.93 -9.68 40.46 5.50 -9.56 40.62 coo -19.92 58.10 51.57 -17.75 57.08 51.34 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 J 142 LYS B 14 LYS.? 6.95 MG MG A 106 J 217 SER B 28 SER^? 20.11 MG MG A 106 J 241 SER B 38 SER.? 19.23 MG A MG B 106 coo -16.11 59.78 61.53 -15.92 58.68 55.43 21.12 -5.80 35.93 24.74 -1.53 38.99 coo -17.65 54.92 54.17 -15.81 56.46 53.79 22.08 -13.91 35.51 24.12 -13.89 34.25 coo -19.92 58.10 51.57 -17.75 57.08 51.34 20.61 -17.82 33.77 20.60 -17.17 31.49 1mt5_c09 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c09 naa= 3 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 K 142 LYS A 14 LYS.? 24.61 C2 TRS B 107 K 217 SER A 28 SER^? 23.29 MG MG A 106 K 241 SER A 38 SER.? 20.21 MG MG A 106 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 8.74 -17.74 39.05 7.96 -22.88 42.54 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 7.93 -9.68 40.46 5.50 -9.56 40.62 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 K 142 LYS B 14 LYS.? 6.95 MG MG A 106 K 217 SER B 16 SER.? 18.72 MG MG A 106 K 241 SER B 25 SER^? 21.93 C2 TRS B 107 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 21.12 -5.80 35.93 24.74 -1.53 38.99 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 19.38 -8.95 30.12 17.10 -8.78 30.97 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 K 142 LYS B 14 LYS.? 6.95 MG MG A 106 K 217 SER B 28 SER^? 20.11 MG MG A 106 K 241 SER B 38 SER.? 19.23 MG A MG B 106 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 21.12 -5.80 35.93 24.74 -1.53 38.99 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 22.08 -13.91 35.51 24.12 -13.89 34.25 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 20.61 -17.82 33.77 20.60 -17.17 31.49 1mt5_c10 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c10 naa= 3 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 L 142 LYS A 14 LYS.? 24.61 C2 TRS B 107 L 217 SER A 28 SER^? 23.29 MG MG A 106 L 241 SER A 38 SER.? 20.21 MG MG A 106 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 7.93 -9.68 40.46 5.50 -9.56 40.62 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 L 142 LYS B 14 LYS.? 6.95 MG MG A 106 L 217 SER B 28 SER^? 20.11 MG MG A 106 L 241 SER B 38 SER.? 19.23 MG A MG B 106 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 20.61 -17.82 33.77 20.60 -17.17 31.49 1mt5_c11 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c11 naa= 3 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 M 142 LYS A 14 LYS.? 24.61 C2 TRS B 107 M 217 SER A 28 SER^? 23.29 MG MG A 106 M 241 SER A 38 SER.? 20.21 MG MG A 106 coo 57.83 99.61 24.25 54.90 95.14 20.60 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 51.07 94.66 21.52 53.18 93.49 22.20 7.93 -9.68 40.46 5.50 -9.56 40.62 coo 51.67 94.23 16.93 51.60 92.47 18.57 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 M 142 LYS B 14 LYS.? 6.95 MG MG A 106 M 217 SER B 16 SER.? 18.72 MG MG A 106 M 241 SER B 25 SER^? 21.93 C2 TRS B 107 coo 57.83 99.61 24.25 54.90 95.14 20.60 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 51.07 94.66 21.52 53.18 93.49 22.20 19.38 -8.95 30.12 17.10 -8.78 30.97 coo 51.67 94.23 16.93 51.60 92.47 18.57 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 M 142 LYS B 14 LYS.? 6.95 MG MG A 106 M 217 SER B 28 SER^? 20.11 MG MG A 106 M 241 SER B 38 SER.? 19.23 MG A MG B 106 coo 57.83 99.61 24.25 54.90 95.14 20.60 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 51.07 94.66 21.52 53.18 93.49 22.20 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 51.67 94.23 16.93 51.60 92.47 18.57 20.61 -17.82 33.77 20.60 -17.17 31.49 1mt5_c12 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c12 naa= 3 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 N 142 LYS A 14 LYS.? 24.61 C2 TRS B 107 N 217 SER A 28 SER^? 23.29 MG MG A 106 N 241 SER A 38 SER.? 20.21 MG MG A 106 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 81.67 67.31 -0.58 79.53 68.28 0.00 7.93 -9.68 40.46 5.50 -9.56 40.62 coo 82.47 71.15 2.07 80.82 69.44 2.28 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 N 142 LYS B 14 LYS.? 6.95 MG MG A 106 N 217 SER B 28 SER^? 20.11 MG MG A 106 N 241 SER B 38 SER.? 19.23 MG A MG B 106 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 81.67 67.31 -0.58 79.53 68.28 0.00 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 82.47 71.15 2.07 80.82 69.44 2.28 20.61 -17.82 33.77 20.60 -17.17 31.49 1mt5_c13 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c13 naa= 3 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 O 142 LYS A 14 LYS.? 24.61 C2 TRS B 107 O 217 SER A 16 SER.? 21.37 C2 TRS B 107 O 241 SER A 25 SER^? 23.03 C2 TRS B 107 coo 81.67 70.12 58.71 78.82 64.87 57.22 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 81.62 62.23 55.05 79.32 62.93 55.20 6.77 -13.81 33.93 9.10 -14.03 33.22 coo 79.39 59.54 58.42 78.72 60.00 56.11 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 O 142 LYS A 14 LYS.? 24.61 C2 TRS B 107 O 217 SER A 28 SER^? 23.29 MG MG A 106 O 241 SER A 38 SER.? 20.21 MG MG A 106 coo 81.67 70.12 58.71 78.82 64.87 57.22 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 81.62 62.23 55.05 79.32 62.93 55.20 7.93 -9.68 40.46 5.50 -9.56 40.62 coo 79.39 59.54 58.42 78.72 60.00 56.11 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 O 142 LYS B 14 LYS.? 6.95 MG MG A 106 O 217 SER B 16 SER.? 18.72 MG MG A 106 O 241 SER B 25 SER^? 21.93 C2 TRS B 107 coo 81.67 70.12 58.71 78.82 64.87 57.22 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 81.62 62.23 55.05 79.32 62.93 55.20 19.38 -8.95 30.12 17.10 -8.78 30.97 coo 79.39 59.54 58.42 78.72 60.00 56.11 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 O 142 LYS B 14 LYS.? 6.95 MG MG A 106 O 217 SER B 28 SER^? 20.11 MG MG A 106 O 241 SER B 38 SER.? 19.23 MG A MG B 106 coo 81.67 70.12 58.71 78.82 64.87 57.22 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 81.62 62.23 55.05 79.32 62.93 55.20 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 79.39 59.54 58.42 78.72 60.00 56.11 20.61 -17.82 33.77 20.60 -17.17 31.49 1mt5_c14 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 4 hits 1mt5_c14 naa= 3 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 P 142 LYS A 14 LYS.? 24.61 C2 TRS B 107 P 217 SER A 28 SER^? 23.29 MG MG A 106 P 241 SER A 38 SER.? 20.21 MG MG A 106 coo 37.29 55.72 69.54 38.73 59.85 65.07 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 35.55 61.40 62.96 37.72 60.41 62.66 7.93 -9.68 40.46 5.50 -9.56 40.62 coo 38.60 64.77 64.10 38.63 63.28 62.26 8.35 -5.49 38.91 7.27 -5.53 36.78 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 P 142 LYS B 14 LYS.? 6.95 MG MG A 106 P 217 SER B 28 SER^? 20.11 MG MG A 106 P 241 SER B 38 SER.? 19.23 MG A MG B 106 coo 37.29 55.72 69.54 38.73 59.85 65.07 21.12 -5.80 35.93 24.74 -1.53 38.99 coo 35.55 61.40 62.96 37.72 60.41 62.66 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 38.60 64.77 64.10 38.63 63.28 62.26 20.61 -17.82 33.77 20.60 -17.17 31.49 1mt5_c15 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c15 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 37 HIS.? 14.34 MG MG A 106 A 197 ASP A 33 ASP.? 14.12 MG MG A 106 A 223 ALA B 9 ALA^? 20.86 MG MG A 106 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 11.15 -3.04 43.19 11.90 -1.76 44.64 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 17.76 -15.45 45.57 17.28 -15.07 44.14 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS A 37 HIS.? 14.34 MG MG A 106 A 197 ASP A 33 ASP.? 14.12 MG MG A 106 A 223 ALA B 11 ALA^? 15.97 MG MG A 106 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 11.15 -3.04 43.19 11.90 -1.76 44.64 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 21.39 -11.21 43.66 22.89 -11.27 43.43 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS A 67 HIS^? 25.71 MG MG A 106 A 197 ASP A 73 ASP.? 24.66 MG MG A 106 A 223 ALA A 64 ALA^? 17.52 MG MG A 106 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 7.29 12.90 25.70 6.12 14.46 24.97 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 11.88 18.46 25.62 13.34 17.78 24.18 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 15.38 5.15 26.91 14.21 4.40 27.56 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS B 37 HIS.? 23.74 MG A MG B 106 A 197 ASP B 33 ASP.? 27.59 MG MG A 106 A 223 ALA A 9 ALA^? 16.42 MG MG A 106 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 21.69 -21.14 38.43 22.55 -22.53 39.75 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 17.85 -9.53 46.38 17.64 -10.28 45.04 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 A 114 HIS B 37 HIS.? 23.74 MG A MG B 106 A 197 ASP B 33 ASP.? 27.59 MG MG A 106 A 223 ALA A 11 ALA^? 22.31 MG MG A 106 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 21.69 -21.14 38.43 22.55 -22.53 39.75 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 13.43 -13.51 46.02 12.15 -13.77 46.76 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 A 114 HIS B 37 HIS.? 23.74 MG A MG B 106 A 197 ASP B 33 ASP.? 27.59 MG MG A 106 A 223 ALA B 11 ALA^? 15.97 MG MG A 106 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 21.69 -21.14 38.43 22.55 -22.53 39.75 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 21.39 -11.21 43.66 22.89 -11.27 43.43 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 A 114 HIS B 67 HIS^? 10.25 N TRS B 107 A 197 ASP B 73 ASP.? 13.34 N TRS B 107 A 223 ALA B 64 ALA^? 10.02 N TRS B 107 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 12.23 -34.37 19.25 12.68 -35.93 17.95 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 9.64 -40.18 22.89 9.15 -42.09 22.32 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 7.19 -26.95 26.54 8.52 -26.19 26.49 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 7 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 37 HIS.? 14.34 MG MG A 106 B 197 ASP A 33 ASP.? 14.12 MG MG A 106 B 223 ALA B 9 ALA^? 20.86 MG MG A 106 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 11.15 -3.04 43.19 11.90 -1.76 44.64 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 17.76 -15.45 45.57 17.28 -15.07 44.14 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS A 37 HIS.? 14.34 MG MG A 106 B 197 ASP A 33 ASP.? 14.12 MG MG A 106 B 223 ALA B 11 ALA^? 15.97 MG MG A 106 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 11.15 -3.04 43.19 11.90 -1.76 44.64 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 21.39 -11.21 43.66 22.89 -11.27 43.43 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS A 67 HIS^? 25.71 MG MG A 106 B 197 ASP A 73 ASP.? 24.66 MG MG A 106 B 223 ALA A 64 ALA^? 17.52 MG MG A 106 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 7.29 12.90 25.70 6.12 14.46 24.97 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 11.88 18.46 25.62 13.34 17.78 24.18 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 15.38 5.15 26.91 14.21 4.40 27.56 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS B 37 HIS.? 23.74 MG A MG B 106 B 197 ASP B 33 ASP.? 27.59 MG MG A 106 B 223 ALA A 9 ALA^? 16.42 MG MG A 106 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 21.69 -21.14 38.43 22.55 -22.53 39.75 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 17.85 -9.53 46.38 17.64 -10.28 45.04 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 B 114 HIS B 37 HIS.? 23.74 MG A MG B 106 B 197 ASP B 33 ASP.? 27.59 MG MG A 106 B 223 ALA A 11 ALA^? 22.31 MG MG A 106 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 21.69 -21.14 38.43 22.55 -22.53 39.75 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 13.43 -13.51 46.02 12.15 -13.77 46.76 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 B 114 HIS B 37 HIS.? 23.74 MG A MG B 106 B 197 ASP B 33 ASP.? 27.59 MG MG A 106 B 223 ALA B 11 ALA^? 15.97 MG MG A 106 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 21.69 -21.14 38.43 22.55 -22.53 39.75 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 21.39 -11.21 43.66 22.89 -11.27 43.43 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 B 114 HIS B 67 HIS^? 10.25 N TRS B 107 B 197 ASP B 73 ASP.? 13.34 N TRS B 107 B 223 ALA B 64 ALA^? 10.02 N TRS B 107 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 12.23 -34.37 19.25 12.68 -35.93 17.95 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 9.64 -40.18 22.89 9.15 -42.09 22.32 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 7.19 -26.95 26.54 8.52 -26.19 26.49 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 7 hits 1n2t_c03 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER A 25 SER^? 23.03 C2 TRS B 107 A 154 ASP A 21 ASP.? 20.18 O2 TRS B 107 A 261 ARG A 24 ARG^? 24.75 MG MG A 106 coo 16.10 74.10 3.11 17.18 73.52 5.20 8.15 -8.88 30.15 10.32 -9.84 29.66 coo 16.07 84.71 8.14 15.20 82.81 8.14 2.80 -6.84 20.40 2.88 -7.95 18.60 coo 10.59 77.85 4.81 13.09 76.36 5.76 6.24 -3.67 29.98 3.39 -2.61 30.35 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 2 3 # 2 A 62 SER A 25 SER^? 23.03 C2 TRS B 107 A 154 ASP A 100 ASP^? 16.25 MG MG A 106 A 261 ARG A 24 ARG^? 24.75 MG MG A 106 coo 16.10 74.10 3.11 17.18 73.52 5.20 8.15 -8.88 30.15 10.32 -9.84 29.66 coo 16.07 84.71 8.14 15.20 82.81 8.14 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 10.59 77.85 4.81 13.09 76.36 5.76 6.24 -3.67 29.98 3.39 -2.61 30.35 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 3 3 # 3 A 62 SER A 28 SER^? 23.29 MG MG A 106 A 154 ASP A 100 ASP^? 16.25 MG MG A 106 A 261 ARG A 27 ARG^? 22.99 C2 TRS B 107 coo 16.10 74.10 3.11 17.18 73.52 5.20 7.93 -9.68 40.46 5.50 -9.56 40.62 coo 16.07 84.71 8.14 15.20 82.81 8.14 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 10.59 77.85 4.81 13.09 76.36 5.76 11.78 -12.78 37.42 11.40 -15.00 35.25 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 4 3 # 4 A 62 SER A 38 SER.? 20.21 MG MG A 106 A 154 ASP A 100 ASP^? 16.25 MG MG A 106 A 261 ARG A 27 ARG^? 22.99 C2 TRS B 107 coo 16.10 74.10 3.11 17.18 73.52 5.20 8.35 -5.49 38.91 7.27 -5.53 36.78 coo 16.07 84.71 8.14 15.20 82.81 8.14 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 10.59 77.85 4.81 13.09 76.36 5.76 11.78 -12.78 37.42 11.40 -15.00 35.25 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 5 3 # 5 A 62 SER A 82 SER^? 9.28 MG MG A 106 A 154 ASP A 100 ASP^? 16.25 MG MG A 106 A 261 ARG A 58 ARG^? 9.13 MG MG A 106 coo 16.10 74.10 3.11 17.18 73.52 5.20 15.58 6.86 38.93 14.78 5.91 41.12 coo 16.07 84.71 8.14 15.20 82.81 8.14 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 10.59 77.85 4.81 13.09 76.36 5.76 17.26 0.85 41.49 16.40 -0.10 44.31 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 6 3 # 6 A 62 SER B 25 SER^? 21.93 C2 TRS B 107 A 154 ASP A 100 ASP^? 16.25 MG MG A 106 A 261 ARG B 17 ARG^? 19.62 MG A MG B 106 coo 16.10 74.10 3.11 17.18 73.52 5.20 15.65 -13.25 27.32 13.56 -12.34 28.19 coo 16.07 84.71 8.14 15.20 82.81 8.14 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 10.59 77.85 4.81 13.09 76.36 5.76 24.18 -12.31 28.78 23.30 -13.33 31.55 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 7 3 # 7 A 62 SER B 25 SER^? 21.93 C2 TRS B 107 A 154 ASP B 21 ASP.? 19.35 O1 TRS B 107 A 261 ARG B 24 ARG^? 14.88 MG A MG B 106 coo 16.10 74.10 3.11 17.18 73.52 5.20 15.65 -13.25 27.32 13.56 -12.34 28.19 coo 16.07 84.71 8.14 15.20 82.81 8.14 13.91 -13.27 16.06 15.24 -13.79 14.55 coo 10.59 77.85 4.81 13.09 76.36 5.76 16.79 -18.48 25.10 19.01 -19.70 23.40 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 8 3 # 8 A 62 SER B 25 SER^? 21.93 C2 TRS B 107 A 154 ASP B 100 ASP^? 19.56 C2 TRS B 107 A 261 ARG B 24 ARG^? 14.88 MG A MG B 106 coo 16.10 74.10 3.11 17.18 73.52 5.20 15.65 -13.25 27.32 13.56 -12.34 28.19 coo 16.07 84.71 8.14 15.20 82.81 8.14 9.71 -18.83 33.97 8.85 -16.99 33.47 coo 10.59 77.85 4.81 13.09 76.36 5.76 16.79 -18.48 25.10 19.01 -19.70 23.40 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 9 3 # 9 A 62 SER B 28 SER^? 20.11 MG MG A 106 A 154 ASP A 100 ASP^? 16.25 MG MG A 106 A 261 ARG B 17 ARG^? 19.62 MG A MG B 106 coo 16.10 74.10 3.11 17.18 73.52 5.20 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 16.07 84.71 8.14 15.20 82.81 8.14 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 10.59 77.85 4.81 13.09 76.36 5.76 24.18 -12.31 28.78 23.30 -13.33 31.55 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 10 3 # 10 A 62 SER B 104 SER.? 20.66 MG A MG B 106 A 154 ASP B 33 ASP.? 27.59 MG MG A 106 A 261 ARG B 58 ARG^? 24.73 MG A MG B 106 coo 16.10 74.10 3.11 17.18 73.52 5.20 22.99 -23.86 34.71 24.14 -24.66 36.71 coo 16.07 84.71 8.14 15.20 82.81 8.14 22.46 -22.72 47.13 22.23 -22.78 45.03 coo 10.59 77.85 4.81 13.09 76.36 5.76 17.07 -26.36 39.29 20.10 -26.73 39.11 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 10 hits 1o98_c00 naa= 3 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 1 3 # 1 A 170 SER A 50 SER.? 27.61 MG MG A 106 A 239 VAL A 53 VAL.? 24.61 MG MG A 106 A 413 ASN A 88 ASN.? 28.92 MG MG A 106 coo 80.14 40.76 52.28 77.73 40.59 51.94 -0.06 4.91 32.10 -1.94 6.16 32.59 coo 75.67 35.37 52.30 76.00 35.96 50.23 -0.54 5.06 40.99 -0.82 3.13 41.93 coo 81.75 35.21 52.13 80.92 37.12 51.69 -3.68 10.05 36.57 -4.41 8.86 38.16 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 2 3 # 2 A 170 SER A 51 SER.? 23.86 MG MG A 106 A 239 VAL A 53 VAL.? 24.61 MG MG A 106 A 413 ASN A 88 ASN.? 28.92 MG MG A 106 coo 80.14 40.76 52.28 77.73 40.59 51.94 -0.50 3.87 35.77 0.51 2.99 37.79 coo 75.67 35.37 52.30 76.00 35.96 50.23 -0.54 5.06 40.99 -0.82 3.13 41.93 coo 81.75 35.21 52.13 80.92 37.12 51.69 -3.68 10.05 36.57 -4.41 8.86 38.16 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 3 3 # 3 A 170 SER B 51 SER.? 11.55 MG A MG B 106 A 239 VAL B 53 VAL.? 10.83 MG A MG B 106 A 413 ASN B 88 ASN.? -8.35 MG A MG B 106s coo 80.14 40.76 52.28 77.73 40.59 51.94 23.96 -26.97 23.29 23.94 -29.25 24.02 coo 75.67 35.37 52.30 76.00 35.96 50.23 28.46 -27.39 27.19 29.44 -25.70 28.20 coo 81.75 35.21 52.13 80.92 37.12 51.69 28.06 -31.46 21.34 28.31 -31.33 19.24 1oqz_c00 source 1oqz GLUTARYL ACYLASE : 3 hits 1oqz_c00 naa= 3 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 1 3 # 1 B 170 SER A 51 SER.? 23.86 MG MG A 106 B 239 VAL A 53 VAL.? 24.61 MG MG A 106 B 413 ASN A 88 ASN.? 28.92 MG MG A 106 coo 25.22 6.41 2.90 27.67 6.33 3.11 -0.50 3.87 35.77 0.51 2.99 37.79 coo 29.71 1.00 2.66 29.43 1.57 4.74 -0.54 5.06 40.99 -0.82 3.13 41.93 coo 23.72 0.88 2.95 24.56 2.79 3.34 -3.68 10.05 36.57 -4.41 8.86 38.16 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 2 3 # 2 B 170 SER B 51 SER.? 11.55 MG A MG B 106 B 239 VAL B 53 VAL.? 10.83 MG A MG B 106 B 413 ASN B 88 ASN.? -8.35 MG A MG B 106s coo 25.22 6.41 2.90 27.67 6.33 3.11 23.96 -26.97 23.29 23.94 -29.25 24.02 coo 29.71 1.00 2.66 29.43 1.57 4.74 28.46 -27.39 27.19 29.44 -25.70 28.20 coo 23.72 0.88 2.95 24.56 2.79 3.34 28.06 -31.46 21.34 28.31 -31.33 19.24 1oqz_c01 source 1oqz GLUTARYL ACYLASE : 2 hits 1oqz_c01 naa= 3 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 61 SER^? 13.76 MG MG A 106 A 708 ASP A 81 ASP.? 9.35 MG MG A 106 A 740 HIS A 78 HIS.? 11.19 MG MG A 106 coo -7.09 7.44 6.22 -7.53 5.14 5.59 20.58 -1.27 32.13 21.77 -3.05 30.92 coo -5.35 2.36 14.19 -6.28 2.60 12.26 18.32 7.36 35.53 19.95 8.35 34.55 coo -8.70 2.86 9.96 -8.03 3.92 8.29 21.83 6.49 31.11 22.88 8.20 31.70 1pfq_c00 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 1 hits 1pfq_c00 naa= 3 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 61 SER^? 13.76 MG MG A 106 B 708 ASP A 81 ASP.? 9.35 MG MG A 106 B 740 HIS A 78 HIS.? 11.19 MG MG A 106 coo 4.44 13.29 37.64 6.01 11.66 38.49 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 6.39 7.18 30.33 6.92 8.20 32.17 18.32 7.36 35.53 19.95 8.35 34.55 coo 8.57 10.09 34.47 7.10 10.73 35.82 21.83 6.49 31.11 22.88 8.20 31.70 1pfq_c01 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 1 hits 1pfq_c01 naa= 3 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 28 SER^? 23.29 MG MG A 106 A 709 ASP A 33 ASP.? 14.12 MG MG A 106 A 740 HIS A 37 HIS.? 14.34 MG MG A 106 coo -7.09 7.44 6.22 -7.53 5.14 5.59 7.93 -9.68 40.46 5.50 -9.56 40.62 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -8.70 2.86 9.96 -8.03 3.92 8.29 11.15 -3.04 43.19 11.90 -1.76 44.64 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER A 38 SER.? 20.21 MG MG A 106 A 709 ASP A 33 ASP.? 14.12 MG MG A 106 A 740 HIS A 37 HIS.? 14.34 MG MG A 106 coo -7.09 7.44 6.22 -7.53 5.14 5.59 8.35 -5.49 38.91 7.27 -5.53 36.78 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -8.70 2.86 9.96 -8.03 3.92 8.29 11.15 -3.04 43.19 11.90 -1.76 44.64 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 A 630 SER A 104 SER.? 14.85 MG MG A 106 A 709 ASP A 33 ASP.? 14.12 MG MG A 106 A 740 HIS A 37 HIS.? 14.34 MG MG A 106 coo -7.09 7.44 6.22 -7.53 5.14 5.59 7.92 -0.22 42.40 9.54 1.15 43.46 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -8.70 2.86 9.96 -8.03 3.92 8.29 11.15 -3.04 43.19 11.90 -1.76 44.64 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 A 630 SER A 105 SER.? 20.37 MG MG A 106 A 709 ASP A 33 ASP.? 14.12 MG MG A 106 A 740 HIS A 37 HIS.? 14.34 MG MG A 106 coo -7.09 7.44 6.22 -7.53 5.14 5.59 4.85 -2.34 43.11 5.68 -4.47 42.24 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -8.70 2.86 9.96 -8.03 3.92 8.29 11.15 -3.04 43.19 11.90 -1.76 44.64 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 5 3 # 5 A 630 SER B 28 SER^? 20.11 MG MG A 106 A 709 ASP B 33 ASP.? 27.59 MG MG A 106 A 740 HIS B 37 HIS.? 23.74 MG A MG B 106 coo -7.09 7.44 6.22 -7.53 5.14 5.59 22.08 -13.91 35.51 24.12 -13.89 34.25 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -8.70 2.86 9.96 -8.03 3.92 8.29 21.69 -21.14 38.43 22.55 -22.53 39.75 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 6 3 # 6 A 630 SER B 38 SER.? 19.23 MG A MG B 106 A 709 ASP B 33 ASP.? 27.59 MG MG A 106 A 740 HIS B 37 HIS.? 23.74 MG A MG B 106 coo -7.09 7.44 6.22 -7.53 5.14 5.59 20.61 -17.82 33.77 20.60 -17.17 31.49 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -8.70 2.86 9.96 -8.03 3.92 8.29 21.69 -21.14 38.43 22.55 -22.53 39.75 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 7 3 # 7 A 630 SER B 104 SER.? 20.66 MG A MG B 106 A 709 ASP B 33 ASP.? 27.59 MG MG A 106 A 740 HIS B 37 HIS.? 23.74 MG A MG B 106 coo -7.09 7.44 6.22 -7.53 5.14 5.59 22.99 -23.86 34.71 24.14 -24.66 36.71 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -8.70 2.86 9.96 -8.03 3.92 8.29 21.69 -21.14 38.43 22.55 -22.53 39.75 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 8 3 # 8 A 630 SER B 105 SER.? 14.90 MG A MG B 106 A 709 ASP B 33 ASP.? 27.59 MG MG A 106 A 740 HIS B 37 HIS.? 23.74 MG A MG B 106 coo -7.09 7.44 6.22 -7.53 5.14 5.59 26.26 -24.98 33.11 26.69 -23.14 31.51 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -8.70 2.86 9.96 -8.03 3.92 8.29 21.69 -21.14 38.43 22.55 -22.53 39.75 1pfq_c02 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 8 hits 1pfq_c02 naa= 3 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 28 SER^? 23.29 MG MG A 106 B 709 ASP A 33 ASP.? 14.12 MG MG A 106 B 740 HIS A 37 HIS.? 14.34 MG MG A 106 coo 4.44 13.29 37.64 6.01 11.66 38.49 7.93 -9.68 40.46 5.50 -9.56 40.62 coo 10.26 2.81 31.69 11.64 4.30 32.43 15.57 -3.11 51.57 14.43 -2.38 49.92 coo 8.57 10.09 34.47 7.10 10.73 35.82 11.15 -3.04 43.19 11.90 -1.76 44.64 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER A 38 SER.? 20.21 MG MG A 106 B 709 ASP A 33 ASP.? 14.12 MG MG A 106 B 740 HIS A 37 HIS.? 14.34 MG MG A 106 coo 4.44 13.29 37.64 6.01 11.66 38.49 8.35 -5.49 38.91 7.27 -5.53 36.78 coo 10.26 2.81 31.69 11.64 4.30 32.43 15.57 -3.11 51.57 14.43 -2.38 49.92 coo 8.57 10.09 34.47 7.10 10.73 35.82 11.15 -3.04 43.19 11.90 -1.76 44.64 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 B 630 SER A 104 SER.? 14.85 MG MG A 106 B 709 ASP A 33 ASP.? 14.12 MG MG A 106 B 740 HIS A 37 HIS.? 14.34 MG MG A 106 coo 4.44 13.29 37.64 6.01 11.66 38.49 7.92 -0.22 42.40 9.54 1.15 43.46 coo 10.26 2.81 31.69 11.64 4.30 32.43 15.57 -3.11 51.57 14.43 -2.38 49.92 coo 8.57 10.09 34.47 7.10 10.73 35.82 11.15 -3.04 43.19 11.90 -1.76 44.64 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 B 630 SER A 105 SER.? 20.37 MG MG A 106 B 709 ASP A 33 ASP.? 14.12 MG MG A 106 B 740 HIS A 37 HIS.? 14.34 MG MG A 106 coo 4.44 13.29 37.64 6.01 11.66 38.49 4.85 -2.34 43.11 5.68 -4.47 42.24 coo 10.26 2.81 31.69 11.64 4.30 32.43 15.57 -3.11 51.57 14.43 -2.38 49.92 coo 8.57 10.09 34.47 7.10 10.73 35.82 11.15 -3.04 43.19 11.90 -1.76 44.64 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 5 3 # 5 B 630 SER B 28 SER^? 20.11 MG MG A 106 B 709 ASP B 33 ASP.? 27.59 MG MG A 106 B 740 HIS B 37 HIS.? 23.74 MG A MG B 106 coo 4.44 13.29 37.64 6.01 11.66 38.49 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 10.26 2.81 31.69 11.64 4.30 32.43 22.46 -22.72 47.13 22.23 -22.78 45.03 coo 8.57 10.09 34.47 7.10 10.73 35.82 21.69 -21.14 38.43 22.55 -22.53 39.75 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 6 3 # 6 B 630 SER B 38 SER.? 19.23 MG A MG B 106 B 709 ASP B 33 ASP.? 27.59 MG MG A 106 B 740 HIS B 37 HIS.? 23.74 MG A MG B 106 coo 4.44 13.29 37.64 6.01 11.66 38.49 20.61 -17.82 33.77 20.60 -17.17 31.49 coo 10.26 2.81 31.69 11.64 4.30 32.43 22.46 -22.72 47.13 22.23 -22.78 45.03 coo 8.57 10.09 34.47 7.10 10.73 35.82 21.69 -21.14 38.43 22.55 -22.53 39.75 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 7 3 # 7 B 630 SER B 104 SER.? 20.66 MG A MG B 106 B 709 ASP B 33 ASP.? 27.59 MG MG A 106 B 740 HIS B 37 HIS.? 23.74 MG A MG B 106 coo 4.44 13.29 37.64 6.01 11.66 38.49 22.99 -23.86 34.71 24.14 -24.66 36.71 coo 10.26 2.81 31.69 11.64 4.30 32.43 22.46 -22.72 47.13 22.23 -22.78 45.03 coo 8.57 10.09 34.47 7.10 10.73 35.82 21.69 -21.14 38.43 22.55 -22.53 39.75 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 8 3 # 8 B 630 SER B 105 SER.? 14.90 MG A MG B 106 B 709 ASP B 33 ASP.? 27.59 MG MG A 106 B 740 HIS B 37 HIS.? 23.74 MG A MG B 106 coo 4.44 13.29 37.64 6.01 11.66 38.49 26.26 -24.98 33.11 26.69 -23.14 31.51 coo 10.26 2.81 31.69 11.64 4.30 32.43 22.46 -22.72 47.13 22.23 -22.78 45.03 coo 8.57 10.09 34.47 7.10 10.73 35.82 21.69 -21.14 38.43 22.55 -22.53 39.75 1pfq_c03 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 8 hits 1pfq_c03 naa= 3 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 1 3 # 1 A 225 HIS A 67 HIS^? 25.71 MG MG A 106 A 259 TYR A 65 TYR^? 20.31 MG MG A 106 A 552 ASP B 4 ASP.? 25.97 C2 TRS B 107 coo 11.34 95.90 25.54 12.13 96.42 23.67 7.29 12.90 25.70 6.12 14.46 24.97 coo 14.91 97.39 18.63 13.39 95.60 20.20 15.06 9.60 24.66 17.54 9.96 23.42 coo 46.37 82.54 38.83 45.97 84.66 38.77 4.45 -22.45 45.85 5.06 -24.19 44.80 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 2 3 # 2 A 225 HIS A 78 HIS.? 11.19 MG MG A 106 A 259 TYR A 65 TYR^? 20.31 MG MG A 106 A 552 ASP B 81 ASP.? 16.51 N TRS B 107 coo 11.34 95.90 25.54 12.13 96.42 23.67 21.83 6.49 31.11 22.88 8.20 31.70 coo 14.91 97.39 18.63 13.39 95.60 20.20 15.06 9.60 24.66 17.54 9.96 23.42 coo 46.37 82.54 38.83 45.97 84.66 38.77 9.98 -30.67 34.70 8.29 -31.92 34.80 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 3 3 # 3 A 225 HIS B 67 HIS^? 10.25 N TRS B 107 A 259 TYR B 65 TYR^? 4.85 N TRS B 107 A 552 ASP A 4 ASP.? 11.89 MG MG A 106 coo 11.34 95.90 25.54 12.13 96.42 23.67 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 14.91 97.39 18.63 13.39 95.60 20.20 5.69 -30.65 23.64 2.95 -31.03 24.05 coo 46.37 82.54 38.83 45.97 84.66 38.77 29.77 -2.68 38.63 30.81 -3.64 37.08 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 4 3 # 4 A 225 HIS B 78 HIS^? 12.04 O3 TRS B 107 A 259 TYR B 65 TYR^? 4.85 N TRS B 107 A 552 ASP A 4 ASP.? 11.89 MG MG A 106 coo 11.34 95.90 25.54 12.13 96.42 23.67 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 14.91 97.39 18.63 13.39 95.60 20.20 5.69 -30.65 23.64 2.95 -31.03 24.05 coo 46.37 82.54 38.83 45.97 84.66 38.77 29.77 -2.68 38.63 30.81 -3.64 37.08 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 5 3 # 5 A 225 HIS B 78 HIS^? 12.04 O3 TRS B 107 A 259 TYR B 65 TYR^? 4.85 N TRS B 107 A 552 ASP A 81 ASP.? 9.35 MG MG A 106 coo 11.34 95.90 25.54 12.13 96.42 23.67 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 14.91 97.39 18.63 13.39 95.60 20.20 5.69 -30.65 23.64 2.95 -31.03 24.05 coo 46.37 82.54 38.83 45.97 84.66 38.77 18.32 7.36 35.53 19.95 8.35 34.55 1pj5_c00 source 1pj5 N,N-DIMETHYLGLYCINE OXIDASE : 5 hits 1pj5_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 79 ALA.? 8.97 MG MG A 106 A 126 LEU A 77 LEU^? 13.85 MG MG A 106 A 158 GLU A 76 GLU^? 15.65 MG MG A 106 coo -2.29 37.66 144.73 -1.46 37.12 145.87 21.53 2.78 33.99 22.71 1.85 33.69 coo -4.62 32.83 147.14 -5.50 32.85 149.12 15.86 6.62 31.21 14.13 7.34 32.43 coo -0.83 29.57 149.77 -0.39 31.47 148.95 19.27 9.35 28.47 21.14 9.50 27.54 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA B 79 ALA.? 18.26 C2 TRS B 107 A 126 LEU B 77 LEU^? 13.15 N TRS B 107 A 158 GLU B 76 GLU^? 8.69 O3 TRS B 107 coo -2.29 37.66 144.73 -1.46 37.12 145.87 6.61 -26.34 36.32 5.53 -25.53 37.02 coo -4.62 32.83 147.14 -5.50 32.85 149.12 9.66 -28.91 30.02 11.77 -29.40 29.78 coo -0.83 29.57 149.77 -0.39 31.47 148.95 5.19 -33.70 27.63 3.11 -33.88 28.01 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 79 ALA.? 8.97 MG MG A 106 B 126 LEU A 77 LEU^? 13.85 MG MG A 106 B 158 GLU A 76 GLU^? 15.65 MG MG A 106 coo -39.79 4.61 147.27 -39.61 5.56 148.47 21.53 2.78 33.99 22.71 1.85 33.69 coo -34.22 5.06 149.25 -33.65 4.24 151.15 15.86 6.62 31.21 14.13 7.34 32.43 coo -33.03 9.93 151.71 -34.98 9.38 151.11 19.27 9.35 28.47 21.14 9.50 27.54 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA B 79 ALA.? 18.26 C2 TRS B 107 B 126 LEU B 77 LEU^? 13.15 N TRS B 107 B 158 GLU B 76 GLU^? 8.69 O3 TRS B 107 coo -39.79 4.61 147.27 -39.61 5.56 148.47 6.61 -26.34 36.32 5.53 -25.53 37.02 coo -34.22 5.06 149.25 -33.65 4.24 151.15 9.66 -28.91 30.02 11.77 -29.40 29.78 coo -33.03 9.93 151.71 -34.98 9.38 151.11 5.19 -33.70 27.63 3.11 -33.88 28.01 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 79 ALA.? 8.97 MG MG A 106 C 126 LEU A 77 LEU^? 13.85 MG MG A 106 C 158 GLU A 76 GLU^? 15.65 MG MG A 106 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 21.53 2.78 33.99 22.71 1.85 33.69 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 15.86 6.62 31.21 14.13 7.34 32.43 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 19.27 9.35 28.47 21.14 9.50 27.54 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA B 79 ALA.? 18.26 C2 TRS B 107 C 126 LEU B 77 LEU^? 13.15 N TRS B 107 C 158 GLU B 76 GLU^? 8.69 O3 TRS B 107 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 6.61 -26.34 36.32 5.53 -25.53 37.02 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 9.66 -28.91 30.02 11.77 -29.40 29.78 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 5.19 -33.70 27.63 3.11 -33.88 28.01 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c02 naa= 3 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 1 3 # 1 B 1 SER A 50 SER.? 27.61 MG MG A 106 B 69 ALA A 87 ALA.? 25.24 MG MG A 106 B 241 ASN A 88 ASN.? 28.92 MG MG A 106 coo 13.24 41.94 33.13 13.08 39.54 33.17 -0.06 4.91 32.10 -1.94 6.16 32.59 coo 9.15 37.89 36.69 10.55 37.76 37.22 0.01 8.51 37.99 -0.89 8.22 39.18 coo 10.91 43.03 38.47 11.81 41.82 36.93 -3.68 10.05 36.57 -4.41 8.86 38.16 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 2 3 # 2 B 1 SER A 51 SER.? 23.86 MG MG A 106 B 69 ALA A 87 ALA.? 25.24 MG MG A 106 B 241 ASN A 88 ASN.? 28.92 MG MG A 106 coo 13.24 41.94 33.13 13.08 39.54 33.17 -0.50 3.87 35.77 0.51 2.99 37.79 coo 9.15 37.89 36.69 10.55 37.76 37.22 0.01 8.51 37.99 -0.89 8.22 39.18 coo 10.91 43.03 38.47 11.81 41.82 36.93 -3.68 10.05 36.57 -4.41 8.86 38.16 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 3 3 # 3 B 1 SER B 50 SER.? 10.24 MG A MG B 106 B 69 ALA B 87 ALA.? 11.95 MG A MG B 106 B 241 ASN B 88 ASN.? -8.35 MG A MG B 106s coo 13.24 41.94 33.13 13.08 39.54 33.17 22.06 -26.75 19.93 22.40 -27.54 17.60 coo 9.15 37.89 36.69 10.55 37.76 37.22 26.83 -31.43 25.64 28.30 -31.66 26.04 coo 10.91 43.03 38.47 11.81 41.82 36.93 28.06 -31.46 21.34 28.31 -31.33 19.24 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 4 3 # 4 B 1 SER B 51 SER.? 11.55 MG A MG B 106 B 69 ALA B 87 ALA.? 11.95 MG A MG B 106 B 241 ASN B 88 ASN.? -8.35 MG A MG B 106s coo 13.24 41.94 33.13 13.08 39.54 33.17 23.96 -26.97 23.29 23.94 -29.25 24.02 coo 9.15 37.89 36.69 10.55 37.76 37.22 26.83 -31.43 25.64 28.30 -31.66 26.04 coo 10.91 43.03 38.47 11.81 41.82 36.93 28.06 -31.46 21.34 28.31 -31.33 19.24 1pnl_c00 source 1pnl PENICILLIN AMIDOHYDROLASE : 4 hits 1pnl_c00 naa= 3 ULMN 3 1pyl_c01 RIBONUCLEASE user 1 3 # 1 B 56 GLU A 26 GLU^? 23.08 MG MG A 106 B 67 ARG A 27 ARG^? 22.99 C2 TRS B 107 B 86 HIS A 37 HIS.? 14.34 MG MG A 106 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 6.59 -6.32 33.57 4.76 -5.37 34.00 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 11.78 -12.78 37.42 11.40 -15.00 35.25 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 11.15 -3.04 43.19 11.90 -1.76 44.64 1pyl_c01 source 1pyl RIBONUCLEASE : 1 hits 1pyl_c01 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 81 ASP.? 9.35 MG MG A 106 A 68 ALA A 79 ALA.? 8.97 MG MG A 106 A 72 LEU A 60 LEU^? 10.47 MG MG A 106 coo 46.76 7.59 18.65 45.27 6.01 18.52 18.32 7.36 35.53 19.95 8.35 34.55 coo 48.88 4.35 16.59 48.73 5.09 15.20 21.53 2.78 33.99 22.71 1.85 33.69 coo 53.89 6.25 15.09 52.88 7.92 14.14 18.79 -2.46 36.06 18.04 -2.95 38.04 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP B 81 ASP.? 16.51 N TRS B 107 A 68 ALA B 79 ALA.? 18.26 C2 TRS B 107 A 72 LEU B 60 LEU^? 22.12 C2 TRS B 107 coo 46.76 7.59 18.65 45.27 6.01 18.52 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 48.88 4.35 16.59 48.73 5.09 15.20 6.61 -26.34 36.32 5.53 -25.53 37.02 coo 53.89 6.25 15.09 52.88 7.92 14.14 10.35 -21.27 37.38 12.21 -20.94 38.46 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 2 hits 1q6l_c05 naa= 3 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 1 3 # 1 A 554 SER A 61 SER^? 13.76 MG MG A 106 A 641 ASP A 81 ASP.? 9.35 MG MG A 106 A 680 HIS A 78 HIS.? 11.19 MG MG A 106 coo 34.48 40.33 79.08 36.40 39.98 80.55 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 40.64 47.22 77.43 39.90 45.49 78.43 18.32 7.36 35.53 19.95 8.35 34.55 coo 38.53 44.50 81.45 37.60 42.73 80.84 21.83 6.49 31.11 22.88 8.20 31.70 1qfm_c00 source 1qfm PROLYL OLIGOPEPTIDASE : 1 hits 1qfm_c00 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 101 TYR^? 16.63 MG MG A 106 A 236 ASP A 81 ASP.? 9.35 MG MG A 106 A 261 LYS B 14 LYS.? 6.95 MG MG A 106 coo 55.48 26.51 40.65 55.39 23.99 39.43 12.29 -0.55 33.68 9.97 -0.77 32.12 coo 48.87 29.19 44.63 49.10 27.34 43.63 18.32 7.36 35.53 19.95 8.35 34.55 coo 47.58 17.35 41.83 51.40 20.85 40.83 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR B 101 TYR^? 17.91 N TRS B 107 A 236 ASP B 81 ASP.? 16.51 N TRS B 107 A 261 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 55.48 26.51 40.65 55.39 23.99 39.43 14.17 -22.17 31.30 14.99 -21.52 28.71 coo 48.87 29.19 44.63 49.10 27.34 43.63 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 47.58 17.35 41.83 51.40 20.85 40.83 8.74 -17.74 39.05 7.96 -22.88 42.54 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR B 101 TYR^? 17.91 N TRS B 107 B 236 ASP B 81 ASP.? 16.51 N TRS B 107 B 261 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 14.17 -22.17 31.30 14.99 -21.52 28.71 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 8.74 -17.74 39.05 7.96 -22.88 42.54 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR A 101 TYR^? 16.63 MG MG A 106 C 236 ASP A 81 ASP.? 9.35 MG MG A 106 C 261 LYS B 14 LYS.? 6.95 MG MG A 106 coo 39.51 34.34 13.63 37.63 32.61 14.79 12.29 -0.55 33.68 9.97 -0.77 32.12 coo 45.78 31.11 9.51 44.25 30.06 10.53 18.32 7.36 35.53 19.95 8.35 34.55 coo 37.54 22.37 12.10 37.83 27.55 13.24 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 163 TYR B 101 TYR^? 17.91 N TRS B 107 C 236 ASP B 81 ASP.? 16.51 N TRS B 107 C 261 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 39.51 34.34 13.63 37.63 32.61 14.79 14.17 -22.17 31.30 14.99 -21.52 28.71 coo 45.78 31.11 9.51 44.25 30.06 10.53 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 37.54 22.37 12.10 37.83 27.55 13.24 8.74 -17.74 39.05 7.96 -22.88 42.54 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR A 101 TYR^? 16.63 MG MG A 106 D 236 ASP A 81 ASP.? 9.35 MG MG A 106 D 261 LYS B 14 LYS.? 6.95 MG MG A 106 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 12.29 -0.55 33.68 9.97 -0.77 32.12 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 18.32 7.36 35.53 19.95 8.35 34.55 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 163 TYR B 101 TYR^? 17.91 N TRS B 107 D 236 ASP B 81 ASP.? 16.51 N TRS B 107 D 261 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 14.17 -22.17 31.30 14.99 -21.52 28.71 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 8.74 -17.74 39.05 7.96 -22.88 42.54 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR B 101 TYR^? 17.91 N TRS B 107 E 236 ASP B 81 ASP.? 16.51 N TRS B 107 E 261 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 14.17 -22.17 31.30 14.99 -21.52 28.71 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 8.74 -17.74 39.05 7.96 -22.88 42.54 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 101 TYR^? 16.63 MG MG A 106 F 236 ASP A 81 ASP.? 9.35 MG MG A 106 F 261 LYS B 14 LYS.? 6.95 MG MG A 106 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 12.29 -0.55 33.68 9.97 -0.77 32.12 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 18.32 7.36 35.53 19.95 8.35 34.55 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR B 101 TYR^? 17.91 N TRS B 107 F 236 ASP B 81 ASP.? 16.51 N TRS B 107 F 261 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 14.17 -22.17 31.30 14.99 -21.52 28.71 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 8.74 -17.74 39.05 7.96 -22.88 42.54 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR A 101 TYR^? 16.63 MG MG A 106 G 236 ASP A 81 ASP.? 9.35 MG MG A 106 G 261 LYS B 14 LYS.? 6.95 MG MG A 106 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 12.29 -0.55 33.68 9.97 -0.77 32.12 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 18.32 7.36 35.53 19.95 8.35 34.55 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 163 TYR B 101 TYR^? 17.91 N TRS B 107 G 236 ASP B 81 ASP.? 16.51 N TRS B 107 G 261 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 14.17 -22.17 31.30 14.99 -21.52 28.71 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 8.74 -17.74 39.05 7.96 -22.88 42.54 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR B 101 TYR^? 17.91 N TRS B 107 H 236 ASP B 81 ASP.? 16.51 N TRS B 107 H 261 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 14.17 -22.17 31.30 14.99 -21.52 28.71 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 8.74 -17.74 39.05 7.96 -22.88 42.54 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c15 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 92 ARG^? 29.81 MG MG A 106 C 163 TYR A 47 TYR^? 25.20 MG MG A 106 C 236 ASP A 21 ASP.? 20.18 O2 TRS B 107 coo 39.01 29.77 22.02 37.48 31.30 19.84 4.92 8.97 23.23 2.03 9.56 22.51 coo 39.51 34.34 13.63 37.63 32.61 14.79 6.73 0.56 24.29 8.36 -1.29 22.99 coo 45.78 31.11 9.51 44.25 30.06 10.53 2.80 -6.84 20.40 2.88 -7.95 18.60 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG B 92 ARG^? 5.10 O1 TRS B 107 C 163 TYR B 47 TYR^? 12.23 O1 TRS B 107 C 236 ASP B 21 ASP.? 19.35 O1 TRS B 107 coo 39.01 29.77 22.02 37.48 31.30 19.84 10.89 -28.76 16.90 8.49 -30.55 16.32 coo 39.51 34.34 13.63 37.63 32.61 14.79 12.41 -21.54 20.17 10.64 -19.48 20.79 coo 45.78 31.11 9.51 44.25 30.06 10.53 13.91 -13.27 16.06 15.24 -13.79 14.55 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 110 ARG B 92 ARG^? 5.10 O1 TRS B 107 C 163 TYR B 66 TYR^? 13.48 N TRS B 107 C 236 ASP B 73 ASP.? 13.34 N TRS B 107 coo 39.01 29.77 22.02 37.48 31.30 19.84 10.89 -28.76 16.90 8.49 -30.55 16.32 coo 39.51 34.34 13.63 37.63 32.61 14.79 14.02 -31.53 25.24 16.67 -32.32 24.84 coo 45.78 31.11 9.51 44.25 30.06 10.53 9.64 -40.18 22.89 9.15 -42.09 22.32 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 92 ARG^? 29.81 MG MG A 106 D 163 TYR A 47 TYR^? 25.20 MG MG A 106 D 236 ASP A 21 ASP.? 20.18 O2 TRS B 107 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 4.92 8.97 23.23 2.03 9.56 22.51 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 6.73 0.56 24.29 8.36 -1.29 22.99 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 2.80 -6.84 20.40 2.88 -7.95 18.60 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG B 92 ARG^? 5.10 O1 TRS B 107 D 163 TYR B 47 TYR^? 12.23 O1 TRS B 107 D 236 ASP B 21 ASP.? 19.35 O1 TRS B 107 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 10.89 -28.76 16.90 8.49 -30.55 16.32 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 12.41 -21.54 20.17 10.64 -19.48 20.79 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 13.91 -13.27 16.06 15.24 -13.79 14.55 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 110 ARG B 92 ARG^? 5.10 O1 TRS B 107 D 163 TYR B 66 TYR^? 13.48 N TRS B 107 D 236 ASP B 73 ASP.? 13.34 N TRS B 107 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 10.89 -28.76 16.90 8.49 -30.55 16.32 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 14.02 -31.53 25.24 16.67 -32.32 24.84 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 9.64 -40.18 22.89 9.15 -42.09 22.32 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR B 47 TYR^? 12.23 O1 TRS B 107 A 236 ASP B 21 ASP.? 19.35 O1 TRS B 107 C 110 ARG B 92 ARG^? 5.10 O1 TRS B 107 coo 55.48 26.51 40.65 55.39 23.99 39.43 12.41 -21.54 20.17 10.64 -19.48 20.79 coo 48.87 29.19 44.63 49.10 27.34 43.63 13.91 -13.27 16.06 15.24 -13.79 14.55 coo 52.39 23.42 32.10 54.51 23.27 34.29 10.89 -28.76 16.90 8.49 -30.55 16.32 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR B 66 TYR^? 13.48 N TRS B 107 A 236 ASP B 73 ASP.? 13.34 N TRS B 107 C 110 ARG B 92 ARG^? 5.10 O1 TRS B 107 coo 55.48 26.51 40.65 55.39 23.99 39.43 14.02 -31.53 25.24 16.67 -32.32 24.84 coo 48.87 29.19 44.63 49.10 27.34 43.63 9.64 -40.18 22.89 9.15 -42.09 22.32 coo 52.39 23.42 32.10 54.51 23.27 34.29 10.89 -28.76 16.90 8.49 -30.55 16.32 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 47 TYR^? 25.20 MG MG A 106 B 236 ASP A 21 ASP.? 20.18 O2 TRS B 107 D 110 ARG A 92 ARG^? 29.81 MG MG A 106 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 6.73 0.56 24.29 8.36 -1.29 22.99 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 2.80 -6.84 20.40 2.88 -7.95 18.60 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 4.92 8.97 23.23 2.03 9.56 22.51 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 47 TYR^? 12.23 O1 TRS B 107 B 236 ASP B 21 ASP.? 19.35 O1 TRS B 107 D 110 ARG B 92 ARG^? 5.10 O1 TRS B 107 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 12.41 -21.54 20.17 10.64 -19.48 20.79 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 13.91 -13.27 16.06 15.24 -13.79 14.55 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 10.89 -28.76 16.90 8.49 -30.55 16.32 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR B 66 TYR^? 13.48 N TRS B 107 B 236 ASP B 73 ASP.? 13.34 N TRS B 107 D 110 ARG B 92 ARG^? 5.10 O1 TRS B 107 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 14.02 -31.53 25.24 16.67 -32.32 24.84 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 9.64 -40.18 22.89 9.15 -42.09 22.32 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 10.89 -28.76 16.90 8.49 -30.55 16.32 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 92 ARG^? 29.81 MG MG A 106 G 163 TYR A 47 TYR^? 25.20 MG MG A 106 G 236 ASP A 21 ASP.? 20.18 O2 TRS B 107 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 4.92 8.97 23.23 2.03 9.56 22.51 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 6.73 0.56 24.29 8.36 -1.29 22.99 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 2.80 -6.84 20.40 2.88 -7.95 18.60 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG B 92 ARG^? 5.10 O1 TRS B 107 G 163 TYR B 47 TYR^? 12.23 O1 TRS B 107 G 236 ASP B 21 ASP.? 19.35 O1 TRS B 107 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 10.89 -28.76 16.90 8.49 -30.55 16.32 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 12.41 -21.54 20.17 10.64 -19.48 20.79 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 13.91 -13.27 16.06 15.24 -13.79 14.55 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 110 ARG B 92 ARG^? 5.10 O1 TRS B 107 G 163 TYR B 66 TYR^? 13.48 N TRS B 107 G 236 ASP B 73 ASP.? 13.34 N TRS B 107 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 10.89 -28.76 16.90 8.49 -30.55 16.32 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 14.02 -31.53 25.24 16.67 -32.32 24.84 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 9.64 -40.18 22.89 9.15 -42.09 22.32 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 92 ARG^? 29.81 MG MG A 106 H 163 TYR A 47 TYR^? 25.20 MG MG A 106 H 236 ASP A 21 ASP.? 20.18 O2 TRS B 107 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 4.92 8.97 23.23 2.03 9.56 22.51 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 6.73 0.56 24.29 8.36 -1.29 22.99 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 2.80 -6.84 20.40 2.88 -7.95 18.60 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG B 92 ARG^? 5.10 O1 TRS B 107 H 163 TYR B 47 TYR^? 12.23 O1 TRS B 107 H 236 ASP B 21 ASP.? 19.35 O1 TRS B 107 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 10.89 -28.76 16.90 8.49 -30.55 16.32 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 12.41 -21.54 20.17 10.64 -19.48 20.79 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 13.91 -13.27 16.06 15.24 -13.79 14.55 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG B 92 ARG^? 5.10 O1 TRS B 107 H 163 TYR B 66 TYR^? 13.48 N TRS B 107 H 236 ASP B 73 ASP.? 13.34 N TRS B 107 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 10.89 -28.76 16.90 8.49 -30.55 16.32 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 14.02 -31.53 25.24 16.67 -32.32 24.84 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 9.64 -40.18 22.89 9.15 -42.09 22.32 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR B 47 TYR^? 12.23 O1 TRS B 107 E 236 ASP B 21 ASP.? 19.35 O1 TRS B 107 G 110 ARG B 92 ARG^? 5.10 O1 TRS B 107 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 12.41 -21.54 20.17 10.64 -19.48 20.79 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 13.91 -13.27 16.06 15.24 -13.79 14.55 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 10.89 -28.76 16.90 8.49 -30.55 16.32 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 66 TYR^? 13.48 N TRS B 107 E 236 ASP B 73 ASP.? 13.34 N TRS B 107 G 110 ARG B 92 ARG^? 5.10 O1 TRS B 107 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 14.02 -31.53 25.24 16.67 -32.32 24.84 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 9.64 -40.18 22.89 9.15 -42.09 22.32 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 10.89 -28.76 16.90 8.49 -30.55 16.32 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 47 TYR^? 25.20 MG MG A 106 F 236 ASP A 21 ASP.? 20.18 O2 TRS B 107 H 110 ARG A 92 ARG^? 29.81 MG MG A 106 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 6.73 0.56 24.29 8.36 -1.29 22.99 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 2.80 -6.84 20.40 2.88 -7.95 18.60 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 4.92 8.97 23.23 2.03 9.56 22.51 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR B 47 TYR^? 12.23 O1 TRS B 107 F 236 ASP B 21 ASP.? 19.35 O1 TRS B 107 H 110 ARG B 92 ARG^? 5.10 O1 TRS B 107 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 12.41 -21.54 20.17 10.64 -19.48 20.79 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 13.91 -13.27 16.06 15.24 -13.79 14.55 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 10.89 -28.76 16.90 8.49 -30.55 16.32 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR B 66 TYR^? 13.48 N TRS B 107 F 236 ASP B 73 ASP.? 13.34 N TRS B 107 H 110 ARG B 92 ARG^? 5.10 O1 TRS B 107 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 14.02 -31.53 25.24 16.67 -32.32 24.84 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 9.64 -40.18 22.89 9.15 -42.09 22.32 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 10.89 -28.76 16.90 8.49 -30.55 16.32 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c23 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 81 ASP.? 9.35 MG MG A 106 A 260 ASP A 4 ASP.? 11.89 MG MG A 106 A 329 ASP A 100 ASP^? 16.25 MG MG A 106 coo 28.46 69.88 26.74 30.40 70.70 26.53 18.32 7.36 35.53 19.95 8.35 34.55 coo 30.73 81.29 37.61 31.23 82.07 35.69 29.77 -2.68 38.63 30.81 -3.64 37.08 coo 37.87 70.12 31.80 36.61 69.74 30.15 17.24 -4.20 32.64 17.59 -5.86 31.44 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 100 ASP^? 16.25 MG MG A 106 A 260 ASP A 4 ASP.? 11.89 MG MG A 106 A 329 ASP A 81 ASP.? 9.35 MG MG A 106 coo 28.46 69.88 26.74 30.40 70.70 26.53 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 30.73 81.29 37.61 31.23 82.07 35.69 29.77 -2.68 38.63 30.81 -3.64 37.08 coo 37.87 70.12 31.80 36.61 69.74 30.15 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 81 ASP.? 16.51 N TRS B 107 A 260 ASP B 4 ASP.? 25.97 C2 TRS B 107 A 329 ASP B 100 ASP^? 19.56 C2 TRS B 107 coo 28.46 69.88 26.74 30.40 70.70 26.53 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 30.73 81.29 37.61 31.23 82.07 35.69 4.45 -22.45 45.85 5.06 -24.19 44.80 coo 37.87 70.12 31.80 36.61 69.74 30.15 9.71 -18.83 33.97 8.85 -16.99 33.47 1qho_c07 source 1qho ALPHA-AMYLASE : 3 hits 1qho_c07 naa= 3 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 1 3 # 1 A 80 SER A 61 SER^? 13.76 MG MG A 106 A 207 ASP A 81 ASP.? 9.35 MG MG A 106 A 235 HIS A 78 HIS.? 11.19 MG MG A 106 coo 15.54 46.73 17.13 17.06 48.44 16.17 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 23.60 50.31 20.82 21.66 50.51 20.06 18.32 7.36 35.53 19.95 8.35 34.55 coo 20.17 51.16 17.08 18.31 50.28 17.44 21.83 6.49 31.11 22.88 8.20 31.70 1qj4_c00 source 1qj4 HYDROXYNITRILE LYASE : 1 hits 1qj4_c00 naa= 3 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 A 51 ALA A 64 ALA^? 17.52 MG MG A 106 A 148 HIS A 78 HIS.? 11.19 MG MG A 106 A 163 ASP A 81 ASP.? 9.35 MG MG A 106 coo 1.42 19.18 21.84 1.11 19.57 23.28 15.38 5.15 26.91 14.21 4.40 27.56 coo 0.71 19.67 27.92 2.43 19.16 26.83 21.83 6.49 31.11 22.88 8.20 31.70 coo 7.15 16.22 27.50 6.15 18.00 27.94 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 A 51 ALA A 68 ALA.? 22.95 MG MG A 106 A 148 HIS A 67 HIS^? 25.71 MG MG A 106 A 163 ASP A 73 ASP.? 24.66 MG MG A 106 coo 1.42 19.18 21.84 1.11 19.57 23.28 5.61 12.80 30.20 5.83 13.73 31.36 coo 0.71 19.67 27.92 2.43 19.16 26.83 7.29 12.90 25.70 6.12 14.46 24.97 coo 7.15 16.22 27.50 6.15 18.00 27.94 11.88 18.46 25.62 13.34 17.78 24.18 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 A 51 ALA B 64 ALA^? 10.02 N TRS B 107 A 148 HIS B 78 HIS^? 12.04 O3 TRS B 107 A 163 ASP B 81 ASP.? 16.51 N TRS B 107 coo 1.42 19.18 21.84 1.11 19.57 23.28 7.19 -26.95 26.54 8.52 -26.19 26.49 coo 0.71 19.67 27.92 2.43 19.16 26.83 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 7.15 16.22 27.50 6.15 18.00 27.94 9.98 -30.67 34.70 8.29 -31.92 34.80 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 A 51 ALA B 68 ALA^? 14.86 N TRS B 107 A 148 HIS B 67 HIS^? 10.25 N TRS B 107 A 163 ASP B 73 ASP.? 13.34 N TRS B 107 coo 1.42 19.18 21.84 1.11 19.57 23.28 16.42 -34.38 21.11 17.07 -35.33 22.06 coo 0.71 19.67 27.92 2.43 19.16 26.83 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 7.15 16.22 27.50 6.15 18.00 27.94 9.64 -40.18 22.89 9.15 -42.09 22.32 1qol_c00 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 4 hits 1qol_c00 naa= 3 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 B 51 ALA A 64 ALA^? 17.52 MG MG A 106 B 148 HIS A 78 HIS.? 11.19 MG MG A 106 B 163 ASP A 81 ASP.? 9.35 MG MG A 106 coo -33.97 19.78 54.18 -33.40 20.11 52.82 15.38 5.15 26.91 14.21 4.40 27.56 coo -33.17 20.01 48.16 -34.95 19.37 49.06 21.83 6.49 31.11 22.88 8.20 31.70 coo -39.82 16.62 48.85 -38.59 18.24 48.48 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 B 51 ALA A 68 ALA.? 22.95 MG MG A 106 B 148 HIS A 67 HIS^? 25.71 MG MG A 106 B 163 ASP A 73 ASP.? 24.66 MG MG A 106 coo -33.97 19.78 54.18 -33.40 20.11 52.82 5.61 12.80 30.20 5.83 13.73 31.36 coo -33.17 20.01 48.16 -34.95 19.37 49.06 7.29 12.90 25.70 6.12 14.46 24.97 coo -39.82 16.62 48.85 -38.59 18.24 48.48 11.88 18.46 25.62 13.34 17.78 24.18 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 B 51 ALA A 71 ALA.? 25.01 MG MG A 106 B 148 HIS A 67 HIS^? 25.71 MG MG A 106 B 163 ASP A 73 ASP.? 24.66 MG MG A 106 coo -33.97 19.78 54.18 -33.40 20.11 52.82 5.76 17.65 27.92 6.71 16.75 28.65 coo -33.17 20.01 48.16 -34.95 19.37 49.06 7.29 12.90 25.70 6.12 14.46 24.97 coo -39.82 16.62 48.85 -38.59 18.24 48.48 11.88 18.46 25.62 13.34 17.78 24.18 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 B 51 ALA B 64 ALA^? 10.02 N TRS B 107 B 148 HIS B 78 HIS^? 12.04 O3 TRS B 107 B 163 ASP B 81 ASP.? 16.51 N TRS B 107 coo -33.97 19.78 54.18 -33.40 20.11 52.82 7.19 -26.95 26.54 8.52 -26.19 26.49 coo -33.17 20.01 48.16 -34.95 19.37 49.06 4.34 -30.02 32.49 3.20 -30.88 30.99 coo -39.82 16.62 48.85 -38.59 18.24 48.48 9.98 -30.67 34.70 8.29 -31.92 34.80 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 B 51 ALA B 68 ALA^? 14.86 N TRS B 107 B 148 HIS B 67 HIS^? 10.25 N TRS B 107 B 163 ASP B 73 ASP.? 13.34 N TRS B 107 coo -33.97 19.78 54.18 -33.40 20.11 52.82 16.42 -34.38 21.11 17.07 -35.33 22.06 coo -33.17 20.01 48.16 -34.95 19.37 49.06 12.23 -34.37 19.25 12.68 -35.93 17.95 coo -39.82 16.62 48.85 -38.59 18.24 48.48 9.64 -40.18 22.89 9.15 -42.09 22.32 1qol_c01 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 5 hits 1qol_c01 naa= 3 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 C 51 ALA A 64 ALA^? 17.52 MG MG A 106 C 148 HIS A 78 HIS.? 11.19 MG MG A 106 C 163 ASP A 81 ASP.? 9.35 MG MG A 106 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 15.38 5.15 26.91 14.21 4.40 27.56 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 21.83 6.49 31.11 22.88 8.20 31.70 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 C 51 ALA A 68 ALA.? 22.95 MG MG A 106 C 148 HIS A 67 HIS^? 25.71 MG MG A 106 C 163 ASP A 73 ASP.? 24.66 MG MG A 106 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 5.61 12.80 30.20 5.83 13.73 31.36 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 7.29 12.90 25.70 6.12 14.46 24.97 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 11.88 18.46 25.62 13.34 17.78 24.18 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 C 51 ALA B 64 ALA^? 10.02 N TRS B 107 C 148 HIS B 78 HIS^? 12.04 O3 TRS B 107 C 163 ASP B 81 ASP.? 16.51 N TRS B 107 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 7.19 -26.95 26.54 8.52 -26.19 26.49 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 4.34 -30.02 32.49 3.20 -30.88 30.99 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 9.98 -30.67 34.70 8.29 -31.92 34.80 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 C 51 ALA B 68 ALA^? 14.86 N TRS B 107 C 148 HIS B 67 HIS^? 10.25 N TRS B 107 C 163 ASP B 73 ASP.? 13.34 N TRS B 107 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 16.42 -34.38 21.11 17.07 -35.33 22.06 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 12.23 -34.37 19.25 12.68 -35.93 17.95 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 9.64 -40.18 22.89 9.15 -42.09 22.32 1qol_c02 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 4 hits 1qol_c02 naa= 3 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 D 51 ALA A 64 ALA^? 17.52 MG MG A 106 D 148 HIS A 78 HIS.? 11.19 MG MG A 106 D 163 ASP A 81 ASP.? 9.35 MG MG A 106 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 15.38 5.15 26.91 14.21 4.40 27.56 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 21.83 6.49 31.11 22.88 8.20 31.70 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 D 51 ALA A 68 ALA.? 22.95 MG MG A 106 D 148 HIS A 67 HIS^? 25.71 MG MG A 106 D 163 ASP A 73 ASP.? 24.66 MG MG A 106 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 5.61 12.80 30.20 5.83 13.73 31.36 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 7.29 12.90 25.70 6.12 14.46 24.97 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 11.88 18.46 25.62 13.34 17.78 24.18 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 D 51 ALA A 71 ALA.? 25.01 MG MG A 106 D 148 HIS A 67 HIS^? 25.71 MG MG A 106 D 163 ASP A 73 ASP.? 24.66 MG MG A 106 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 5.76 17.65 27.92 6.71 16.75 28.65 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 7.29 12.90 25.70 6.12 14.46 24.97 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 11.88 18.46 25.62 13.34 17.78 24.18 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 D 51 ALA B 64 ALA^? 10.02 N TRS B 107 D 148 HIS B 78 HIS^? 12.04 O3 TRS B 107 D 163 ASP B 81 ASP.? 16.51 N TRS B 107 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 7.19 -26.95 26.54 8.52 -26.19 26.49 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 4.34 -30.02 32.49 3.20 -30.88 30.99 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 9.98 -30.67 34.70 8.29 -31.92 34.80 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 D 51 ALA B 68 ALA^? 14.86 N TRS B 107 D 148 HIS B 67 HIS^? 10.25 N TRS B 107 D 163 ASP B 73 ASP.? 13.34 N TRS B 107 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 16.42 -34.38 21.11 17.07 -35.33 22.06 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 12.23 -34.37 19.25 12.68 -35.93 17.95 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 9.64 -40.18 22.89 9.15 -42.09 22.32 1qol_c03 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 5 hits 1qol_c03 naa= 3 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 E 51 ALA A 64 ALA^? 17.52 MG MG A 106 E 148 HIS A 78 HIS.? 11.19 MG MG A 106 E 163 ASP A 81 ASP.? 9.35 MG MG A 106 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 15.38 5.15 26.91 14.21 4.40 27.56 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 21.83 6.49 31.11 22.88 8.20 31.70 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 E 51 ALA A 68 ALA.? 22.95 MG MG A 106 E 148 HIS A 67 HIS^? 25.71 MG MG A 106 E 163 ASP A 73 ASP.? 24.66 MG MG A 106 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 5.61 12.80 30.20 5.83 13.73 31.36 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 7.29 12.90 25.70 6.12 14.46 24.97 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 11.88 18.46 25.62 13.34 17.78 24.18 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 E 51 ALA A 71 ALA.? 25.01 MG MG A 106 E 148 HIS A 67 HIS^? 25.71 MG MG A 106 E 163 ASP A 73 ASP.? 24.66 MG MG A 106 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 5.76 17.65 27.92 6.71 16.75 28.65 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 7.29 12.90 25.70 6.12 14.46 24.97 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 11.88 18.46 25.62 13.34 17.78 24.18 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 E 51 ALA B 64 ALA^? 10.02 N TRS B 107 E 148 HIS B 78 HIS^? 12.04 O3 TRS B 107 E 163 ASP B 81 ASP.? 16.51 N TRS B 107 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 7.19 -26.95 26.54 8.52 -26.19 26.49 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 9.98 -30.67 34.70 8.29 -31.92 34.80 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 E 51 ALA B 68 ALA^? 14.86 N TRS B 107 E 148 HIS B 67 HIS^? 10.25 N TRS B 107 E 163 ASP B 73 ASP.? 13.34 N TRS B 107 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 16.42 -34.38 21.11 17.07 -35.33 22.06 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 9.64 -40.18 22.89 9.15 -42.09 22.32 1qol_c04 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 5 hits 1qol_c04 naa= 3 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 F 51 ALA A 64 ALA^? 17.52 MG MG A 106 F 148 HIS A 78 HIS.? 11.19 MG MG A 106 F 163 ASP A 81 ASP.? 9.35 MG MG A 106 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 15.38 5.15 26.91 14.21 4.40 27.56 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 21.83 6.49 31.11 22.88 8.20 31.70 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 F 51 ALA A 68 ALA.? 22.95 MG MG A 106 F 148 HIS A 67 HIS^? 25.71 MG MG A 106 F 163 ASP A 73 ASP.? 24.66 MG MG A 106 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 5.61 12.80 30.20 5.83 13.73 31.36 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 7.29 12.90 25.70 6.12 14.46 24.97 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 11.88 18.46 25.62 13.34 17.78 24.18 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 F 51 ALA A 71 ALA.? 25.01 MG MG A 106 F 148 HIS A 67 HIS^? 25.71 MG MG A 106 F 163 ASP A 73 ASP.? 24.66 MG MG A 106 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 5.76 17.65 27.92 6.71 16.75 28.65 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 7.29 12.90 25.70 6.12 14.46 24.97 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 11.88 18.46 25.62 13.34 17.78 24.18 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 F 51 ALA B 64 ALA^? 10.02 N TRS B 107 F 148 HIS B 78 HIS^? 12.04 O3 TRS B 107 F 163 ASP B 81 ASP.? 16.51 N TRS B 107 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 7.19 -26.95 26.54 8.52 -26.19 26.49 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 9.98 -30.67 34.70 8.29 -31.92 34.80 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 F 51 ALA B 68 ALA^? 14.86 N TRS B 107 F 148 HIS B 67 HIS^? 10.25 N TRS B 107 F 163 ASP B 73 ASP.? 13.34 N TRS B 107 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 16.42 -34.38 21.11 17.07 -35.33 22.06 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 9.64 -40.18 22.89 9.15 -42.09 22.32 1qol_c05 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 5 hits 1qol_c05 naa= 3 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 G 51 ALA A 64 ALA^? 17.52 MG MG A 106 G 148 HIS A 78 HIS.? 11.19 MG MG A 106 G 163 ASP A 81 ASP.? 9.35 MG MG A 106 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 15.38 5.15 26.91 14.21 4.40 27.56 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 21.83 6.49 31.11 22.88 8.20 31.70 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 G 51 ALA A 68 ALA.? 22.95 MG MG A 106 G 148 HIS A 67 HIS^? 25.71 MG MG A 106 G 163 ASP A 73 ASP.? 24.66 MG MG A 106 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 5.61 12.80 30.20 5.83 13.73 31.36 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 7.29 12.90 25.70 6.12 14.46 24.97 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 11.88 18.46 25.62 13.34 17.78 24.18 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 G 51 ALA A 71 ALA.? 25.01 MG MG A 106 G 148 HIS A 67 HIS^? 25.71 MG MG A 106 G 163 ASP A 73 ASP.? 24.66 MG MG A 106 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 5.76 17.65 27.92 6.71 16.75 28.65 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 7.29 12.90 25.70 6.12 14.46 24.97 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 11.88 18.46 25.62 13.34 17.78 24.18 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 G 51 ALA B 64 ALA^? 10.02 N TRS B 107 G 148 HIS B 78 HIS^? 12.04 O3 TRS B 107 G 163 ASP B 81 ASP.? 16.51 N TRS B 107 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 7.19 -26.95 26.54 8.52 -26.19 26.49 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 4.34 -30.02 32.49 3.20 -30.88 30.99 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 9.98 -30.67 34.70 8.29 -31.92 34.80 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 G 51 ALA B 68 ALA^? 14.86 N TRS B 107 G 148 HIS B 67 HIS^? 10.25 N TRS B 107 G 163 ASP B 73 ASP.? 13.34 N TRS B 107 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 16.42 -34.38 21.11 17.07 -35.33 22.06 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 12.23 -34.37 19.25 12.68 -35.93 17.95 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 9.64 -40.18 22.89 9.15 -42.09 22.32 1qol_c06 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 5 hits 1qol_c06 naa= 3 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 H 51 ALA A 64 ALA^? 17.52 MG MG A 106 H 148 HIS A 78 HIS.? 11.19 MG MG A 106 H 163 ASP A 81 ASP.? 9.35 MG MG A 106 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 15.38 5.15 26.91 14.21 4.40 27.56 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 21.83 6.49 31.11 22.88 8.20 31.70 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 H 51 ALA A 68 ALA.? 22.95 MG MG A 106 H 148 HIS A 67 HIS^? 25.71 MG MG A 106 H 163 ASP A 73 ASP.? 24.66 MG MG A 106 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 5.61 12.80 30.20 5.83 13.73 31.36 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 7.29 12.90 25.70 6.12 14.46 24.97 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 11.88 18.46 25.62 13.34 17.78 24.18 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 H 51 ALA B 64 ALA^? 10.02 N TRS B 107 H 148 HIS B 78 HIS^? 12.04 O3 TRS B 107 H 163 ASP B 81 ASP.? 16.51 N TRS B 107 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 7.19 -26.95 26.54 8.52 -26.19 26.49 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 4.34 -30.02 32.49 3.20 -30.88 30.99 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 9.98 -30.67 34.70 8.29 -31.92 34.80 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 H 51 ALA B 68 ALA^? 14.86 N TRS B 107 H 148 HIS B 67 HIS^? 10.25 N TRS B 107 H 163 ASP B 73 ASP.? 13.34 N TRS B 107 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 16.42 -34.38 21.11 17.07 -35.33 22.06 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 12.23 -34.37 19.25 12.68 -35.93 17.95 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 9.64 -40.18 22.89 9.15 -42.09 22.32 1qol_c07 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 4 hits 1qol_c07 naa= 3 ULMN 3 1qrz_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 43 HIS.? 24.06 C2 TRS B 107 A 646 ASP A 21 ASP.? 20.18 O2 TRS B 107 A 741 SER A 25 SER^? 23.03 C2 TRS B 107 coo -20.72 2.99 34.37 -21.94 1.82 35.61 12.35 -6.62 23.61 12.63 -8.53 24.45 coo -18.83 7.68 26.86 -20.89 7.78 26.56 2.80 -6.84 20.40 2.88 -7.95 18.60 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 3 1qrz_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS A 43 HIS.? 24.06 C2 TRS B 107 A 646 ASP A 100 ASP^? 16.25 MG MG A 106 A 741 SER A 25 SER^? 23.03 C2 TRS B 107 coo -20.72 2.99 34.37 -21.94 1.82 35.61 12.35 -6.62 23.61 12.63 -8.53 24.45 coo -18.83 7.68 26.86 -20.89 7.78 26.56 17.24 -4.20 32.64 17.59 -5.86 31.44 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 3 1qrz_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS A 43 HIS.? 24.06 C2 TRS B 107 A 646 ASP A 100 ASP^? 16.25 MG MG A 106 A 741 SER B 25 SER^? 21.93 C2 TRS B 107 coo -20.72 2.99 34.37 -21.94 1.82 35.61 12.35 -6.62 23.61 12.63 -8.53 24.45 coo -18.83 7.68 26.86 -20.89 7.78 26.56 17.24 -4.20 32.64 17.59 -5.86 31.44 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 1qrz_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS A 43 HIS.? 24.06 C2 TRS B 107 A 646 ASP B 21 ASP.? 19.35 O1 TRS B 107 A 741 SER B 25 SER^? 21.93 C2 TRS B 107 coo -20.72 2.99 34.37 -21.94 1.82 35.61 12.35 -6.62 23.61 12.63 -8.53 24.45 coo -18.83 7.68 26.86 -20.89 7.78 26.56 13.91 -13.27 16.06 15.24 -13.79 14.55 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 1qrz_c12 PLASMINOGEN user 5 3 # 5 A 603 HIS B 37 HIS.? 23.74 MG A MG B 106 A 646 ASP B 33 ASP.? 27.59 MG MG A 106 A 741 SER B 104 SER.? 20.66 MG A MG B 106 coo -20.72 2.99 34.37 -21.94 1.82 35.61 21.69 -21.14 38.43 22.55 -22.53 39.75 coo -18.83 7.68 26.86 -20.89 7.78 26.56 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 22.99 -23.86 34.71 24.14 -24.66 36.71 ULMN 3 1qrz_c12 PLASMINOGEN user 6 3 # 6 A 603 HIS B 43 HIS.? 17.46 C2 TRS B 107 A 646 ASP A 21 ASP.? 20.18 O2 TRS B 107 A 741 SER A 25 SER^? 23.03 C2 TRS B 107 coo -20.72 2.99 34.37 -21.94 1.82 35.61 8.53 -14.49 24.38 9.05 -12.59 25.12 coo -18.83 7.68 26.86 -20.89 7.78 26.56 2.80 -6.84 20.40 2.88 -7.95 18.60 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 3 1qrz_c12 PLASMINOGEN user 7 3 # 7 A 603 HIS B 43 HIS.? 17.46 C2 TRS B 107 A 646 ASP B 21 ASP.? 19.35 O1 TRS B 107 A 741 SER B 25 SER^? 21.93 C2 TRS B 107 coo -20.72 2.99 34.37 -21.94 1.82 35.61 8.53 -14.49 24.38 9.05 -12.59 25.12 coo -18.83 7.68 26.86 -20.89 7.78 26.56 13.91 -13.27 16.06 15.24 -13.79 14.55 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 1qrz_c12 PLASMINOGEN user 8 3 # 8 A 603 HIS B 43 HIS.? 17.46 C2 TRS B 107 A 646 ASP B 100 ASP^? 19.56 C2 TRS B 107 A 741 SER A 25 SER^? 23.03 C2 TRS B 107 coo -20.72 2.99 34.37 -21.94 1.82 35.61 8.53 -14.49 24.38 9.05 -12.59 25.12 coo -18.83 7.68 26.86 -20.89 7.78 26.56 9.71 -18.83 33.97 8.85 -16.99 33.47 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 3 1qrz_c12 PLASMINOGEN user 9 3 # 9 A 603 HIS B 43 HIS.? 17.46 C2 TRS B 107 A 646 ASP B 100 ASP^? 19.56 C2 TRS B 107 A 741 SER B 25 SER^? 21.93 C2 TRS B 107 coo -20.72 2.99 34.37 -21.94 1.82 35.61 8.53 -14.49 24.38 9.05 -12.59 25.12 coo -18.83 7.68 26.86 -20.89 7.78 26.56 9.71 -18.83 33.97 8.85 -16.99 33.47 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 15.65 -13.25 27.32 13.56 -12.34 28.19 1qrz_c12 source 1qrz PLASMINOGEN : 9 hits 1qrz_c12 naa= 3 ULMN 3 1qrz_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 43 HIS.? 24.06 C2 TRS B 107 B 646 ASP A 21 ASP.? 20.18 O2 TRS B 107 B 741 SER A 25 SER^? 23.03 C2 TRS B 107 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 12.35 -6.62 23.61 12.63 -8.53 24.45 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 2.80 -6.84 20.40 2.88 -7.95 18.60 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 3 1qrz_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS A 43 HIS.? 24.06 C2 TRS B 107 B 646 ASP A 100 ASP^? 16.25 MG MG A 106 B 741 SER A 25 SER^? 23.03 C2 TRS B 107 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 12.35 -6.62 23.61 12.63 -8.53 24.45 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 17.24 -4.20 32.64 17.59 -5.86 31.44 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 3 1qrz_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS A 43 HIS.? 24.06 C2 TRS B 107 B 646 ASP A 100 ASP^? 16.25 MG MG A 106 B 741 SER B 25 SER^? 21.93 C2 TRS B 107 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 12.35 -6.62 23.61 12.63 -8.53 24.45 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 17.24 -4.20 32.64 17.59 -5.86 31.44 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 1qrz_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS A 43 HIS.? 24.06 C2 TRS B 107 B 646 ASP B 21 ASP.? 19.35 O1 TRS B 107 B 741 SER B 25 SER^? 21.93 C2 TRS B 107 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 12.35 -6.62 23.61 12.63 -8.53 24.45 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 13.91 -13.27 16.06 15.24 -13.79 14.55 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 1qrz_c13 PLASMINOGEN user 5 3 # 5 B 603 HIS B 43 HIS.? 17.46 C2 TRS B 107 B 646 ASP A 21 ASP.? 20.18 O2 TRS B 107 B 741 SER A 25 SER^? 23.03 C2 TRS B 107 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 8.53 -14.49 24.38 9.05 -12.59 25.12 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 2.80 -6.84 20.40 2.88 -7.95 18.60 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 3 1qrz_c13 PLASMINOGEN user 6 3 # 6 B 603 HIS B 43 HIS.? 17.46 C2 TRS B 107 B 646 ASP B 21 ASP.? 19.35 O1 TRS B 107 B 741 SER B 25 SER^? 21.93 C2 TRS B 107 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 8.53 -14.49 24.38 9.05 -12.59 25.12 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 13.91 -13.27 16.06 15.24 -13.79 14.55 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 1qrz_c13 PLASMINOGEN user 7 3 # 7 B 603 HIS B 43 HIS.? 17.46 C2 TRS B 107 B 646 ASP B 100 ASP^? 19.56 C2 TRS B 107 B 741 SER A 25 SER^? 23.03 C2 TRS B 107 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 8.53 -14.49 24.38 9.05 -12.59 25.12 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 9.71 -18.83 33.97 8.85 -16.99 33.47 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 3 1qrz_c13 PLASMINOGEN user 8 3 # 8 B 603 HIS B 43 HIS.? 17.46 C2 TRS B 107 B 646 ASP B 100 ASP^? 19.56 C2 TRS B 107 B 741 SER B 25 SER^? 21.93 C2 TRS B 107 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 8.53 -14.49 24.38 9.05 -12.59 25.12 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 9.71 -18.83 33.97 8.85 -16.99 33.47 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 15.65 -13.25 27.32 13.56 -12.34 28.19 1qrz_c13 source 1qrz PLASMINOGEN : 8 hits 1qrz_c13 naa= 3 ULMN 3 1qrz_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 43 HIS.? 24.06 C2 TRS B 107 C 646 ASP A 21 ASP.? 20.18 O2 TRS B 107 C 741 SER A 25 SER^? 23.03 C2 TRS B 107 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 2.80 -6.84 20.40 2.88 -7.95 18.60 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 3 1qrz_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS A 43 HIS.? 24.06 C2 TRS B 107 C 646 ASP A 100 ASP^? 16.25 MG MG A 106 C 741 SER A 25 SER^? 23.03 C2 TRS B 107 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 3 1qrz_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS A 43 HIS.? 24.06 C2 TRS B 107 C 646 ASP A 100 ASP^? 16.25 MG MG A 106 C 741 SER B 25 SER^? 21.93 C2 TRS B 107 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 1qrz_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS A 43 HIS.? 24.06 C2 TRS B 107 C 646 ASP B 21 ASP.? 19.35 O1 TRS B 107 C 741 SER B 25 SER^? 21.93 C2 TRS B 107 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 13.91 -13.27 16.06 15.24 -13.79 14.55 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 1qrz_c14 PLASMINOGEN user 5 3 # 5 C 603 HIS B 43 HIS.? 17.46 C2 TRS B 107 C 646 ASP A 21 ASP.? 20.18 O2 TRS B 107 C 741 SER A 25 SER^? 23.03 C2 TRS B 107 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 2.80 -6.84 20.40 2.88 -7.95 18.60 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 3 1qrz_c14 PLASMINOGEN user 6 3 # 6 C 603 HIS B 43 HIS.? 17.46 C2 TRS B 107 C 646 ASP B 21 ASP.? 19.35 O1 TRS B 107 C 741 SER B 25 SER^? 21.93 C2 TRS B 107 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 13.91 -13.27 16.06 15.24 -13.79 14.55 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 1qrz_c14 PLASMINOGEN user 7 3 # 7 C 603 HIS B 43 HIS.? 17.46 C2 TRS B 107 C 646 ASP B 100 ASP^? 19.56 C2 TRS B 107 C 741 SER A 25 SER^? 23.03 C2 TRS B 107 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 9.71 -18.83 33.97 8.85 -16.99 33.47 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 3 1qrz_c14 PLASMINOGEN user 8 3 # 8 C 603 HIS B 43 HIS.? 17.46 C2 TRS B 107 C 646 ASP B 100 ASP^? 19.56 C2 TRS B 107 C 741 SER B 25 SER^? 21.93 C2 TRS B 107 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 9.71 -18.83 33.97 8.85 -16.99 33.47 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 15.65 -13.25 27.32 13.56 -12.34 28.19 1qrz_c14 source 1qrz PLASMINOGEN : 8 hits 1qrz_c14 naa= 3 ULMN 3 1qrz_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 43 HIS.? 24.06 C2 TRS B 107 D 646 ASP A 21 ASP.? 20.18 O2 TRS B 107 D 741 SER A 25 SER^? 23.03 C2 TRS B 107 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 12.35 -6.62 23.61 12.63 -8.53 24.45 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 2.80 -6.84 20.40 2.88 -7.95 18.60 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 3 1qrz_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS A 43 HIS.? 24.06 C2 TRS B 107 D 646 ASP A 100 ASP^? 16.25 MG MG A 106 D 741 SER A 25 SER^? 23.03 C2 TRS B 107 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 12.35 -6.62 23.61 12.63 -8.53 24.45 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 17.24 -4.20 32.64 17.59 -5.86 31.44 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 3 1qrz_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS A 43 HIS.? 24.06 C2 TRS B 107 D 646 ASP A 100 ASP^? 16.25 MG MG A 106 D 741 SER B 25 SER^? 21.93 C2 TRS B 107 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 12.35 -6.62 23.61 12.63 -8.53 24.45 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 17.24 -4.20 32.64 17.59 -5.86 31.44 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 1qrz_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS A 43 HIS.? 24.06 C2 TRS B 107 D 646 ASP B 21 ASP.? 19.35 O1 TRS B 107 D 741 SER B 25 SER^? 21.93 C2 TRS B 107 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 12.35 -6.62 23.61 12.63 -8.53 24.45 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 13.91 -13.27 16.06 15.24 -13.79 14.55 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 1qrz_c15 PLASMINOGEN user 5 3 # 5 D 603 HIS B 37 HIS.? 23.74 MG A MG B 106 D 646 ASP B 33 ASP.? 27.59 MG MG A 106 D 741 SER B 104 SER.? 20.66 MG A MG B 106 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 21.69 -21.14 38.43 22.55 -22.53 39.75 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 22.99 -23.86 34.71 24.14 -24.66 36.71 ULMN 3 1qrz_c15 PLASMINOGEN user 6 3 # 6 D 603 HIS B 43 HIS.? 17.46 C2 TRS B 107 D 646 ASP A 21 ASP.? 20.18 O2 TRS B 107 D 741 SER A 25 SER^? 23.03 C2 TRS B 107 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 8.53 -14.49 24.38 9.05 -12.59 25.12 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 2.80 -6.84 20.40 2.88 -7.95 18.60 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 3 1qrz_c15 PLASMINOGEN user 7 3 # 7 D 603 HIS B 43 HIS.? 17.46 C2 TRS B 107 D 646 ASP B 21 ASP.? 19.35 O1 TRS B 107 D 741 SER B 25 SER^? 21.93 C2 TRS B 107 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 8.53 -14.49 24.38 9.05 -12.59 25.12 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 13.91 -13.27 16.06 15.24 -13.79 14.55 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 1qrz_c15 PLASMINOGEN user 8 3 # 8 D 603 HIS B 43 HIS.? 17.46 C2 TRS B 107 D 646 ASP B 100 ASP^? 19.56 C2 TRS B 107 D 741 SER A 25 SER^? 23.03 C2 TRS B 107 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 8.53 -14.49 24.38 9.05 -12.59 25.12 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 9.71 -18.83 33.97 8.85 -16.99 33.47 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 3 1qrz_c15 PLASMINOGEN user 9 3 # 9 D 603 HIS B 43 HIS.? 17.46 C2 TRS B 107 D 646 ASP B 100 ASP^? 19.56 C2 TRS B 107 D 741 SER B 25 SER^? 21.93 C2 TRS B 107 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 8.53 -14.49 24.38 9.05 -12.59 25.12 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 9.71 -18.83 33.97 8.85 -16.99 33.47 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 15.65 -13.25 27.32 13.56 -12.34 28.19 1qrz_c15 source 1qrz PLASMINOGEN : 9 hits 1qrz_c15 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS A 37 HIS.? 14.34 MG MG A 106 A 646 ASP A 33 ASP.? 14.12 MG MG A 106 A 739 GLY A 13 GLY^? 24.25 MG MG A 106 coo -20.72 2.99 34.37 -21.94 1.82 35.61 11.15 -3.04 43.19 11.90 -1.76 44.64 coo -18.83 7.68 26.86 -20.89 7.78 26.56 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 9.06 -14.52 41.03 9.77 -14.73 40.69 ULMN 3 1qrz_c20 PLASMINOGEN user 2 3 # 2 A 603 HIS A 37 HIS.? 14.34 MG MG A 106 A 646 ASP A 33 ASP.? 14.12 MG MG A 106 A 739 GLY A 80 GLY.? 5.31 MG MG A 106 coo -20.72 2.99 34.37 -21.94 1.82 35.61 11.15 -3.04 43.19 11.90 -1.76 44.64 coo -18.83 7.68 26.86 -20.89 7.78 26.56 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 21.40 4.18 37.49 20.81 4.36 37.01 ULMN 3 1qrz_c20 PLASMINOGEN user 3 3 # 3 A 603 HIS A 37 HIS.? 14.34 MG MG A 106 A 646 ASP A 33 ASP.? 14.12 MG MG A 106 A 739 GLY B 0 GLY.? 26.84 MG MG A 106 coo -20.72 2.99 34.37 -21.94 1.82 35.61 11.15 -3.04 43.19 11.90 -1.76 44.64 coo -18.83 7.68 26.86 -20.89 7.78 26.56 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 2.31 -10.32 47.70 2.75 -10.98 48.04 ULMN 3 1qrz_c20 PLASMINOGEN user 4 3 # 4 A 603 HIS A 37 HIS.? 14.34 MG MG A 106 A 646 ASP A 33 ASP.? 14.12 MG MG A 106 A 739 GLY B 13 GLY^? 14.84 MG MG A 106 coo -20.72 2.99 34.37 -21.94 1.82 35.61 11.15 -3.04 43.19 11.90 -1.76 44.64 coo -18.83 7.68 26.86 -20.89 7.78 26.56 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 21.83 -9.26 37.30 21.03 -9.05 37.47 ULMN 3 1qrz_c20 PLASMINOGEN user 5 3 # 5 A 603 HIS B 37 HIS.? 23.74 MG A MG B 106 A 646 ASP B 33 ASP.? 27.59 MG MG A 106 A 739 GLY A 13 GLY^? 24.25 MG MG A 106 coo -20.72 2.99 34.37 -21.94 1.82 35.61 21.69 -21.14 38.43 22.55 -22.53 39.75 coo -18.83 7.68 26.86 -20.89 7.78 26.56 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 9.06 -14.52 41.03 9.77 -14.73 40.69 ULMN 3 1qrz_c20 PLASMINOGEN user 6 3 # 6 A 603 HIS B 37 HIS.? 23.74 MG A MG B 106 A 646 ASP B 33 ASP.? 27.59 MG MG A 106 A 739 GLY B 13 GLY^? 14.84 MG MG A 106 coo -20.72 2.99 34.37 -21.94 1.82 35.61 21.69 -21.14 38.43 22.55 -22.53 39.75 coo -18.83 7.68 26.86 -20.89 7.78 26.56 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 21.83 -9.26 37.30 21.03 -9.05 37.47 ULMN 3 1qrz_c20 PLASMINOGEN user 7 3 # 7 A 603 HIS B 37 HIS.? 23.74 MG A MG B 106 A 646 ASP B 33 ASP.? 27.59 MG MG A 106 A 739 GLY B 80 GLY.? 20.50 N TRS B 107 coo -20.72 2.99 34.37 -21.94 1.82 35.61 21.69 -21.14 38.43 22.55 -22.53 39.75 coo -18.83 7.68 26.86 -20.89 7.78 26.56 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 8.91 -28.16 38.69 9.02 -28.24 37.93 1qrz_c20 source 1qrz PLASMINOGEN : 7 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS A 37 HIS.? 14.34 MG MG A 106 B 646 ASP A 33 ASP.? 14.12 MG MG A 106 B 739 GLY A 13 GLY^? 24.25 MG MG A 106 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 11.15 -3.04 43.19 11.90 -1.76 44.64 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 9.06 -14.52 41.03 9.77 -14.73 40.69 ULMN 3 1qrz_c21 PLASMINOGEN user 2 3 # 2 B 603 HIS A 37 HIS.? 14.34 MG MG A 106 B 646 ASP A 33 ASP.? 14.12 MG MG A 106 B 739 GLY A 80 GLY.? 5.31 MG MG A 106 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 11.15 -3.04 43.19 11.90 -1.76 44.64 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 21.40 4.18 37.49 20.81 4.36 37.01 ULMN 3 1qrz_c21 PLASMINOGEN user 3 3 # 3 B 603 HIS A 37 HIS.? 14.34 MG MG A 106 B 646 ASP A 33 ASP.? 14.12 MG MG A 106 B 739 GLY B 0 GLY.? 26.84 MG MG A 106 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 11.15 -3.04 43.19 11.90 -1.76 44.64 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 2.31 -10.32 47.70 2.75 -10.98 48.04 ULMN 3 1qrz_c21 PLASMINOGEN user 4 3 # 4 B 603 HIS A 37 HIS.? 14.34 MG MG A 106 B 646 ASP A 33 ASP.? 14.12 MG MG A 106 B 739 GLY B 13 GLY^? 14.84 MG MG A 106 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 11.15 -3.04 43.19 11.90 -1.76 44.64 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 21.83 -9.26 37.30 21.03 -9.05 37.47 ULMN 3 1qrz_c21 PLASMINOGEN user 5 3 # 5 B 603 HIS A 43 HIS.? 24.06 C2 TRS B 107 B 646 ASP A 21 ASP.? 20.18 O2 TRS B 107 B 739 GLY B 45 GLY^? 9.56 O1 TRS B 107 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 12.35 -6.62 23.61 12.63 -8.53 24.45 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 2.80 -6.84 20.40 2.88 -7.95 18.60 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 7.16 -20.68 19.62 7.19 -21.28 20.22 ULMN 3 1qrz_c21 PLASMINOGEN user 6 3 # 6 B 603 HIS B 37 HIS.? 23.74 MG A MG B 106 B 646 ASP B 33 ASP.? 27.59 MG MG A 106 B 739 GLY A 13 GLY^? 24.25 MG MG A 106 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 21.69 -21.14 38.43 22.55 -22.53 39.75 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 9.06 -14.52 41.03 9.77 -14.73 40.69 ULMN 3 1qrz_c21 PLASMINOGEN user 7 3 # 7 B 603 HIS B 37 HIS.? 23.74 MG A MG B 106 B 646 ASP B 33 ASP.? 27.59 MG MG A 106 B 739 GLY B 13 GLY^? 14.84 MG MG A 106 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 21.69 -21.14 38.43 22.55 -22.53 39.75 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 21.83 -9.26 37.30 21.03 -9.05 37.47 ULMN 3 1qrz_c21 PLASMINOGEN user 8 3 # 8 B 603 HIS B 37 HIS.? 23.74 MG A MG B 106 B 646 ASP B 33 ASP.? 27.59 MG MG A 106 B 739 GLY B 80 GLY.? 20.50 N TRS B 107 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 21.69 -21.14 38.43 22.55 -22.53 39.75 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 8.91 -28.16 38.69 9.02 -28.24 37.93 1qrz_c21 source 1qrz PLASMINOGEN : 8 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS A 37 HIS.? 14.34 MG MG A 106 C 646 ASP A 33 ASP.? 14.12 MG MG A 106 C 739 GLY A 13 GLY^? 24.25 MG MG A 106 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 11.15 -3.04 43.19 11.90 -1.76 44.64 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 15.57 -3.11 51.57 14.43 -2.38 49.92 coo 7.82 1.25 3.03 7.30 1.31 3.65 9.06 -14.52 41.03 9.77 -14.73 40.69 ULMN 3 1qrz_c22 PLASMINOGEN user 2 3 # 2 C 603 HIS A 37 HIS.? 14.34 MG MG A 106 C 646 ASP A 33 ASP.? 14.12 MG MG A 106 C 739 GLY A 80 GLY.? 5.31 MG MG A 106 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 11.15 -3.04 43.19 11.90 -1.76 44.64 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 15.57 -3.11 51.57 14.43 -2.38 49.92 coo 7.82 1.25 3.03 7.30 1.31 3.65 21.40 4.18 37.49 20.81 4.36 37.01 ULMN 3 1qrz_c22 PLASMINOGEN user 3 3 # 3 C 603 HIS A 37 HIS.? 14.34 MG MG A 106 C 646 ASP A 33 ASP.? 14.12 MG MG A 106 C 739 GLY B 0 GLY.? 26.84 MG MG A 106 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 11.15 -3.04 43.19 11.90 -1.76 44.64 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 15.57 -3.11 51.57 14.43 -2.38 49.92 coo 7.82 1.25 3.03 7.30 1.31 3.65 2.31 -10.32 47.70 2.75 -10.98 48.04 ULMN 3 1qrz_c22 PLASMINOGEN user 4 3 # 4 C 603 HIS A 37 HIS.? 14.34 MG MG A 106 C 646 ASP A 33 ASP.? 14.12 MG MG A 106 C 739 GLY B 13 GLY^? 14.84 MG MG A 106 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 11.15 -3.04 43.19 11.90 -1.76 44.64 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 15.57 -3.11 51.57 14.43 -2.38 49.92 coo 7.82 1.25 3.03 7.30 1.31 3.65 21.83 -9.26 37.30 21.03 -9.05 37.47 ULMN 3 1qrz_c22 PLASMINOGEN user 5 3 # 5 C 603 HIS B 37 HIS.? 23.74 MG A MG B 106 C 646 ASP B 33 ASP.? 27.59 MG MG A 106 C 739 GLY A 13 GLY^? 24.25 MG MG A 106 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 21.69 -21.14 38.43 22.55 -22.53 39.75 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 22.46 -22.72 47.13 22.23 -22.78 45.03 coo 7.82 1.25 3.03 7.30 1.31 3.65 9.06 -14.52 41.03 9.77 -14.73 40.69 ULMN 3 1qrz_c22 PLASMINOGEN user 6 3 # 6 C 603 HIS B 37 HIS.? 23.74 MG A MG B 106 C 646 ASP B 33 ASP.? 27.59 MG MG A 106 C 739 GLY B 13 GLY^? 14.84 MG MG A 106 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 21.69 -21.14 38.43 22.55 -22.53 39.75 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 22.46 -22.72 47.13 22.23 -22.78 45.03 coo 7.82 1.25 3.03 7.30 1.31 3.65 21.83 -9.26 37.30 21.03 -9.05 37.47 ULMN 3 1qrz_c22 PLASMINOGEN user 7 3 # 7 C 603 HIS B 37 HIS.? 23.74 MG A MG B 106 C 646 ASP B 33 ASP.? 27.59 MG MG A 106 C 739 GLY B 80 GLY.? 20.50 N TRS B 107 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 21.69 -21.14 38.43 22.55 -22.53 39.75 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 22.46 -22.72 47.13 22.23 -22.78 45.03 coo 7.82 1.25 3.03 7.30 1.31 3.65 8.91 -28.16 38.69 9.02 -28.24 37.93 1qrz_c22 source 1qrz PLASMINOGEN : 7 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS A 37 HIS.? 14.34 MG MG A 106 D 646 ASP A 33 ASP.? 14.12 MG MG A 106 D 739 GLY A 13 GLY^? 24.25 MG MG A 106 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 11.15 -3.04 43.19 11.90 -1.76 44.64 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -45.82 1.31 41.67 -46.38 1.39 42.31 9.06 -14.52 41.03 9.77 -14.73 40.69 ULMN 3 1qrz_c23 PLASMINOGEN user 2 3 # 2 D 603 HIS A 37 HIS.? 14.34 MG MG A 106 D 646 ASP A 33 ASP.? 14.12 MG MG A 106 D 739 GLY A 80 GLY.? 5.31 MG MG A 106 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 11.15 -3.04 43.19 11.90 -1.76 44.64 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -45.82 1.31 41.67 -46.38 1.39 42.31 21.40 4.18 37.49 20.81 4.36 37.01 ULMN 3 1qrz_c23 PLASMINOGEN user 3 3 # 3 D 603 HIS A 37 HIS.? 14.34 MG MG A 106 D 646 ASP A 33 ASP.? 14.12 MG MG A 106 D 739 GLY B 0 GLY.? 26.84 MG MG A 106 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 11.15 -3.04 43.19 11.90 -1.76 44.64 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -45.82 1.31 41.67 -46.38 1.39 42.31 2.31 -10.32 47.70 2.75 -10.98 48.04 ULMN 3 1qrz_c23 PLASMINOGEN user 4 3 # 4 D 603 HIS A 37 HIS.? 14.34 MG MG A 106 D 646 ASP A 33 ASP.? 14.12 MG MG A 106 D 739 GLY B 13 GLY^? 14.84 MG MG A 106 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 11.15 -3.04 43.19 11.90 -1.76 44.64 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -45.82 1.31 41.67 -46.38 1.39 42.31 21.83 -9.26 37.30 21.03 -9.05 37.47 ULMN 3 1qrz_c23 PLASMINOGEN user 5 3 # 5 D 603 HIS B 37 HIS.? 23.74 MG A MG B 106 D 646 ASP B 33 ASP.? 27.59 MG MG A 106 D 739 GLY A 13 GLY^? 24.25 MG MG A 106 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 21.69 -21.14 38.43 22.55 -22.53 39.75 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -45.82 1.31 41.67 -46.38 1.39 42.31 9.06 -14.52 41.03 9.77 -14.73 40.69 ULMN 3 1qrz_c23 PLASMINOGEN user 6 3 # 6 D 603 HIS B 37 HIS.? 23.74 MG A MG B 106 D 646 ASP B 33 ASP.? 27.59 MG MG A 106 D 739 GLY B 13 GLY^? 14.84 MG MG A 106 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 21.69 -21.14 38.43 22.55 -22.53 39.75 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -45.82 1.31 41.67 -46.38 1.39 42.31 21.83 -9.26 37.30 21.03 -9.05 37.47 ULMN 3 1qrz_c23 PLASMINOGEN user 7 3 # 7 D 603 HIS B 37 HIS.? 23.74 MG A MG B 106 D 646 ASP B 33 ASP.? 27.59 MG MG A 106 D 739 GLY B 80 GLY.? 20.50 N TRS B 107 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 21.69 -21.14 38.43 22.55 -22.53 39.75 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -45.82 1.31 41.67 -46.38 1.39 42.31 8.91 -28.16 38.69 9.02 -28.24 37.93 1qrz_c23 source 1qrz PLASMINOGEN : 7 hits 1qrz_c23 naa= 3 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 78 HIS.? 11.19 MG MG A 106 B 102 ASP A 81 ASP.? 9.35 MG MG A 106 B 195 SER A 61 SER^? 13.76 MG MG A 106 coo -4.60 27.52 42.88 -4.63 27.41 40.76 21.83 6.49 31.11 22.88 8.20 31.70 coo -0.27 31.24 43.51 -1.49 29.62 42.98 18.32 7.36 35.53 19.95 8.35 34.55 coo -2.83 25.96 36.71 -4.77 27.03 37.63 20.58 -1.27 32.13 21.77 -3.05 30.92 1rtf_c03 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 1 hits 1rtf_c03 naa= 3 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 81 ASP.? 9.35 MG MG A 106 64 HIS A 78 HIS.? 11.19 MG MG A 106 221 SER A 61 SER^? 13.76 MG MG A 106 coo 80.16 73.25 62.48 80.01 71.25 61.82 18.32 7.36 35.53 19.95 8.35 34.55 coo 78.27 67.69 61.83 79.58 67.76 60.19 21.83 6.49 31.11 22.88 8.20 31.70 coo 83.63 66.07 58.16 81.31 66.75 57.98 20.58 -1.27 32.13 21.77 -3.05 30.92 1sca_c00 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 1 hits 1sca_c00 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP A 73 ASP.? 24.66 MG MG A 106 595 GLU A 76 GLU^? 15.65 MG MG A 106 713 TYR A 65 TYR^? 20.31 MG MG A 106 coo 5.64 2.82 38.49 4.59 4.19 37.25 11.88 18.46 25.62 13.34 17.78 24.18 coo 4.35 13.73 37.63 3.39 12.18 36.55 19.27 9.35 28.47 21.14 9.50 27.54 coo 3.76 10.25 31.38 3.16 9.87 34.10 15.06 9.60 24.66 17.54 9.96 23.42 1sll_c00 source 1sll SIALIDASE L : 1 hits 1sll_c00 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS B 67 HIS^? 10.25 N TRS B 107 B 80 GLU B 69 GLU.? 15.42 MG A MG B 106 B 223 ARG A 23 ARG.? 26.26 O2 TRS B 107 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 12.23 -34.37 19.25 12.68 -35.93 17.95 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 18.54 -34.22 15.35 19.90 -33.02 14.45 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 7.13 -4.89 20.32 8.16 -2.85 18.32 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 1 hits 1t0u_c01 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY A 70 GLY.? 29.17 MG MG A 106 B 17 GLN A 89 GLN.? 23.47 MG MG A 106 B 140 GLU A 69 GLU.? 30.27 MG MG A 106 coo 61.49 19.86 5.96 61.52 19.46 5.16 2.17 16.80 27.00 2.84 16.47 27.29 coo 63.76 11.90 7.93 65.18 13.07 6.77 1.40 11.32 33.96 3.22 10.81 32.98 coo 66.44 19.00 7.38 67.69 17.67 8.37 -0.37 13.72 28.81 -2.24 12.81 29.30 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 2 3 # 2 A 261 GLY B 70 GLY.? 16.80 N TRS B 107 B 17 GLN B 89 GLN.? 15.86 MG A MG B 106 B 140 GLU B 69 GLU.? 15.42 MG A MG B 106 coo 61.49 19.86 5.96 61.52 19.46 5.16 18.04 -38.49 17.68 17.55 -38.22 18.20 coo 63.76 11.90 7.93 65.18 13.07 6.77 20.92 -32.58 22.66 20.98 -34.55 21.99 coo 66.44 19.00 7.38 67.69 17.67 8.37 18.54 -34.22 15.35 19.90 -33.02 14.45 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 2 hits 1t4c_c02 naa= 3 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 1 3 # 1 A 88 SER A 25 SER^? 23.03 C2 TRS B 107 A 90 SER A 16 SER.? 21.37 C2 TRS B 107 A 145 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo -3.31 40.95 15.56 -0.94 40.79 14.97 8.15 -8.88 30.15 10.32 -9.84 29.66 coo 1.47 40.03 18.48 2.45 41.37 16.68 6.77 -13.81 33.93 9.10 -14.03 33.22 coo 7.35 44.71 16.29 4.71 40.98 14.52 8.74 -17.74 39.05 7.96 -22.88 42.54 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 2 3 # 2 A 88 SER A 38 SER.? 20.21 MG MG A 106 A 90 SER A 28 SER^? 23.29 MG MG A 106 A 145 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo -3.31 40.95 15.56 -0.94 40.79 14.97 8.35 -5.49 38.91 7.27 -5.53 36.78 coo 1.47 40.03 18.48 2.45 41.37 16.68 7.93 -9.68 40.46 5.50 -9.56 40.62 coo 7.35 44.71 16.29 4.71 40.98 14.52 8.74 -17.74 39.05 7.96 -22.88 42.54 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 3 3 # 3 A 88 SER B 25 SER^? 21.93 C2 TRS B 107 A 90 SER B 16 SER.? 18.72 MG MG A 106 A 145 LYS B 14 LYS.? 6.95 MG MG A 106 coo -3.31 40.95 15.56 -0.94 40.79 14.97 15.65 -13.25 27.32 13.56 -12.34 28.19 coo 1.47 40.03 18.48 2.45 41.37 16.68 19.38 -8.95 30.12 17.10 -8.78 30.97 coo 7.35 44.71 16.29 4.71 40.98 14.52 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 4 3 # 4 A 88 SER B 38 SER.? 19.23 MG A MG B 106 A 90 SER B 28 SER^? 20.11 MG MG A 106 A 145 LYS B 14 LYS.? 6.95 MG MG A 106 coo -3.31 40.95 15.56 -0.94 40.79 14.97 20.61 -17.82 33.77 20.60 -17.17 31.49 coo 1.47 40.03 18.48 2.45 41.37 16.68 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 7.35 44.71 16.29 4.71 40.98 14.52 21.12 -5.80 35.93 24.74 -1.53 38.99 1t7d_c00 source 1t7d SIGNAL PEPTIDASE I : 4 hits 1t7d_c00 naa= 3 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 1 3 # 1 B 88 SER A 25 SER^? 23.03 C2 TRS B 107 B 90 SER A 16 SER.? 21.37 C2 TRS B 107 B 145 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 61.01 10.03 12.97 58.78 10.97 12.69 8.15 -8.88 30.15 10.32 -9.84 29.66 coo 56.85 12.22 16.37 55.62 11.34 14.45 6.77 -13.81 33.93 9.10 -14.03 33.22 coo 49.80 9.51 14.88 53.14 11.99 12.77 8.74 -17.74 39.05 7.96 -22.88 42.54 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 2 3 # 2 B 88 SER A 38 SER.? 20.21 MG MG A 106 B 90 SER A 28 SER^? 23.29 MG MG A 106 B 145 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 61.01 10.03 12.97 58.78 10.97 12.69 8.35 -5.49 38.91 7.27 -5.53 36.78 coo 56.85 12.22 16.37 55.62 11.34 14.45 7.93 -9.68 40.46 5.50 -9.56 40.62 coo 49.80 9.51 14.88 53.14 11.99 12.77 8.74 -17.74 39.05 7.96 -22.88 42.54 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 3 3 # 3 B 88 SER B 25 SER^? 21.93 C2 TRS B 107 B 90 SER B 16 SER.? 18.72 MG MG A 106 B 145 LYS B 14 LYS.? 6.95 MG MG A 106 coo 61.01 10.03 12.97 58.78 10.97 12.69 15.65 -13.25 27.32 13.56 -12.34 28.19 coo 56.85 12.22 16.37 55.62 11.34 14.45 19.38 -8.95 30.12 17.10 -8.78 30.97 coo 49.80 9.51 14.88 53.14 11.99 12.77 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 4 3 # 4 B 88 SER B 38 SER.? 19.23 MG A MG B 106 B 90 SER B 28 SER^? 20.11 MG MG A 106 B 145 LYS B 14 LYS.? 6.95 MG MG A 106 coo 61.01 10.03 12.97 58.78 10.97 12.69 20.61 -17.82 33.77 20.60 -17.17 31.49 coo 56.85 12.22 16.37 55.62 11.34 14.45 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 49.80 9.51 14.88 53.14 11.99 12.77 21.12 -5.80 35.93 24.74 -1.53 38.99 1t7d_c01 source 1t7d SIGNAL PEPTIDASE I : 4 hits 1t7d_c01 naa= 3 ULMN 3 1tah_c00 LIPASE user 1 3 # 1 B 87 SER A 61 SER^? 13.76 MG MG A 106 B 263 ASP A 81 ASP.? 9.35 MG MG A 106 B 285 HIS A 78 HIS.? 11.19 MG MG A 106 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 18.32 7.36 35.53 19.95 8.35 34.55 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 21.83 6.49 31.11 22.88 8.20 31.70 1tah_c00 source 1tah LIPASE : 1 hits 1tah_c00 naa= 3 ULMN 3 1tah_c01 LIPASE user 1 3 # 1 A 87 SER A 61 SER^? 13.76 MG MG A 106 A 263 ASP A 81 ASP.? 9.35 MG MG A 106 A 285 HIS A 78 HIS.? 11.19 MG MG A 106 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 18.32 7.36 35.53 19.95 8.35 34.55 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 21.83 6.49 31.11 22.88 8.20 31.70 1tah_c01 source 1tah LIPASE : 1 hits 1tah_c01 naa= 3 ULMN 3 1tah_c02 LIPASE user 1 3 # 1 C 87 SER A 61 SER^? 13.76 MG MG A 106 C 263 ASP A 81 ASP.? 9.35 MG MG A 106 C 285 HIS A 78 HIS.? 11.19 MG MG A 106 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 20.58 -1.27 32.13 21.77 -3.05 30.92 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 18.32 7.36 35.53 19.95 8.35 34.55 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 21.83 6.49 31.11 22.88 8.20 31.70 1tah_c02 source 1tah LIPASE : 1 hits 1tah_c02 naa= 3 ULMN 3 1tah_c03 LIPASE user 1 3 # 1 D 87 SER A 61 SER^? 13.76 MG MG A 106 D 263 ASP A 81 ASP.? 9.35 MG MG A 106 D 285 HIS A 78 HIS.? 11.19 MG MG A 106 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 20.58 -1.27 32.13 21.77 -3.05 30.92 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 18.32 7.36 35.53 19.95 8.35 34.55 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 21.83 6.49 31.11 22.88 8.20 31.70 1tah_c03 source 1tah LIPASE : 1 hits 1tah_c03 naa= 3 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 A 144 HIS A 43 HIS.? 24.06 C2 TRS B 107 A 174 ASP A 100 ASP^? 16.25 MG MG A 106 A 404 TYR A 47 TYR^? 25.20 MG MG A 106 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 6.73 0.56 24.29 8.36 -1.29 22.99 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 A 144 HIS A 67 HIS^? 25.71 MG MG A 106 A 174 ASP A 73 ASP.? 24.66 MG MG A 106 A 404 TYR A 91 TYR^? 21.63 MG MG A 106 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 7.29 12.90 25.70 6.12 14.46 24.97 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 11.88 18.46 25.62 13.34 17.78 24.18 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 4.86 7.39 31.16 5.04 4.97 32.56 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 A 144 HIS B 43 HIS.? 17.46 C2 TRS B 107 A 174 ASP B 100 ASP^? 19.56 C2 TRS B 107 A 404 TYR B 47 TYR^? 12.23 O1 TRS B 107 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 9.71 -18.83 33.97 8.85 -16.99 33.47 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 12.41 -21.54 20.17 10.64 -19.48 20.79 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 A 144 HIS B 67 HIS^? 10.25 N TRS B 107 A 174 ASP B 73 ASP.? 13.34 N TRS B 107 A 404 TYR B 91 TYR^? 15.35 N TRS B 107 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 9.64 -40.18 22.89 9.15 -42.09 22.32 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 17.61 -29.10 22.17 18.36 -26.78 23.51 1ti6_c06 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 4 hits 1ti6_c06 naa= 3 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 C 144 HIS A 43 HIS.? 24.06 C2 TRS B 107 C 174 ASP A 100 ASP^? 16.25 MG MG A 106 C 404 TYR A 47 TYR^? 25.20 MG MG A 106 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 12.35 -6.62 23.61 12.63 -8.53 24.45 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 17.24 -4.20 32.64 17.59 -5.86 31.44 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 6.73 0.56 24.29 8.36 -1.29 22.99 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 C 144 HIS A 67 HIS^? 25.71 MG MG A 106 C 174 ASP A 73 ASP.? 24.66 MG MG A 106 C 404 TYR A 91 TYR^? 21.63 MG MG A 106 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 7.29 12.90 25.70 6.12 14.46 24.97 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 11.88 18.46 25.62 13.34 17.78 24.18 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 4.86 7.39 31.16 5.04 4.97 32.56 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 C 144 HIS B 43 HIS.? 17.46 C2 TRS B 107 C 174 ASP B 100 ASP^? 19.56 C2 TRS B 107 C 404 TYR B 47 TYR^? 12.23 O1 TRS B 107 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 8.53 -14.49 24.38 9.05 -12.59 25.12 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 9.71 -18.83 33.97 8.85 -16.99 33.47 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 12.41 -21.54 20.17 10.64 -19.48 20.79 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 C 144 HIS B 67 HIS^? 10.25 N TRS B 107 C 174 ASP B 73 ASP.? 13.34 N TRS B 107 C 404 TYR B 91 TYR^? 15.35 N TRS B 107 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 12.23 -34.37 19.25 12.68 -35.93 17.95 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 9.64 -40.18 22.89 9.15 -42.09 22.32 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 17.61 -29.10 22.17 18.36 -26.78 23.51 1ti6_c07 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 4 hits 1ti6_c07 naa= 3 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 E 144 HIS A 43 HIS.? 24.06 C2 TRS B 107 E 174 ASP A 100 ASP^? 16.25 MG MG A 106 E 404 TYR A 47 TYR^? 25.20 MG MG A 106 coo -7.53-107.59 75.19 -8.14-106.04 76.47 12.35 -6.62 23.61 12.63 -8.53 24.45 coo -3.55-105.39 83.13 -5.21-106.24 82.09 17.24 -4.20 32.64 17.59 -5.86 31.44 coo -16.31-108.78 75.35 -14.20-107.14 76.16 6.73 0.56 24.29 8.36 -1.29 22.99 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 E 144 HIS A 67 HIS^? 25.71 MG MG A 106 E 174 ASP A 73 ASP.? 24.66 MG MG A 106 E 404 TYR A 91 TYR^? 21.63 MG MG A 106 coo -7.53-107.59 75.19 -8.14-106.04 76.47 7.29 12.90 25.70 6.12 14.46 24.97 coo -3.55-105.39 83.13 -5.21-106.24 82.09 11.88 18.46 25.62 13.34 17.78 24.18 coo -16.31-108.78 75.35 -14.20-107.14 76.16 4.86 7.39 31.16 5.04 4.97 32.56 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 E 144 HIS B 43 HIS.? 17.46 C2 TRS B 107 E 174 ASP B 100 ASP^? 19.56 C2 TRS B 107 E 404 TYR B 47 TYR^? 12.23 O1 TRS B 107 coo -7.53-107.59 75.19 -8.14-106.04 76.47 8.53 -14.49 24.38 9.05 -12.59 25.12 coo -3.55-105.39 83.13 -5.21-106.24 82.09 9.71 -18.83 33.97 8.85 -16.99 33.47 coo -16.31-108.78 75.35 -14.20-107.14 76.16 12.41 -21.54 20.17 10.64 -19.48 20.79 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 E 144 HIS B 67 HIS^? 10.25 N TRS B 107 E 174 ASP B 73 ASP.? 13.34 N TRS B 107 E 404 TYR B 91 TYR^? 15.35 N TRS B 107 coo -7.53-107.59 75.19 -8.14-106.04 76.47 12.23 -34.37 19.25 12.68 -35.93 17.95 coo -3.55-105.39 83.13 -5.21-106.24 82.09 9.64 -40.18 22.89 9.15 -42.09 22.32 coo -16.31-108.78 75.35 -14.20-107.14 76.16 17.61 -29.10 22.17 18.36 -26.78 23.51 1ti6_c08 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 4 hits 1ti6_c08 naa= 3 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 G 144 HIS A 43 HIS.? 24.06 C2 TRS B 107 G 174 ASP A 100 ASP^? 16.25 MG MG A 106 G 404 TYR A 47 TYR^? 25.20 MG MG A 106 coo 60.48-101.16 45.95 60.56-101.20 43.85 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 58.10-108.15 40.62 59.57-106.86 41.51 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 6.73 0.56 24.29 8.36 -1.29 22.99 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 G 144 HIS A 67 HIS^? 25.71 MG MG A 106 G 174 ASP A 73 ASP.? 24.66 MG MG A 106 G 404 TYR A 91 TYR^? 21.63 MG MG A 106 coo 60.48-101.16 45.95 60.56-101.20 43.85 7.29 12.90 25.70 6.12 14.46 24.97 coo 58.10-108.15 40.62 59.57-106.86 41.51 11.88 18.46 25.62 13.34 17.78 24.18 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 4.86 7.39 31.16 5.04 4.97 32.56 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 G 144 HIS B 43 HIS.? 17.46 C2 TRS B 107 G 174 ASP B 100 ASP^? 19.56 C2 TRS B 107 G 404 TYR B 47 TYR^? 12.23 O1 TRS B 107 coo 60.48-101.16 45.95 60.56-101.20 43.85 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 58.10-108.15 40.62 59.57-106.86 41.51 9.71 -18.83 33.97 8.85 -16.99 33.47 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 12.41 -21.54 20.17 10.64 -19.48 20.79 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 G 144 HIS B 67 HIS^? 10.25 N TRS B 107 G 174 ASP B 73 ASP.? 13.34 N TRS B 107 G 404 TYR B 91 TYR^? 15.35 N TRS B 107 coo 60.48-101.16 45.95 60.56-101.20 43.85 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 58.10-108.15 40.62 59.57-106.86 41.51 9.64 -40.18 22.89 9.15 -42.09 22.32 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 17.61 -29.10 22.17 18.36 -26.78 23.51 1ti6_c09 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 4 hits 1ti6_c09 naa= 3 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 I 144 HIS A 43 HIS.? 24.06 C2 TRS B 107 I 174 ASP A 100 ASP^? 16.25 MG MG A 106 I 404 TYR A 47 TYR^? 25.20 MG MG A 106 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 12.35 -6.62 23.61 12.63 -8.53 24.45 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 17.24 -4.20 32.64 17.59 -5.86 31.44 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 6.73 0.56 24.29 8.36 -1.29 22.99 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 I 144 HIS A 67 HIS^? 25.71 MG MG A 106 I 174 ASP A 73 ASP.? 24.66 MG MG A 106 I 404 TYR A 91 TYR^? 21.63 MG MG A 106 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 7.29 12.90 25.70 6.12 14.46 24.97 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 11.88 18.46 25.62 13.34 17.78 24.18 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 4.86 7.39 31.16 5.04 4.97 32.56 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 I 144 HIS B 43 HIS.? 17.46 C2 TRS B 107 I 174 ASP B 100 ASP^? 19.56 C2 TRS B 107 I 404 TYR B 47 TYR^? 12.23 O1 TRS B 107 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 8.53 -14.49 24.38 9.05 -12.59 25.12 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 9.71 -18.83 33.97 8.85 -16.99 33.47 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 12.41 -21.54 20.17 10.64 -19.48 20.79 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 I 144 HIS B 67 HIS^? 10.25 N TRS B 107 I 174 ASP B 73 ASP.? 13.34 N TRS B 107 I 404 TYR B 91 TYR^? 15.35 N TRS B 107 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 12.23 -34.37 19.25 12.68 -35.93 17.95 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 9.64 -40.18 22.89 9.15 -42.09 22.32 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 17.61 -29.10 22.17 18.36 -26.78 23.51 1ti6_c10 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 4 hits 1ti6_c10 naa= 3 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 K 144 HIS A 43 HIS.? 24.06 C2 TRS B 107 K 174 ASP A 100 ASP^? 16.25 MG MG A 106 K 404 TYR A 47 TYR^? 25.20 MG MG A 106 coo 100.18 26.45 -1.32 99.24 26.12 0.53 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 102.36 30.86 6.31 102.45 29.08 5.12 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 99.93 17.48 -0.85 99.14 19.86 0.39 6.73 0.56 24.29 8.36 -1.29 22.99 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 K 144 HIS A 67 HIS^? 25.71 MG MG A 106 K 174 ASP A 73 ASP.? 24.66 MG MG A 106 K 404 TYR A 91 TYR^? 21.63 MG MG A 106 coo 100.18 26.45 -1.32 99.24 26.12 0.53 7.29 12.90 25.70 6.12 14.46 24.97 coo 102.36 30.86 6.31 102.45 29.08 5.12 11.88 18.46 25.62 13.34 17.78 24.18 coo 99.93 17.48 -0.85 99.14 19.86 0.39 4.86 7.39 31.16 5.04 4.97 32.56 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 K 144 HIS B 43 HIS.? 17.46 C2 TRS B 107 K 174 ASP B 100 ASP^? 19.56 C2 TRS B 107 K 404 TYR B 47 TYR^? 12.23 O1 TRS B 107 coo 100.18 26.45 -1.32 99.24 26.12 0.53 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 102.36 30.86 6.31 102.45 29.08 5.12 9.71 -18.83 33.97 8.85 -16.99 33.47 coo 99.93 17.48 -0.85 99.14 19.86 0.39 12.41 -21.54 20.17 10.64 -19.48 20.79 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 K 144 HIS B 67 HIS^? 10.25 N TRS B 107 K 174 ASP B 73 ASP.? 13.34 N TRS B 107 K 404 TYR B 91 TYR^? 15.35 N TRS B 107 coo 100.18 26.45 -1.32 99.24 26.12 0.53 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 102.36 30.86 6.31 102.45 29.08 5.12 9.64 -40.18 22.89 9.15 -42.09 22.32 coo 99.93 17.48 -0.85 99.14 19.86 0.39 17.61 -29.10 22.17 18.36 -26.78 23.51 1ti6_c11 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 4 hits 1ti6_c11 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA A 32 ALA.? 14.79 MG MG A 106 A 251 GLY A 34 GLY.? 18.62 MG MG A 106 A 252 ASP A 33 ASP.? 14.12 MG MG A 106 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 17.33 -7.26 49.84 18.81 -6.93 49.85 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 12.15 -6.45 51.43 12.31 -5.88 50.91 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 15.57 -3.11 51.57 14.43 -2.38 49.92 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 2 3 # 2 A 250 ALA A 79 ALA.? 8.97 MG MG A 106 A 251 GLY A 80 GLY.? 5.31 MG MG A 106 A 252 ASP A 81 ASP.? 9.35 MG MG A 106 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 21.53 2.78 33.99 22.71 1.85 33.69 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 21.40 4.18 37.49 20.81 4.36 37.01 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 3 3 # 3 A 250 ALA B 32 ALA.? 24.99 MG MG A 106 A 251 GLY B 34 GLY.? 23.96 MG MG A 106 A 252 ASP B 33 ASP.? 27.59 MG MG A 106 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 20.24 -18.50 47.99 18.99 -18.97 48.80 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 25.27 -18.98 46.10 24.83 -19.43 45.63 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 22.46 -22.72 47.13 22.23 -22.78 45.03 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 4 3 # 4 A 250 ALA B 79 ALA.? 18.26 C2 TRS B 107 A 251 GLY B 80 GLY.? 20.50 N TRS B 107 A 252 ASP B 81 ASP.? 16.51 N TRS B 107 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 6.61 -26.34 36.32 5.53 -25.53 37.02 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 8.91 -28.16 38.69 9.02 -28.24 37.93 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 9.98 -30.67 34.70 8.29 -31.92 34.80 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 4 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA A 32 ALA.? 14.79 MG MG A 106 B 251 GLY A 34 GLY.? 18.62 MG MG A 106 B 252 ASP A 33 ASP.? 14.12 MG MG A 106 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 17.33 -7.26 49.84 18.81 -6.93 49.85 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 12.15 -6.45 51.43 12.31 -5.88 50.91 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 15.57 -3.11 51.57 14.43 -2.38 49.92 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 2 3 # 2 B 250 ALA A 79 ALA.? 8.97 MG MG A 106 B 251 GLY A 80 GLY.? 5.31 MG MG A 106 B 252 ASP A 81 ASP.? 9.35 MG MG A 106 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 21.53 2.78 33.99 22.71 1.85 33.69 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 21.40 4.18 37.49 20.81 4.36 37.01 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 3 3 # 3 B 250 ALA B 32 ALA.? 24.99 MG MG A 106 B 251 GLY B 34 GLY.? 23.96 MG MG A 106 B 252 ASP B 33 ASP.? 27.59 MG MG A 106 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 20.24 -18.50 47.99 18.99 -18.97 48.80 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 25.27 -18.98 46.10 24.83 -19.43 45.63 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 22.46 -22.72 47.13 22.23 -22.78 45.03 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 4 3 # 4 B 250 ALA B 79 ALA.? 18.26 C2 TRS B 107 B 251 GLY B 80 GLY.? 20.50 N TRS B 107 B 252 ASP B 81 ASP.? 16.51 N TRS B 107 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 6.61 -26.34 36.32 5.53 -25.53 37.02 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 8.91 -28.16 38.69 9.02 -28.24 37.93 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 9.98 -30.67 34.70 8.29 -31.92 34.80 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 4 hits 1tz3_c03 naa= 3 ULMN 3 1uk7_c00 3.07.01.0009 user 1 3 # 1 A 103 ALA A 64 ALA^? 17.52 MG MG A 106 A 224 ASP A 81 ASP.? 9.35 MG MG A 106 A 252 HIS A 78 HIS.? 11.19 MG MG A 106 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 15.38 5.15 26.91 14.21 4.40 27.56 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 18.32 7.36 35.53 19.95 8.35 34.55 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 21.83 6.49 31.11 22.88 8.20 31.70 ULMN 3 1uk7_c00 3.07.01.0009 user 2 3 # 2 A 103 ALA A 68 ALA.? 22.95 MG MG A 106 A 224 ASP A 73 ASP.? 24.66 MG MG A 106 A 252 HIS A 67 HIS^? 25.71 MG MG A 106 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 5.61 12.80 30.20 5.83 13.73 31.36 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 11.88 18.46 25.62 13.34 17.78 24.18 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 7.29 12.90 25.70 6.12 14.46 24.97 ULMN 3 1uk7_c00 3.07.01.0009 user 3 3 # 3 A 103 ALA B 64 ALA^? 10.02 N TRS B 107 A 224 ASP B 81 ASP.? 16.51 N TRS B 107 A 252 HIS B 78 HIS^? 12.04 O3 TRS B 107 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 7.19 -26.95 26.54 8.52 -26.19 26.49 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 4.34 -30.02 32.49 3.20 -30.88 30.99 1uk7_c00 source 1uk7 3.07.01.0009 : 3 hits 1uk7_c00 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN B 72 ASN.? 16.16 N TRS B 107 457 GLY B 70 GLY.? 16.80 N TRS B 107 459 GLU B 69 GLU.? 15.42 MG A MG B 106 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 11.77 -42.42 18.70 13.18 -43.21 17.33 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 18.04 -38.49 17.68 17.55 -38.22 18.20 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 18.54 -34.22 15.35 19.90 -33.02 14.45 1vom_c00 source 1vom MYOSIN : 1 hits 1vom_c00 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 101 TYR^? 16.63 MG MG A 106 A 40 ASP A 81 ASP.? 9.35 MG MG A 106 A 103 LEU A 60 LEU^? 10.47 MG MG A 106 coo 12.09 16.13 10.57 11.28 18.80 10.73 12.29 -0.55 33.68 9.97 -0.77 32.12 coo 7.55 25.51 14.34 9.65 25.73 14.24 18.32 7.36 35.53 19.95 8.35 34.55 coo 11.83 18.73 16.99 10.99 19.71 15.26 18.79 -2.46 36.06 18.04 -2.95 38.04 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR B 101 TYR^? 17.91 N TRS B 107 A 40 ASP B 81 ASP.? 16.51 N TRS B 107 A 103 LEU B 60 LEU^? 22.12 C2 TRS B 107 coo 12.09 16.13 10.57 11.28 18.80 10.73 14.17 -22.17 31.30 14.99 -21.52 28.71 coo 7.55 25.51 14.34 9.65 25.73 14.24 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 11.83 18.73 16.99 10.99 19.71 15.26 10.35 -21.27 37.38 12.21 -20.94 38.46 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 2 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 101 TYR^? 16.63 MG MG A 106 B 40 ASP A 81 ASP.? 9.35 MG MG A 106 B 103 LEU A 60 LEU^? 10.47 MG MG A 106 coo 14.25 20.09 37.35 13.48 17.40 37.38 12.29 -0.55 33.68 9.97 -0.77 32.12 coo 9.39 10.77 34.53 11.50 10.63 34.41 18.32 7.36 35.53 19.95 8.35 34.55 coo 12.89 17.60 31.13 12.34 16.51 32.90 18.79 -2.46 36.06 18.04 -2.95 38.04 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR B 101 TYR^? 17.91 N TRS B 107 B 40 ASP B 81 ASP.? 16.51 N TRS B 107 B 103 LEU B 60 LEU^? 22.12 C2 TRS B 107 coo 14.25 20.09 37.35 13.48 17.40 37.38 14.17 -22.17 31.30 14.99 -21.52 28.71 coo 9.39 10.77 34.53 11.50 10.63 34.41 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 12.89 17.60 31.13 12.34 16.51 32.90 10.35 -21.27 37.38 12.21 -20.94 38.46 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 2 hits 1vzz_c01 naa= 3 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 105 ALA A 64 ALA^? 17.52 MG MG A 106 A 244 ASP A 81 ASP.? 9.35 MG MG A 106 A 271 HIS A 78 HIS.? 11.19 MG MG A 106 coo 15.05 3.71 6.93 14.58 4.88 7.78 15.38 5.15 26.91 14.21 4.40 27.56 coo 9.85 8.15 0.76 10.61 7.04 2.39 18.32 7.36 35.53 19.95 8.35 34.55 coo 10.61 7.65 6.01 12.39 6.55 6.23 21.83 6.49 31.11 22.88 8.20 31.70 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 2 3 # 2 A 105 ALA A 68 ALA.? 22.95 MG MG A 106 A 244 ASP A 73 ASP.? 24.66 MG MG A 106 A 271 HIS A 67 HIS^? 25.71 MG MG A 106 coo 15.05 3.71 6.93 14.58 4.88 7.78 5.61 12.80 30.20 5.83 13.73 31.36 coo 9.85 8.15 0.76 10.61 7.04 2.39 11.88 18.46 25.62 13.34 17.78 24.18 coo 10.61 7.65 6.01 12.39 6.55 6.23 7.29 12.90 25.70 6.12 14.46 24.97 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 3 3 # 3 A 105 ALA B 64 ALA^? 10.02 N TRS B 107 A 244 ASP B 81 ASP.? 16.51 N TRS B 107 A 271 HIS B 78 HIS^? 12.04 O3 TRS B 107 coo 15.05 3.71 6.93 14.58 4.88 7.78 7.19 -26.95 26.54 8.52 -26.19 26.49 coo 9.85 8.15 0.76 10.61 7.04 2.39 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 10.61 7.65 6.01 12.39 6.55 6.23 4.34 -30.02 32.49 3.20 -30.88 30.99 1xqw_c00 source 1xqw PROLINE IMINOPEPTIDASE : 3 hits 1xqw_c00 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 79 ALA.? 8.97 MG MG A 106 B 126 ARG A 58 ARG^? 9.13 MG MG A 106 B 138 GLU A 76 GLU^? 15.65 MG MG A 106 coo 2.11 4.00 19.31 3.14 4.86 19.99 21.53 2.78 33.99 22.71 1.85 33.69 coo 2.45 5.53 11.28 3.59 7.56 13.29 17.26 0.85 41.49 16.40 -0.10 44.31 coo 6.10 2.00 25.24 6.12 1.84 23.13 19.27 9.35 28.47 21.14 9.50 27.54 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA A 79 ALA.? 8.97 MG MG A 106 C 126 ARG A 58 ARG^? 9.13 MG MG A 106 C 138 GLU A 76 GLU^? 15.65 MG MG A 106 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 21.53 2.78 33.99 22.71 1.85 33.69 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 17.26 0.85 41.49 16.40 -0.10 44.31 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 19.27 9.35 28.47 21.14 9.50 27.54 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 79 ALA.? 8.97 MG MG A 106 D 126 ARG A 58 ARG^? 9.13 MG MG A 106 D 138 GLU A 76 GLU^? 15.65 MG MG A 106 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 21.53 2.78 33.99 22.71 1.85 33.69 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 17.26 0.85 41.49 16.40 -0.10 44.31 coo 6.23 0.50 57.10 5.93 0.72 59.19 19.27 9.35 28.47 21.14 9.50 27.54 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 79 ALA.? 8.97 MG MG A 106 E 126 ARG A 58 ARG^? 9.13 MG MG A 106 E 138 GLU A 76 GLU^? 15.65 MG MG A 106 coo -4.56 10.03 62.36 -4.38 11.31 61.55 21.53 2.78 33.99 22.71 1.85 33.69 coo -3.02 12.00 70.07 -1.94 13.84 67.82 17.26 0.85 41.49 16.40 -0.10 44.31 coo -8.67 12.22 56.54 -8.68 12.09 58.65 19.27 9.35 28.47 21.14 9.50 27.54 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA A 79 ALA.? 8.97 MG MG A 106 F 126 ARG A 58 ARG^? 9.13 MG MG A 106 F 138 GLU A 76 GLU^? 15.65 MG MG A 106 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 21.53 2.78 33.99 22.71 1.85 33.69 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 17.26 0.85 41.49 16.40 -0.10 44.31 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 19.27 9.35 28.47 21.14 9.50 27.54 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c11 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 22 GLY.? 19.61 O2 TRS B 107 B 175 ARG A 24 ARG^? 24.75 MG MG A 106 B 242 TYR A 47 TYR^? 25.20 MG MG A 106 coo 99.45 58.28 3.33 99.57 58.61 4.10 5.80 -9.58 23.18 5.77 -8.78 23.21 coo 106.37 63.53 0.89 108.02 63.40 -1.62 6.24 -3.67 29.98 3.39 -2.61 30.35 coo 100.93 69.04 4.38 99.52 68.48 2.09 6.73 0.56 24.29 8.36 -1.29 22.99 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY A 45 GLY^? 25.95 MG MG A 106 B 175 ARG A 92 ARG^? 29.81 MG MG A 106 B 242 TYR A 65 TYR^? 20.31 MG MG A 106 coo 99.45 58.28 3.33 99.57 58.61 4.10 10.42 0.54 20.35 10.86 0.94 20.96 coo 106.37 63.53 0.89 108.02 63.40 -1.62 4.92 8.97 23.23 2.03 9.56 22.51 coo 100.93 69.04 4.38 99.52 68.48 2.09 15.06 9.60 24.66 17.54 9.96 23.42 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY A 70 GLY.? 29.17 MG MG A 106 B 175 ARG A 92 ARG^? 29.81 MG MG A 106 B 242 TYR A 66 TYR^? 18.96 MG MG A 106 coo 99.45 58.28 3.33 99.57 58.61 4.10 2.17 16.80 27.00 2.84 16.47 27.29 coo 106.37 63.53 0.89 108.02 63.40 -1.62 4.92 8.97 23.23 2.03 9.56 22.51 coo 100.93 69.04 4.38 99.52 68.48 2.09 9.99 9.72 31.21 7.76 10.46 32.78 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 4 3 # 4 B 137 GLY A 70 GLY.? 29.17 MG MG A 106 B 175 ARG A 92 ARG^? 29.81 MG MG A 106 B 242 TYR A 91 TYR^? 21.63 MG MG A 106 coo 99.45 58.28 3.33 99.57 58.61 4.10 2.17 16.80 27.00 2.84 16.47 27.29 coo 106.37 63.53 0.89 108.02 63.40 -1.62 4.92 8.97 23.23 2.03 9.56 22.51 coo 100.93 69.04 4.38 99.52 68.48 2.09 4.86 7.39 31.16 5.04 4.97 32.56 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 5 3 # 5 B 137 GLY B 22 GLY.? 20.64 O1 TRS B 107 B 175 ARG B 24 ARG^? 14.88 MG A MG B 106 B 242 TYR B 47 TYR^? 12.23 O1 TRS B 107 coo 99.45 58.28 3.33 99.57 58.61 4.10 13.37 -11.29 20.52 13.34 -12.05 20.46 coo 106.37 63.53 0.89 108.02 63.40 -1.62 16.79 -18.48 25.10 19.01 -19.70 23.40 coo 100.93 69.04 4.38 99.52 68.48 2.09 12.41 -21.54 20.17 10.64 -19.48 20.79 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 6 3 # 6 B 137 GLY B 45 GLY^? 9.56 O1 TRS B 107 B 175 ARG B 92 ARG^? 5.10 O1 TRS B 107 B 242 TYR B 65 TYR^? 4.85 N TRS B 107 coo 99.45 58.28 3.33 99.57 58.61 4.10 7.16 -20.68 19.62 7.19 -21.28 20.22 coo 106.37 63.53 0.89 108.02 63.40 -1.62 10.89 -28.76 16.90 8.49 -30.55 16.32 coo 100.93 69.04 4.38 99.52 68.48 2.09 5.69 -30.65 23.64 2.95 -31.03 24.05 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 7 3 # 7 B 137 GLY B 80 GLY.? 20.50 N TRS B 107 B 175 ARG B 58 ARG^? 24.73 MG A MG B 106 B 242 TYR B 101 TYR^? 17.91 N TRS B 107 coo 99.45 58.28 3.33 99.57 58.61 4.10 8.91 -28.16 38.69 9.02 -28.24 37.93 coo 106.37 63.53 0.89 108.02 63.40 -1.62 17.07 -26.36 39.29 20.10 -26.73 39.11 coo 100.93 69.04 4.38 99.52 68.48 2.09 14.17 -22.17 31.30 14.99 -21.52 28.71 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 7 hits 1xva_c03 naa= 3 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 1 3 # 1 146 SER A 61 SER^? 13.76 MG MG A 106 338 ASP A 81 ASP.? 9.35 MG MG A 106 397 HIS A 78 HIS.? 11.19 MG MG A 106 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 18.32 7.36 35.53 19.95 8.35 34.55 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 21.83 6.49 31.11 22.88 8.20 31.70 1ysc_c01 source 1ysc SERINE CARBOXYPEPTIDASE (CPY, CPD-Y, OR PROTEI: 1 hits 1ysc_c01 naa= 3 ULMN 3 1zoi_c00 ESTERASE user 1 3 # 1 A 97 SER A 61 SER^? 13.76 MG MG A 106 A 227 ASP A 81 ASP.? 9.35 MG MG A 106 A 256 HIS A 78 HIS.? 11.19 MG MG A 106 coo 64.84 24.93 59.62 66.28 24.42 57.72 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 73.80 27.56 60.96 72.24 26.45 60.08 18.32 7.36 35.53 19.95 8.35 34.55 coo 70.86 23.63 59.28 68.91 24.23 58.80 21.83 6.49 31.11 22.88 8.20 31.70 1zoi_c00 source 1zoi ESTERASE : 1 hits 1zoi_c00 naa= 3 ULMN 3 1zoi_c01 ESTERASE user 1 3 # 1 B 97 SER A 61 SER^? 13.76 MG MG A 106 B 227 ASP A 81 ASP.? 9.35 MG MG A 106 B 256 HIS A 78 HIS.? 11.19 MG MG A 106 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 18.32 7.36 35.53 19.95 8.35 34.55 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 21.83 6.49 31.11 22.88 8.20 31.70 1zoi_c01 source 1zoi ESTERASE : 1 hits 1zoi_c01 naa= 3 ULMN 3 1zoi_c02 ESTERASE user 1 3 # 1 C 97 SER A 61 SER^? 13.76 MG MG A 106 C 227 ASP A 81 ASP.? 9.35 MG MG A 106 C 256 HIS A 78 HIS.? 11.19 MG MG A 106 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 18.32 7.36 35.53 19.95 8.35 34.55 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 21.83 6.49 31.11 22.88 8.20 31.70 1zoi_c02 source 1zoi ESTERASE : 1 hits 1zoi_c02 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 17 ARG^? 24.52 MG MG A 106 A 161 ASP A 100 ASP^? 16.25 MG MG A 106 A 174 TYR A 101 TYR^? 16.63 MG MG A 106 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 2.20 -10.40 35.71 4.44 -9.62 37.71 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 12.29 -0.55 33.68 9.97 -0.77 32.12 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG A 23 ARG.? 26.26 O2 TRS B 107 A 161 ASP A 100 ASP^? 16.25 MG MG A 106 A 174 TYR A 101 TYR^? 16.63 MG MG A 106 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 7.13 -4.89 20.32 8.16 -2.85 18.32 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 12.29 -0.55 33.68 9.97 -0.77 32.12 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 3 3 # 3 A 14 ARG B 17 ARG^? 19.62 MG A MG B 106 A 161 ASP B 100 ASP^? 19.56 C2 TRS B 107 A 174 TYR B 101 TYR^? 17.91 N TRS B 107 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 24.18 -12.31 28.78 23.30 -13.33 31.55 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 9.71 -18.83 33.97 8.85 -16.99 33.47 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 14.17 -22.17 31.30 14.99 -21.52 28.71 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 4 3 # 4 A 14 ARG B 23 ARG.? 13.56 O1 TRS B 107 A 161 ASP B 100 ASP^? 19.56 C2 TRS B 107 A 174 TYR B 101 TYR^? 17.91 N TRS B 107 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 9.90 -15.60 19.03 10.94 -17.68 17.04 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 9.71 -18.83 33.97 8.85 -16.99 33.47 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 14.17 -22.17 31.30 14.99 -21.52 28.71 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 17 ARG^? 24.52 MG MG A 106 B 161 ASP A 100 ASP^? 16.25 MG MG A 106 B 174 TYR A 101 TYR^? 16.63 MG MG A 106 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 2.20 -10.40 35.71 4.44 -9.62 37.71 coo -14.86 10.19 8.14 -14.82 12.31 8.42 17.24 -4.20 32.64 17.59 -5.86 31.44 coo -21.46 12.70 8.53 -19.04 12.30 7.24 12.29 -0.55 33.68 9.97 -0.77 32.12 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG A 23 ARG.? 26.26 O2 TRS B 107 B 161 ASP A 100 ASP^? 16.25 MG MG A 106 B 174 TYR A 101 TYR^? 16.63 MG MG A 106 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 7.13 -4.89 20.32 8.16 -2.85 18.32 coo -14.86 10.19 8.14 -14.82 12.31 8.42 17.24 -4.20 32.64 17.59 -5.86 31.44 coo -21.46 12.70 8.53 -19.04 12.30 7.24 12.29 -0.55 33.68 9.97 -0.77 32.12 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 3 3 # 3 B 14 ARG B 17 ARG^? 19.62 MG A MG B 106 B 161 ASP B 100 ASP^? 19.56 C2 TRS B 107 B 174 TYR B 101 TYR^? 17.91 N TRS B 107 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 24.18 -12.31 28.78 23.30 -13.33 31.55 coo -14.86 10.19 8.14 -14.82 12.31 8.42 9.71 -18.83 33.97 8.85 -16.99 33.47 coo -21.46 12.70 8.53 -19.04 12.30 7.24 14.17 -22.17 31.30 14.99 -21.52 28.71 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 4 3 # 4 B 14 ARG B 23 ARG.? 13.56 O1 TRS B 107 B 161 ASP B 100 ASP^? 19.56 C2 TRS B 107 B 174 TYR B 101 TYR^? 17.91 N TRS B 107 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 9.90 -15.60 19.03 10.94 -17.68 17.04 coo -14.86 10.19 8.14 -14.82 12.31 8.42 9.71 -18.83 33.97 8.85 -16.99 33.47 coo -21.46 12.70 8.53 -19.04 12.30 7.24 14.17 -22.17 31.30 14.99 -21.52 28.71 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 17 ARG^? 24.52 MG MG A 106 C 161 ASP A 100 ASP^? 16.25 MG MG A 106 C 174 TYR A 101 TYR^? 16.63 MG MG A 106 coo 2.84 19.43 40.34 1.59 20.35 37.65 2.20 -10.40 35.71 4.44 -9.62 37.71 coo -0.62 11.10 28.05 -0.65 13.15 27.46 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 5.94 13.28 27.17 3.53 13.05 28.58 12.29 -0.55 33.68 9.97 -0.77 32.12 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG A 23 ARG.? 26.26 O2 TRS B 107 C 161 ASP A 100 ASP^? 16.25 MG MG A 106 C 174 TYR A 101 TYR^? 16.63 MG MG A 106 coo 2.84 19.43 40.34 1.59 20.35 37.65 7.13 -4.89 20.32 8.16 -2.85 18.32 coo -0.62 11.10 28.05 -0.65 13.15 27.46 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 5.94 13.28 27.17 3.53 13.05 28.58 12.29 -0.55 33.68 9.97 -0.77 32.12 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 3 3 # 3 C 14 ARG B 17 ARG^? 19.62 MG A MG B 106 C 161 ASP B 100 ASP^? 19.56 C2 TRS B 107 C 174 TYR B 101 TYR^? 17.91 N TRS B 107 coo 2.84 19.43 40.34 1.59 20.35 37.65 24.18 -12.31 28.78 23.30 -13.33 31.55 coo -0.62 11.10 28.05 -0.65 13.15 27.46 9.71 -18.83 33.97 8.85 -16.99 33.47 coo 5.94 13.28 27.17 3.53 13.05 28.58 14.17 -22.17 31.30 14.99 -21.52 28.71 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 4 3 # 4 C 14 ARG B 23 ARG.? 13.56 O1 TRS B 107 C 161 ASP B 100 ASP^? 19.56 C2 TRS B 107 C 174 TYR B 101 TYR^? 17.91 N TRS B 107 coo 2.84 19.43 40.34 1.59 20.35 37.65 9.90 -15.60 19.03 10.94 -17.68 17.04 coo -0.62 11.10 28.05 -0.65 13.15 27.46 9.71 -18.83 33.97 8.85 -16.99 33.47 coo 5.94 13.28 27.17 3.53 13.05 28.58 14.17 -22.17 31.30 14.99 -21.52 28.71 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 17 ARG^? 24.52 MG MG A 106 D 161 ASP A 100 ASP^? 16.25 MG MG A 106 D 174 TYR A 101 TYR^? 16.63 MG MG A 106 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 2.20 -10.40 35.71 4.44 -9.62 37.71 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 17.24 -4.20 32.64 17.59 -5.86 31.44 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 12.29 -0.55 33.68 9.97 -0.77 32.12 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG A 23 ARG.? 26.26 O2 TRS B 107 D 161 ASP A 100 ASP^? 16.25 MG MG A 106 D 174 TYR A 101 TYR^? 16.63 MG MG A 106 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 7.13 -4.89 20.32 8.16 -2.85 18.32 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 17.24 -4.20 32.64 17.59 -5.86 31.44 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 12.29 -0.55 33.68 9.97 -0.77 32.12 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 3 3 # 3 D 14 ARG B 17 ARG^? 19.62 MG A MG B 106 D 161 ASP B 100 ASP^? 19.56 C2 TRS B 107 D 174 TYR B 101 TYR^? 17.91 N TRS B 107 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 24.18 -12.31 28.78 23.30 -13.33 31.55 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 9.71 -18.83 33.97 8.85 -16.99 33.47 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 14.17 -22.17 31.30 14.99 -21.52 28.71 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 4 3 # 4 D 14 ARG B 23 ARG.? 13.56 O1 TRS B 107 D 161 ASP B 100 ASP^? 19.56 C2 TRS B 107 D 174 TYR B 101 TYR^? 17.91 N TRS B 107 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 9.90 -15.60 19.03 10.94 -17.68 17.04 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 9.71 -18.83 33.97 8.85 -16.99 33.47 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 14.17 -22.17 31.30 14.99 -21.52 28.71 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c11 naa= 3 ULMN 3 2lip_c00 LIPASE user 1 3 # 1 87 SER A 61 SER^? 13.76 MG MG A 106 264 ASP A 81 ASP.? 9.35 MG MG A 106 286 HIS A 78 HIS.? 11.19 MG MG A 106 coo 10.47 25.91 18.67 10.67 27.13 20.84 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 2.34 22.49 22.56 3.80 23.95 22.00 18.32 7.36 35.53 19.95 8.35 34.55 coo 7.10 24.11 23.40 8.18 25.09 21.87 21.83 6.49 31.11 22.88 8.20 31.70 2lip_c00 source 2lip LIPASE : 1 hits 2lip_c00 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 33 ASP.? 14.12 MG MG A 106 166 GLY A 80 GLY.? 5.31 MG MG A 106 169 GLU A 76 GLU^? 15.65 MG MG A 106 coo 8.28 6.87 1.62 10.08 5.77 1.34 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -8.58 13.22 3.21 -8.90 13.15 4.05 21.40 4.18 37.49 20.81 4.36 37.01 coo -16.67 7.89 2.78 -17.65 6.56 1.49 19.27 9.35 28.47 21.14 9.50 27.54 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 33 ASP.? 14.12 MG MG A 106 166 GLY B 13 GLY^? 14.84 MG MG A 106 169 GLU B 26 GLU^? 16.98 MG A MG B 106 coo 8.28 6.87 1.62 10.08 5.77 1.34 15.57 -3.11 51.57 14.43 -2.38 49.92 coo -8.58 13.22 3.21 -8.90 13.15 4.05 21.83 -9.26 37.30 21.03 -9.05 37.47 coo -16.67 7.89 2.78 -17.65 6.56 1.49 20.09 -15.15 29.16 20.65 -16.86 27.99 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 81 ASP.? 9.35 MG MG A 106 166 GLY B 13 GLY^? 14.84 MG MG A 106 169 GLU B 26 GLU^? 16.98 MG A MG B 106 coo 8.28 6.87 1.62 10.08 5.77 1.34 18.32 7.36 35.53 19.95 8.35 34.55 coo -8.58 13.22 3.21 -8.90 13.15 4.05 21.83 -9.26 37.30 21.03 -9.05 37.47 coo -16.67 7.89 2.78 -17.65 6.56 1.49 20.09 -15.15 29.16 20.65 -16.86 27.99 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP B 21 ASP.? 19.35 O1 TRS B 107 166 GLY A 62 GLY^? 14.78 MG MG A 106 169 GLU A 76 GLU^? 15.65 MG MG A 106 coo 8.28 6.87 1.62 10.08 5.77 1.34 13.91 -13.27 16.06 15.24 -13.79 14.55 coo -8.58 13.22 3.21 -8.90 13.15 4.05 19.88 0.13 28.65 20.08 0.65 29.27 coo -16.67 7.89 2.78 -17.65 6.56 1.49 19.27 9.35 28.47 21.14 9.50 27.54 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP B 33 ASP.? 27.59 MG MG A 106 166 GLY A 13 GLY^? 24.25 MG MG A 106 169 GLU A 26 GLU^? 23.08 MG MG A 106 coo 8.28 6.87 1.62 10.08 5.77 1.34 22.46 -22.72 47.13 22.23 -22.78 45.03 coo -8.58 13.22 3.21 -8.90 13.15 4.05 9.06 -14.52 41.03 9.77 -14.73 40.69 coo -16.67 7.89 2.78 -17.65 6.56 1.49 6.59 -6.32 33.57 4.76 -5.37 34.00 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP B 81 ASP.? 16.51 N TRS B 107 166 GLY A 13 GLY^? 24.25 MG MG A 106 169 GLU A 26 GLU^? 23.08 MG MG A 106 coo 8.28 6.87 1.62 10.08 5.77 1.34 9.98 -30.67 34.70 8.29 -31.92 34.80 coo -8.58 13.22 3.21 -8.90 13.15 4.05 9.06 -14.52 41.03 9.77 -14.73 40.69 coo -16.67 7.89 2.78 -17.65 6.56 1.49 6.59 -6.32 33.57 4.76 -5.37 34.00 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 6 hits 2tdt_c00 naa= 3 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 A 169 TYR A 66 TYR^? 18.96 MG MG A 106 A 172 HIS A 67 HIS^? 25.71 MG MG A 106 A 267 ASP A 73 ASP.? 24.66 MG MG A 106 coo 26.78 20.44 0.03 28.51 18.26 0.09 9.99 9.72 31.21 7.76 10.46 32.78 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 7.29 12.90 25.70 6.12 14.46 24.97 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 11.88 18.46 25.62 13.34 17.78 24.18 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 A 169 TYR B 65 TYR^? 4.85 N TRS B 107 A 172 HIS B 67 HIS^? 10.25 N TRS B 107 A 267 ASP B 73 ASP.? 13.34 N TRS B 107 coo 26.78 20.44 0.03 28.51 18.26 0.09 5.69 -30.65 23.64 2.95 -31.03 24.05 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 9.64 -40.18 22.89 9.15 -42.09 22.32 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 A 169 TYR B 66 TYR^? 13.48 N TRS B 107 A 172 HIS B 67 HIS^? 10.25 N TRS B 107 A 267 ASP B 73 ASP.? 13.34 N TRS B 107 coo 26.78 20.44 0.03 28.51 18.26 0.09 14.02 -31.53 25.24 16.67 -32.32 24.84 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 9.64 -40.18 22.89 9.15 -42.09 22.32 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 4 3 # 4 A 169 TYR B 91 TYR^? 15.35 N TRS B 107 A 172 HIS B 67 HIS^? 10.25 N TRS B 107 A 267 ASP B 73 ASP.? 13.34 N TRS B 107 coo 26.78 20.44 0.03 28.51 18.26 0.09 17.61 -29.10 22.17 18.36 -26.78 23.51 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 9.64 -40.18 22.89 9.15 -42.09 22.32 2tmd_c00 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 4 hits 2tmd_c00 naa= 3 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 B 169 TYR A 66 TYR^? 18.96 MG MG A 106 B 172 HIS A 67 HIS^? 25.71 MG MG A 106 B 267 ASP A 73 ASP.? 24.66 MG MG A 106 coo 44.86 1.98 33.27 42.75 1.12 31.67 9.99 9.72 31.21 7.76 10.46 32.78 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 7.29 12.90 25.70 6.12 14.46 24.97 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 11.88 18.46 25.62 13.34 17.78 24.18 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 B 169 TYR B 65 TYR^? 4.85 N TRS B 107 B 172 HIS B 67 HIS^? 10.25 N TRS B 107 B 267 ASP B 73 ASP.? 13.34 N TRS B 107 coo 44.86 1.98 33.27 42.75 1.12 31.67 5.69 -30.65 23.64 2.95 -31.03 24.05 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 9.64 -40.18 22.89 9.15 -42.09 22.32 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 B 169 TYR B 66 TYR^? 13.48 N TRS B 107 B 172 HIS B 67 HIS^? 10.25 N TRS B 107 B 267 ASP B 73 ASP.? 13.34 N TRS B 107 coo 44.86 1.98 33.27 42.75 1.12 31.67 14.02 -31.53 25.24 16.67 -32.32 24.84 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 9.64 -40.18 22.89 9.15 -42.09 22.32 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 4 3 # 4 B 169 TYR B 91 TYR^? 15.35 N TRS B 107 B 172 HIS B 67 HIS^? 10.25 N TRS B 107 B 267 ASP B 73 ASP.? 13.34 N TRS B 107 coo 44.86 1.98 33.27 42.75 1.12 31.67 17.61 -29.10 22.17 18.36 -26.78 23.51 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 9.64 -40.18 22.89 9.15 -42.09 22.32 2tmd_c01 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 4 hits 2tmd_c01 naa= 3 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 A 169 TYR A 91 TYR^? 21.63 MG MG A 106 A 172 HIS A 67 HIS^? 25.71 MG MG A 106 A 174 TYR A 66 TYR^? 18.96 MG MG A 106 coo 26.78 20.44 0.03 28.51 18.26 0.09 4.86 7.39 31.16 5.04 4.97 32.56 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 7.29 12.90 25.70 6.12 14.46 24.97 coo 24.73 15.69 1.93 26.72 14.32 3.31 9.99 9.72 31.21 7.76 10.46 32.78 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 A 169 TYR B 66 TYR^? 13.48 N TRS B 107 A 172 HIS B 67 HIS^? 10.25 N TRS B 107 A 174 TYR B 91 TYR^? 15.35 N TRS B 107 coo 26.78 20.44 0.03 28.51 18.26 0.09 14.02 -31.53 25.24 16.67 -32.32 24.84 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 24.73 15.69 1.93 26.72 14.32 3.31 17.61 -29.10 22.17 18.36 -26.78 23.51 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 A 169 TYR B 91 TYR^? 15.35 N TRS B 107 A 172 HIS B 67 HIS^? 10.25 N TRS B 107 A 174 TYR B 66 TYR^? 13.48 N TRS B 107 coo 26.78 20.44 0.03 28.51 18.26 0.09 17.61 -29.10 22.17 18.36 -26.78 23.51 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 24.73 15.69 1.93 26.72 14.32 3.31 14.02 -31.53 25.24 16.67 -32.32 24.84 2tmd_c02 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 3 hits 2tmd_c02 naa= 3 ULMN 3 2tmd_c03 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 B 169 TYR A 91 TYR^? 21.63 MG MG A 106 B 172 HIS A 67 HIS^? 25.71 MG MG A 106 B 174 TYR A 66 TYR^? 18.96 MG MG A 106 coo 44.86 1.98 33.27 42.75 1.12 31.67 4.86 7.39 31.16 5.04 4.97 32.56 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 7.29 12.90 25.70 6.12 14.46 24.97 coo 45.95 0.11 28.25 43.87 0.82 26.55 9.99 9.72 31.21 7.76 10.46 32.78 ULMN 3 2tmd_c03 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 B 169 TYR B 91 TYR^? 15.35 N TRS B 107 B 172 HIS B 67 HIS^? 10.25 N TRS B 107 B 174 TYR B 66 TYR^? 13.48 N TRS B 107 coo 44.86 1.98 33.27 42.75 1.12 31.67 17.61 -29.10 22.17 18.36 -26.78 23.51 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 45.95 0.11 28.25 43.87 0.82 26.55 14.02 -31.53 25.24 16.67 -32.32 24.84 2tmd_c03 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 2 hits 2tmd_c03 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR A 65 TYR^? 20.31 MG MG A 106 A 214 ASP A 81 ASP.? 9.35 MG MG A 106 A 256 LYS B 14 LYS.? 6.95 MG MG A 106 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 15.06 9.60 24.66 17.54 9.96 23.42 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 18.32 7.36 35.53 19.95 8.35 34.55 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 2 3 # 2 A 122 TYR A 66 TYR^? 18.96 MG MG A 106 A 214 ASP A 81 ASP.? 9.35 MG MG A 106 A 256 LYS B 14 LYS.? 6.95 MG MG A 106 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 9.99 9.72 31.21 7.76 10.46 32.78 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 18.32 7.36 35.53 19.95 8.35 34.55 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 3 3 # 3 A 122 TYR B 65 TYR^? 4.85 N TRS B 107 A 214 ASP B 81 ASP.? 16.51 N TRS B 107 A 256 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 5.69 -30.65 23.64 2.95 -31.03 24.05 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 9.98 -30.67 34.70 8.29 -31.92 34.80 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 8.74 -17.74 39.05 7.96 -22.88 42.54 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 4 3 # 4 A 122 TYR B 66 TYR^? 13.48 N TRS B 107 A 214 ASP B 81 ASP.? 16.51 N TRS B 107 A 256 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 14.02 -31.53 25.24 16.67 -32.32 24.84 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 9.98 -30.67 34.70 8.29 -31.92 34.80 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 8.74 -17.74 39.05 7.96 -22.88 42.54 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 4 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR A 65 TYR^? 20.31 MG MG A 106 B 214 ASP A 81 ASP.? 9.35 MG MG A 106 B 256 LYS B 14 LYS.? 6.95 MG MG A 106 coo -32.67 22.74 10.17 -32.85 23.98 7.70 15.06 9.60 24.66 17.54 9.96 23.42 coo -26.88 17.61 16.89 -26.08 17.11 15.00 18.32 7.36 35.53 19.95 8.35 34.55 coo -16.04 12.06 11.09 -17.97 10.54 5.71 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR A 66 TYR^? 18.96 MG MG A 106 B 214 ASP A 81 ASP.? 9.35 MG MG A 106 B 256 LYS B 14 LYS.? 6.95 MG MG A 106 coo -32.67 22.74 10.17 -32.85 23.98 7.70 9.99 9.72 31.21 7.76 10.46 32.78 coo -26.88 17.61 16.89 -26.08 17.11 15.00 18.32 7.36 35.53 19.95 8.35 34.55 coo -16.04 12.06 11.09 -17.97 10.54 5.71 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 3 3 # 3 B 122 TYR B 65 TYR^? 4.85 N TRS B 107 B 214 ASP B 81 ASP.? 16.51 N TRS B 107 B 256 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo -32.67 22.74 10.17 -32.85 23.98 7.70 5.69 -30.65 23.64 2.95 -31.03 24.05 coo -26.88 17.61 16.89 -26.08 17.11 15.00 9.98 -30.67 34.70 8.29 -31.92 34.80 coo -16.04 12.06 11.09 -17.97 10.54 5.71 8.74 -17.74 39.05 7.96 -22.88 42.54 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 4 3 # 4 B 122 TYR B 66 TYR^? 13.48 N TRS B 107 B 214 ASP B 81 ASP.? 16.51 N TRS B 107 B 256 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo -32.67 22.74 10.17 -32.85 23.98 7.70 14.02 -31.53 25.24 16.67 -32.32 24.84 coo -26.88 17.61 16.89 -26.08 17.11 15.00 9.98 -30.67 34.70 8.29 -31.92 34.80 coo -16.04 12.06 11.09 -17.97 10.54 5.71 8.74 -17.74 39.05 7.96 -22.88 42.54 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 4 hits 2tpl_c05 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG A 27 ARG^? 22.99 C2 TRS B 107 A 130 SER A 25 SER^? 23.03 C2 TRS B 107 A 159 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 18.35 45.84 20.99 16.20 47.83 21.89 11.78 -12.78 37.42 11.40 -15.00 35.25 coo 15.14 43.67 10.77 15.61 44.43 13.04 8.15 -8.88 30.15 10.32 -9.84 29.66 coo 11.57 48.49 22.18 13.51 49.99 17.21 8.74 -17.74 39.05 7.96 -22.88 42.54 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 A 59 ARG A 27 ARG^? 22.99 C2 TRS B 107 A 130 SER B 25 SER^? 21.93 C2 TRS B 107 A 159 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 18.35 45.84 20.99 16.20 47.83 21.89 11.78 -12.78 37.42 11.40 -15.00 35.25 coo 15.14 43.67 10.77 15.61 44.43 13.04 15.65 -13.25 27.32 13.56 -12.34 28.19 coo 11.57 48.49 22.18 13.51 49.99 17.21 8.74 -17.74 39.05 7.96 -22.88 42.54 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 A 59 ARG A 27 ARG^? 22.99 C2 TRS B 107 A 130 SER B 28 SER^? 20.11 MG MG A 106 A 159 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 18.35 45.84 20.99 16.20 47.83 21.89 11.78 -12.78 37.42 11.40 -15.00 35.25 coo 15.14 43.67 10.77 15.61 44.43 13.04 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 11.57 48.49 22.18 13.51 49.99 17.21 8.74 -17.74 39.05 7.96 -22.88 42.54 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 A 59 ARG A 27 ARG^? 22.99 C2 TRS B 107 A 130 SER B 38 SER.? 19.23 MG A MG B 106 A 159 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 18.35 45.84 20.99 16.20 47.83 21.89 11.78 -12.78 37.42 11.40 -15.00 35.25 coo 15.14 43.67 10.77 15.61 44.43 13.04 20.61 -17.82 33.77 20.60 -17.17 31.49 coo 11.57 48.49 22.18 13.51 49.99 17.21 8.74 -17.74 39.05 7.96 -22.88 42.54 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 5 3 # 5 A 59 ARG B 27 ARG^? 16.66 MG MG A 106 A 130 SER A 25 SER^? 23.03 C2 TRS B 107 A 159 LYS B 14 LYS.? 6.95 MG MG A 106 coo 18.35 45.84 20.99 16.20 47.83 21.89 17.35 -10.54 35.83 16.56 -8.02 34.14 coo 15.14 43.67 10.77 15.61 44.43 13.04 8.15 -8.88 30.15 10.32 -9.84 29.66 coo 11.57 48.49 22.18 13.51 49.99 17.21 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 6 3 # 6 A 59 ARG B 27 ARG^? 16.66 MG MG A 106 A 130 SER A 28 SER^? 23.29 MG MG A 106 A 159 LYS B 14 LYS.? 6.95 MG MG A 106 coo 18.35 45.84 20.99 16.20 47.83 21.89 17.35 -10.54 35.83 16.56 -8.02 34.14 coo 15.14 43.67 10.77 15.61 44.43 13.04 7.93 -9.68 40.46 5.50 -9.56 40.62 coo 11.57 48.49 22.18 13.51 49.99 17.21 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 7 3 # 7 A 59 ARG B 27 ARG^? 16.66 MG MG A 106 A 130 SER A 38 SER.? 20.21 MG MG A 106 A 159 LYS B 14 LYS.? 6.95 MG MG A 106 coo 18.35 45.84 20.99 16.20 47.83 21.89 17.35 -10.54 35.83 16.56 -8.02 34.14 coo 15.14 43.67 10.77 15.61 44.43 13.04 8.35 -5.49 38.91 7.27 -5.53 36.78 coo 11.57 48.49 22.18 13.51 49.99 17.21 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 8 3 # 8 A 59 ARG B 27 ARG^? 16.66 MG MG A 106 A 130 SER B 25 SER^? 21.93 C2 TRS B 107 A 159 LYS B 14 LYS.? 6.95 MG MG A 106 coo 18.35 45.84 20.99 16.20 47.83 21.89 17.35 -10.54 35.83 16.56 -8.02 34.14 coo 15.14 43.67 10.77 15.61 44.43 13.04 15.65 -13.25 27.32 13.56 -12.34 28.19 coo 11.57 48.49 22.18 13.51 49.99 17.21 21.12 -5.80 35.93 24.74 -1.53 38.99 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 8 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG A 27 ARG^? 22.99 C2 TRS B 107 B 130 SER B 25 SER^? 21.93 C2 TRS B 107 B 159 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 58.72 31.58 20.45 60.80 29.39 20.94 11.78 -12.78 37.42 11.40 -15.00 35.25 coo 61.66 35.17 10.39 61.29 34.14 12.56 15.65 -13.25 27.32 13.56 -12.34 28.19 coo 65.38 28.77 21.17 63.49 28.03 16.12 8.74 -17.74 39.05 7.96 -22.88 42.54 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 B 59 ARG A 27 ARG^? 22.99 C2 TRS B 107 B 130 SER B 28 SER^? 20.11 MG MG A 106 B 159 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 58.72 31.58 20.45 60.80 29.39 20.94 11.78 -12.78 37.42 11.40 -15.00 35.25 coo 61.66 35.17 10.39 61.29 34.14 12.56 22.08 -13.91 35.51 24.12 -13.89 34.25 coo 65.38 28.77 21.17 63.49 28.03 16.12 8.74 -17.74 39.05 7.96 -22.88 42.54 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 B 59 ARG A 27 ARG^? 22.99 C2 TRS B 107 B 130 SER B 38 SER.? 19.23 MG A MG B 106 B 159 LYS A 14 LYS.? 24.61 C2 TRS B 107 coo 58.72 31.58 20.45 60.80 29.39 20.94 11.78 -12.78 37.42 11.40 -15.00 35.25 coo 61.66 35.17 10.39 61.29 34.14 12.56 20.61 -17.82 33.77 20.60 -17.17 31.49 coo 65.38 28.77 21.17 63.49 28.03 16.12 8.74 -17.74 39.05 7.96 -22.88 42.54 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 B 59 ARG B 27 ARG^? 16.66 MG MG A 106 B 130 SER A 25 SER^? 23.03 C2 TRS B 107 B 159 LYS B 14 LYS.? 6.95 MG MG A 106 coo 58.72 31.58 20.45 60.80 29.39 20.94 17.35 -10.54 35.83 16.56 -8.02 34.14 coo 61.66 35.17 10.39 61.29 34.14 12.56 8.15 -8.88 30.15 10.32 -9.84 29.66 coo 65.38 28.77 21.17 63.49 28.03 16.12 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 5 3 # 5 B 59 ARG B 27 ARG^? 16.66 MG MG A 106 B 130 SER A 28 SER^? 23.29 MG MG A 106 B 159 LYS B 14 LYS.? 6.95 MG MG A 106 coo 58.72 31.58 20.45 60.80 29.39 20.94 17.35 -10.54 35.83 16.56 -8.02 34.14 coo 61.66 35.17 10.39 61.29 34.14 12.56 7.93 -9.68 40.46 5.50 -9.56 40.62 coo 65.38 28.77 21.17 63.49 28.03 16.12 21.12 -5.80 35.93 24.74 -1.53 38.99 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 6 3 # 6 B 59 ARG B 27 ARG^? 16.66 MG MG A 106 B 130 SER A 38 SER.? 20.21 MG MG A 106 B 159 LYS B 14 LYS.? 6.95 MG MG A 106 coo 58.72 31.58 20.45 60.80 29.39 20.94 17.35 -10.54 35.83 16.56 -8.02 34.14 coo 61.66 35.17 10.39 61.29 34.14 12.56 8.35 -5.49 38.91 7.27 -5.53 36.78 coo 65.38 28.77 21.17 63.49 28.03 16.12 21.12 -5.80 35.93 24.74 -1.53 38.99 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 6 hits 2tps_c01 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 72 ASN.? 29.16 MG MG A 106 coo 5.80 63.03 55.85 5.52 65.03 56.45 8.18 21.40 26.42 8.86 22.63 24.85 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 88 ASN.? 28.92 MG MG A 106 coo 5.80 63.03 55.85 5.52 65.03 56.45 -3.68 10.05 36.57 -4.41 8.86 38.16 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN B 72 ASN.? 16.16 N TRS B 107 coo 5.80 63.03 55.85 5.52 65.03 56.45 11.77 -42.42 18.70 13.18 -43.21 17.33 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN B 88 ASN.? -8.35 MG A MG B 106s coo 5.80 63.03 55.85 5.52 65.03 56.45 28.06 -31.46 21.34 28.31 -31.33 19.24 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 4 hits 1kbk_p00 naa= 1 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 1 3 # 1 A 26 HIS A 67 HIS^? 25.71 MG MG A 106 A 76 ASN A 72 ASN.? 29.16 MG MG A 106 A 81 ASP A 73 ASP.? 24.66 MG MG A 106 coo 4.09 43.69 67.89 2.45 42.40 68.10 7.29 12.90 25.70 6.12 14.46 24.97 coo 4.75 48.17 75.81 4.99 47.30 77.74 8.18 21.40 26.42 8.86 22.63 24.85 coo 0.57 50.41 73.18 0.46 48.28 73.56 11.88 18.46 25.62 13.34 17.78 24.18 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 2 3 # 2 A 26 HIS B 67 HIS^? 10.25 N TRS B 107 A 76 ASN B 72 ASN.? 16.16 N TRS B 107 A 81 ASP B 73 ASP.? 13.34 N TRS B 107 coo 4.09 43.69 67.89 2.45 42.40 68.10 12.23 -34.37 19.25 12.68 -35.93 17.95 coo 4.75 48.17 75.81 4.99 47.30 77.74 11.77 -42.42 18.70 13.18 -43.21 17.33 coo 0.57 50.41 73.18 0.46 48.28 73.56 9.64 -40.18 22.89 9.15 -42.09 22.32 2c3x_p00 source 2c3x ALPHA-AMYLASE G-6 : 2 hits 2c3x_p00 naa= 3 ULMN 4 2cl8_p00 DECTIN-1 user 1 4 # 1 A 145 ARG B 27 ARG^? 16.66 MG MG A 106 A 148 SER A 61 SER^? 13.76 MG MG A 106 A 152 ALA A 79 ALA.? 8.97 MG MG A 106 A 194 GLU A 97 GLU^? 17.69 MG MG A 106 coo -29.52 -1.51 -10.80 -29.25 -1.07 -13.87 17.35 -10.54 35.83 16.56 -8.02 34.14 coo -35.30 0.90 -4.91 -36.19 -1.20 -5.57 20.58 -1.27 32.13 21.77 -3.05 30.92 coo -37.81 4.22 -2.30 -36.99 5.43 -2.37 21.53 2.78 33.99 22.71 1.85 33.69 coo -43.25 5.44 -9.45 -44.36 4.89 -7.68 21.20 0.85 23.82 22.93 1.52 24.76 2cl8_p00 source 2cl8 DECTIN-1 : 1 hits 2cl8_p00 naa= 4 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 65 TYR^? 20.31 MG MG A 106 I 306 VAL A 95 VAL^? 20.54 MG MG A 106 I 308 VAL A 46 VAL^? 26.18 MG MG A 106 coo 26.18 35.24 6.87 24.33 35.18 8.97 15.06 9.60 24.66 17.54 9.96 23.42 coo 23.55 29.53 9.81 23.15 27.39 10.24 13.74 2.42 24.07 13.35 0.64 25.29 coo 16.43 30.18 9.35 15.05 30.67 11.01 8.21 3.37 21.50 8.52 5.37 20.67 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR B 65 TYR^? 4.85 N TRS B 107 I 306 VAL B 95 VAL^? 9.53 C2 TRS B 107 I 308 VAL B 46 VAL^? 7.27 O1 TRS B 107 coo 26.18 35.24 6.87 24.33 35.18 8.97 5.69 -30.65 23.64 2.95 -31.03 24.05 coo 23.55 29.53 9.81 23.15 27.39 10.24 6.94 -23.72 23.95 8.14 -22.24 25.03 coo 16.43 30.18 9.35 15.05 30.67 11.01 9.17 -23.51 18.10 8.72 -24.81 16.42 1cqt_d00 source 1cqt GENE REGULATION/DNA : 2 hits 1cqt_d00 naa= 3 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 8 PRO^? 12.06 MG MG A 106 A 272 LEU A 31 LEU^? 13.36 MG MG A 106 A 276 ARG A 58 ARG^? 9.13 MG MG A 106 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 22.80 -6.07 46.83 21.24 -7.12 45.55 coo 10.97 0.43 16.73 11.31 2.11 18.06 15.18 -5.32 46.53 15.36 -4.68 44.48 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 17.26 0.85 41.49 16.40 -0.10 44.31 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO A 44 PRO.? 23.59 MG MG A 106 A 272 LEU A 99 LEU^? 16.16 MG MG A 106 A 276 ARG A 24 ARG^? 24.75 MG MG A 106 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 15.57 -2.49 21.34 13.46 -2.06 21.94 coo 10.97 0.43 16.73 11.31 2.11 18.06 14.72 -0.28 28.92 14.78 1.59 29.95 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 6.24 -3.67 29.98 3.39 -2.61 30.35 ULMN 3 1emh_d00 HYDROLASE/DNA user 3 3 # 3 A 271 PRO A 98 PRO^? 20.25 MG MG A 106 A 272 LEU A 41 LEU.? 20.27 MG MG A 106 A 276 ARG A 24 ARG^? 24.75 MG MG A 106 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 17.90 -4.38 24.16 17.26 -2.48 25.19 coo 10.97 0.43 16.73 11.31 2.11 18.06 13.21 -7.22 29.82 14.81 -7.44 28.39 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 6.24 -3.67 29.98 3.39 -2.61 30.35 ULMN 3 1emh_d00 HYDROLASE/DNA user 4 3 # 4 A 271 PRO A 98 PRO^? 20.25 MG MG A 106 A 272 LEU A 41 LEU.? 20.27 MG MG A 106 A 276 ARG B 27 ARG^? 16.66 MG MG A 106 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 17.90 -4.38 24.16 17.26 -2.48 25.19 coo 10.97 0.43 16.73 11.31 2.11 18.06 13.21 -7.22 29.82 14.81 -7.44 28.39 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 17.35 -10.54 35.83 16.56 -8.02 34.14 ULMN 3 1emh_d00 HYDROLASE/DNA user 5 3 # 5 A 271 PRO A 98 PRO^? 20.25 MG MG A 106 A 272 LEU A 99 LEU^? 16.16 MG MG A 106 A 276 ARG A 24 ARG^? 24.75 MG MG A 106 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 17.90 -4.38 24.16 17.26 -2.48 25.19 coo 10.97 0.43 16.73 11.31 2.11 18.06 14.72 -0.28 28.92 14.78 1.59 29.95 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 6.24 -3.67 29.98 3.39 -2.61 30.35 ULMN 3 1emh_d00 HYDROLASE/DNA user 6 3 # 6 A 271 PRO B 8 PRO^? 25.70 MG MG A 106 A 272 LEU B 31 LEU^? 24.79 MG MG A 106 A 276 ARG B 58 ARG^? 24.73 MG A MG B 106 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 13.99 -19.24 48.47 14.48 -17.87 46.78 coo 10.97 0.43 16.73 11.31 2.11 18.06 19.94 -19.57 43.77 18.62 -19.89 42.07 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 17.07 -26.36 39.29 20.10 -26.73 39.11 ULMN 3 1emh_d00 HYDROLASE/DNA user 7 3 # 7 A 271 PRO B 44 PRO.? 11.33 C2 TRS B 107 A 272 LEU B 99 LEU^? 13.70 C2 TRS B 107 A 276 ARG B 24 ARG^? 14.88 MG A MG B 106 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 4.07 -18.49 24.32 6.01 -18.89 23.31 coo 10.97 0.43 16.73 11.31 2.11 18.06 9.39 -21.94 28.86 9.87 -24.01 29.36 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 16.79 -18.48 25.10 19.01 -19.70 23.40 ULMN 3 1emh_d00 HYDROLASE/DNA user 8 3 # 8 A 271 PRO B 98 PRO^? 13.77 C2 TRS B 107 A 272 LEU B 41 LEU.? 19.13 C2 TRS B 107 A 276 ARG A 27 ARG^? 22.99 C2 TRS B 107 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 4.05 -17.33 28.11 5.14 -19.32 28.14 coo 10.97 0.43 16.73 11.31 2.11 18.06 11.42 -15.19 29.86 9.29 -14.84 29.70 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 11.78 -12.78 37.42 11.40 -15.00 35.25 ULMN 3 1emh_d00 HYDROLASE/DNA user 9 3 # 9 A 271 PRO B 98 PRO^? 13.77 C2 TRS B 107 A 272 LEU B 41 LEU.? 19.13 C2 TRS B 107 A 276 ARG B 24 ARG^? 14.88 MG A MG B 106 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 4.05 -17.33 28.11 5.14 -19.32 28.14 coo 10.97 0.43 16.73 11.31 2.11 18.06 11.42 -15.19 29.86 9.29 -14.84 29.70 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 16.79 -18.48 25.10 19.01 -19.70 23.40 ULMN 3 1emh_d00 HYDROLASE/DNA user 10 3 # 10 A 271 PRO B 98 PRO^? 13.77 C2 TRS B 107 A 272 LEU B 99 LEU^? 13.70 C2 TRS B 107 A 276 ARG B 24 ARG^? 14.88 MG A MG B 106 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 4.05 -17.33 28.11 5.14 -19.32 28.14 coo 10.97 0.43 16.73 11.31 2.11 18.06 9.39 -21.94 28.86 9.87 -24.01 29.36 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 16.79 -18.48 25.10 19.01 -19.70 23.40 1emh_d00 source 1emh HYDROLASE/DNA : 10 hits 1emh_d00 naa= 3 ULMN 4 1kqq_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 92 THR A 56 THR^? 13.39 MG MG A 106 A 93 SER A 104 SER.? 14.85 MG MG A 106 A 96 LEU A 102 LEU^? 12.51 MG MG A 106 A 131 ARG A 24 ARG^? 24.75 MG MG A 106 coo 3.35 5.93 10.54 2.79 5.49 12.55 9.35 4.66 41.11 10.55 5.11 42.82 coo 3.53 2.76 8.43 3.13 1.02 10.05 7.92 -0.22 42.40 9.54 1.15 43.46 coo 5.64 -0.49 6.46 5.57 -2.53 7.21 13.33 -1.93 39.72 14.55 -3.45 40.68 coo 12.62 -3.51 13.26 13.87 -0.97 14.34 6.24 -3.67 29.98 3.39 -2.61 30.35 ULMN 4 1kqq_d00 TRANSCRIPTION/DNA user 2 4 # 2 A 92 THR A 56 THR^? 13.39 MG MG A 106 A 93 SER A 104 SER.? 14.85 MG MG A 106 A 96 LEU A 103 LEU^? 17.50 MG MG A 106 A 131 ARG A 24 ARG^? 24.75 MG MG A 106 coo 3.35 5.93 10.54 2.79 5.49 12.55 9.35 4.66 41.11 10.55 5.11 42.82 coo 3.53 2.76 8.43 3.13 1.02 10.05 7.92 -0.22 42.40 9.54 1.15 43.46 coo 5.64 -0.49 6.46 5.57 -2.53 7.21 7.86 -0.38 38.00 7.58 0.92 36.29 coo 12.62 -3.51 13.26 13.87 -0.97 14.34 6.24 -3.67 29.98 3.39 -2.61 30.35 1kqq_d00 source 1kqq TRANSCRIPTION/DNA : 2 hits 1kqq_d00 naa= 4 ULMN 4 1pt3_d00 HYDROLASE/DNA user 1 4 # 1 A 493 ASP B 100 ASP^? 19.56 C2 TRS B 107 A 496 ARG A 27 ARG^? 22.99 C2 TRS B 107 A 497 LYS A 14 LYS.? 24.61 C2 TRS B 107 A 538 ARG A 24 ARG^? 24.75 MG MG A 106 coo 15.86 25.80 6.36 15.63 24.95 4.48 9.71 -18.83 33.97 8.85 -16.99 33.47 coo 13.63 31.13 3.81 13.19 28.14 4.37 11.78 -12.78 37.42 11.40 -15.00 35.25 coo 13.35 31.27 9.53 12.86 25.24 10.46 8.74 -17.74 39.05 7.96 -22.88 42.54 coo 9.10 29.26 -6.38 11.11 30.45 -8.37 6.24 -3.67 29.98 3.39 -2.61 30.35 1pt3_d00 source 1pt3 HYDROLASE/DNA : 1 hits 1pt3_d00 naa= 4 ULMN 3 2bsq_d00 TRANSCRIPTION user 1 3 # 1 E 3 SER A 61 SER^? 13.76 MG MG A 106 E 5 VAL A 59 VAL^? 10.74 MG MG A 106 E 7 ARG A 58 ARG^? 9.13 MG MG A 106 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 20.58 -1.27 32.13 21.77 -3.05 30.92 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 16.80 1.84 35.41 16.72 2.89 33.51 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 17.26 0.85 41.49 16.40 -0.10 44.31 ULMN 3 2bsq_d00 TRANSCRIPTION user 2 3 # 2 E 3 SER B 61 SER^? 18.05 C2 TRS B 107 E 5 VAL B 59 VAL^? 17.45 N TRS B 107 E 7 ARG B 58 ARG^? 24.73 MG A MG B 106 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 6.61 -22.01 35.09 5.00 -20.16 35.04 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 11.51 -25.16 34.84 10.42 -25.85 33.12 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 17.07 -26.36 39.29 20.10 -26.73 39.11 2bsq_d00 source 2bsq TRANSCRIPTION : 2 hits 2bsq_d00 naa= 3 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 18 SER A 25 SER^? 23.03 C2 TRS B 107 A 20 HIS B 43 HIS.? 17.46 C2 TRS B 107 A 22 LEU B 20 LEU.? 17.06 O1 TRS B 107 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 8.15 -8.88 30.15 10.32 -9.84 29.66 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 8.53 -14.49 24.38 9.05 -12.59 25.12 coo -14.55 2.62 13.63 -14.94 2.66 11.50 15.45 -16.97 19.93 16.63 -18.81 20.38 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 18 SER A 25 SER^? 23.03 C2 TRS B 107 A 20 HIS B 43 HIS.? 17.46 C2 TRS B 107 A 22 LEU B 99 LEU^? 13.70 C2 TRS B 107 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 8.15 -8.88 30.15 10.32 -9.84 29.66 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 8.53 -14.49 24.38 9.05 -12.59 25.12 coo -14.55 2.62 13.63 -14.94 2.66 11.50 9.39 -21.94 28.86 9.87 -24.01 29.36 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 18 SER B 25 SER^? 21.93 C2 TRS B 107 A 20 HIS A 43 HIS.? 24.06 C2 TRS B 107 A 22 LEU A 20 LEU.? 25.75 O2 TRS B 107 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 15.65 -13.25 27.32 13.56 -12.34 28.19 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 12.35 -6.62 23.61 12.63 -8.53 24.45 coo -14.55 2.62 13.63 -14.94 2.66 11.50 3.87 -4.16 24.96 3.32 -2.51 26.31 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 18 SER B 25 SER^? 21.93 C2 TRS B 107 A 20 HIS A 43 HIS.? 24.06 C2 TRS B 107 A 22 LEU A 99 LEU^? 16.16 MG MG A 106 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 15.65 -13.25 27.32 13.56 -12.34 28.19 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 12.35 -6.62 23.61 12.63 -8.53 24.45 coo -14.55 2.62 13.63 -14.94 2.66 11.50 14.72 -0.28 28.92 14.78 1.59 29.95 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 A 18 SER B 35 SER.? 26.37 MG A MG B 106 A 20 HIS B 37 HIS.? 23.74 MG A MG B 106 A 22 LEU B 103 LEU^? 17.74 MG A MG B 106 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 25.15 -20.56 42.66 23.31 -22.12 42.44 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 21.69 -21.14 38.43 22.55 -22.53 39.75 coo -14.55 2.62 13.63 -14.94 2.66 11.50 19.71 -22.16 31.73 21.07 -22.63 30.10 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 A 18 SER B 105 SER.? 14.90 MG A MG B 106 A 20 HIS B 37 HIS.? 23.74 MG A MG B 106 A 22 LEU B 39 LEU.? 22.96 MG MG A 106 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 26.26 -24.98 33.11 26.69 -23.14 31.51 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 21.69 -21.14 38.43 22.55 -22.53 39.75 coo -14.55 2.62 13.63 -14.94 2.66 11.50 16.62 -15.99 35.81 14.67 -15.98 36.73 3gxq_d00 source 3gxq DNA BINDING PROTEIN/DNA : 6 hits 3gxq_d00 naa= 3 ULMN 3 3pta_d00 TRANSFERASE/DNA user 1 3 # 1 A 682 SER B 15 SER.? 15.78 MG MG A 106 A 683 LYS B 14 LYS.? 6.95 MG MG A 106 A 684 GLN A 5 GLN.? 15.12 MG MG A 106 coo -8.24 -20.23 36.50 -7.44 -18.27 37.68 21.32 -6.59 32.27 23.57 -7.13 31.60 coo -5.30 -22.52 37.30 -6.47 -26.26 32.30 21.12 -5.80 35.93 24.74 -1.53 38.99 coo -3.80 -18.22 38.13 -1.93 -17.88 37.17 27.00 -6.52 35.46 28.61 -7.60 34.55 3pta_d00 source 3pta TRANSFERASE/DNA : 1 hits 3pta_d00 naa= 3 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 G 386 ARG A 23 ARG.? 26.26 O2 TRS B 107 G 387 HIS B 43 HIS.? 17.46 C2 TRS B 107 G 390 SER A 25 SER^? 23.03 C2 TRS B 107 coo 93.17 52.97 31.81 95.66 54.71 32.14 7.13 -4.89 20.32 8.16 -2.85 18.32 coo 95.60 53.07 40.31 97.10 52.52 41.67 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 93.25 46.91 38.79 94.12 47.43 36.62 8.15 -8.88 30.15 10.32 -9.84 29.66 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 G 386 ARG A 58 ARG^? 9.13 MG MG A 106 G 387 HIS A 37 HIS.? 14.34 MG MG A 106 G 390 SER A 35 SER.? 14.72 MG MG A 106 coo 93.17 52.97 31.81 95.66 54.71 32.14 17.26 0.85 41.49 16.40 -0.10 44.31 coo 95.60 53.07 40.31 97.10 52.52 41.67 11.15 -3.04 43.19 11.90 -1.76 44.64 coo 93.25 46.91 38.79 94.12 47.43 36.62 10.65 -4.05 48.86 12.50 -2.79 47.78 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 G 386 ARG B 23 ARG.? 13.56 O1 TRS B 107 G 387 HIS A 43 HIS.? 24.06 C2 TRS B 107 G 390 SER B 25 SER^? 21.93 C2 TRS B 107 coo 93.17 52.97 31.81 95.66 54.71 32.14 9.90 -15.60 19.03 10.94 -17.68 17.04 coo 95.60 53.07 40.31 97.10 52.52 41.67 12.35 -6.62 23.61 12.63 -8.53 24.45 coo 93.25 46.91 38.79 94.12 47.43 36.62 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 G 386 ARG B 58 ARG^? 24.73 MG A MG B 106 G 387 HIS B 37 HIS.? 23.74 MG A MG B 106 G 390 SER B 35 SER.? 26.37 MG A MG B 106 coo 93.17 52.97 31.81 95.66 54.71 32.14 17.07 -26.36 39.29 20.10 -26.73 39.11 coo 95.60 53.07 40.31 97.10 52.52 41.67 21.69 -21.14 38.43 22.55 -22.53 39.75 coo 93.25 46.91 38.79 94.12 47.43 36.62 25.15 -20.56 42.66 23.31 -22.12 42.44 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 G 386 ARG B 58 ARG^? 24.73 MG A MG B 106 G 387 HIS B 37 HIS.? 23.74 MG A MG B 106 G 390 SER B 38 SER.? 19.23 MG A MG B 106 coo 93.17 52.97 31.81 95.66 54.71 32.14 17.07 -26.36 39.29 20.10 -26.73 39.11 coo 95.60 53.07 40.31 97.10 52.52 41.67 21.69 -21.14 38.43 22.55 -22.53 39.75 coo 93.25 46.91 38.79 94.12 47.43 36.62 20.61 -17.82 33.77 20.60 -17.17 31.49 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 G 386 ARG B 58 ARG^? 24.73 MG A MG B 106 G 387 HIS B 37 HIS.? 23.74 MG A MG B 106 G 390 SER B 105 SER.? 14.90 MG A MG B 106 coo 93.17 52.97 31.81 95.66 54.71 32.14 17.07 -26.36 39.29 20.10 -26.73 39.11 coo 95.60 53.07 40.31 97.10 52.52 41.67 21.69 -21.14 38.43 22.55 -22.53 39.75 coo 93.25 46.91 38.79 94.12 47.43 36.62 26.26 -24.98 33.11 26.69 -23.14 31.51 3qrf_d00 source 3qrf DNA BINDING PROTEIN/DNA : 6 hits 3qrf_d00 naa= 3 ULMN 3 3qsv_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 81 ARG B 27 ARG^? 16.66 MG MG A 106 A 83 GLN A 5 GLN.? 15.12 MG MG A 106 A 88 LYS B 14 LYS.? 6.95 MG MG A 106 coo 19.97 2.61 -45.02 18.79 3.68 -42.41 17.35 -10.54 35.83 16.56 -8.02 34.14 coo 24.10 10.39 -42.90 23.65 10.53 -40.83 27.00 -6.52 35.46 28.61 -7.60 34.55 coo 20.32 8.01 -45.76 23.08 6.63 -41.24 21.12 -5.80 35.93 24.74 -1.53 38.99 3qsv_d00 source 3qsv TRANSCRIPTION/DNA : 1 hits 3qsv_d00 naa= 3 ULMN 5 3sm4_d00 HYDROLASE/DNA user 1 5 # 1 B 53 MET A 83 MET?? 15.18 MG MG A 106 B 73 VAL A 29 VAL^? 18.39 MG MG A 106 B 75 ALA A 9 ALA^? 16.42 MG MG A 106 B 77 ALA B 11 ALA^? 15.97 MG MG A 106 B 78 LEU B 12 LEU^? 15.99 MG MG A 106 coo 6.68 -12.20 6.91 4.65 -8.54 6.72 12.52 8.97 39.30 11.59 10.16 35.25 coo 4.09 -11.16 -10.83 4.39 -11.22 -8.63 10.98 -9.53 42.72 12.44 -8.77 41.25 coo -0.13 -5.63 -11.43 -0.24 -5.75 -9.91 17.85 -9.53 46.38 17.64 -10.28 45.04 coo 0.92 -0.50 -9.34 0.65 -0.74 -7.86 21.39 -11.21 43.66 22.89 -11.27 43.43 coo 4.14 -4.02 -10.28 4.18 -5.28 -8.49 18.25 -9.54 40.42 16.41 -10.26 41.21 3sm4_d00 source 3sm4 HYDROLASE/DNA : 1 hits 3sm4_d00 naa= 5 ULMN 4 4ail_d00 TRANSFERASE user 1 4 # 1 C 495 TYR A 66 TYR^? 18.96 MG MG A 106 C 593 LYS B 14 LYS.? 6.95 MG MG A 106 C 613 ARG A 27 ARG^? 22.99 C2 TRS B 107 C 615 ASP B 100 ASP^? 19.56 C2 TRS B 107 coo 15.47 67.10 68.66 15.00 68.14 71.20 9.99 9.72 31.21 7.76 10.46 32.78 coo -0.58 65.96 78.57 4.36 67.40 76.38 21.12 -5.80 35.93 24.74 -1.53 38.99 coo -0.42 56.97 83.23 2.13 57.80 84.74 11.78 -12.78 37.42 11.40 -15.00 35.25 coo 1.55 52.45 87.75 1.51 54.41 86.94 9.71 -18.83 33.97 8.85 -16.99 33.47 ULMN 4 4ail_d00 TRANSFERASE user 2 4 # 2 C 495 TYR B 66 TYR^? 13.48 N TRS B 107 C 593 LYS A 14 LYS.? 24.61 C2 TRS B 107 C 613 ARG B 27 ARG^? 16.66 MG MG A 106 C 615 ASP A 100 ASP^? 16.25 MG MG A 106 coo 15.47 67.10 68.66 15.00 68.14 71.20 14.02 -31.53 25.24 16.67 -32.32 24.84 coo -0.58 65.96 78.57 4.36 67.40 76.38 8.74 -17.74 39.05 7.96 -22.88 42.54 coo -0.42 56.97 83.23 2.13 57.80 84.74 17.35 -10.54 35.83 16.56 -8.02 34.14 coo 1.55 52.45 87.75 1.51 54.41 86.94 17.24 -4.20 32.64 17.59 -5.86 31.44 4ail_d00 source 4ail TRANSFERASE : 2 hits 4ail_d00 naa= 4 ULMN 3 2odj_o00 PORIN D user 1 3 # 1 A 156 HIS A 67 HIS^? 25.71 MG MG A 106 A 208 ASP A 81 ASP.? 9.35 MG MG A 106 A 296 SER A 19 SER^? 24.19 O2 TRS B 107 coo 12.72 17.48 24.71 12.80 19.37 23.81 7.29 12.90 25.70 6.12 14.46 24.97 coo 18.47 29.19 29.68 19.30 29.17 27.75 18.32 7.36 35.53 19.95 8.35 34.55 coo 6.89 17.22 46.63 5.08 16.21 47.91 2.67 -7.78 27.23 3.23 -6.16 28.95 ULMN 3 2odj_o00 PORIN D user 2 3 # 2 A 156 HIS A 78 HIS.? 11.19 MG MG A 106 A 208 ASP A 4 ASP.? 11.89 MG MG A 106 A 296 SER A 28 SER^? 23.29 MG MG A 106 coo 12.72 17.48 24.71 12.80 19.37 23.81 21.83 6.49 31.11 22.88 8.20 31.70 coo 18.47 29.19 29.68 19.30 29.17 27.75 29.77 -2.68 38.63 30.81 -3.64 37.08 coo 6.89 17.22 46.63 5.08 16.21 47.91 7.93 -9.68 40.46 5.50 -9.56 40.62 ULMN 3 2odj_o00 PORIN D user 3 3 # 3 A 156 HIS A 78 HIS.? 11.19 MG MG A 106 A 208 ASP A 4 ASP.? 11.89 MG MG A 106 A 296 SER A 105 SER.? 20.37 MG MG A 106 coo 12.72 17.48 24.71 12.80 19.37 23.81 21.83 6.49 31.11 22.88 8.20 31.70 coo 18.47 29.19 29.68 19.30 29.17 27.75 29.77 -2.68 38.63 30.81 -3.64 37.08 coo 6.89 17.22 46.63 5.08 16.21 47.91 4.85 -2.34 43.11 5.68 -4.47 42.24 ULMN 3 2odj_o00 PORIN D user 4 3 # 4 A 156 HIS A 78 HIS.? 11.19 MG MG A 106 A 208 ASP A 4 ASP.? 11.89 MG MG A 106 A 296 SER B 19 SER^? 16.73 MG A MG B 106 coo 12.72 17.48 24.71 12.80 19.37 23.81 21.83 6.49 31.11 22.88 8.20 31.70 coo 18.47 29.19 29.68 19.30 29.17 27.75 29.77 -2.68 38.63 30.81 -3.64 37.08 coo 6.89 17.22 46.63 5.08 16.21 47.91 18.16 -13.84 21.51 18.56 -15.70 23.02 ULMN 3 2odj_o00 PORIN D user 5 3 # 5 A 156 HIS B 37 HIS.? 23.74 MG A MG B 106 A 208 ASP B 100 ASP^? 19.56 C2 TRS B 107 A 296 SER B 90 SER^? 13.47 MG A MG B 106 coo 12.72 17.48 24.71 12.80 19.37 23.81 21.69 -21.14 38.43 22.55 -22.53 39.75 coo 18.47 29.19 29.68 19.30 29.17 27.75 9.71 -18.83 33.97 8.85 -16.99 33.47 coo 6.89 17.22 46.63 5.08 16.21 47.91 20.80 -30.45 18.82 19.90 -29.83 16.69 ULMN 3 2odj_o00 PORIN D user 6 3 # 6 A 156 HIS B 43 HIS.? 17.46 C2 TRS B 107 A 208 ASP A 100 ASP^? 16.25 MG MG A 106 A 296 SER B 105 SER.? 14.90 MG A MG B 106 coo 12.72 17.48 24.71 12.80 19.37 23.81 8.53 -14.49 24.38 9.05 -12.59 25.12 coo 18.47 29.19 29.68 19.30 29.17 27.75 17.24 -4.20 32.64 17.59 -5.86 31.44 coo 6.89 17.22 46.63 5.08 16.21 47.91 26.26 -24.98 33.11 26.69 -23.14 31.51 ULMN 3 2odj_o00 PORIN D user 7 3 # 7 A 156 HIS B 78 HIS^? 12.04 O3 TRS B 107 A 208 ASP B 4 ASP.? 25.97 C2 TRS B 107 A 296 SER A 19 SER^? 24.19 O2 TRS B 107 coo 12.72 17.48 24.71 12.80 19.37 23.81 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 18.47 29.19 29.68 19.30 29.17 27.75 4.45 -22.45 45.85 5.06 -24.19 44.80 coo 6.89 17.22 46.63 5.08 16.21 47.91 2.67 -7.78 27.23 3.23 -6.16 28.95 ULMN 3 2odj_o00 PORIN D user 8 3 # 8 A 156 HIS B 78 HIS^? 12.04 O3 TRS B 107 A 208 ASP B 4 ASP.? 25.97 C2 TRS B 107 A 296 SER B 25 SER^? 21.93 C2 TRS B 107 coo 12.72 17.48 24.71 12.80 19.37 23.81 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 18.47 29.19 29.68 19.30 29.17 27.75 4.45 -22.45 45.85 5.06 -24.19 44.80 coo 6.89 17.22 46.63 5.08 16.21 47.91 15.65 -13.25 27.32 13.56 -12.34 28.19 ULMN 3 2odj_o00 PORIN D user 9 3 # 9 A 156 HIS B 78 HIS^? 12.04 O3 TRS B 107 A 208 ASP B 4 ASP.? 25.97 C2 TRS B 107 A 296 SER B 28 SER^? 20.11 MG MG A 106 coo 12.72 17.48 24.71 12.80 19.37 23.81 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 18.47 29.19 29.68 19.30 29.17 27.75 4.45 -22.45 45.85 5.06 -24.19 44.80 coo 6.89 17.22 46.63 5.08 16.21 47.91 22.08 -13.91 35.51 24.12 -13.89 34.25 ULMN 3 2odj_o00 PORIN D user 10 3 # 10 A 156 HIS B 78 HIS^? 12.04 O3 TRS B 107 A 208 ASP B 4 ASP.? 25.97 C2 TRS B 107 A 296 SER B 105 SER.? 14.90 MG A MG B 106 coo 12.72 17.48 24.71 12.80 19.37 23.81 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 18.47 29.19 29.68 19.30 29.17 27.75 4.45 -22.45 45.85 5.06 -24.19 44.80 coo 6.89 17.22 46.63 5.08 16.21 47.91 26.26 -24.98 33.11 26.69 -23.14 31.51 ULMN 3 2odj_o00 PORIN D user 11 3 # 11 A 156 HIS B 78 HIS^? 12.04 O3 TRS B 107 A 208 ASP B 73 ASP.? 13.34 N TRS B 107 A 296 SER B 105 SER.? 14.90 MG A MG B 106 coo 12.72 17.48 24.71 12.80 19.37 23.81 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 18.47 29.19 29.68 19.30 29.17 27.75 9.64 -40.18 22.89 9.15 -42.09 22.32 coo 6.89 17.22 46.63 5.08 16.21 47.91 26.26 -24.98 33.11 26.69 -23.14 31.51 ULMN 3 2odj_o00 PORIN D user 12 3 # 12 A 156 HIS B 78 HIS^? 12.04 O3 TRS B 107 A 208 ASP B 100 ASP^? 19.56 C2 TRS B 107 A 296 SER B 90 SER^? 13.47 MG A MG B 106 coo 12.72 17.48 24.71 12.80 19.37 23.81 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 18.47 29.19 29.68 19.30 29.17 27.75 9.71 -18.83 33.97 8.85 -16.99 33.47 coo 6.89 17.22 46.63 5.08 16.21 47.91 20.80 -30.45 18.82 19.90 -29.83 16.69 2odj_o00 source 2ODJ PORIN D : 12 hits 2odj_o00 naa= 3 ULMN 3 2odj_o01 PORIN D user 1 3 # 1 B 156 HIS A 37 HIS.? 14.34 MG MG A 106 B 208 ASP A 100 ASP^? 16.25 MG MG A 106 B 296 SER A 90 SER.? 29.47 MG MG A 106 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 11.15 -3.04 43.19 11.90 -1.76 44.64 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 17.24 -4.20 32.64 17.59 -5.86 31.44 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 0.15 8.86 29.39 -2.01 8.24 28.62 ULMN 3 2odj_o01 PORIN D user 2 3 # 2 B 156 HIS A 67 HIS^? 25.71 MG MG A 106 B 208 ASP A 81 ASP.? 9.35 MG MG A 106 B 296 SER A 19 SER^? 24.19 O2 TRS B 107 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 7.29 12.90 25.70 6.12 14.46 24.97 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 18.32 7.36 35.53 19.95 8.35 34.55 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 2.67 -7.78 27.23 3.23 -6.16 28.95 ULMN 3 2odj_o01 PORIN D user 3 3 # 3 B 156 HIS A 78 HIS.? 11.19 MG MG A 106 B 208 ASP A 4 ASP.? 11.89 MG MG A 106 B 296 SER A 28 SER^? 23.29 MG MG A 106 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 21.83 6.49 31.11 22.88 8.20 31.70 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 29.77 -2.68 38.63 30.81 -3.64 37.08 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 7.93 -9.68 40.46 5.50 -9.56 40.62 ULMN 3 2odj_o01 PORIN D user 4 3 # 4 B 156 HIS A 78 HIS.? 11.19 MG MG A 106 B 208 ASP A 4 ASP.? 11.89 MG MG A 106 B 296 SER A 35 SER.? 14.72 MG MG A 106 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 21.83 6.49 31.11 22.88 8.20 31.70 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 29.77 -2.68 38.63 30.81 -3.64 37.08 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 10.65 -4.05 48.86 12.50 -2.79 47.78 ULMN 3 2odj_o01 PORIN D user 5 3 # 5 B 156 HIS A 78 HIS.? 11.19 MG MG A 106 B 208 ASP A 4 ASP.? 11.89 MG MG A 106 B 296 SER B 19 SER^? 16.73 MG A MG B 106 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 21.83 6.49 31.11 22.88 8.20 31.70 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 29.77 -2.68 38.63 30.81 -3.64 37.08 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 18.16 -13.84 21.51 18.56 -15.70 23.02 ULMN 3 2odj_o01 PORIN D user 6 3 # 6 B 156 HIS B 37 HIS.? 23.74 MG A MG B 106 B 208 ASP B 100 ASP^? 19.56 C2 TRS B 107 B 296 SER B 90 SER^? 13.47 MG A MG B 106 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 21.69 -21.14 38.43 22.55 -22.53 39.75 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 9.71 -18.83 33.97 8.85 -16.99 33.47 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 20.80 -30.45 18.82 19.90 -29.83 16.69 ULMN 3 2odj_o01 PORIN D user 7 3 # 7 B 156 HIS B 43 HIS.? 17.46 C2 TRS B 107 B 208 ASP A 100 ASP^? 16.25 MG MG A 106 B 296 SER B 105 SER.? 14.90 MG A MG B 106 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 8.53 -14.49 24.38 9.05 -12.59 25.12 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 17.24 -4.20 32.64 17.59 -5.86 31.44 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 26.26 -24.98 33.11 26.69 -23.14 31.51 ULMN 3 2odj_o01 PORIN D user 8 3 # 8 B 156 HIS B 78 HIS^? 12.04 O3 TRS B 107 B 208 ASP B 4 ASP.? 25.97 C2 TRS B 107 B 296 SER A 19 SER^? 24.19 O2 TRS B 107 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 4.34 -30.02 32.49 3.20 -30.88 30.99 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 4.45 -22.45 45.85 5.06 -24.19 44.80 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 2.67 -7.78 27.23 3.23 -6.16 28.95 ULMN 3 2odj_o01 PORIN D user 9 3 # 9 B 156 HIS B 78 HIS^? 12.04 O3 TRS B 107 B 208 ASP B 4 ASP.? 25.97 C2 TRS B 107 B 296 SER B 28 SER^? 20.11 MG MG A 106 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 4.34 -30.02 32.49 3.20 -30.88 30.99 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 4.45 -22.45 45.85 5.06 -24.19 44.80 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 22.08 -13.91 35.51 24.12 -13.89 34.25 ULMN 3 2odj_o01 PORIN D user 10 3 # 10 B 156 HIS B 78 HIS^? 12.04 O3 TRS B 107 B 208 ASP B 73 ASP.? 13.34 N TRS B 107 B 296 SER B 105 SER.? 14.90 MG A MG B 106 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 4.34 -30.02 32.49 3.20 -30.88 30.99 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 9.64 -40.18 22.89 9.15 -42.09 22.32 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 26.26 -24.98 33.11 26.69 -23.14 31.51 ULMN 3 2odj_o01 PORIN D user 11 3 # 11 B 156 HIS B 78 HIS^? 12.04 O3 TRS B 107 B 208 ASP B 100 ASP^? 19.56 C2 TRS B 107 B 296 SER B 90 SER^? 13.47 MG A MG B 106 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 4.34 -30.02 32.49 3.20 -30.88 30.99 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 9.71 -18.83 33.97 8.85 -16.99 33.47 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 20.80 -30.45 18.82 19.90 -29.83 16.69 2odj_o01 source 2ODJ PORIN D : 11 hits 2odj_o01 naa= 3 ULMN 3 2qs9_o00 RETINOBLASTOMA-BINDING PROTEIN 9 user 1 3 # 1 A 75 SER A 61 SER^? 13.76 MG MG A 106 A 138 ASP A 81 ASP.? 9.35 MG MG A 106 A 165 HIS A 78 HIS.? 11.19 MG MG A 106 coo -3.36 14.75 15.05 -1.15 14.48 16.07 20.58 -1.27 32.13 21.77 -3.05 30.92 coo -1.70 6.81 20.56 -1.10 8.43 19.35 18.32 7.36 35.53 19.95 8.35 34.55 coo 0.22 9.72 16.41 -0.34 11.71 16.80 21.83 6.49 31.11 22.88 8.20 31.70 2qs9_o00 source 2QS9 RETINOBLASTOMA-BINDING PROTEIN 9 : 1 hits 2qs9_o00 naa= 3 ULMN 3 2qs9_o01 RETINOBLASTOMA-BINDING PROTEIN 9 user 1 3 # 1 B 75 SER A 61 SER^? 13.76 MG MG A 106 B 138 ASP A 81 ASP.? 9.35 MG MG A 106 B 165 HIS A 78 HIS.? 11.19 MG MG A 106 coo 6.59 48.30 3.28 6.43 48.98 5.63 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 13.13 55.06 6.15 11.38 53.90 6.43 18.32 7.36 35.53 19.95 8.35 34.55 coo 7.83 53.78 5.96 7.73 51.68 6.00 21.83 6.49 31.11 22.88 8.20 31.70 2qs9_o01 source 2QS9 RETINOBLASTOMA-BINDING PROTEIN 9 : 1 hits 2qs9_o01 naa= 3 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 81 ASP.? 9.35 MG MG A 106 A 86 HIS A 78 HIS.? 11.19 MG MG A 106 A 250 ALA A 64 ALA^? 17.52 MG MG A 106 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 18.32 7.36 35.53 19.95 8.35 34.55 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 21.83 6.49 31.11 22.88 8.20 31.70 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 15.38 5.15 26.91 14.21 4.40 27.56 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP B 81 ASP.? 16.51 N TRS B 107 A 86 HIS B 78 HIS^? 12.04 O3 TRS B 107 A 250 ALA B 64 ALA^? 10.02 N TRS B 107 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 7.19 -26.95 26.54 8.52 -26.19 26.49 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 2 hits 2wwt_o00 naa= 3 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 B 49 ASP A 81 ASP.? 9.35 MG MG A 106 B 86 HIS A 78 HIS.? 11.19 MG MG A 106 B 250 ALA A 64 ALA^? 17.52 MG MG A 106 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 18.32 7.36 35.53 19.95 8.35 34.55 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 21.83 6.49 31.11 22.88 8.20 31.70 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 15.38 5.15 26.91 14.21 4.40 27.56 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 B 49 ASP B 81 ASP.? 16.51 N TRS B 107 B 86 HIS B 78 HIS^? 12.04 O3 TRS B 107 B 250 ALA B 64 ALA^? 10.02 N TRS B 107 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 9.98 -30.67 34.70 8.29 -31.92 34.80 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 4.34 -30.02 32.49 3.20 -30.88 30.99 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 7.19 -26.95 26.54 8.52 -26.19 26.49 2wwt_o01 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 2 hits 2wwt_o01 naa= 3 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 C 49 ASP A 81 ASP.? 9.35 MG MG A 106 C 86 HIS A 78 HIS.? 11.19 MG MG A 106 C 250 ALA A 64 ALA^? 17.52 MG MG A 106 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 18.32 7.36 35.53 19.95 8.35 34.55 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 21.83 6.49 31.11 22.88 8.20 31.70 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 15.38 5.15 26.91 14.21 4.40 27.56 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 C 49 ASP B 81 ASP.? 16.51 N TRS B 107 C 86 HIS B 78 HIS^? 12.04 O3 TRS B 107 C 250 ALA B 64 ALA^? 10.02 N TRS B 107 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 7.19 -26.95 26.54 8.52 -26.19 26.49 2wwt_o02 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 2 hits 2wwt_o02 naa= 3 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 D 49 ASP A 81 ASP.? 9.35 MG MG A 106 D 86 HIS A 78 HIS.? 11.19 MG MG A 106 D 250 ALA A 64 ALA^? 17.52 MG MG A 106 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 18.32 7.36 35.53 19.95 8.35 34.55 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 21.83 6.49 31.11 22.88 8.20 31.70 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 15.38 5.15 26.91 14.21 4.40 27.56 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 D 49 ASP B 81 ASP.? 16.51 N TRS B 107 D 86 HIS B 78 HIS^? 12.04 O3 TRS B 107 D 250 ALA B 64 ALA^? 10.02 N TRS B 107 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 9.98 -30.67 34.70 8.29 -31.92 34.80 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 7.19 -26.95 26.54 8.52 -26.19 26.49 2wwt_o03 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 2 hits 2wwt_o03 naa= 3 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 E 49 ASP A 81 ASP.? 9.35 MG MG A 106 E 86 HIS A 78 HIS.? 11.19 MG MG A 106 E 250 ALA A 64 ALA^? 17.52 MG MG A 106 coo -36.18 24.97 18.78 -36.93 26.11 17.11 18.32 7.36 35.53 19.95 8.35 34.55 coo -36.85 29.32 15.06 -38.90 29.14 15.48 21.83 6.49 31.11 22.88 8.20 31.70 coo -44.49 29.68 13.98 -43.47 28.67 13.52 15.38 5.15 26.91 14.21 4.40 27.56 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 E 49 ASP B 81 ASP.? 16.51 N TRS B 107 E 86 HIS B 78 HIS^? 12.04 O3 TRS B 107 E 250 ALA B 64 ALA^? 10.02 N TRS B 107 coo -36.18 24.97 18.78 -36.93 26.11 17.11 9.98 -30.67 34.70 8.29 -31.92 34.80 coo -36.85 29.32 15.06 -38.90 29.14 15.48 4.34 -30.02 32.49 3.20 -30.88 30.99 coo -44.49 29.68 13.98 -43.47 28.67 13.52 7.19 -26.95 26.54 8.52 -26.19 26.49 2wwt_o04 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 2 hits 2wwt_o04 naa= 3 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 F 49 ASP A 81 ASP.? 9.35 MG MG A 106 F 86 HIS A 78 HIS.? 11.19 MG MG A 106 F 250 ALA A 64 ALA^? 17.52 MG MG A 106 coo -82.12 8.55 35.60 -81.93 9.84 37.19 18.32 7.36 35.53 19.95 8.35 34.55 coo -84.21 11.81 39.90 -82.43 12.70 39.26 21.83 6.49 31.11 22.88 8.20 31.70 coo -78.49 17.13 41.31 -79.25 15.85 41.61 15.38 5.15 26.91 14.21 4.40 27.56 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 F 49 ASP B 81 ASP.? 16.51 N TRS B 107 F 86 HIS B 78 HIS^? 12.04 O3 TRS B 107 F 250 ALA B 64 ALA^? 10.02 N TRS B 107 coo -82.12 8.55 35.60 -81.93 9.84 37.19 9.98 -30.67 34.70 8.29 -31.92 34.80 coo -84.21 11.81 39.90 -82.43 12.70 39.26 4.34 -30.02 32.49 3.20 -30.88 30.99 coo -78.49 17.13 41.31 -79.25 15.85 41.61 7.19 -26.95 26.54 8.52 -26.19 26.49 2wwt_o05 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 2 hits 2wwt_o05 naa= 3 ULMN 3 2xmz_o00 HYDROLASE, ALPHA/BETA HYDROLASE FOLDuser 1 3 # 1 A 89 SER A 61 SER^? 13.76 MG MG A 106 A 216 ASP A 81 ASP.? 9.35 MG MG A 106 A 243 HIS A 78 HIS.? 11.19 MG MG A 106 coo 11.52 10.39 18.97 12.10 9.11 20.95 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 20.60 4.89 19.19 18.56 4.62 19.55 18.32 7.36 35.53 19.95 8.35 34.55 coo 16.75 7.77 21.42 14.85 7.46 20.58 21.83 6.49 31.11 22.88 8.20 31.70 2xmz_o00 source 2XMZ HYDROLASE, ALPHA/BETA HYDROLASE FOLD FAMILY : 1 hits 2xmz_o00 naa= 3 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 1 3 # 1 A 445 SER A 61 SER^? 13.76 MG MG A 106 A 524 ASP A 81 ASP.? 9.35 MG MG A 106 A 556 HIS A 78 HIS.? 11.19 MG MG A 106 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 18.32 7.36 35.53 19.95 8.35 34.55 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 21.83 6.49 31.11 22.88 8.20 31.70 3o4g_o00 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 1 hits 3o4g_o00 naa= 3 ULMN 3 3o4g_o02 ACYLAMINO-ACID-RELEASING ENZYME user 1 3 # 1 C 445 SER A 61 SER^? 13.76 MG MG A 106 C 524 ASP A 81 ASP.? 9.35 MG MG A 106 C 556 HIS A 78 HIS.? 11.19 MG MG A 106 coo -35.83 1.21 57.61 -37.94 0.15 57.18 20.58 -1.27 32.13 21.77 -3.05 30.92 coo -39.65 7.59 52.45 -39.69 5.70 53.46 18.32 7.36 35.53 19.95 8.35 34.55 coo -39.51 2.45 52.87 -38.69 1.68 54.64 21.83 6.49 31.11 22.88 8.20 31.70 3o4g_o02 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 1 hits 3o4g_o02 naa= 3 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 A 98 SER A 61 SER^? 13.76 MG MG A 106 A 123 HIS A 78 HIS.? 11.19 MG MG A 106 A 172 ASP A 81 ASP.? 9.35 MG MG A 106 coo 45.74 29.80 42.79 47.58 31.06 41.64 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 44.17 25.61 37.60 45.21 25.56 35.81 21.83 6.49 31.11 22.88 8.20 31.70 coo 39.85 24.35 34.94 41.12 25.58 33.83 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 A 98 SER B 61 SER^? 18.05 C2 TRS B 107 A 123 HIS B 78 HIS^? 12.04 O3 TRS B 107 A 172 ASP B 81 ASP.? 16.51 N TRS B 107 coo 45.74 29.80 42.79 47.58 31.06 41.64 6.61 -22.01 35.09 5.00 -20.16 35.04 coo 44.17 25.61 37.60 45.21 25.56 35.81 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 39.85 24.35 34.94 41.12 25.58 33.83 9.98 -30.67 34.70 8.29 -31.92 34.80 3qwd_o00 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 2 hits 3qwd_o00 naa= 3 ULMN 3 3qwd_o01 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 B 98 SER A 61 SER^? 13.76 MG MG A 106 B 123 HIS A 78 HIS.? 11.19 MG MG A 106 B 172 ASP A 81 ASP.? 9.35 MG MG A 106 coo 71.87 39.14 40.71 71.75 41.26 39.36 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 73.25 34.64 35.72 73.65 35.23 33.78 21.83 6.49 31.11 22.88 8.20 31.70 coo 70.98 30.38 33.77 70.74 32.03 32.50 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 3qwd_o01 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 B 98 SER B 61 SER^? 18.05 C2 TRS B 107 B 123 HIS B 78 HIS^? 12.04 O3 TRS B 107 B 172 ASP B 81 ASP.? 16.51 N TRS B 107 coo 71.87 39.14 40.71 71.75 41.26 39.36 6.61 -22.01 35.09 5.00 -20.16 35.04 coo 73.25 34.64 35.72 73.65 35.23 33.78 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 70.98 30.38 33.77 70.74 32.03 32.50 9.98 -30.67 34.70 8.29 -31.92 34.80 3qwd_o01 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 2 hits 3qwd_o01 naa= 3 ULMN 3 3qwd_o02 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 C 98 SER A 61 SER^? 13.76 MG MG A 106 C 123 HIS A 78 HIS.? 11.19 MG MG A 106 C 172 ASP A 81 ASP.? 9.35 MG MG A 106 coo 80.36 64.80 34.44 78.44 65.95 33.29 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 83.70 62.42 29.01 83.15 62.88 27.08 21.83 6.49 31.11 22.88 8.20 31.70 coo 85.17 57.73 27.21 83.46 58.45 26.25 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 3qwd_o02 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 C 98 SER B 61 SER^? 18.05 C2 TRS B 107 C 123 HIS B 78 HIS^? 12.04 O3 TRS B 107 C 172 ASP B 81 ASP.? 16.51 N TRS B 107 coo 80.36 64.80 34.44 78.44 65.95 33.29 6.61 -22.01 35.09 5.00 -20.16 35.04 coo 83.70 62.42 29.01 83.15 62.88 27.08 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 85.17 57.73 27.21 83.46 58.45 26.25 9.98 -30.67 34.70 8.29 -31.92 34.80 3qwd_o02 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 2 hits 3qwd_o02 naa= 3 ULMN 3 3qwd_o03 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 D 98 SER A 61 SER^? 13.76 MG MG A 106 D 123 HIS A 78 HIS.? 11.19 MG MG A 106 D 172 ASP A 81 ASP.? 9.35 MG MG A 106 coo 65.12 87.33 28.49 62.90 86.32 27.74 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 67.96 87.91 22.28 66.90 87.63 20.52 21.83 6.49 31.11 22.88 8.20 31.70 coo 72.12 85.84 19.92 70.35 84.94 19.30 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 3qwd_o03 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 D 98 SER B 61 SER^? 18.05 C2 TRS B 107 D 123 HIS B 78 HIS^? 12.04 O3 TRS B 107 D 172 ASP B 81 ASP.? 16.51 N TRS B 107 coo 65.12 87.33 28.49 62.90 86.32 27.74 6.61 -22.01 35.09 5.00 -20.16 35.04 coo 67.96 87.91 22.28 66.90 87.63 20.52 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 72.12 85.84 19.92 70.35 84.94 19.30 9.98 -30.67 34.70 8.29 -31.92 34.80 3qwd_o03 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 2 hits 3qwd_o03 naa= 3 ULMN 3 3qwd_o04 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 E 98 SER A 61 SER^? 13.76 MG MG A 106 E 123 HIS A 78 HIS.? 11.19 MG MG A 106 E 172 ASP A 81 ASP.? 9.35 MG MG A 106 coo 37.23 89.57 27.33 36.32 87.23 27.07 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 37.64 91.40 20.82 36.88 90.22 19.31 21.83 6.49 31.11 22.88 8.20 31.70 coo 41.40 92.80 17.47 40.89 90.79 17.30 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 3qwd_o04 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 E 98 SER B 61 SER^? 18.05 C2 TRS B 107 E 123 HIS B 78 HIS^? 12.04 O3 TRS B 107 E 172 ASP B 81 ASP.? 16.51 N TRS B 107 coo 37.23 89.57 27.33 36.32 87.23 27.07 6.61 -22.01 35.09 5.00 -20.16 35.04 coo 37.64 91.40 20.82 36.88 90.22 19.31 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 41.40 92.80 17.47 40.89 90.79 17.30 9.98 -30.67 34.70 8.29 -31.92 34.80 3qwd_o04 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 2 hits 3qwd_o04 naa= 3 ULMN 3 3qwd_o05 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 F 98 SER A 61 SER^? 13.76 MG MG A 106 F 123 HIS A 78 HIS.? 11.19 MG MG A 106 F 172 ASP A 81 ASP.? 9.35 MG MG A 106 coo 17.74 70.20 32.16 18.92 67.99 31.89 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 15.23 70.97 25.89 15.37 69.49 24.46 21.83 6.49 31.11 22.88 8.20 31.70 coo 15.81 74.47 22.06 16.86 72.70 21.69 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 3qwd_o05 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 F 98 SER B 61 SER^? 18.05 C2 TRS B 107 F 123 HIS B 78 HIS^? 12.04 O3 TRS B 107 F 172 ASP B 81 ASP.? 16.51 N TRS B 107 coo 17.74 70.20 32.16 18.92 67.99 31.89 6.61 -22.01 35.09 5.00 -20.16 35.04 coo 15.23 70.97 25.89 15.37 69.49 24.46 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 15.81 74.47 22.06 16.86 72.70 21.69 9.98 -30.67 34.70 8.29 -31.92 34.80 3qwd_o05 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 2 hits 3qwd_o05 naa= 3 ULMN 3 3qwd_o06 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 G 98 SER A 61 SER^? 13.76 MG MG A 106 G 123 HIS A 78 HIS.? 11.19 MG MG A 106 G 172 ASP A 81 ASP.? 9.35 MG MG A 106 coo 21.77 43.27 39.21 24.15 42.72 38.52 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 18.42 41.13 33.64 19.33 40.10 32.10 21.83 6.49 31.11 22.88 8.20 31.70 coo 15.38 43.36 30.02 17.34 43.09 29.34 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 3qwd_o06 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 G 98 SER B 61 SER^? 18.05 C2 TRS B 107 G 123 HIS B 78 HIS^? 12.04 O3 TRS B 107 G 172 ASP B 81 ASP.? 16.51 N TRS B 107 coo 21.77 43.27 39.21 24.15 42.72 38.52 6.61 -22.01 35.09 5.00 -20.16 35.04 coo 18.42 41.13 33.64 19.33 40.10 32.10 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 15.38 43.36 30.02 17.34 43.09 29.34 9.98 -30.67 34.70 8.29 -31.92 34.80 3qwd_o06 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 2 hits 3qwd_o06 naa= 3 ULMN 3 3qwd_o07 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 H 98 SER A 61 SER^? 13.76 MG MG A 106 H 123 HIS A 78 HIS.? 11.19 MG MG A 106 H 172 ASP A 81 ASP.? 9.35 MG MG A 106 coo 156.20 56.60 78.78 153.83 56.16 78.10 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 159.24 56.62 72.66 158.17 56.50 70.89 21.83 6.49 31.11 22.88 8.20 31.70 coo 162.98 53.88 70.28 161.08 53.28 69.65 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 3qwd_o07 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 H 98 SER B 61 SER^? 18.05 C2 TRS B 107 H 123 HIS B 78 HIS^? 12.04 O3 TRS B 107 H 172 ASP B 81 ASP.? 16.51 N TRS B 107 coo 156.20 56.60 78.78 153.83 56.16 78.10 6.61 -22.01 35.09 5.00 -20.16 35.04 coo 159.24 56.62 72.66 158.17 56.50 70.89 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 162.98 53.88 70.28 161.08 53.28 69.65 9.98 -30.67 34.70 8.29 -31.92 34.80 3qwd_o07 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 2 hits 3qwd_o07 naa= 3 ULMN 3 3qwd_o08 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 I 98 SER A 61 SER^? 13.76 MG MG A 106 I 123 HIS A 78 HIS.? 11.19 MG MG A 106 I 172 ASP A 81 ASP.? 9.35 MG MG A 106 coo 129.29 63.53 77.27 127.98 61.40 77.00 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 129.99 65.24 70.73 129.03 64.19 69.22 21.83 6.49 31.11 22.88 8.20 31.70 coo 133.90 66.07 67.39 133.05 64.19 67.15 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 3qwd_o08 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 I 98 SER B 61 SER^? 18.05 C2 TRS B 107 I 123 HIS B 78 HIS^? 12.04 O3 TRS B 107 I 172 ASP B 81 ASP.? 16.51 N TRS B 107 coo 129.29 63.53 77.27 127.98 61.40 77.00 6.61 -22.01 35.09 5.00 -20.16 35.04 coo 129.99 65.24 70.73 129.03 64.19 69.22 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 133.90 66.07 67.39 133.05 64.19 67.15 9.98 -30.67 34.70 8.29 -31.92 34.80 3qwd_o08 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 2 hits 3qwd_o08 naa= 3 ULMN 3 3qwd_o09 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 J 98 SER A 61 SER^? 13.76 MG MG A 106 J 123 HIS A 78 HIS.? 11.19 MG MG A 106 J 172 ASP A 81 ASP.? 9.35 MG MG A 106 coo 106.76 47.89 81.70 107.53 45.50 81.44 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 104.68 49.18 75.33 104.59 47.70 73.89 21.83 6.49 31.11 22.88 8.20 31.70 coo 105.94 52.49 71.50 106.71 50.57 71.17 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 3qwd_o09 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 J 98 SER B 61 SER^? 18.05 C2 TRS B 107 J 123 HIS B 78 HIS^? 12.04 O3 TRS B 107 J 172 ASP B 81 ASP.? 16.51 N TRS B 107 coo 106.76 47.89 81.70 107.53 45.50 81.44 6.61 -22.01 35.09 5.00 -20.16 35.04 coo 104.68 49.18 75.33 104.59 47.70 73.89 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 105.94 52.49 71.50 106.71 50.57 71.17 9.98 -30.67 34.70 8.29 -31.92 34.80 3qwd_o09 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 2 hits 3qwd_o09 naa= 3 ULMN 3 3qwd_o10 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 K 98 SER A 61 SER^? 13.76 MG MG A 106 K 123 HIS A 78 HIS.? 11.19 MG MG A 106 K 172 ASP A 81 ASP.? 9.35 MG MG A 106 coo 105.44 20.79 88.82 107.67 19.79 88.18 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 101.74 19.42 83.14 102.50 18.27 81.61 21.83 6.49 31.11 22.88 8.20 31.70 coo 99.17 22.17 79.49 101.04 21.51 78.80 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 3qwd_o10 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 K 98 SER B 61 SER^? 18.05 C2 TRS B 107 K 123 HIS B 78 HIS^? 12.04 O3 TRS B 107 K 172 ASP B 81 ASP.? 16.51 N TRS B 107 coo 105.44 20.79 88.82 107.67 19.79 88.18 6.61 -22.01 35.09 5.00 -20.16 35.04 coo 101.74 19.42 83.14 102.50 18.27 81.61 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 99.17 22.17 79.49 101.04 21.51 78.80 9.98 -30.67 34.70 8.29 -31.92 34.80 3qwd_o10 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 2 hits 3qwd_o10 naa= 3 ULMN 3 3qwd_o11 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 L 98 SER A 61 SER^? 13.76 MG MG A 106 L 123 HIS A 78 HIS.? 11.19 MG MG A 106 L 172 ASP A 81 ASP.? 9.35 MG MG A 106 coo 126.72 3.21 92.89 128.70 4.33 91.79 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 124.38 -0.64 87.74 125.44 -0.88 85.98 21.83 6.49 31.11 22.88 8.20 31.70 coo 120.03 -1.09 84.87 121.54 -0.11 83.83 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 3qwd_o11 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 L 98 SER B 61 SER^? 18.05 C2 TRS B 107 L 123 HIS B 78 HIS^? 12.04 O3 TRS B 107 L 172 ASP B 81 ASP.? 16.51 N TRS B 107 coo 126.72 3.21 92.89 128.70 4.33 91.79 6.61 -22.01 35.09 5.00 -20.16 35.04 coo 124.38 -0.64 87.74 125.44 -0.88 85.98 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 120.03 -1.09 84.87 121.54 -0.11 83.83 9.98 -30.67 34.70 8.29 -31.92 34.80 3qwd_o11 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 2 hits 3qwd_o11 naa= 3 ULMN 3 3qwd_o12 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 M 98 SER A 61 SER^? 13.76 MG MG A 106 M 123 HIS A 78 HIS.? 11.19 MG MG A 106 M 172 ASP A 81 ASP.? 9.35 MG MG A 106 coo 154.12 8.07 91.14 154.40 10.16 89.78 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 154.65 3.37 86.18 155.13 3.88 84.24 21.83 6.49 31.11 22.88 8.20 31.70 coo 151.68 -0.46 84.21 151.70 1.23 82.98 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 3qwd_o12 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 M 98 SER B 61 SER^? 18.05 C2 TRS B 107 M 123 HIS B 78 HIS^? 12.04 O3 TRS B 107 M 172 ASP B 81 ASP.? 16.51 N TRS B 107 coo 154.12 8.07 91.14 154.40 10.16 89.78 6.61 -22.01 35.09 5.00 -20.16 35.04 coo 154.65 3.37 86.18 155.13 3.88 84.24 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 151.68 -0.46 84.21 151.70 1.23 82.98 9.98 -30.67 34.70 8.29 -31.92 34.80 3qwd_o12 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 2 hits 3qwd_o12 naa= 3 ULMN 3 3qwd_o13 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 N 98 SER A 61 SER^? 13.76 MG MG A 106 N 123 HIS A 78 HIS.? 11.19 MG MG A 106 N 172 ASP A 81 ASP.? 9.35 MG MG A 106 coo 167.14 31.88 84.83 165.46 33.38 83.69 20.58 -1.27 32.13 21.77 -3.05 30.92 coo 170.00 29.01 79.37 169.53 29.60 77.44 21.83 6.49 31.11 22.88 8.20 31.70 coo 170.55 24.16 77.55 169.03 25.18 76.56 18.32 7.36 35.53 19.95 8.35 34.55 ULMN 3 3qwd_o13 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 N 98 SER B 61 SER^? 18.05 C2 TRS B 107 N 123 HIS B 78 HIS^? 12.04 O3 TRS B 107 N 172 ASP B 81 ASP.? 16.51 N TRS B 107 coo 167.14 31.88 84.83 165.46 33.38 83.69 6.61 -22.01 35.09 5.00 -20.16 35.04 coo 170.00 29.01 79.37 169.53 29.60 77.44 4.34 -30.02 32.49 3.20 -30.88 30.99 coo 170.55 24.16 77.55 169.03 25.18 76.56 9.98 -30.67 34.70 8.29 -31.92 34.80 3qwd_o13 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 2 hits 3qwd_o13 naa= 3 ULMN 3 3zwq_o00 ALPHA/BETA HYDROLASE FOLD-3 DOMAIN Puser 1 3 # 1 A 157 SER A 61 SER^? 13.76 MG MG A 106 A 254 ASP A 81 ASP.? 9.35 MG MG A 106 A 284 HIS A 78 HIS.? 11.19 MG MG A 106 coo -20.09 -13.76 4.99 -18.56 -11.94 4.87 20.58 -1.27 32.13 21.77 -3.05 30.92 coo -21.52 -7.55 12.04 -21.23 -8.42 10.14 18.32 7.36 35.53 19.95 8.35 34.55 coo -18.29 -9.68 9.15 -18.87 -10.69 7.41 21.83 6.49 31.11 22.88 8.20 31.70 3zwq_o00 source 3ZWQ ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN : 1 hits 3zwq_o00 naa= 3 ULMN 3 3zwq_o01 ALPHA/BETA HYDROLASE FOLD-3 DOMAIN Puser 1 3 # 1 B 157 SER A 61 SER^? 13.76 MG MG A 106 B 254 ASP A 81 ASP.? 9.35 MG MG A 106 B 284 HIS A 78 HIS.? 11.19 MG MG A 106 coo -37.32 -16.63 33.25 -39.45 -15.48 33.60 20.58 -1.27 32.13 21.77 -3.05 30.92 coo -37.64 -10.09 26.32 -37.69 -11.02 28.21 18.32 7.36 35.53 19.95 8.35 34.55 coo -40.12 -13.34 29.11 -39.19 -14.07 30.85 21.83 6.49 31.11 22.88 8.20 31.70 3zwq_o01 source 3ZWQ ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN : 1 hits 3zwq_o01 naa= 3